ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
ENSG00000165996	3-hydroxyacyl-CoA dehydratase 1(HACD1)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0007275~multicellular organism development,GO:0010811~positive regulation of cell-substrate adhesion,GO:0030148~sphingolipid biosynthetic process,GO:0030497~fatty acid elongation,GO:0034622~cellular macromolecular complex assembly,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,GO:0071529~cementum mineralization,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0018812~3-hydroxyacyl-CoA dehydratase activity,GO:0019899~enzyme binding,GO:0046848~hydroxyapatite binding,GO:0080023~3R-hydroxyacyl-CoA dehydratase activity,GO:0102344~3-hydroxy-behenoyl-CoA dehydratase activity,GO:0102345~3-hydroxy-lignoceroyl-CoA dehydratase activity,	IPR007482:Protein-tyrosine phosphatase-like, PTPLA,	hsa00062:Fatty acid elongation,hsa01040:Biosynthesis of unsaturated fatty acids,hsa01212:Fatty acid metabolism,				Alternative splicing,Complete proteome,Developmental protein,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Lipid biosynthesis,Lipid metabolism,Lyase,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein-tyrosine phosphatase-like member A,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000168268	5'-nucleotidase domain containing 2(NT5DC2)	Homo sapiens				GO:0016311~dephosphorylation,		GO:0008253~5'-nucleotidase activity,GO:0046872~metal ion binding,	IPR008380:HAD-superfamily hydrolase, subfamily IG, 5'-nucleotidase,IPR016695:Purine 5'-nucleotidase,IPR023214:HAD-like domain,			PIRSF017434:cytosolic purine 5'-nucleotidase,		Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	active site:Nucleophile,active site:Proton donor,chain:5'-nucleotidase domain-containing protein 2,metal ion-binding site:Magnesium,metal ion-binding site:Magnesium; via carbonyl oxygen,sequence conflict,sequence variant,splice variant,
ENSG00000182196	ADP ribosylation factor like GTPase 6 interacting protein 4(ARL6IP4)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0016607~nuclear speck,	GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,	IPR019532:Nuclear RNA-splicing-associated protein, SR-25,					Alternative splicing,Coiled coil,Complete proteome,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,RNA editing,	chain:ADP-ribosylation factor-like protein 6- interacting protein 4,compositionally biased region:Lys-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000198899	ATP synthase F0 subunit 6(ATP6)	Homo sapiens				GO:0006754~ATP biosynthetic process,GO:0007568~aging,GO:0015986~ATP synthesis coupled proton transport,GO:0042776~mitochondrial ATP synthesis coupled proton transport,GO:0055093~response to hyperoxia,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005753~mitochondrial proton-transporting ATP synthase complex,GO:0016021~integral component of membrane,GO:0045263~proton-transporting ATP synthase complex, coupling factor F(o),GO:0070062~extracellular exosome,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR000568:ATPase, F0 complex, subunit A,IPR023011:ATPase, F0 complex, subunit A, active site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,hsa05016:Huntington's disease,				ATP synthesis,CF(0),Complete proteome,Disease mutation,Hydrogen ion transport,Ion transport,Leber hereditary optic neuropathy,Leigh syndrome,Membrane,Mitochondrion,Mitochondrion inner membrane,Polymorphism,Reference proteome,Retinitis pigmentosa,Signal,Transmembrane,Transmembrane helix,Transport,	chain:ATP synthase protein 8,chain:ATP synthase subunit a,chain:Cytochrome c oxidase subunit 3,modified residue,sequence conflict,sequence variant,transmembrane region,
ENSG00000180389	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit pseudogene 2(ATP5EP2)	Homo sapiens				GO:0015986~ATP synthesis coupled proton transport,	GO:0000275~mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,	GO:0016887~ATPase activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,GO:0046961~proton-transporting ATPase activity, rotational mechanism,	IPR006721:ATPase, F1 complex, epsilon  subunit, mitochondrial,					Acetylation,ATP synthesis,CF(1),Complete proteome,Hydrogen ion transport,Hydrolase,Ion transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Transport,	chain:ATP synthase subunit epsilon, mitochondrial,chain:ATP synthase subunit epsilon-like protein, mitochondrial,modified residue,
ENSG00000249222	ATP synthase, H+ transporting, mitochondrial Fo complex subunit G2(ATP5L2)	Homo sapiens				GO:0015986~ATP synthesis coupled proton transport,	GO:0000276~mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),GO:0005739~mitochondrion,	GO:0015078~hydrogen ion transmembrane transporter activity,GO:0046933~proton-transporting ATP synthase activity, rotational mechanism,	IPR006808:ATPase, F0 complex, subunit G, mitochondrial,IPR016702:Mitochondrial ATP synthase subunit g, animal,			PIRSF017835:F-type ATP synthase, subunit g, animal mitochondria type,		Acetylation,ATP synthesis,CF(0),Complete proteome,Hydrogen ion transport,Ion transport,Membrane,Mitochondrion,Reference proteome,Transport,	chain:ATP synthase subunit g 2, mitochondrial,
ENSG00000105409	ATPase Na+/K+ transporting subunit alpha 3(ATP1A3)	Homo sapiens				GO:0006883~cellular sodium ion homeostasis,GO:0007613~memory,GO:0008344~adult locomotory behavior,GO:0008542~visual learning,GO:0010107~potassium ion import,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0015991~ATP hydrolysis coupled proton transport,GO:0030007~cellular potassium ion homeostasis,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0036376~sodium ion export from cell,GO:0042493~response to drug,GO:0060048~cardiac muscle contraction,GO:0071383~cellular response to steroid hormone stimulus,GO:0086036~regulation of cardiac muscle cell membrane potential,GO:0086064~cell communication by electrical coupling involved in cardiac conduction,GO:1903416~response to glycoside,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016021~integral component of membrane,GO:0030424~axon,GO:0042383~sarcolemma,GO:0043209~myelin sheath,GO:0044326~dendritic spine neck,GO:0044327~dendritic spine head,GO:0045202~synapse,GO:1903561~extracellular vesicle,	GO:0000166~nucleotide binding,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0005524~ATP binding,GO:0031748~D1 dopamine receptor binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0046872~metal ion binding,GO:0051087~chaperone binding,GO:0086037~sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,GO:1990239~steroid hormone binding,	IPR001757:Cation-transporting P-type ATPase,IPR004014:Cation-transporting P-type ATPase, N-terminal,IPR005775:Sodium/potassium-transporting P-type ATPase, subfamily IIC,IPR006068:Cation-transporting P-type ATPase, C-terminal,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023298:P-type ATPase,  transmembrane domain,IPR023299:P-type ATPase, cytoplasmic domain N,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04971:Gastric acid secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	128235~Dystonia-12,601338~CAPOS syndrome,614820~Alternating hemiplegia of childhood 2,		SM00831:SM00831,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Deafness,Disease mutation,Dystonia,Hydrolase,Ion transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Parkinsonism,Phosphoprotein,Potassium,Potassium transport,Proteomics identification,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Sodium/potassium-transporting ATPase subunit alpha-3,metal ion-binding site:Magnesium,modified residue,region of interest:Interaction with phosphoinositide-3 kinase,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000215915	ATPase family, AAA domain containing 3C(ATAD3C)	Homo sapiens						GO:0005524~ATP binding,	IPR003593:AAA+ ATPase domain,IPR003959:ATPase, AAA-type, core,IPR021911:ATPase family AAA domain-containing protein 3, domain of unknown function DUF3523,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00382:AAA,	ATP-binding,Complete proteome,Nucleotide-binding,Proteomics identification,Reference proteome,	chain:ATPase family AAA domain-containing protein 3C,modified residue,nucleotide phosphate-binding region:ATP,
ENSG00000130270	ATPase phospholipid transporting 8B3(ATP8B3)	Homo sapiens				GO:0007030~Golgi organization,GO:0007339~binding of sperm to zona pellucida,GO:0045332~phospholipid translocation,	GO:0002080~acrosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IK,metal ion-binding site:Magnesium,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000104043	ATPase phospholipid transporting 8B4 (putative)(ATP8B4)	Homo sapiens				GO:0007030~Golgi organization,GO:0045332~phospholipid translocation,	GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					ATP-binding,Cell membrane,Complete proteome,Golgi apparatus,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IM,metal ion-binding site:Magnesium,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000188234	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4(AGAP4)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,		GO:0005096~GTPase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00105:ArfGap,SM00233:PH,SM00248:ANK,	ANK repeat,Complete proteome,GTPase activation,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6,domain:Arf-GAP,domain:PH,repeat:ANK 1,repeat:ANK 2,sequence variant,zinc finger region:C4-type,
ENSG00000172650	ArfGAP with GTPase domain, ankyrin repeat and PH domain 5(AGAP5)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,		GO:0005096~GTPase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00105:ArfGap,SM00233:PH,SM00248:ANK,	ANK repeat,Complete proteome,GTPase activation,Metal-binding,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9,domain:Arf-GAP,domain:PH,region of interest:2 X 23 AA tandem repeats of A-L-E-F-N- [LS]-S-A-N-P-E-A-S-T-I-F-Q-R-N-S-Q-T-D,repeat:1,repeat:2,repeat:ANK,zinc finger region:C4-type,
ENSG00000119866	B-cell CLL/lymphoma 11A(BCL11A)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0010977~negative regulation of neuron projection development,GO:0016925~protein sumoylation,GO:0030517~negative regulation of axon extension,GO:0032463~negative regulation of protein homooligomerization,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048671~negative regulation of collateral sprouting,GO:0048672~positive regulation of collateral sprouting,GO:0050773~regulation of dendrite development,GO:2000171~negative regulation of dendrite development,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Chromosomal rearrangement,Coiled coil,Complete proteome,Cytoplasm,Isopeptide bond,Metal-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:B-cell lymphoma/leukemia 11A,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,modified residue,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ENSG00000095585	B-cell linker(BLNK)	Homo sapiens		h_bcrPathway:BCR Signaling Pathway,		GO:0006954~inflammatory response,GO:0006959~humoral immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0009967~positive regulation of signal transduction,GO:0030183~B cell differentiation,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005515~protein binding,	IPR000980:SH2 domain,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04662:B cell receptor signaling pathway,hsa05340:Primary immunodeficiency,	613502~Agammaglobulinemia 4,		SM00252:SH2,	Alternative splicing,B-cell activation,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,SH2 domain,	chain:B-cell linker protein,compositionally biased region:Pro-rich,domain:SH2,modified residue,mutagenesis site,sequence conflict,splice variant,
ENSG00000128298	BAI1 associated protein 2 like 2(BAIAP2L2)	Homo sapiens				GO:0007009~plasma membrane organization,GO:0008286~insulin receptor signaling pathway,GO:0030838~positive regulation of actin filament polymerization,GO:0051017~actin filament bundle assembly,GO:0051764~actin crosslink formation,GO:0061024~membrane organization,GO:2000251~positive regulation of actin cytoskeleton reorganization,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0012506~vesicle membrane,GO:0015629~actin cytoskeleton,GO:0030659~cytoplasmic vesicle membrane,GO:0044291~cell-cell contact zone,GO:0071439~clathrin complex,	GO:0005543~phospholipid binding,GO:0008093~cytoskeletal adaptor activity,	IPR001452:Src homology-3 domain,IPR013606:IRSp53/MIM homology domain (IMD),				SM00326:SH3,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Lipid-binding,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,SH3 domain,	chain:Brain-specific angiogenesis inhibitor 1- associated protein 2-like protein 2,domain:IMD,domain:SH3,sequence conflict,splice variant,
ENSG00000121380	BCL2 like 14(BCL2L14)	Homo sapiens				GO:0006915~apoptotic process,GO:0042981~regulation of apoptotic process,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0012505~endomembrane system,GO:0016020~membrane,GO:0043229~intracellular organelle,	GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR002475:Bcl2-like,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Apoptosis facilitator Bcl-2-like protein 14,modified residue,short sequence motif:BH2,short sequence motif:BH3,splice variant,
ENSG00000085185	BCL6 corepressor-like 1(BCORL1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005886~plasma membrane,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,Chromatin regulator,Complete proteome,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:BCL-6 corepressor-like protein 1,compositionally biased region:Pro-rich,modified residue,mutagenesis site,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
ENSG00000136573	BLK proto-oncogene, Src family tyrosine kinase(BLK)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0030154~cell differentiation,GO:0032024~positive regulation of insulin secretion,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0042127~regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045087~innate immune response,GO:0050764~regulation of phagocytosis,GO:0050853~B cell receptor signaling pathway,GO:0071801~regulation of podosome assembly,	GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,		613375~Maturity-onset diabetes of the young, type 11,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	ATP-binding,Cell membrane,Complete proteome,Diabetes mellitus,Kinase,Lipoprotein,Membrane,Myristate,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase Blk,domain:Protein kinase,domain:SH2,domain:SH3,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,
ENSG00000095739	BMP and activin membrane bound inhibitor(BAMBI)	Homo sapiens				GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0016477~cell migration,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0032092~positive regulation of protein binding,GO:0035413~positive regulation of catenin import into nucleus,GO:0045893~positive regulation of transcription, DNA-templated,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005109~frizzled binding,GO:0005114~type II transforming growth factor beta receptor binding,	IPR009345:BMP/activin membrane-bound inhibitor,	hsa04310:Wnt signaling pathway,hsa04350:TGF-beta signaling pathway,		PIRSF037456:BMP and activin membrane-bound inhibitor,		Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:BMP and activin membrane-bound inhibitor homolog,glycosylation site:N-linked (GlcNAc...),signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000010671	Bruton tyrosine kinase(BTK)	Homo sapiens	101.Gprot_coupled_Rec_MAP_Kinase,	h_bcrPathway:BCR Signaling Pathway,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_ptdinsPathway:Phosphoinositides and their downstream targets.,		GO:0001805~positive regulation of type III hypersensitivity,GO:0001812~positive regulation of type I hypersensitivity,GO:0001818~negative regulation of cytokine production,GO:0002250~adaptive immune response,GO:0002553~histamine secretion by mast cell,GO:0002721~regulation of B cell cytokine production,GO:0002755~MyD88-dependent toll-like receptor signaling pathway,GO:0002902~regulation of B cell apoptotic process,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007498~mesoderm development,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019722~calcium-mediated signaling,GO:0034614~cellular response to reactive oxygen species,GO:0035556~intracellular signal transduction,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0045087~innate immune response,GO:0045579~positive regulation of B cell differentiation,GO:0048469~cell maturation,GO:0050853~B cell receptor signaling pathway,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0071226~cellular response to molecule of fungal origin,GO:0097190~apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0042629~mast cell granule,GO:0043231~intracellular membrane-bounded organelle,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0016301~kinase activity,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR001562:Zinc finger, Btk motif,IPR001849:Pleckstrin homology domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR011993:Pleckstrin homology-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04064:NF-kappa B signaling pathway,hsa04380:Osteoclast differentiation,hsa04611:Platelet activation,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa05340:Primary immunodeficiency,	300755~Agammaglobulinemia, X-linked 1,307200~Agammaglobulinemia and isolated hormone deficiency,		SM00107:BTK,SM00219:TyrKc,SM00233:PH,SM00252:SH2,SM00326:SH3,	3D-structure,Acetylation,Adaptive immunity,Alternative promoter usage,Apoptosis,ATP-binding,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Immunity,Innate immunity,Kinase,Lipid-binding,Membrane,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH2 domain,SH3 domain,Transcription,Transcription regulation,Transferase,Tyrosine-protein kinase,Zinc,Zinc-finger,	active site:Proton acceptor,binding site:ATP,chain:Tyrosine-protein kinase BTK,domain:PH,domain:Protein kinase,domain:SH2,domain:SH3,helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,zinc finger region:Btk-type,
ENSG00000184451	C-C motif chemokine receptor 10(CCR10)	Homo sapiens				GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0070098~chemokine-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0016493~C-C chemokine receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000355:Chemokine receptor family,IPR005382:CC chemokine receptor 10,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Membrane,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:C-C chemokine receptor type 10,disulfide bond,modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000168329	C-X3-C motif chemokine receptor 1(CX3CR1)	Homo sapiens				GO:0002052~positive regulation of neuroblast proliferation,GO:0002282~microglial cell activation involved in immune response,GO:0002881~negative regulation of chronic inflammatory response to non-antigenic stimulus,GO:0006935~chemotaxis,GO:0006968~cellular defense response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007613~memory,GO:0009611~response to wounding,GO:0016032~viral process,GO:0016525~negative regulation of angiogenesis,GO:0021795~cerebral cortex cell migration,GO:0030336~negative regulation of cell migration,GO:0045766~positive regulation of angiogenesis,GO:0048246~macrophage chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:1900272~negative regulation of long-term synaptic potentiation,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0032809~neuronal cell body membrane,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,	GO:0004950~chemokine receptor activity,GO:0005515~protein binding,GO:0016495~C-X3-C chemokine receptor activity,GO:0019960~C-X3-C chemokine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR005387:CX3C chemokine receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,	607339~Coronary artery disease, resistance to,609423~Rapid progression to AIDS from HIV1 infection,613784~Macular degeneration, age-related, 12,			Age-related macular degeneration,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:CX3C chemokine receptor 1,disulfide bond,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000105472	C-type lectin domain family 11 member A(CLEC11A)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0008083~growth factor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	Coiled coil,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Lectin,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-type lectin domain family 11 member A,disulfide bond,domain:C-type lectin,sequence variant,short sequence motif:Cell attachment site,signal peptide,
ENSG00000225556	C2 calcium dependent domain containing 4D(C2CD4D)	Homo sapiens				GO:0006906~vesicle fusion,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,	GO:0005886~plasma membrane,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0019905~syntaxin binding,GO:0030276~clathrin binding,	IPR000008:C2 calcium-dependent membrane targeting,				SM00239:C2,	Complete proteome,Reference proteome,
ENSG00000160111	C3 and PZP like, alpha-2-macroglobulin domain containing 8(CPAMD8)	Homo sapiens				GO:0010951~negative regulation of endopeptidase activity,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,	IPR001599:Alpha-2-macroglobulin,IPR002350:Kazal domain,IPR002890:Alpha-2-macroglobulin, N-terminal,IPR008930:Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid,IPR009048:Alpha-macroglobulin, receptor-binding,IPR011625:Alpha-2-macroglobulin, N-terminal 2,IPR011626:A-macroglobulin complement component,IPR014756:Immunoglobulin E-set,IPR019565:Alpha-2-macroglobulin, thiol-ester bond-forming,IPR019742:Alpha-2-macroglobulin, conserved site,IPR022041:Farnesoic acid O-methyl transferase,				SM00280:KAZAL,SM01359:SM01359,SM01360:SM01360,SM01361:SM01361,	Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Asp,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Ser,domain:Kazal-like,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Cleavage; by furin-like protease,splice variant,
ENSG00000105270	CAP-Gly domain containing linker protein 3(CLIP3)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0010828~positive regulation of glucose transport,GO:0018230~peptidyl-L-cysteine S-palmitoylation,GO:0031115~negative regulation of microtubule polymerization,GO:0043065~positive regulation of apoptotic process,GO:0044091~membrane biogenesis,GO:0045444~fat cell differentiation,GO:0045807~positive regulation of endocytosis,GO:0072321~chaperone-mediated protein transport,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,	GO:0005795~Golgi stack,GO:0005802~trans-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031901~early endosome membrane,GO:0032588~trans-Golgi network membrane,GO:0045121~membrane raft,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0035594~ganglioside binding,	IPR000938:CAP Gly-rich domain,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM01052:SM01052,	3D-structure,ANK repeat,Cell membrane,Complete proteome,Cytoplasm,Golgi apparatus,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:CAP-Gly domain-containing linker protein 3,compositionally biased region:Poly-Glu,domain:CAP-Gly 1,domain:CAP-Gly 2,helix,region of interest:GoLD,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence variant,strand,turn,
ENSG00000221869	CCAAT/enhancer binding protein delta(CEBPD)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0045444~fat cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048839~inner ear development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR004827:Basic-leucine zipper domain,IPR016468:CCAAT/enhancer-binding,			PIRSF005879:CCAAT/enhancer-binding protein,	SM00338:BRLZ,	Acetylation,Activator,Complete proteome,DNA-binding,Isopeptide bond,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:CCAAT/enhancer-binding protein delta,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Basic motif,domain:Leucine-zipper,mutagenesis site,sequence conflict,sequence variant,
ENSG00000177455	CD19 molecule(CD19)	Homo sapiens	78.B_Cell_Development,			GO:0006968~cellular defense response,GO:0007166~cell surface receptor signaling pathway,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0031052~chromosome breakage,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050776~regulation of immune response,GO:0050853~B cell receptor signaling pathway,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,	hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04662:B cell receptor signaling pathway,hsa05169:Epstein-Barr virus infection,hsa05340:Primary immunodeficiency,	613493~Immunodeficiency, common variable, 3,		SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:B-lymphocyte antigen CD19,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000174807	CD248 molecule(CD248)	Homo sapiens	84.Ubiquitination_Pathways_Cell_Cycle,			GO:0008284~positive regulation of cell proliferation,GO:0016477~cell migration,GO:0048535~lymph node development,GO:0060033~anatomical structure regression,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005578~proteinaceous extracellular matrix,GO:0005737~cytoplasm,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,GO:0030246~carbohydrate binding,GO:0050840~extracellular matrix binding,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001304:C-type lectin,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018097:EGF-like calcium-binding, conserved site,				SM00034:CLECT,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Lectin,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Endosialin,compositionally biased region:Pro-rich,disulfide bond,domain:C-type lectin,domain:EGF-like; calcium-binding,domain:Sushi,glycosylation site:O-linked (GalNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000174059	CD34 molecule(CD34)	Homo sapiens	7.IL17_hematopoesis,	h_il17Pathway:IL 17 Signaling Pathway,h_lymPathway:Adhesion and Diapedesis of Lymphocytes,		GO:0001894~tissue homeostasis,GO:0001935~endothelial cell proliferation,GO:0003094~glomerular filtration,GO:0003158~endothelium development,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0016337~single organismal cell-cell adhesion,GO:0030097~hemopoiesis,GO:0030195~negative regulation of blood coagulation,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032733~positive regulation of interleukin-10 production,GO:0035759~mesangial cell-matrix adhesion,GO:0038001~paracrine signaling,GO:0042482~positive regulation of odontogenesis,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0045766~positive regulation of angiogenesis,GO:0048870~cell motility,GO:0050776~regulation of immune response,GO:0050900~leukocyte migration,GO:0060290~transdifferentiation,GO:0061042~vascular wound healing,GO:0071425~hematopoietic stem cell proliferation,GO:0071636~positive regulation of transforming growth factor beta production,GO:0071657~positive regulation of granulocyte colony-stimulating factor production,GO:0071971~extracellular exosome assembly,GO:0072011~glomerular endothelium development,GO:0072089~stem cell proliferation,GO:0072254~metanephric glomerular mesangial cell differentiation,GO:1900035~negative regulation of cellular response to heat,GO:1900038~negative regulation of cellular response to hypoxia,GO:1900041~negative regulation of interleukin-2 secretion,GO:1900168~positive regulation of glial cell-derived neurotrophic factor secretion,GO:1901215~negative regulation of neuron death,GO:2001214~positive regulation of vasculogenesis,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009925~basal plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0036053~glomerular endothelium fenestra,GO:0045171~intercellular bridge,GO:0048471~perinuclear region of cytoplasm,	GO:0008134~transcription factor binding,GO:0030246~carbohydrate binding,GO:0043199~sulfate binding,	IPR008083:CD34 antigen,IPR013836:CD34/Podocalyxin,	hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,				Alternative splicing,Cell adhesion,Complete proteome,Direct protein sequencing,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Hematopoietic progenitor cell antigen CD34,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000172116	CD8b molecule(CD8B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0006955~immune response,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0042110~T cell activation,GO:0050690~regulation of defense response to virus by virus,GO:0050776~regulation of immune response,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0031901~early endosome membrane,GO:0042101~T cell receptor complex,	GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0042288~MHC class I protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04660:T cell receptor signaling pathway,hsa05340:Primary immunodeficiency,			SM00406:IGv,SM00409:IG,	Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:T-cell surface glycoprotein CD8 beta chain,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000010278	CD9 molecule(CD9)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0002576~platelet degranulation,GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007342~fusion of sperm to egg plasma membrane,GO:0007420~brain development,GO:0008285~negative regulation of cell proliferation,GO:0009414~response to water deprivation,GO:0014003~oligodendrocyte development,GO:0030168~platelet activation,GO:0030913~paranodal junction assembly,GO:0031623~receptor internalization,GO:0071404~cellular response to low-density lipoprotein particle stimulus,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0009897~external side of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa04640:Hematopoietic cell lineage,		PIRSF002419:tetraspanin,		Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Fertilization,Glycoprotein,Lipoprotein,Membrane,Palmitate,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:CD9 antigen,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000215126	COBW domain containing 6(CBWD6)	Homo sapiens			General function prediction only,			GO:0005524~ATP binding,	IPR003495:CobW/HypB/UreG domain,IPR011629:Cobalamin (vitamin B12) biosynthesis CobW-like, C-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00833:SM00833,	ATP-binding,Complete proteome,Nucleotide-binding,Reference proteome,	chain:COBW domain-containing protein 1,chain:COBW domain-containing protein 6,compositionally biased region:Poly-Glu,domain:CobW C-terminal,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ENSG00000080007	DEAD-box helicase 43(DDX43)	Homo sapiens				GO:0010501~RNA secondary structure unwinding,	GO:0005622~intracellular,	GO:0003723~RNA binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00322:KH,SM00487:DEXDc,SM00490:HELICc,	Alternative splicing,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Polymorphism,Reference proteome,RNA-binding,	chain:Probable ATP-dependent RNA helicase DDX43,domain:Helicase ATP-binding,domain:Helicase C-terminal,domain:KH,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
ENSG00000116544	DLG associated protein 3(DLGAP3)	Homo sapiens				GO:0023052~signaling,	GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0045211~postsynaptic membrane,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,	IPR005026:Guanylate-kinase-associated protein,					Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Postsynaptic cell membrane,Reference proteome,Synapse,	chain:Disks large-associated protein 3,compositionally biased region:Poly-His,modified residue,
ENSG00000107447	DNA nucleotidylexotransferase(DNTT)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0006304~DNA modification,GO:0033198~response to ATP,GO:0071897~DNA biosynthetic process,	GO:0000790~nuclear chromatin,GO:0000791~euchromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,	GO:0003677~DNA binding,GO:0003887~DNA-directed DNA polymerase activity,GO:0003912~DNA nucleotidylexotransferase activity,GO:0005515~protein binding,GO:0016740~transferase activity,GO:0046872~metal ion binding,	IPR001357:BRCT domain,IPR001726:DNA nucleotidylexotransferase (TdT) / DNA-directed DNA/RNA polymerase mu,IPR002054:DNA-directed DNA polymerase X,IPR010996:DNA polymerase beta-like, N-terminal domain,IPR018944:DNA polymerase lambda, fingers domain,IPR019843:DNA polymerase family X, binding site,IPR022312:DNA polymerase family X,IPR027292:DNA nucleotidylexotransferase (TdT),IPR027421:DNA polymerase family X lyase domain,	hsa03450:Non-homologous end-joining,hsa04640:Hematopoietic cell lineage,		PIRSF000817:DNA nucleotidyltransferase,PIRSF501175:DNA nucleotidylexotransferase [Parent=PIRSF000817],	SM00292:BRCT,SM00483:POLXc,	3D-structure,Alternative splicing,Complete proteome,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Terminal addition,Transferase,	chain:DNA nucleotidylexotransferase,domain:BRCT,helix,metal ion-binding site:Magnesium,metal ion-binding site:Sodium; via carbonyl oxygen,region of interest:Involved in ssDNA binding,region of interest:Mediates interaction with DNTTIP2,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000182108	Dexi homolog(DEXI)	Homo sapiens							IPR023259:Dexamethasone-induced protein,					Complete proteome,Reference proteome,	chain:Dexamethasone-induced protein,
ENSG00000163576	EF-hand domain family member B(EFHB)	Homo sapiens						GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing family member B,domain:EF-hand 1,domain:EF-hand 2,sequence conflict,sequence variant,splice variant,
ENSG00000115468	EF-hand domain family member D1(EFHD1)	Homo sapiens				GO:0031175~neuron projection development,	GO:0005743~mitochondrial inner membrane,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,				SM00054:EFh,	Alternative splicing,Calcium,Coiled coil,Complete proteome,Membrane,Metal-binding,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	calcium-binding region:1,calcium-binding region:2,chain:EF-hand domain-containing protein D1,domain:EF-hand 1,domain:EF-hand 2,sequence variant,
ENSG00000172889	EGF like domain multiple 7(EGFL7)	Homo sapiens				GO:0001525~angiogenesis,GO:0001568~blood vessel development,GO:0001570~vasculogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0007155~cell adhesion,GO:0045746~negative regulation of Notch signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,	GO:0005509~calcium ion binding,	IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR018097:EGF-like calcium-binding, conserved site,				SM00179:EGF_CA,SM00181:EGF,	Angiogenesis,Calcium,Cell adhesion,Coiled coil,Complete proteome,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Epidermal growth factor-like protein 7,disulfide bond,domain:EGF-like 1,domain:EGF-like 2; calcium-binding,domain:EMI,sequence variant,signal peptide,
ENSG00000118402	ELOVL fatty acid elongase 4(ELOVL4)	Homo sapiens				GO:0006633~fatty acid biosynthetic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0009584~detection of visible light,GO:0019367~fatty acid elongation, saturated fatty acid,GO:0030148~sphingolipid biosynthetic process,GO:0034625~fatty acid elongation, monounsaturated fatty acid,GO:0034626~fatty acid elongation, polyunsaturated fatty acid,GO:0035338~long-chain fatty-acyl-CoA biosynthetic process,GO:0042761~very long-chain fatty acid biosynthetic process,	GO:0005783~endoplasmic reticulum,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0008020~G-protein coupled photoreceptor activity,GO:0009922~fatty acid elongase activity,GO:0102336~3-oxo-arachidoyl-CoA synthase activity,GO:0102337~3-oxo-cerotoyl-CoA synthase activity,GO:0102338~3-oxo-lignoceronyl-CoA synthase activity,	IPR002076:GNS1/SUR4 membrane protein,	hsa00062:Fatty acid elongation,	133190~Spinocerebellar ataxia 34,600110~Stargardt disease 3,614457~Ichthyosis, spastic quadriplegia, and mental retardation,			Complete proteome,Disease mutation,Endoplasmic reticulum,Fatty acid biosynthesis,Fatty acid metabolism,Glycoprotein,Ichthyosis,Lipid biosynthesis,Lipid metabolism,Membrane,Mental retardation,Neurodegeneration,Polymorphism,Reference proteome,Spinocerebellar ataxia,Stargardt disease,Transferase,Transmembrane,Transmembrane helix,	chain:Elongation of very long chain fatty acids protein 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Di-lysine motif,transmembrane region,
ENSG00000157554	ERG, ETS transcription factor(ERG)	Homo sapiens				GO:0003197~endocardial cushion development,GO:0003199~endocardial cushion to mesenchymal transition involved in heart valve formation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0016477~cell migration,GO:0030154~cell differentiation,GO:2000504~positive regulation of blood vessel remodeling,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0030529~intracellular ribonucleoprotein complex,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR003118:Pointed domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR013761:Sterile alpha motif/pointed domain,	hsa05202:Transcriptional misregulation in cancer,			SM00251:SAM_PNT,SM00413:ETS,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,Cytoplasm,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Transcriptional regulator ERG,DNA-binding region:ETS,domain:PNT,helix,modified residue,splice variant,strand,turn,
ENSG00000105672	ETS variant 2(ETV2)	Homo sapiens				GO:0001824~blastocyst development,GO:0001890~placenta development,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007219~Notch signaling pathway,GO:0016055~Wnt signaling pathway,GO:0030154~cell differentiation,GO:0030218~erythrocyte differentiation,GO:0045603~positive regulation of endothelial cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048514~blood vessel morphogenesis,GO:0060803~BMP signaling pathway involved in mesodermal cell fate specification,GO:2000382~positive regulation of mesoderm development,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR000418:Ets domain,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00413:ETS,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,
ENSG00000000938	FGR proto-oncogene, Src family tyrosine kinase(FGR)	Homo sapiens		h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,		GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006468~protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0008360~regulation of cell shape,GO:0009615~response to virus,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016477~cell migration,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030154~cell differentiation,GO:0030335~positive regulation of cell migration,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042127~regulation of cell proliferation,GO:0043306~positive regulation of mast cell degranulation,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045859~regulation of protein kinase activity,GO:0046777~protein autophosphorylation,GO:0050715~positive regulation of cytokine secretion,GO:0050764~regulation of phagocytosis,GO:0050830~defense response to Gram-positive bacterium,	GO:0005743~mitochondrial inner membrane,GO:0005758~mitochondrial intermembrane space,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0015629~actin cytoskeleton,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032587~ruffle membrane,GO:0070062~extracellular exosome,	GO:0001784~phosphotyrosine binding,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019901~protein kinase binding,GO:0034987~immunoglobulin receptor binding,GO:0034988~Fc-gamma receptor I complex binding,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04062:Chemokine signaling pathway,hsa05169:Epstein-Barr virus infection,			SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	ATP-binding,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Immunity,Innate immunity,Kinase,Lipoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Myristate,Nucleotide-binding,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Fgr,domain:Protein kinase,domain:SH2,domain:SH3,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,
ENSG00000198468	FLVCR1 antisense RNA 1 (head to head)(FLVCR1-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein LQK1,
ENSG00000137731	FXYD domain containing ion transport regulator 2(FXYD2)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,		GO:0001558~regulation of cell growth,GO:0006810~transport,GO:0010248~establishment or maintenance of transmembrane electrochemical gradient,GO:0034220~ion transmembrane transport,GO:0036376~sodium ion export from cell,GO:0042127~regulation of cell proliferation,GO:0090662~ATP hydrolysis coupled transmembrane transport,GO:1903779~regulation of cardiac conduction,GO:1990573~potassium ion import across plasma membrane,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,GO:0016323~basolateral plasma membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005216~ion channel activity,GO:0005391~sodium:potassium-exchanging ATPase activity,GO:0017080~sodium channel regulator activity,	IPR000272:Ion-transport regulator, FXYD motif,	hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04260:Cardiac muscle contraction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04911:Insulin secretion,hsa04918:Thyroid hormone synthesis,hsa04919:Thyroid hormone signaling pathway,hsa04960:Aldosterone-regulated sodium reabsorption,hsa04961:Endocrine and other factor-regulated calcium reabsorption,hsa04964:Proximal tubule bicarbonate reclamation,hsa04970:Salivary secretion,hsa04972:Pancreatic secretion,hsa04973:Carbohydrate digestion and absorption,hsa04974:Protein digestion and absorption,hsa04976:Bile secretion,hsa04978:Mineral absorption,	154020~Hypomagnesemia 2, renal,			3D-structure,Alternative splicing,Complete proteome,Disease mutation,Ion transport,Membrane,Potassium,Potassium transport,Primary hypomagnesemia,Reference proteome,Sodium,Sodium transport,Sodium/potassium transport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium/potassium-transporting ATPase subunit gamma,sequence variant,splice variant,transmembrane region,
ENSG00000163534	Fc receptor like 1(FCRL1)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Fc receptor-like protein 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),sequence variant,short sequence motif:ITIM motif 1,short sequence motif:ITIM motif 2,short sequence motif:ITIM motif 3,short sequence motif:ITIM motif 4,short sequence motif:ITIM motif 5,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000125740	FosB proto-oncogene, AP-1 transcription factor subunit(FOSB)	Homo sapiens		h_fosbPathway:FOSB gene expression and drug abuse,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0007565~female pregnancy,GO:0009612~response to mechanical stimulus,GO:0032570~response to progesterone,GO:0032870~cellular response to hormone stimulus,GO:0042493~response to drug,GO:0043278~response to morphine,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051412~response to corticosterone,GO:0051591~response to cAMP,GO:0071277~cellular response to calcium ion,	GO:0005634~nucleus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000982~transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008134~transcription factor binding,GO:0043565~sequence-specific DNA binding,	IPR000837:Fos transforming protein,IPR004827:Basic-leucine zipper domain,	hsa04380:Osteoclast differentiation,hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05034:Alcoholism,			SM00338:BRLZ,	Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein fosB,DNA-binding region:Basic motif,domain:Leucine-zipper,sequence conflict,sequence variant,
ENSG00000087258	G protein subunit alpha o1(GNAO1)	Homo sapiens				GO:0006457~protein folding,GO:0006936~muscle contraction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0007568~aging,GO:0007626~locomotory behavior,GO:0008016~regulation of heart contraction,GO:0030900~forebrain development,GO:0031175~neuron projection development,GO:0034097~response to cytokine,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043278~response to morphine,GO:0043547~positive regulation of GTPase activity,GO:0051926~negative regulation of calcium ion transport,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0043209~myelin sheath,GO:0044297~cell body,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031821~G-protein coupled serotonin receptor binding,GO:0031852~mu-type opioid receptor binding,GO:0032794~GTPase activating protein binding,GO:0046872~metal ion binding,GO:0051430~corticotropin-releasing hormone receptor 1 binding,	IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR001408:G-protein alpha subunit, group I,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04015:Rap1 signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04915:Estrogen signaling pathway,hsa04916:Melanogenesis,hsa04921:Oxytocin signaling pathway,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,	615473~Epileptic encephalopathy, early infantile, 17,		SM00275:SM00275,	ADP-ribosylation,Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Epilepsy,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Myristate,Nucleotide-binding,Palmitate,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(o) subunit alpha,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
ENSG00000111664	G protein subunit beta 3(GNB3)	Homo sapiens				GO:0006457~protein folding,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008217~regulation of blood pressure,GO:0071377~cellular response to glucagon stimulus,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030425~dendrite,GO:0044297~cell body,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0030507~spectrin binding,GO:0051020~GTPase binding,	IPR001632:G-protein, beta subunit,IPR001680:WD40 repeat,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016346:Guanine nucleotide-binding protein, beta subunit,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR020472:G-protein beta WD-40 repeat,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04742:Taste transduction,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,	145500~Hypertension, essential, susceptibility to,		SM00320:WD40,	Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transducer,WD repeat,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3,modified residue,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,repeat:WD 7,sequence variant,
ENSG00000242616	G protein subunit gamma 10(GNG10)	Homo sapiens				GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0071377~cellular response to glucagon stimulus,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Acetylation,Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:DnaJ homolog subfamily C member 25,chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10,domain:J,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,splice variant,transmembrane region,
ENSG00000167414	G protein subunit gamma 8(GNG8)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007399~nervous system development,GO:0035176~social behavior,GO:0043584~nose development,GO:0071377~cellular response to glucagon stimulus,GO:0071444~cellular response to pheromone,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR001770:G-protein, gamma subunit,IPR015898:G-protein gamma-like domain,	hsa04014:Ras signaling pathway,hsa04062:Chemokine signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04713:Circadian entrainment,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa05032:Morphine addiction,hsa05034:Alcoholism,hsa05200:Pathways in cancer,			SM00224:GGL,	Cell membrane,Complete proteome,Lipoprotein,Membrane,Methylation,Prenylation,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,propeptide:Removed in mature form,
ENSG00000180998	G protein-coupled receptor 137C(GPR137C)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Integral membrane protein GPR137C,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000123901	G protein-coupled receptor 83(GPR83)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,GO:0051384~response to glucocorticoid,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0031513~nonmotile primary cilium,	GO:0004930~G-protein coupled receptor activity,GO:0004983~neuropeptide Y receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000611:Neuropeptide Y receptor family,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,			SM01381:SM01381,	Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 83,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000179348	GATA binding protein 2(GATA2)	Homo sapiens			Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001655~urogenital system development,GO:0001709~cell fate determination,GO:0001764~neuron migration,GO:0001892~embryonic placenta development,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006909~phagocytosis,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007507~heart development,GO:0007596~blood coagulation,GO:0009887~organ morphogenesis,GO:0009888~tissue development,GO:0010725~regulation of primitive erythrocyte differentiation,GO:0021514~ventral spinal cord interneuron differentiation,GO:0021533~cell differentiation in hindbrain,GO:0021902~commitment of neuronal cell to specific neuron type in forebrain,GO:0021954~central nervous system neuron development,GO:0021983~pituitary gland development,GO:0030097~hemopoiesis,GO:0033993~response to lipid,GO:0035019~somatic stem cell population maintenance,GO:0035065~regulation of histone acetylation,GO:0035854~eosinophil fate commitment,GO:0042472~inner ear morphogenesis,GO:0043306~positive regulation of mast cell degranulation,GO:0045599~negative regulation of fat cell differentiation,GO:0045648~positive regulation of erythrocyte differentiation,GO:0045650~negative regulation of macrophage differentiation,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045746~negative regulation of Notch signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048469~cell maturation,GO:0048565~digestive tract development,GO:0048873~homeostasis of number of cells within a tissue,GO:0050766~positive regulation of phagocytosis,GO:0060100~positive regulation of phagocytosis, engulfment,GO:0060216~definitive hemopoiesis,GO:0060872~semicircular canal development,GO:0070345~negative regulation of fat cell proliferation,GO:0090102~cochlea development,GO:0097154~GABAergic neuron differentiation,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000977~regulation of forebrain neuron differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001158~enhancer sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0070742~C2H2 zinc finger domain binding,	IPR000679:Zinc finger, GATA-type,IPR013088:Zinc finger, NHR/GATA-type,IPR016374:Transcription factor, GATA-1/2/3,		601626~Leukemia, acute myeloid, susceptibility to,614038~Emberger syndrome,614172~Immunodeficiency 21,614286~Myelodysplastic syndrome, susceptibility to,	PIRSF003027:transcription factor, GATA-1/2/3 types,	SM00401:ZnF_GATA,	Activator,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Metal-binding,Methylation,Nucleus,Phagocytosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Endothelial transcription factor GATA-2,sequence conflict,sequence variant,zinc finger region:GATA-type 1,zinc finger region:GATA-type 2,
ENSG00000180481	GLI pathogenesis-related 1 like 2(GLIPR1L2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR001283:Allergen V5/Tpx-1-related,IPR014044:CAP domain,				SM00198:SCP,	Alternative splicing,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:GLIPR1-like protein 2,compositionally biased region:Glu-rich,splice variant,transmembrane region,
ENSG00000197568	HERV-H LTR-associating 3(HHLA3)	Homo sapiens						GO:0005515~protein binding,						Alternative splicing,Complete proteome,Reference proteome,	chain:HERV-H LTR-associating protein 3,sequence conflict,splice variant,
ENSG00000171476	HOP homeobox(HOPX)	Homo sapiens		h_hopPathway:Hop Pathway in Cardiac Development,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0008016~regulation of heart contraction,GO:0016575~histone deacetylation,GO:0043393~regulation of protein binding,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0045596~negative regulation of cell differentiation,GO:0048286~lung alveolus development,GO:0051155~positive regulation of striated muscle cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,				SM00389:HOX,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Homeobox,Nucleus,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeodomain-only protein,DNA-binding region:Homeobox; atypical,sequence conflict,splice variant,
ENSG00000123411	IKAROS family zinc finger 4(IKZF4)	Homo sapiens			Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005813~centrosome,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	3D-structure,Acetylation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein Eos,mutagenesis site,sequence conflict,short sequence motif:CTBP-binding motif PEDLA,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ENSG00000120645	IQ motif and Sec7 domain 3(IQSEC3)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0032012~regulation of ARF protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,	GO:0005086~ARF guanyl-nucleotide exchange factor activity,	IPR000048:IQ motif, EF-hand binding site,IPR000904:SEC7-like,IPR011993:Pleckstrin homology-like domain,IPR023394:SEC7-like, alpha orthogonal bundle,	hsa04144:Endocytosis,			SM00222:Sec7,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:IQ motif and SEC7 domain-containing protein 3,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:IQ,domain:PH,domain:SEC7,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000269821	KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)(KCNQ1OT1)	Homo sapiens									130650~Beckwith-Wiedemann syndrome,
ENSG00000122548	KIAA0087(KIAA0087)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein KIAA0087,modified residue,sequence variant,
ENSG00000116014	KISS1 receptor(KISS1R)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007218~neuropeptide signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004930~G-protein coupled receptor activity,GO:0005515~protein binding,GO:0008188~neuropeptide receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR008103:KiSS-1 peptide receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,	176400~Precocious puberty, central, 1,614837~Hypogonadotropic hypogonadism 8 with or without anosmia,			Cell membrane,Complete proteome,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Hypogonadotropic hypogonadism,Membrane,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:KiSS-1 receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000198910	L1 cell adhesion molecule(L1CAM)	Homo sapiens		h_ephA4Pathway:Eph Kinases and ephrins support platelet aggregation,		GO:0006935~chemotaxis,GO:0007155~cell adhesion,GO:0007399~nervous system development,GO:0007411~axon guidance,GO:0045773~positive regulation of axon extension,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0044295~axonal growth cone,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR026966:Fibronectin type III C-terminal domain,	hsa04360:Axon guidance,hsa04514:Cell adhesion molecules (CAMs),	303350~CRASH syndrome,303350~MASA syndrome,304100~Corpus callosum, partial agenesis of,307000~Hydrocephalus due to aqueductal stenosis,307000~Hydrocephalus with congenital idiopathic intestinal pseudoobstruction,307000~Hydrocephalus with Hirschsprung disease,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hereditary spastic paraplegia,Hirschsprung disease,Immunoglobulin domain,Membrane,Mental retardation,Neurodegeneration,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Neural cell adhesion molecule L1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000147650	LDL receptor related protein 12(LRP12)	Homo sapiens				GO:0006897~endocytosis,GO:0006898~receptor-mediated endocytosis,GO:0007165~signal transduction,GO:0040008~regulation of growth,	GO:0005887~integral component of plasma membrane,GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,	GO:0005041~low-density lipoprotein receptor activity,GO:0005515~protein binding,	IPR000859:CUB domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,				SM00042:CUB,SM00192:LDLa,	Alternative splicing,Coated pit,Complete proteome,Disulfide bond,Endocytosis,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor-related protein 12,disulfide bond,domain:CUB 1,domain:CUB 2,domain:LDL-receptor class A 1,domain:LDL-receptor class A 2,domain:LDL-receptor class A 3,domain:LDL-receptor class A 4,domain:LDL-receptor class A 5,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000135363	LIM domain only 2(LMO2)	Homo sapiens				GO:0007275~multicellular organism development,GO:0042789~mRNA transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097067~cellular response to thyroid hormone stimulus,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001190~transcriptional activator activity, RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043425~bHLH transcription factor binding,GO:0048037~cofactor binding,GO:0070888~E-box binding,	IPR001781:Zinc finger, LIM-type,	hsa05202:Transcriptional misregulation in cancer,	Leukemia, acute T-cell~Leukemia, acute T-cell,		SM00132:LIM,	3D-structure,Alternative splicing,Chromosomal rearrangement,Complete proteome,LIM domain,Metal-binding,Nucleus,Proto-oncogene,Reference proteome,Repeat,Zinc,	chain:Rhombotin-2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,splice variant,
ENSG00000072163	LIM zinc finger domain containing 2(LIMS2)	Homo sapiens				GO:0016337~single organismal cell-cell adhesion,GO:0034329~cell junction assembly,GO:0043066~negative regulation of apoptotic process,GO:0045216~cell-cell junction organization,GO:2000178~negative regulation of neural precursor cell proliferation,GO:2000346~negative regulation of hepatocyte proliferation,GO:2001046~positive regulation of integrin-mediated signaling pathway,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR017351:PINCH,			PIRSF038003:PINCH protein,	SM00132:LIM,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disease mutation,LIM domain,Limb-girdle muscular dystrophy,Membrane,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:LIM and senescent cell antigen-like- containing domain protein 2,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,domain:LIM zinc-binding 5,modified residue,sequence conflict,splice variant,
ENSG00000124466	LY6/PLAUR domain containing 3(LYPD3)	Homo sapiens				GO:0007160~cell-matrix adhesion,	GO:0005615~extracellular space,GO:0016021~integral component of membrane,GO:0046658~anchored component of plasma membrane,	GO:0043236~laminin binding,	IPR016054:Ly-6 antigen / uPA receptor -like,				SM00134:LU,	Cell membrane,Complete proteome,Direct protein sequencing,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Reference proteome,Repeat,Signal,	chain:Ly6/PLAUR domain-containing protein 3,domain:UPAR/Ly6 1,domain:UPAR/Ly6 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,propeptide:Removed in mature form,signal peptide,
ENSG00000112139	MAM domain containing glycosylphosphatidylinositol anchor 1(MDGA1)	Homo sapiens				GO:0001764~neuron migration,GO:0007420~brain development,GO:0021527~spinal cord association neuron differentiation,	GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0046658~anchored component of plasma membrane,		IPR000998:MAM domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,				SM00137:MAM,SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Neurogenesis,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,	chain:MAM domain-containing glycosylphosphatidylinositol anchor protein 1,disulfide bond,domain:Fibronectin type-III,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,domain:Ig-like 6,domain:MAM,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,
ENSG00000164877	MICAL like 2(MICALL2)	Homo sapiens				GO:0030041~actin filament polymerization,GO:0031175~neuron projection development,GO:0031532~actin cytoskeleton reorganization,GO:0032456~endocytic recycling,GO:0034446~substrate adhesion-dependent cell spreading,GO:0070830~bicellular tight junction assembly,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0001725~stress fiber,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0032432~actin filament bundle,GO:0043005~neuron projection,GO:0055037~recycling endosome,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0017137~Rab GTPase binding,GO:0031005~filamin binding,GO:0042805~actinin binding,GO:0051015~actin filament binding,	IPR001715:Calponin homology domain,IPR001781:Zinc finger, LIM-type,IPR022735:Domain of unknown function DUF3585,				SM00033:CH,SM00132:LIM,	Alternative splicing,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,LIM domain,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Signal,Tight junction,Zinc,	chain:MICAL-like protein 2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Ser,domain:CH,domain:LIM zinc-binding,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000169184	MN1 proto-oncogene, transcriptional regulator(MN1)	Homo sapiens				GO:0001957~intramembranous ossification,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,					607174~Meningioma,			Acetylation,Activator,Chromosomal rearrangement,Coiled coil,Complete proteome,Developmental protein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Tumor suppressor,	chain:Probable tumor suppressor protein MN1,compositionally biased region:Poly-Gln,modified residue,sequence conflict,sequence variant,
ENSG00000198763	MTND2(ND2)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0072593~reactive oxygen species metabolic process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR001750:NADH:ubiquinone/plastoquinone oxidoreductase,IPR003917:NADH:ubiquinone oxidoreductase, chain 2,IPR010933:NADH dehydrogenase subunit 2, C-terminal,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05012:Parkinson's disease,				Alzheimer disease,Amyloidosis,Complete proteome,Disease mutation,Electron transport,Leber hereditary optic neuropathy,Membrane,Mitochondrion,Mitochondrion inner membrane,NAD,Neurodegeneration,Oxidoreductase,Polymorphism,Reference proteome,Respiratory chain,Signal,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase chain 2,modified residue,sequence variant,transmembrane region,
ENSG00000177694	N-acetylated alpha-linked acidic dipeptidase like 2(NAALADL2)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR007365:Transferrin receptor-like, dimerisation domain,IPR007484:Peptidase M28,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000198888	NADH dehydrogenase, subunit 1 (complex I)(ND1)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0014070~response to organic cyclic compound,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0033194~response to hydroperoxide,GO:0042493~response to drug,GO:0045333~cellular respiration,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0031966~mitochondrial membrane,GO:0043025~neuronal cell body,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR001694:NADH:ubiquinone oxidoreductase, subunit 1/F420H2 oxidoreductase subunit H,IPR018086:NADH:ubiquinone oxidoreductase, subunit 1, conserved site,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05012:Parkinson's disease,				Alzheimer disease,Amyloidosis,Complete proteome,Diabetes mellitus,Disease mutation,Electron transport,Epilepsy,Leber hereditary optic neuropathy,MELAS syndrome,Membrane,Mitochondrion,Mitochondrion inner membrane,NAD,Neurodegeneration,Oxidoreductase,Polymorphism,Reference proteome,Respiratory chain,Signal,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase chain 1,sequence variant,transmembrane region,
ENSG00000198886	NADH dehydrogenase, subunit 4 (complex I)(ND4)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0007568~aging,GO:0021549~cerebellum development,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0035094~response to nicotine,GO:0042773~ATP synthesis coupled electron transport,GO:0045471~response to ethanol,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005747~mitochondrial respiratory chain complex I,GO:0016021~integral component of membrane,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR000260:NADH:ubiquinone oxidoreductase, chain 4, N-terminal,IPR001750:NADH:ubiquinone/plastoquinone oxidoreductase,IPR003918:NADH:ubiquinone oxidoreductase,IPR010227:NADH-quinone oxidoreductase, chain M/4,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05012:Parkinson's disease,				Complete proteome,Disease mutation,Dystonia,Electron transport,Leber hereditary optic neuropathy,MELAS syndrome,Membrane,Mitochondrion,NAD,Oxidoreductase,Polymorphism,Reference proteome,Respiratory chain,Signal,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase chain 4,chain:NADH-ubiquinone oxidoreductase chain 4L,sequence conflict,sequence variant,transmembrane region,
ENSG00000198695	NADH dehydrogenase, subunit 6 (complex I)(ND6)	Homo sapiens				GO:0006120~mitochondrial electron transport, NADH to ubiquinone,GO:0032981~mitochondrial respiratory chain complex I assembly,GO:0035094~response to nicotine,GO:0042220~response to cocaine,GO:0042542~response to hydrogen peroxide,	GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,GO:0070469~respiratory chain,	GO:0008137~NADH dehydrogenase (ubiquinone) activity,	IPR001457:NADH:ubiquinone/plastoquinone oxidoreductase, chain 6,	hsa00190:Oxidative phosphorylation,hsa01100:Metabolic pathways,hsa05012:Parkinson's disease,				Complete proteome,Disease mutation,Dystonia,Electron transport,Leber hereditary optic neuropathy,MELAS syndrome,Membrane,Mitochondrion,NAD,Oxidoreductase,Polymorphism,Reference proteome,Respiratory chain,Transmembrane,Transmembrane helix,Transport,Ubiquinone,	chain:NADH-ubiquinone oxidoreductase chain 6,sequence conflict,sequence variant,transmembrane region,
ENSG00000022556	NLR family pyrin domain containing 2(NLRP2)	Homo sapiens				GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0043280~positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045087~innate immune response,GO:0050718~positive regulation of interleukin-1 beta secretion,	GO:0000784~nuclear chromosome, telomeric region,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032090~Pyrin domain binding,	IPR001611:Leucine-rich repeat,IPR004020:DAPIN domain,IPR007111:NACHT nucleoside triphosphatase,IPR011029:Death-like domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM01289:SM01289,	Alternative splicing,Apoptosis,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:NACHT, LRR and PYD domains-containing protein 2,compositionally biased region:Poly-Glu,domain:DAPIN,domain:NACHT,nucleotide phosphate-binding region:ATP,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence conflict,sequence variant,splice variant,
ENSG00000243678	NME/NM23 nucleoside diphosphate kinase 2(NME2)	Homo sapiens		h_ndkDynaminPathway:Endocytotic role of NDK, Phosphins and Dynamin,		GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0006163~purine nucleotide metabolic process,GO:0006165~nucleoside diphosphate phosphorylation,GO:0006183~GTP biosynthetic process,GO:0006220~pyrimidine nucleotide metabolic process,GO:0006228~UTP biosynthetic process,GO:0006241~CTP biosynthetic process,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0009142~nucleoside triphosphate biosynthetic process,GO:0010976~positive regulation of neuron projection development,GO:0015949~nucleobase-containing small molecule interconversion,GO:0018106~peptidyl-histidine phosphorylation,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0043066~negative regulation of apoptotic process,GO:0045618~positive regulation of keratinocyte differentiation,GO:0045682~regulation of epidermis development,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046777~protein autophosphorylation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051259~protein oligomerization,GO:0060416~response to growth hormone,GO:0071333~cellular response to glucose stimulus,GO:0071398~cellular response to fatty acid,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005882~intermediate filament,GO:0005925~focal adhesion,GO:0030027~lamellipodium,GO:0031966~mitochondrial membrane,GO:0043209~myelin sheath,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,GO:0071944~cell periphery,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004550~nucleoside diphosphate kinase activity,GO:0004673~protein histidine kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005504~fatty acid binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008144~drug binding,GO:0019215~intermediate filament binding,GO:0019899~enzyme binding,GO:0046872~metal ion binding,	IPR001564:Nucleoside diphosphate kinase,IPR023005:Nucleoside diphosphate kinase, active site,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,			SM00562:NDK,	3D-structure,Activator,Alternative splicing,ATP-binding,Cell projection,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Kinase,Magnesium,Metal-binding,Nucleotide metabolism,Nucleotide-binding,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Transferase,	active site:Pros-phosphohistidine intermediate,binding site:ATP,chain:Nucleoside diphosphate kinase A,chain:Nucleoside diphosphate kinase B,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,region of interest:Interaction with AKAP13,sequence variant,splice variant,strand,
ENSG00000146453	PARN like, ribonuclease domain containing 1(PNLDC1)	Homo sapiens				GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0005634~nucleus,GO:0016021~integral component of membrane,	GO:0003676~nucleic acid binding,GO:0004535~poly(A)-specific ribonuclease activity,	IPR006941:Ribonuclease CAF1,IPR012337:Ribonuclease H-like domain,					Alternative splicing,Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Poly(A)-specific ribonuclease PARN-like domain-containing protein 1,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000107438	PDZ and LIM domain 1(PDLIM1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0006355~regulation of transcription, DNA-templated,GO:0006979~response to oxidative stress,GO:0098609~cell-cell adhesion,	GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,	GO:0003713~transcription coactivator activity,GO:0008270~zinc ion binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,IPR006643:ZASP,				SM00132:LIM,SM00228:PDZ,SM00735:ZM,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,LIM domain,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Zinc,	chain:PDZ and LIM domain protein 1,domain:LIM zinc-binding,domain:PDZ,helix,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,sequence conflict,sequence variant,strand,turn,
ENSG00000196923	PDZ and LIM domain 7(PDLIM7)	Homo sapiens				GO:0001503~ossification,GO:0006898~receptor-mediated endocytosis,GO:0007275~multicellular organism development,GO:0030036~actin cytoskeleton organization,GO:0030154~cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,	GO:0001725~stress fiber,GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,	GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,				SM00132:LIM,SM00228:PDZ,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Developmental protein,Differentiation,Direct protein sequencing,LIM domain,Metal-binding,Methylation,Osteogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Zinc,	chain:PDZ and LIM domain protein 7,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:PDZ,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,strand,
ENSG00000186862	PDZ domain containing 7(PDZD7)	Homo sapiens				GO:0045184~establishment of protein localization,GO:0050910~detection of mechanical stimulus involved in sensory perception of sound,GO:0060088~auditory receptor cell stereocilium organization,	GO:0002141~stereocilia ankle link,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005929~cilium,GO:1990696~USH2 complex,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR001478:PDZ domain,		276901~Retinal disease in Usher syndrome type IIA, modifier of,605472~Usher syndrome, type IIC, GPR98/PDZD7 digenic,		SM00228:PDZ,	3D-structure,Alternative splicing,Cell projection,Chromosomal rearrangement,Cilium,Complete proteome,Deafness,Nucleus,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Usher syndrome,	chain:PDZ domain-containing protein 7,compositionally biased region:Ser-rich,domain:PDZ 1,domain:PDZ 2,helix,sequence conflict,splice variant,strand,
ENSG00000139200	PILR alpha associated neural protein(PIANP)	Homo sapiens					GO:0005912~adherens junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,							Alternative splicing,Complete proteome,Glycoprotein,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C12orf53,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000118495	PLAG1 like zinc finger 1(PLAGL1)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007050~cell cycle arrest,GO:0030154~cell differentiation,GO:0035914~skeletal muscle cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,		601410~Diabetes mellitus, transient neonatal,		SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein PLAGL1,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,
ENSG00000110777	POU class 2 associating factor 1(POU2AF1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006959~humoral immune response,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,	IPR015389:POU, class 2, associating factor 1,					3D-structure,Chromosomal rearrangement,Complete proteome,Direct protein sequencing,Nucleus,Polymorphism,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:POU domain class 2-associating factor 1,helix,sequence variant,
ENSG00000166387	PPFIA binding protein 2(PPFIBP2)	Homo sapiens					GO:0005615~extracellular space,GO:0005622~intracellular,		IPR001660:Sterile alpha motif domain,IPR013761:Sterile alpha motif/pointed domain,				SM00454:SAM,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Liprin-beta-2,domain:SAM 1,domain:SAM 2,domain:SAM 3,modified residue,sequence conflict,sequence variant,
ENSG00000243279	PRA1 domain family member 2(PRAF2)	Homo sapiens				GO:0015031~protein transport,GO:0015813~L-glutamate transport,	GO:0010008~endosome membrane,GO:0016021~integral component of membrane,		IPR004895:Prenylated rab acceptor PRA1,					Complete proteome,Endosome,Membrane,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:PRA1 family protein 2,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000141391	PRELI domain containing 3A(PRELID3A)	Homo sapiens				GO:0015914~phospholipid transport,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005758~mitochondrial intermembrane space,	GO:0005515~protein binding,GO:1990050~phosphatidic acid transporter activity,	IPR006797:PRELI/MSF1,					3D-structure,Alternative splicing,Complete proteome,Lipid transport,Mitochondrion,Proteomics identification,Reference proteome,Transport,	chain:Protein slowmo homolog 1,domain:PRELI/MSF1,
ENSG00000248485	Purkinje cell protein 4 like 1(PCP4L1)	Homo sapiens												Complete proteome,Phosphoprotein,Reference proteome,	chain:Purkinje cell protein 4-like protein 1,domain:IQ,
ENSG00000168461	RAB31, member RAS oncogene family(RAB31)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0031623~receptor internalization,GO:0032869~cellular response to insulin stimulus,GO:0043001~Golgi to plasma membrane protein transport,GO:0045055~regulated exocytosis,GO:0090382~phagosome maturation,	GO:0005622~intracellular,GO:0005769~early endosome,GO:0030670~phagocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0045335~phagocytic vesicle,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,				3D-structure,Complete proteome,Cytoplasmic vesicle,Endosome,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,	chain:Ras-related protein Rab-31,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,
ENSG00000169435	Ras association domain family member 6(RASSF6)	Homo sapiens				GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0042981~regulation of apoptotic process,		GO:0005515~protein binding,	IPR000159:Ras-association,IPR011524:SARAH domain,	hsa04390:Hippo signaling pathway,			SM00314:RA,	Alternative splicing,Apoptosis,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Ras association domain-containing protein 6,domain:Ras-associating,domain:SARAH,sequence variant,splice variant,
ENSG00000105538	Ras interacting protein 1(RASIP1)	Homo sapiens				GO:0001525~angiogenesis,GO:0001570~vasculogenesis,GO:0007165~signal transduction,GO:0010507~negative regulation of autophagy,GO:0043087~regulation of GTPase activity,GO:0048754~branching morphogenesis of an epithelial tube,	GO:0005795~Golgi stack,GO:0048471~perinuclear region of cytoplasm,		IPR000159:Ras-association,IPR000253:Forkhead-associated (FHA) domain,IPR002710:Dilute,IPR008984:SMAD/FHA domain,				SM00314:RA,SM01132:SM01132,	Angiogenesis,Complete proteome,Cytoplasm,Golgi apparatus,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Ras-interacting protein 1,compositionally biased region:Poly-Pro,domain:Dilute,domain:Ras-associating,modified residue,sequence conflict,sequence variant,
ENSG00000004777	Rho GTPase activating protein 33(ARHGAP33)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0015031~protein transport,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0035091~phosphatidylinositol binding,	IPR000198:Rho GTPase-activating protein domain,IPR001452:Src homology-3 domain,IPR001683:Phox homologous domain,IPR008936:Rho GTPase activation protein,				SM00324:RhoGAP,SM00326:SH3,	Alternative splicing,Complete proteome,GTPase activation,Methylation,Phosphoprotein,Protein transport,Proteomics identification,Reference proteome,SH3 domain,Transport,	chain:TC10/CDC42 GTPase-activating protein,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,domain:PX; atypical,domain:Rho-GAP,domain:SH3,modified residue,sequence conflict,splice variant,
ENSG00000108830	Rho family GTPase 2(RND2)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0048672~positive regulation of collateral sprouting,	GO:0002080~acrosomal membrane,GO:0005769~early endosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0047485~protein N-terminus binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasmic vesicle,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Reference proteome,	chain:Rho-related GTP-binding protein RhoN,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,
ENSG00000110237	Rho guanine nucleotide exchange factor 17(ARHGEF17)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0035023~regulation of Rho protein signal transduction,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0051056~regulation of small GTPase mediated signal transduction,	GO:0005829~cytosol,	GO:0005085~guanyl-nucleotide exchange factor activity,GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR011993:Pleckstrin homology-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,				SM00325:RhoGEF,	Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rho guanine nucleotide exchange factor 17,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:DH,modified residue,sequence conflict,sequence variant,
ENSG00000213214	Rho guanine nucleotide exchange factor 35(ARHGEF35)	Homo sapiens												Complete proteome,Phosphoprotein,Reference proteome,	chain:Rho guanine nucleotide exchange factor 5- like protein,compositionally biased region:Glu-rich,modified residue,sequence conflict,
ENSG00000183111	Rho guanine nucleotide exchange factor 37(ARHGEF37)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001452:Src homology-3 domain,IPR004148:BAR domain,IPR011511:Variant SH3,IPR027267:Arfaptin homology (AH) domain/BAR domain,				SM00325:RhoGEF,SM00326:SH3,SM00721:BAR,	Complete proteome,Guanine-nucleotide releasing factor,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Probable guanine nucleotide exchange factor FLJ41603,domain:BAR,domain:DH,domain:SH3 1,domain:SH3 2,sequence variant,
ENSG00000163220	S100 calcium binding protein A9(S100A9)	Homo sapiens				GO:0001816~cytokine production,GO:0002523~leukocyte migration involved in inflammatory response,GO:0002793~positive regulation of peptide secretion,GO:0006417~regulation of translation,GO:0006914~autophagy,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0014002~astrocyte development,GO:0030194~positive regulation of blood coagulation,GO:0030307~positive regulation of cell growth,GO:0030593~neutrophil chemotaxis,GO:0031532~actin cytoskeleton reorganization,GO:0032119~sequestering of zinc ion,GO:0032602~chemokine production,GO:0035606~peptidyl-cysteine S-trans-nitrosylation,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0045113~regulation of integrin biosynthetic process,GO:0050729~positive regulation of inflammatory response,GO:0050832~defense response to fungus,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051493~regulation of cytoskeleton organization,GO:0070488~neutrophil aggregation,GO:0098869~cellular oxidant detoxification,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004871~signal transducer activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0008270~zinc ion binding,GO:0016209~antioxidant activity,GO:0035662~Toll-like receptor 4 binding,GO:0050544~arachidonic acid binding,GO:0050786~RAGE receptor binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,SM01394:SM01394,	3D-structure,Antimicrobial,Antioxidant,Apoptosis,Autophagy,Calcium,Cell membrane,Chemotaxis,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Immunity,Inflammatory response,Innate immunity,Membrane,Metal-binding,Methylation,Phosphoprotein,Polymorphism,Reference proteome,Repeat,S-nitrosylation,Secreted,Zinc,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-A9,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,turn,
ENSG00000160307	S100 calcium binding protein B(S100B)	Homo sapiens				GO:0007409~axonogenesis,GO:0007417~central nervous system development,GO:0007611~learning or memory,GO:0007613~memory,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045087~innate immune response,GO:0048168~regulation of neuronal synaptic plasticity,GO:0048708~astrocyte differentiation,GO:0051384~response to glucocorticoid,GO:0051597~response to methylmercury,GO:0060291~long-term synaptic potentiation,GO:0071456~cellular response to hypoxia,GO:2001015~negative regulation of skeletal muscle cell differentiation,	GO:0001726~ruffle,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0043025~neuronal cell body,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0044548~S100 protein binding,GO:0048156~tau protein binding,GO:0048306~calcium-dependent protein binding,GO:0050786~RAGE receptor binding,	IPR001751:S100/Calbindin-D9k, conserved site,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR013787:S100/CaBP-9k-type, calcium binding, subdomain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,SM01394:SM01394,	3D-structure,Acetylation,Calcium,Complete proteome,Cytoplasm,Direct protein sequencing,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Zinc,	calcium-binding region:1; low affinity,calcium-binding region:2; high affinity,chain:Protein S100-B,domain:EF-hand 1,domain:EF-hand 2,helix,modified residue,strand,turn,
ENSG00000198574	SH2 domain containing 1B(SH2D1B)	Homo sapiens				GO:0002250~adaptive immune response,GO:0002366~leukocyte activation involved in immune response,GO:0002717~positive regulation of natural killer cell mediated immunity,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0050776~regulation of immune response,	GO:0005622~intracellular,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0030674~protein binding, bridging,	IPR000980:SH2 domain,	hsa04650:Natural killer cell mediated cytotoxicity,			SM00252:SH2,	Adaptive immunity,Alternative splicing,Complete proteome,Immunity,Innate immunity,Phosphoprotein,Polymorphism,Reference proteome,SH2 domain,	chain:SH2 domain-containing protein 1B,domain:SH2,sequence variant,splice variant,
ENSG00000130147	SH3 domain binding protein 4(SH3BP4)	Homo sapiens				GO:0006897~endocytosis,GO:0008285~negative regulation of cell proliferation,GO:0010508~positive regulation of autophagy,GO:0030308~negative regulation of cell growth,GO:0032007~negative regulation of TOR signaling,GO:0034260~negative regulation of GTPase activity,GO:0043090~amino acid import,GO:0050790~regulation of catalytic activity,GO:0061462~protein localization to lysosome,GO:0071230~cellular response to amino acid stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005905~clathrin-coated pit,GO:0030136~clathrin-coated vesicle,GO:0070062~extracellular exosome,	GO:0005092~GDP-dissociation inhibitor activity,GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0042802~identical protein binding,	IPR000906:ZU5,IPR001452:Src homology-3 domain,IPR011511:Variant SH3,				SM00326:SH3,	Alternative splicing,Coated pit,Complete proteome,Cytoplasmic vesicle,Endocytosis,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,	chain:SH3 domain-binding protein 4,domain:SH3,modified residue,mutagenesis site,sequence conflict,sequence variant,splice variant,
ENSG00000177045	SIX homeobox 5(SIX5)	Homo sapiens			Transcription,	GO:0002088~lens development in camera-type eye,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007286~spermatid development,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:1902723~negative regulation of skeletal muscle satellite cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0043231~intracellular membrane-bounded organelle,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,		610896~Branchiootorenal syndrome 2,		SM00389:HOX,	Activator,Coiled coil,Complete proteome,Cytoplasm,Deafness,Developmental protein,Disease mutation,DNA-binding,Homeobox,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein SIX5,DNA-binding region:Homeobox,sequence conflict,sequence variant,splice variant,
ENSG00000065054	SLC9A3 regulator 2(SLC9A3R2)	Homo sapiens				GO:0006461~protein complex assembly,GO:0098609~cell-cell adhesion,	GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0005913~cell-cell adherens junction,GO:0005925~focal adhesion,GO:0012505~endomembrane system,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008022~protein C-terminus binding,GO:0019902~phosphatase binding,GO:0032947~protein complex scaffold,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001478:PDZ domain,IPR015098:EBP50, C-terminal,IPR017300:Na(+)/H(+) exchange regulatory cofactor NHE-RF,	hsa04960:Aldosterone-regulated sodium reabsorption,		PIRSF037866:Na(+)/H(+) exchange regulatory cofactor NHE-RF,	SM00228:PDZ,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Membrane,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Na(+)/H(+) exchange regulatory cofactor NHE-RF2,domain:PDZ 1,domain:PDZ 2,helix,modified residue,sequence conflict,splice variant,strand,
ENSG00000170365	SMAD family member 1(SMAD1)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,		GO:0000165~MAPK cascade,GO:0001657~ureteric bud development,GO:0001710~mesodermal cell fate commitment,GO:0002051~osteoblast fate commitment,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007183~SMAD protein complex assembly,GO:0007276~gamete generation,GO:0008285~negative regulation of cell proliferation,GO:0009880~embryonic pattern specification,GO:0010628~positive regulation of gene expression,GO:0030509~BMP signaling pathway,GO:0030901~midbrain development,GO:0030902~hindbrain development,GO:0031053~primary miRNA processing,GO:0042592~homeostatic process,GO:0045669~positive regulation of osteoblast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051216~cartilage development,GO:0060038~cardiac muscle cell proliferation,GO:0060348~bone development,GO:0060395~SMAD protein signal transduction,GO:0061036~positive regulation of cartilage development,GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0043234~protein complex,GO:0071141~SMAD protein complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005057~receptor signaling protein activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030618~transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0070410~co-SMAD binding,GO:0070411~I-SMAD binding,GO:0070878~primary miRNA binding,	IPR001132:SMAD domain, Dwarfin-type,IPR003619:MAD homology 1, Dwarfin-type,IPR008984:SMAD/FHA domain,IPR013019:MAD homology, MH1,IPR013790:Dwarfin,IPR017855:SMAD domain-like,	hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa05202:Transcriptional misregulation in cancer,			SM00523:DWA,SM00524:DWB,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,	chain:Mothers against decapentaplegic homolog 1,compositionally biased region:Poly-Lys,compositionally biased region:Poly-Ser,domain:MH1,domain:MH2,helix,modified residue,mutagenesis site,strand,turn,
ENSG00000197122	SRC proto-oncogene, non-receptor tyrosine kinase(SRC)	Homo sapiens	85.Nuc_Rec-Coact_Complex,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_agrPathway:Agrin in Postsynaptic Differentiation,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_bArrestin-srcPathway:Roles of ï¿½-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling,h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors,h_cell2cellPathway:Cell to Cell Adhesion Signaling,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_erkPathway:Erk1/Erk2 Mapk Signaling pathway,h_gabaPathway:Gamma-aminobutyric Acid Receptor Life Cycle,h_hbxPathway:Calcium Signaling by HBx of Hepatitis B virus,h_integrinPathway:Integrin Signaling Pathway,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mPRPathway:How Progesterone Initiates the Oocyte Maturation,h_pelp1Pathway:Pelp1 Modulation of Estrogen Receptor Activity,h_pyk2Pathway:Links between Pyk2 and Map Kinases,h_rhoPathway:Rho cell motility signaling pathway,h_sam68Pathway:Regulation of Splicing through Sam68,h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation,h_spryPathway:Sprouty regulation of tyrosine kinase signals,h_srcRPTPPathway:Activation of Src by Protein-tyrosine phosphatase alpha,h_uCalpainPathway:uCalpain and friends in Cell spread,		GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007049~cell cycle,GO:0007165~signal transduction,GO:0007172~signal complex assembly,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,GO:0008283~cell proliferation,GO:0009612~response to mechanical stimulus,GO:0009615~response to virus,GO:0010447~response to acidic pH,GO:0010632~regulation of epithelial cell migration,GO:0010634~positive regulation of epithelial cell migration,GO:0010641~positive regulation of platelet-derived growth factor receptor signaling pathway,GO:0010907~positive regulation of glucose metabolic process,GO:0010954~positive regulation of protein processing,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0018105~peptidyl-serine phosphorylation,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0022407~regulation of cell-cell adhesion,GO:0030168~platelet activation,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0030900~forebrain development,GO:0031295~T cell costimulation,GO:0031648~protein destabilization,GO:0031667~response to nutrient levels,GO:0031954~positive regulation of protein autophosphorylation,GO:0032148~activation of protein kinase B activity,GO:0032211~negative regulation of telomere maintenance via telomerase,GO:0032463~negative regulation of protein homooligomerization,GO:0032869~cellular response to insulin stimulus,GO:0033146~regulation of intracellular estrogen receptor signaling pathway,GO:0033625~positive regulation of integrin activation,GO:0034332~adherens junction organization,GO:0034446~substrate adhesion-dependent cell spreading,GO:0034614~cellular response to reactive oxygen species,GO:0035556~intracellular signal transduction,GO:0036035~osteoclast development,GO:0036120~cellular response to platelet-derived growth factor stimulus,GO:0038083~peptidyl-tyrosine autophosphorylation,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038128~ERBB2 signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043114~regulation of vascular permeability,GO:0043149~stress fiber assembly,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043393~regulation of protein binding,GO:0043406~positive regulation of MAP kinase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045056~transcytosis,GO:0045087~innate immune response,GO:0045124~regulation of bone resorption,GO:0045453~bone resorption,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0046628~positive regulation of insulin receptor signaling pathway,GO:0046777~protein autophosphorylation,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048011~neurotrophin TRK receptor signaling pathway,GO:0048013~ephrin receptor signaling pathway,GO:0048477~oogenesis,GO:0050715~positive regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050847~progesterone receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051057~positive regulation of small GTPase mediated signal transduction,GO:0051385~response to mineralocorticoid,GO:0051602~response to electrical stimulus,GO:0051726~regulation of cell cycle,GO:0051895~negative regulation of focal adhesion assembly,GO:0051897~positive regulation of protein kinase B signaling,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051974~negative regulation of telomerase activity,GO:0060065~uterus development,GO:0060444~branching involved in mammary gland duct morphogenesis,GO:0060491~regulation of cell projection assembly,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070555~response to interleukin-1,GO:0071222~cellular response to lipopolysaccharide,GO:0071375~cellular response to peptide hormone stimulus,GO:0071393~cellular response to progesterone stimulus,GO:0071398~cellular response to fatty acid,GO:0071456~cellular response to hypoxia,GO:0071498~cellular response to fluid shear stress,GO:0071801~regulation of podosome assembly,GO:0071803~positive regulation of podosome assembly,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0086098~angiotensin-activated signaling pathway involved in heart process,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1900182~positive regulation of protein localization to nucleus,GO:2000394~positive regulation of lamellipodium morphogenesis,GO:2000573~positive regulation of DNA biosynthetic process,GO:2000641~regulation of early endosome to late endosome transport,GO:2000811~negative regulation of anoikis,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001286~regulation of caveolin-mediated endocytosis,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005764~lysosome,GO:0005770~late endosome,GO:0005829~cytosol,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0032587~ruffle membrane,GO:0043005~neuron projection,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004715~non-membrane spanning protein tyrosine kinase activity,GO:0005070~SH3/SH2 adaptor activity,GO:0005080~protein kinase C binding,GO:0005102~receptor binding,GO:0005158~insulin receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0019900~kinase binding,GO:0020037~heme binding,GO:0030331~estrogen receptor binding,GO:0042169~SH2 domain binding,GO:0044325~ion channel binding,GO:0046875~ephrin receptor binding,GO:0051219~phosphoprotein binding,GO:0051427~hormone receptor binding,GO:0070851~growth factor receptor binding,GO:0097110~scaffold protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000719:Protein kinase, catalytic domain,IPR000980:SH2 domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001452:Src homology-3 domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04144:Endocytosis,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04727:GABAergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04912:GnRH signaling pathway,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05100:Bacterial invasion of epithelial cells,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05219:Bladder cancer,	Colon cancer, advanced, somatic~Colon cancer, advanced, somatic,		SM00219:TyrKc,SM00252:SH2,SM00326:SH3,	3D-structure,Alternative splicing,ATP-binding,Cell adhesion,Cell cycle,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Host-virus interaction,Immunity,Kinase,Lipoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Myristate,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,SH2 domain,SH3 domain,Transferase,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Src,domain:Protein kinase,domain:SH2,domain:SH3,helix,lipid moiety-binding region:N-myristoyl glycine,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,strand,turn,
ENSG00000124766	SRY-box 4(SOX4)	Homo sapiens				GO:0001501~skeletal system development,GO:0001841~neural tube formation,GO:0002328~pro-B cell differentiation,GO:0003183~mitral valve morphogenesis,GO:0003211~cardiac ventricle formation,GO:0003215~cardiac right ventricle morphogenesis,GO:0003289~atrial septum primum morphogenesis,GO:0003357~noradrenergic neuron differentiation,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007507~heart development,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0014009~glial cell proliferation,GO:0021510~spinal cord development,GO:0021522~spinal cord motor neuron differentiation,GO:0021782~glial cell development,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030217~T cell differentiation,GO:0031018~endocrine pancreas development,GO:0031397~negative regulation of protein ubiquitination,GO:0031647~regulation of protein stability,GO:0032024~positive regulation of insulin secretion,GO:0035019~somatic stem cell population maintenance,GO:0035910~ascending aorta morphogenesis,GO:0042593~glucose homeostasis,GO:0042769~DNA damage response, detection of DNA damage,GO:0043065~positive regulation of apoptotic process,GO:0045727~positive regulation of translation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046826~negative regulation of protein export from nucleus,GO:0048485~sympathetic nervous system development,GO:0050821~protein stabilization,GO:0060070~canonical Wnt signaling pathway,GO:0060174~limb bud formation,GO:0060412~ventricular septum morphogenesis,GO:0060548~negative regulation of cell death,GO:0060563~neuroepithelial cell differentiation,GO:0060993~kidney morphogenesis,GO:0071333~cellular response to glucose stimulus,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:2000761~positive regulation of N-terminal peptidyl-lysine acetylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0044798~nuclear transcription factor complex,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001105~RNA polymerase II transcription coactivator activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	Activator,Complete proteome,DNA-binding,Nucleus,Reference proteome,Transcription,Transcription regulation,	chain:Transcription factor SOX-4,compositionally biased region:Poly-Ser,DNA-binding region:HMG box,modified residue,sequence conflict,
ENSG00000064225	ST3 beta-galactoside alpha-2,3-sialyltransferase 6(ST3GAL6)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0006464~cellular protein modification process,GO:0006486~protein glycosylation,GO:0006664~glycolipid metabolic process,GO:0009311~oligosaccharide metabolic process,GO:0018146~keratan sulfate biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0071354~cellular response to interleukin-6,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,GO:0030173~integral component of Golgi membrane,GO:0070062~extracellular exosome,	GO:0003836~beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,GO:0008373~sialyltransferase activity,GO:0052798~beta-galactoside alpha-2,3-sialyltransferase activity,	IPR001675:Glycosyl transferase, family 29,IPR012163:Sialyltransferase,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,		PIRSF005557:sialyltransferase,		Alternative splicing,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Type 2 lactosamine alpha-2,3- sialyltransferase,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000070526	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1(ST6GALNAC1)	Homo sapiens				GO:0001574~ganglioside biosynthetic process,GO:0006486~protein glycosylation,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,GO:0097503~sialylation,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016021~integral component of membrane,	GO:0001665~alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,GO:0008373~sialyltransferase activity,	IPR001675:Glycosyl transferase, family 29,	hsa00512:Mucin type O-Glycan biosynthesis,hsa01100:Metabolic pathways,				Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-N-acetylgalactosaminide alpha-2,6- sialyltransferase 1,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000157703	SVOP like(SVOPL)	Homo sapiens				GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0022857~transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,	IPR005828:General substrate transporter,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Putative transporter SVOPL,sequence variant,splice variant,transmembrane region,
ENSG00000164744	Sad1 and UNC84 domain containing 3(SUN3)	Homo sapiens				GO:0006998~nuclear envelope organization,GO:0090286~cytoskeletal anchoring at nuclear membrane,	GO:0005635~nuclear envelope,GO:0016021~integral component of membrane,GO:0034993~LINC complex,		IPR012919:Sad1/UNC-like, C-terminal,					Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Sad1/unc-84 domain-containing protein 1,domain:SUN,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000167182	Sp2 transcription factor(SP2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006955~immune response,GO:0035264~multicellular organism growth,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor Sp2,modified residue,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
ENSG00000073861	T-box 21(TBX21)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0009615~response to virus,GO:0030217~T cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0071310~cellular response to organic substance,GO:0072676~lymphocyte migration,	GO:0005634~nucleus,GO:0043025~neuronal cell body,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,	IPR001699:Transcription factor, T-box,IPR008967:p53-like transcription factor, DNA-binding,IPR018186:Transcription factor, T-box, conserved site,	hsa05321:Inflammatory bowel disease (IBD),	208550~Asthma and nasal polyps,208550~Asthma, aspirin-induced, susceptibility to,		SM00425:TBOX,	Activator,Asthma,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:T-box transcription factor TBX21,DNA-binding region:T-box,sequence variant,
ENSG00000048462	TNF receptor superfamily member 17(TNFRSF17)	Homo sapiens		h_tall1Pathway:TACI and BCMA stimulation of B cell immune responses.,		GO:0002250~adaptive immune response,GO:0002260~lymphocyte homeostasis,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008283~cell proliferation,GO:0033209~tumor necrosis factor-mediated signaling pathway,	GO:0005886~plasma membrane,GO:0012505~endomembrane system,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,	IPR015337:BCMA, TALL-1 binding,IPR022320:Tumour necrosis factor receptor 17,	hsa04060:Cytokine-cytokine receptor interaction,hsa04672:Intestinal immune network for IgA production,		PIRSF011859:tumor necrosis factor receptor superfamily member 17,		3D-structure,Adaptive immunity,Alternative splicing,Cell membrane,Chromosomal rearrangement,Complete proteome,Disulfide bond,Immunity,Membrane,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 17,disulfide bond,helix,repeat:TNFR-Cys,sequence variant,site:Breakpoint for translocation to form IL2/TNFRSF17 oncogene,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000186891	TNF receptor superfamily member 18(TNFRSF18)	Homo sapiens				GO:0002687~positive regulation of leukocyte migration,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0043066~negative regulation of apoptotic process,GO:0045785~positive regulation of cell adhesion,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0005031~tumor necrosis factor-activated receptor activity,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022318:Tumour necrosis factor receptor 18,	hsa04060:Cytokine-cytokine receptor interaction,			SM00208:TNFR,	Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 18,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000127863	TNF receptor superfamily member 19(TNFRSF19)	Homo sapiens				GO:0001942~hair follicle development,GO:0006915~apoptotic process,GO:0007254~JNK cascade,GO:0009888~tissue development,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0046330~positive regulation of JNK cascade,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,	IPR001368:TNFR/NGFR cysteine-rich region,IPR022342:Tumour necrosis factor receptor 19,	hsa04060:Cytokine-cytokine receptor interaction,			SM00208:TNFR,	Alternative splicing,Apoptosis,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 19,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000116783	TNNI3 interacting kinase(TNNI3K)	Homo sapiens			General function prediction only,	GO:0002027~regulation of heart rate,GO:0006468~protein phosphorylation,GO:0055117~regulation of cardiac muscle contraction,GO:0086069~bundle of His cell to Purkinje myocyte communication,GO:1903779~regulation of cardiac conduction,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0031013~troponin I binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002110:Ankyrin repeat,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020683:Ankyrin repeat-containing domain,		616117~Cardiac conduction disease with or without dilated cardiomyopathy,		SM00248:ANK,	3D-structure,Alternative splicing,ANK repeat,ATP-binding,Cardiomyopathy,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Kinase,Magnesium,Metal-binding,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Fucose-1-phosphate guanylyltransferase,chain:Serine/threonine-protein kinase TNNI3K,compositionally biased region:Poly-Ser,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 10,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,splice variant,
ENSG00000124191	TOX high mobility group box family member 2(TOX2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005654~nucleoplasm,	GO:0003677~DNA binding,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	Alternative splicing,Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:TOX high mobility group box family member 2,compositionally biased region:Poly-Lys,compositionally biased region:Pro-rich,DNA-binding region:HMG box,region of interest:Required for transcriptional activation,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
ENSG00000011600	TYRO protein tyrosine kinase binding protein(TYROBP)	Homo sapiens				GO:0002281~macrophage activation involved in immune response,GO:0002283~neutrophil activation involved in immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0035556~intracellular signal transduction,GO:0045087~innate immune response,GO:0050776~regulation of immune response,GO:2001204~regulation of osteoclast development,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0005057~receptor signaling protein activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR026200:TYRO protein tyrosine kinase-binding protein,	hsa04380:Osteoclast differentiation,hsa04650:Natural killer cell mediated cytotoxicity,	221770~Nasu-Hakola disease,			3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:TYRO protein tyrosine kinase-binding protein,modified residue,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000103005	U6 snRNA biogenesis phosphodiesterase 1(USB1)	Homo sapiens				GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0034477~U6 snRNA 3'-end processing,GO:0090503~RNA phosphodiester bond hydrolysis, exonucleolytic,	GO:0005634~nucleus,GO:0045171~intercellular bridge,	GO:0000175~3'-5'-exoribonuclease activity,GO:0004518~nuclease activity,	IPR027521:Putative U6 snRNA phosphodiesterase,		604173~Poikiloderma with neutropenia,			3D-structure,Alternative splicing,Complete proteome,Hydrolase,mRNA processing,mRNA splicing,Nuclease,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:UPF0406 protein C16orf57,modified residue,sequence conflict,sequence variant,
ENSG00000179913	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3(B3GNT3)	Homo sapiens				GO:0006486~protein glycosylation,GO:0016266~O-glycan processing,GO:0018146~keratan sulfate biosynthetic process,GO:0030311~poly-N-acetyllactosamine biosynthetic process,	GO:0000139~Golgi membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0008532~N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,GO:0047223~beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-GlcNAc:betaGal beta-1,3-N- acetylglucosaminyltransferase 3,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000019102	V-set and immunoglobulin domain containing 2(VSIG2)	Homo sapiens					GO:0005887~integral component of plasma membrane,GO:0016020~membrane,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:V-set and immunoglobulin domain- containing protein 2,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000243284	V-set and immunoglobulin domain containing 8(VSIG8)	Homo sapiens					GO:0005622~intracellular,GO:0016021~integral component of membrane,	GO:0044822~poly(A) RNA binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Membrane,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:V-set and immunoglobulin domain- containing protein 8,compositionally biased region:Poly-Cys,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000173218	VANGL planar cell polarity protein 1(VANGL1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,	GO:0016021~integral component of membrane,GO:0016328~lateral plasma membrane,	GO:0005515~protein binding,	IPR009539:Strabismus,	hsa04310:Wnt signaling pathway,	182940~Neural tube defects, susceptibility to,600145~Caudal regression syndrome,	PIRSF007991:Vang-like protein,		Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Vang-like protein 1,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000112290	WAS protein family member 1(WASF1)	Homo sapiens		h_actinYPathway:Y branching of actin filaments,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_salmonellaPathway:How does salmonella hijack a cell,		GO:0006461~protein complex assembly,GO:0006928~movement of cell or subcellular component,GO:0016601~Rac protein signal transduction,GO:0030036~actin cytoskeleton organization,GO:0030041~actin filament polymerization,GO:0072673~lamellipodium morphogenesis,GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation,	GO:0005741~mitochondrial outer membrane,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0030027~lamellipodium,GO:0031209~SCAR complex,GO:0045202~synapse,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0032403~protein complex binding,GO:0048365~Rac GTPase binding,	IPR003124:WH2 domain,	hsa04520:Adherens junction,hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05100:Bacterial invasion of epithelial cells,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05231:Choline metabolism in cancer,			SM00246:WH2,	3D-structure,Actin-binding,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,Synapse,	chain:Wiskott-Aldrich syndrome protein family member 1,compositionally biased region:Poly-Pro,domain:WH2,
ENSG00000128815	WDFY family member 4(WDFY4)	Homo sapiens					GO:0012505~endomembrane system,GO:0016021~integral component of membrane,GO:0019898~extrinsic component of membrane,	GO:0005543~phospholipid binding,	IPR000409:BEACH domain,IPR001680:WD40 repeat,IPR011989:Armadillo-like helical,IPR011993:Pleckstrin homology-like domain,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016024:Armadillo-type fold,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR023362:PH-BEACH domain,				SM00320:WD40,SM01026:SM01026,	Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,WD repeat,	chain:Protein WDFY4,domain:BEACH,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000113645	WW and C2 domain containing 1(WWC1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0016477~cell migration,GO:0030010~establishment of cell polarity,GO:0032386~regulation of intracellular transport,GO:0035329~hippo signaling,GO:0035330~regulation of hippo signaling,GO:0035331~negative regulation of hippo signaling,GO:0043410~positive regulation of MAPK cascade,GO:0046621~negative regulation of organ growth,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032587~ruffle membrane,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0030674~protein binding, bridging,GO:0032947~protein complex scaffold,	IPR000008:C2 calcium-dependent membrane targeting,IPR001202:WW domain,	hsa04390:Hippo signaling pathway,	615602~Memory, enhanced, QTL,		SM00456:WW,	3D-structure,Activator,Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Protein WWC1,compositionally biased region:Glu-rich,compositionally biased region:Poly-Ser,domain:C2,domain:WW 1,domain:WW 2,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000165171	Williams Beuren syndrome chromosome region 27(WBSCR27)	Homo sapiens				GO:0032259~methylation,	GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008757~S-adenosylmethionine-dependent methyltransferase activity,						Complete proteome,Polymorphism,Reference proteome,Williams-Beuren syndrome,	chain:Williams-Beuren syndrome chromosomal region 27 protein,sequence variant,
ENSG00000135925	Wnt family member 10A(WNT10A)	Homo sapiens				GO:0001942~hair follicle development,GO:0007275~multicellular organism development,GO:0010628~positive regulation of gene expression,GO:0014033~neural crest cell differentiation,GO:0016055~Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0031069~hair follicle morphogenesis,GO:0042476~odontogenesis,GO:0042487~regulation of odontogenesis of dentin-containing tooth,GO:0043586~tongue development,GO:0043588~skin development,GO:0045165~cell fate commitment,GO:0048730~epidermis morphogenesis,GO:0048733~sebaceous gland development,GO:0071560~cellular response to transforming growth factor beta stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR013302:Wnt-10 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,	150400~Tooth agenesis, selective, 4,224750~Schopf-Schulz-Passarge syndrome,257980~Odontoonychodermal dysplasia,		SM00097:WNT1,	Complete proteome,Developmental protein,Disease mutation,Disulfide bond,Ectodermal dysplasia,Extracellular matrix,Glycoprotein,Hypotrichosis,Lipoprotein,Palmoplantar keratoderma,Polymorphism,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-10a,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000143184	X-C motif chemokine ligand 1(XCL1)	Homo sapiens				GO:0001916~positive regulation of T cell mediated cytotoxicity,GO:0002548~monocyte chemotaxis,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0002725~negative regulation of T cell cytokine production,GO:0002726~positive regulation of T cell cytokine production,GO:0002826~negative regulation of T-helper 1 type immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0010820~positive regulation of T cell chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0032689~negative regulation of interferon-gamma production,GO:0032703~negative regulation of interleukin-2 production,GO:0032733~positive regulation of interleukin-10 production,GO:0035782~mature natural killer cell chemotaxis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043547~positive regulation of GTPase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071353~cellular response to interleukin-4,GO:0071356~cellular response to tumor necrosis factor,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071636~positive regulation of transforming growth factor beta production,GO:0071663~positive regulation of granzyme B production,GO:0090023~positive regulation of neutrophil chemotaxis,GO:2000412~positive regulation of thymocyte migration,GO:2000503~positive regulation of natural killer cell chemotaxis,GO:2000513~positive regulation of granzyme A production,GO:2000518~negative regulation of T-helper 1 cell activation,GO:2000538~positive regulation of B cell chemotaxis,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000556~positive regulation of T-helper 1 cell cytokine production,GO:2000558~positive regulation of immunoglobulin production in mucosal tissue,GO:2000562~negative regulation of CD4-positive, alpha-beta T cell proliferation,GO:2000563~positive regulation of CD4-positive, alpha-beta T cell proliferation,GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0008009~chemokine activity,GO:0042379~chemokine receptor binding,GO:0042803~protein homodimerization activity,GO:0048020~CCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,IPR008105:C chemokine ligand 1,	hsa04062:Chemokine signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Reference proteome,Secreted,Signal,	chain:Lymphotactin,disulfide bond,helix,signal peptide,strand,
ENSG00000143185	X-C motif chemokine ligand 2(XCL2)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008015~blood circulation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,IPR008105:C chemokine ligand 1,	hsa04062:Chemokine signaling pathway,			SM00199:SCY,	Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Polymorphism,Reference proteome,Secreted,Signal,	chain:Cytokine SCM-1 beta,disulfide bond,sequence variant,signal peptide,
ENSG00000122121	X-prolyl aminopeptidase 2(XPNPEP2)	Homo sapiens				GO:0006508~proteolysis,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0004177~aminopeptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,	IPR000587:Creatinase,IPR000994:Peptidase M24, structural domain,IPR001131:Peptidase M24B, X-Pro dipeptidase/aminopeptidase P, conserved site,	hsa04974:Protein digestion and absorption,	300909~Angioedema induced by ACE inhibitors, susceptibility to,			Aminopeptidase,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Manganese,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,	chain:Xaa-Pro aminopeptidase 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated alanine,metal ion-binding site:Manganese 1,metal ion-binding site:Manganese 2,propeptide:Removed in mature form,sequence conflict,signal peptide,
ENSG00000250067	YjeF N-terminal domain containing 3(YJEFN3)	Homo sapiens					GO:0005739~mitochondrion,	GO:0052856~NADHX epimerase activity,GO:0052857~NADPHX epimerase activity,	IPR004443:YjeF N-terminal domain,					Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:YjeF N-terminal domain-containing protein 3,domain:YjeF N-terminal,sequence conflict,sequence variant,splice variant,
ENSG00000249087	ZNF436 antisense RNA 1(ZNF436-AS1)	Homo sapiens												Complete proteome,Reference proteome,	chain:Putative uncharacterized protein C1orf213,sequence conflict,
ENSG00000110881	acid sensing ion channel subunit 1(ASIC1)	Homo sapiens				GO:0006810~transport,GO:0006814~sodium ion transport,GO:0007165~signal transduction,GO:0007613~memory,GO:0008306~associative learning,GO:0009268~response to pH,GO:0010447~response to acidic pH,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0046929~negative regulation of neurotransmitter secretion,GO:0050915~sensory perception of sour taste,GO:0070207~protein homotrimerization,GO:0070588~calcium ion transmembrane transport,GO:0071467~cellular response to pH,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0045202~synapse,	GO:0005272~sodium channel activity,GO:0005515~protein binding,GO:0015280~ligand-gated sodium channel activity,GO:0022839~ion gated channel activity,GO:0044736~acid-sensing ion channel activity,	IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,IPR020903:Na+ channel, amiloride-sensitive, conserved site,	hsa04750:Inflammatory mediator regulation of TRP channels,				Alternative splicing,Calcium,Calcium transport,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Amiloride-sensitive cation channel 2, neuronal,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000157510	actin filament associated protein 1 like 1(AFAP1L1)	Homo sapiens					GO:0002102~podosome,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0071437~invadopodium,	GO:0005515~protein binding,	IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,	Alternative splicing,Cell junction,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Reference proteome,Repeat,	chain:Actin filament-associated protein 1-like 1,compositionally biased region:Poly-Glu,domain:PH 1,domain:PH 2,modified residue,sequence conflict,splice variant,
ENSG00000170653	activating transcription factor 7(ATF7)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016032~viral process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0034399~nuclear periphery,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0051019~mitogen-activated protein kinase binding,	IPR004827:Basic-leucine zipper domain,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR016378:Transcription factor, cyclic AMP-dependent,			PIRSF003153:cyclic AMP-dependent transcription factor, CRE-BP1 type,	SM00338:BRLZ,SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Host-virus interaction,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Cyclic AMP-dependent transcription factor ATF-7,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,splice variant,zinc finger region:C2H2-type,
ENSG00000164556	acyloxyacyl hydrolase (neutrophil)(FAM183BP)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000140955	adenosine deaminase domain containing 2(ADAD2)	Homo sapiens				GO:0006396~RNA processing,		GO:0003723~RNA binding,GO:0004000~adenosine deaminase activity,	IPR002466:Adenosine deaminase/editase,IPR014720:Double-stranded RNA-binding-like domain,				SM00552:ADEAMc,	Alternative splicing,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,RNA-binding,	chain:Adenosine deaminase domain-containing protein 2,domain:A to I editase,domain:DRBM,sequence variant,splice variant,
ENSG00000213638	adenosine deaminase, tRNA specific 3(ADAT3)	Homo sapiens				GO:0006400~tRNA modification,GO:0009451~RNA modification,	GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0008270~zinc ion binding,GO:0019239~deaminase activity,	IPR002125:CMP/dCMP deaminase, zinc-binding,IPR016193:Cytidine deaminase-like,		615286~Mental retardation, autosomal recessive 36,			Acetylation,Complete proteome,Disease mutation,Mental retardation,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,tRNA processing,Zinc,	chain:tRNA-specific adenosine deaminase-like protein 3,metal ion-binding site:Zinc,modified residue,sequence variant,
ENSG00000196581	adherens junctions associated protein 1(AJAP1)	Homo sapiens				GO:0007155~cell adhesion,	GO:0005912~adherens junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,							Cell adhesion,Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Adherens junction-associated protein 1,compositionally biased region:Thr-rich,modified residue,mutagenesis site,region of interest:Targeting signals,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000181790	adhesion G protein-coupled receptor B1(ADGRB1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007409~axonogenesis,GO:0007422~peripheral nervous system development,GO:0008285~negative regulation of cell proliferation,GO:0016525~negative regulation of angiogenesis,GO:0051965~positive regulation of synapse assembly,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR000884:Thrombospondin, type 1 repeat,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR008077:GPCR, family 2, brain-specific angiogenesis inhibitor,IPR017981:GPCR, family 2-like,	hsa04115:p53 signaling pathway,			SM00008:HormR,SM00209:TSP1,SM00303:GPS,	Autocatalytic cleavage,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Brain-specific angiogenesis inhibitor 1,compositionally biased region:Poly-Pro,disulfide bond,domain:GPS,domain:TSP type-1 1,domain:TSP type-1 2,domain:TSP type-1 3,domain:TSP type-1 4,domain:TSP type-1 5,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Indispensable for interaction with MAGI1,region of interest:Necessary for interaction with MAGI1,short sequence motif:Cell attachment site,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000205336	adhesion G protein-coupled receptor G1(ADGRG1)	Homo sapiens				GO:0001525~angiogenesis,GO:0007155~cell adhesion,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007266~Rho protein signal transduction,GO:0007267~cell-cell signaling,GO:0007420~brain development,GO:0008285~negative regulation of cell proliferation,GO:0010573~vascular endothelial growth factor production,GO:0016477~cell migration,GO:0021796~cerebral cortex regionalization,GO:0021801~cerebral cortex radial glia guided migration,GO:0021819~layer formation in cerebral cortex,GO:0035025~positive regulation of Rho protein signal transduction,GO:0045785~positive regulation of cell adhesion,GO:0070528~protein kinase C signaling,GO:0072520~seminiferous tubule development,GO:2000179~positive regulation of neural precursor cell proliferation,GO:2001223~negative regulation of neuron migration,	GO:0005622~intracellular,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0045121~membrane raft,GO:0070062~extracellular exosome,GO:0097451~glial limiting end-foot,	GO:0004930~G-protein coupled receptor activity,GO:0005518~collagen binding,GO:0008201~heparin binding,GO:0050840~extracellular matrix binding,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR003910:GPCR, family 2, orphan receptor, GPR56,IPR017981:GPCR, family 2-like,		606854~Polymicrogyria, bilateral frontoparietal,615752~Polymicrogyria, bilateral perisylvian,		SM00303:GPS,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disease mutation,G-protein coupled receptor,Glycoprotein,Heparin-binding,Membrane,Neurogenesis,Polymorphism,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:G-protein coupled receptor 56,domain:GPS,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000159618	adhesion G protein-coupled receptor G5(ADGRG5)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,	IPR000203:GPS domain,IPR000832:GPCR, family 2, secretin-like,IPR003910:GPCR, family 2, orphan receptor, GPR56,IPR017981:GPCR, family 2-like,				SM00303:GPS,	Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Membrane,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Probable G-protein coupled receptor 114,domain:GPS,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000148671	adipogenesis regulatory factor(ADIRF)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0030154~cell differentiation,GO:0045600~positive regulation of fat cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0071478~cellular response to radiation,GO:0072719~cellular response to cisplatin,GO:2001023~regulation of response to drug,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,							Complete proteome,Differentiation,Nucleus,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Adipose most abundant gene transcript 2 protein,
ENSG00000169252	adrenoceptor beta 2(ADRB2)	Homo sapiens		h_cftrPathway:Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway,h_gcrpathway:Corticosteroids and cardioprotection,h_plcePathway:Phospholipase C-epsilon pathway,		GO:0002024~diet induced thermogenesis,GO:0002025~vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure,GO:0002028~regulation of sodium ion transport,GO:0002032~desensitization of G-protein coupled receptor protein signaling pathway by arrestin,GO:0006898~receptor-mediated endocytosis,GO:0006940~regulation of smooth muscle contraction,GO:0007166~cell surface receptor signaling pathway,GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007190~activation of adenylate cyclase activity,GO:0007267~cell-cell signaling,GO:0008333~endosome to lysosome transport,GO:0009409~response to cold,GO:0030501~positive regulation of bone mineralization,GO:0031398~positive regulation of protein ubiquitination,GO:0031649~heat generation,GO:0040015~negative regulation of multicellular organism growth,GO:0042312~regulation of vasodilation,GO:0043410~positive regulation of MAPK cascade,GO:0045453~bone resorption,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045986~negative regulation of smooth muscle contraction,GO:0050873~brown fat cell differentiation,GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway,GO:1901098~positive regulation of autophagosome maturation,GO:1904504~positive regulation of lipophagy,	GO:0005634~nucleus,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0043235~receptor complex,	GO:0004941~beta2-adrenergic receptor activity,GO:0005515~protein binding,GO:0008179~adenylate cyclase binding,GO:0015459~potassium channel regulator activity,GO:0042803~protein homodimerization activity,GO:0051379~epinephrine binding,GO:0051380~norepinephrine binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000332:Adrenergic receptor beta 2,IPR002233:Adrenergic receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04144:Endocytosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04923:Regulation of lipolysis in adipocytes,hsa04924:Renin secretion,hsa04970:Salivary secretion,	600807~Asthma, nocturnal, susceptibility to,601665~Obesity, susceptibility to,Beta-2-adrenoreceptor agonist, reduced response to~Beta-2-adrenoreceptor agonist, reduced response to,		SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Hydroxylation,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	binding site:Agonist or antagonist,chain:Beta-2 adrenergic receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Agonist and antagonist binding,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000128165	adrenomedullin 2(ADM2)	Homo sapiens				GO:0001525~angiogenesis,GO:0006468~protein phosphorylation,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007586~digestion,GO:0007631~feeding behavior,GO:0010628~positive regulation of gene expression,GO:0045766~positive regulation of angiogenesis,GO:0045776~negative regulation of blood pressure,	GO:0005576~extracellular region,	GO:0005179~hormone activity,GO:0032403~protein complex binding,	IPR021116:Procalcitonin/adrenomedullin,					Amidation,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Hormone,Reference proteome,Secreted,Signal,	disulfide bond,modified residue,peptide:Adrenomedullin-2,peptide:Intermedin-short,signal peptide,
ENSG00000196139	aldo-keto reductase family 1 member C3(AKR1C3)	Homo sapiens				GO:0000060~protein import into nucleus, translocation,GO:0001523~retinoid metabolic process,GO:0006693~prostaglandin metabolic process,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007584~response to nutrient,GO:0008202~steroid metabolic process,GO:0008284~positive regulation of cell proliferation,GO:0008584~male gonad development,GO:0009267~cellular response to starvation,GO:0010942~positive regulation of cell death,GO:0016488~farnesol catabolic process,GO:0019371~cyclooxygenase pathway,GO:0030216~keratinocyte differentiation,GO:0034614~cellular response to reactive oxygen species,GO:0042448~progesterone metabolic process,GO:0042572~retinol metabolic process,GO:0042574~retinal metabolic process,GO:0044259~multicellular organismal macromolecule metabolic process,GO:0044597~daunorubicin metabolic process,GO:0044598~doxorubicin metabolic process,GO:0048385~regulation of retinoic acid receptor signaling pathway,GO:0051897~positive regulation of protein kinase B signaling,GO:0055114~oxidation-reduction process,GO:0061370~testosterone biosynthetic process,GO:0070293~renal absorption,GO:0071276~cellular response to cadmium ion,GO:0071277~cellular response to calcium ion,GO:0071379~cellular response to prostaglandin stimulus,GO:0071384~cellular response to corticosteroid stimulus,GO:0071395~cellular response to jasmonic acid stimulus,GO:0071799~cellular response to prostaglandin D stimulus,GO:1900053~negative regulation of retinoic acid biosynthetic process,GO:2000224~regulation of testosterone biosynthetic process,GO:2000353~positive regulation of endothelial cell apoptotic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0001758~retinal dehydrogenase activity,GO:0004032~alditol:NADP+ 1-oxidoreductase activity,GO:0004033~aldo-keto reductase (NADP) activity,GO:0004745~retinol dehydrogenase activity,GO:0016491~oxidoreductase activity,GO:0016655~oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,GO:0018636~phenanthrene 9,10-monooxygenase activity,GO:0035410~dihydrotestosterone 17-beta-dehydrogenase activity,GO:0036130~prostaglandin H2 endoperoxidase reductase activity,GO:0036131~prostaglandin D2 11-ketoreductase activity,GO:0045550~geranylgeranyl reductase activity,GO:0045703~ketoreductase activity,GO:0047017~prostaglandin-F synthase activity,GO:0047020~15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,GO:0047023~androsterone dehydrogenase activity,GO:0047035~testosterone dehydrogenase (NAD+) activity,GO:0047045~testosterone 17-beta-dehydrogenase (NADP+) activity,GO:0047086~ketosteroid monooxygenase activity,GO:0047115~trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,GO:0047718~indanol dehydrogenase activity,GO:0047787~delta4-3-oxosteroid 5beta-reductase activity,GO:0052650~NADP-retinol dehydrogenase activity,	IPR001395:Aldo/keto reductase,IPR018170:Aldo/keto reductase, conserved site,IPR020471:Aldo/keto reductase subgroup,IPR023210:NADP-dependent oxidoreductase domain,	hsa00140:Steroid hormone biosynthesis,hsa00590:Arachidonic acid metabolism,hsa01100:Metabolic pathways,hsa04913:Ovarian steroidogenesis,		PIRSF000097:aldo-keto reductase,		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,NAD,NADP,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	active site:Proton donor,binding site:Substrate,chain:Aldo-keto reductase family 1 member C3,helix,mutagenesis site,nucleotide phosphate-binding region:NADP,sequence conflict,sequence variant,site:Important for substrate specificity,site:Involved in ligand recognition and product release,site:Lowers pKa of active site Tyr,strand,turn,
ENSG00000121410	alpha-1-B glycoprotein(A1BG)	Homo sapiens				GO:0002576~platelet degranulation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR016332:Alpha-1B-glycoprotein/leukocyte immunoglobulin-like receptor,			PIRSF001979:alpha-1B-glycoprotein,	SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Alpha-1B-glycoprotein,disulfide bond,domain:Ig-like V-type 1,domain:Ig-like V-type 2,domain:Ig-like V-type 3,domain:Ig-like V-type 4,domain:Ig-like V-type 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000132744	aminoacylase 3(ACY3)	Homo sapiens				GO:0006805~xenobiotic metabolic process,GO:0008152~metabolic process,GO:0016032~viral process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0004046~aminoacylase activity,GO:0005515~protein binding,GO:0016788~hydrolase activity, acting on ester bonds,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR007036:Succinylglutamate desuccinylase/aspartoacylase,IPR016708:Aspartoacylase,			PIRSF018001:aspartoacylase,		Cell membrane,Complete proteome,Cytoplasm,Host-virus interaction,Hydrolase,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Zinc,	binding site:Substrate,chain:Aspartoacylase-2,metal ion-binding site:Zinc,region of interest:Substrate binding,sequence variant,
ENSG00000154188	angiopoietin 1(ANGPT1)	Homo sapiens				GO:0000165~MAPK cascade,GO:0001525~angiogenesis,GO:0001701~in utero embryonic development,GO:0001933~negative regulation of protein phosphorylation,GO:0001936~regulation of endothelial cell proliferation,GO:0002040~sprouting angiogenesis,GO:0002092~positive regulation of receptor internalization,GO:0002740~negative regulation of cytokine secretion involved in immune response,GO:0007162~negative regulation of cell adhesion,GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity,GO:0010595~positive regulation of endothelial cell migration,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014842~regulation of skeletal muscle satellite cell proliferation,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0030210~heparin biosynthetic process,GO:0031398~positive regulation of protein ubiquitination,GO:0031589~cell-substrate adhesion,GO:0032680~regulation of tumor necrosis factor production,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034394~protein localization to cell surface,GO:0042308~negative regulation of protein import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043116~negative regulation of vascular permeability,GO:0043122~regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043393~regulation of protein binding,GO:0043524~negative regulation of neuron apoptotic process,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0043547~positive regulation of GTPase activity,GO:0045785~positive regulation of cell adhesion,GO:0048014~Tie signaling pathway,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050900~leukocyte migration,GO:0050918~positive chemotaxis,GO:0051897~positive regulation of protein kinase B signaling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0072012~glomerulus vasculature development,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000446~regulation of macrophage migration inhibitory factor signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005902~microvillus,GO:0045121~membrane raft,GO:0070062~extracellular exosome,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0030971~receptor tyrosine kinase binding,	IPR002181:Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain,IPR014715:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 2,IPR014716:Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1,IPR020837:Fibrinogen, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa05323:Rheumatoid arthritis,			SM00186:FBG,	3D-structure,Alternative splicing,Angiogenesis,Coiled coil,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Angiopoietin-1,disulfide bond,domain:Fibrinogen C-terminal,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ENSG00000166839	ankyrin repeat and death domain containing 1A(ANKDD1A)	Homo sapiens				GO:0007165~signal transduction,			IPR000488:Death domain,IPR002110:Ankyrin repeat,IPR011029:Death-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Polymorphism,Reference proteome,Repeat,Signal,	chain:Ankyrin repeat and death domain- containing protein 1A,domain:Death,repeat:ANK 1,repeat:ANK 10,repeat:ANK 11,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence variant,splice variant,
ENSG00000152766	ankyrin repeat domain 22(ANKRD22)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 22,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence variant,
ENSG00000154065	ankyrin repeat domain 29(ANKRD29)	Homo sapiens					GO:0016021~integral component of membrane,		IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	Alternative splicing,ANK repeat,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,	chain:Ankyrin repeat domain-containing protein 29,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,sequence variant,splice variant,
ENSG00000118137	apolipoprotein A1(APOA1)	Homo sapiens		h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),		GO:0001523~retinoid metabolic process,GO:0001932~regulation of protein phosphorylation,GO:0001935~endothelial cell proliferation,GO:0002576~platelet degranulation,GO:0002740~negative regulation of cytokine secretion involved in immune response,GO:0006644~phospholipid metabolic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0006695~cholesterol biosynthetic process,GO:0006869~lipid transport,GO:0006898~receptor-mediated endocytosis,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007229~integrin-mediated signaling pathway,GO:0007584~response to nutrient,GO:0008203~cholesterol metabolic process,GO:0008211~glucocorticoid metabolic process,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0010873~positive regulation of cholesterol esterification,GO:0010898~positive regulation of triglyceride catabolic process,GO:0010903~negative regulation of very-low-density lipoprotein particle remodeling,GO:0014012~peripheral nervous system axon regeneration,GO:0018158~protein oxidation,GO:0018206~peptidyl-methionine modification,GO:0019433~triglyceride catabolic process,GO:0019915~lipid storage,GO:0030300~regulation of intestinal cholesterol absorption,GO:0030301~cholesterol transport,GO:0030325~adrenal gland development,GO:0031100~organ regeneration,GO:0031102~neuron projection regeneration,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0034375~high-density lipoprotein particle remodeling,GO:0034380~high-density lipoprotein particle assembly,GO:0034384~high-density lipoprotein particle clearance,GO:0035025~positive regulation of Rho protein signal transduction,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0043534~blood vessel endothelial cell migration,GO:0043627~response to estrogen,GO:0043691~reverse cholesterol transport,GO:0044267~cellular protein metabolic process,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0050713~negative regulation of interleukin-1 beta secretion,GO:0050728~negative regulation of inflammatory response,GO:0050821~protein stabilization,GO:0050919~negative chemotaxis,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0051180~vitamin transport,GO:0051345~positive regulation of hydrolase activity,GO:0051496~positive regulation of stress fiber assembly,GO:0055085~transmembrane transport,GO:0055091~phospholipid homeostasis,GO:0060192~negative regulation of lipase activity,GO:0060354~negative regulation of cell adhesion molecule production,GO:0060761~negative regulation of response to cytokine stimulus,GO:0070328~triglyceride homeostasis,GO:0070371~ERK1 and ERK2 cascade,GO:0070508~cholesterol import,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030139~endocytic vesicle,GO:0031410~cytoplasmic vesicle,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0034365~discoidal high-density lipoprotein particle,GO:0034366~spherical high-density lipoprotein particle,GO:0034774~secretory granule lumen,GO:0042627~chylomicron,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,	GO:0001540~beta-amyloid binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0005548~phospholipid transporter activity,GO:0008035~high-density lipoprotein particle binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0017127~cholesterol transporter activity,GO:0019899~enzyme binding,GO:0031210~phosphatidylcholine binding,GO:0034190~apolipoprotein receptor binding,GO:0034191~apolipoprotein A-I receptor binding,GO:0042802~identical protein binding,GO:0045499~chemorepellent activity,GO:0055102~lipase inhibitor activity,GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0070653~high-density lipoprotein particle receptor binding,	IPR000074:Apolipoprotein A1/A4/E,	hsa03320:PPAR signaling pathway,hsa04975:Fat digestion and absorption,hsa04977:Vitamin digestion and absorption,hsa05143:African trypanosomiasis,	105200~Amyloidosis, 3 or more types,604091~Hypoalphalipoproteinemia,ApoA-I and apoC-III deficiency, combined~ApoA-I and apoC-III deficiency, combined,Corneal clouding, autosomal recessive~Corneal clouding, autosomal recessive,			3D-structure,Amyloid,Amyloidosis,Atherosclerosis,Cholesterol metabolism,Complete proteome,Direct protein sequencing,Disease mutation,Glycation,Glycoprotein,HDL,Lipid metabolism,Lipid transport,Lipoprotein,Neuropathy,Oxidation,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Steroid metabolism,Sterol metabolism,Transport,	chain:Apolipoprotein A-I,chain:Apolipoprotein A-I(1-242),glycosylation site:N-linked (Glc) (glycation),helix,modified residue,region of interest:10 X approximate tandem repeats,repeat:1,repeat:10,repeat:2,repeat:3; half-length,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9; half-length,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000184730	apolipoprotein B receptor(APOBR)	Homo sapiens				GO:0006641~triglyceride metabolic process,GO:0006869~lipid transport,GO:0006898~receptor-mediated endocytosis,GO:0008203~cholesterol metabolic process,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0034361~very-low-density lipoprotein particle,GO:0034362~low-density lipoprotein particle,GO:0042627~chylomicron,	GO:0030229~very-low-density lipoprotein particle receptor activity,	IPR026158:Apolipoprotein B receptor,					Alternative splicing,Atherosclerosis,Cell membrane,Cholesterol metabolism,Chylomicron,Complete proteome,Direct protein sequencing,LDL,Lipid metabolism,Lipid transport,Membrane,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Steroid metabolism,Sterol metabolism,Transport,VLDL,	chain:Apolipoprotein B-100 receptor,compositionally biased region:Glu-rich,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000183773	apoptosis inducing factor, mitochondria associated 3(AIFM3)	Homo sapiens				GO:0045454~cell redox homeostasis,GO:0055114~oxidation-reduction process,GO:0097194~execution phase of apoptosis,	GO:0005623~cell,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005743~mitochondrial inner membrane,GO:0005783~endoplasmic reticulum,	GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,GO:0051537~2 iron, 2 sulfur cluster binding,	IPR000103:Pyridine nucleotide-disulphide oxidoreductase, class-II,IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation,IPR016156:FAD/NAD-linked reductase, dimerisation,IPR017941:Rieske [2Fe-2S] iron-sulphur domain,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,					2Fe-2S,Alternative splicing,Apoptosis,Complete proteome,Electron transport,FAD,Flavoprotein,Iron,Iron-sulfur,Metal-binding,Mitochondrion,Oxidoreductase,Polymorphism,Reference proteome,Transport,	binding site:FAD,binding site:FAD; via amide nitrogen and carbonyl oxygen,binding site:FAD; via carbonyl oxygen,chain:Apoptosis-inducing factor 3,domain:Rieske,metal ion-binding site:Iron-sulfur (2Fe-2S),metal ion-binding site:Iron-sulfur (2Fe-2S); via pros nitrogen,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,splice variant,
ENSG00000161905	arachidonate 15-lipoxygenase(ALOX15)	Homo sapiens				GO:0001503~ossification,GO:0002820~negative regulation of adaptive immune response,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006691~leukotriene metabolic process,GO:0006954~inflammatory response,GO:0010811~positive regulation of cell-substrate adhesion,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0030282~bone mineralization,GO:0030838~positive regulation of actin filament polymerization,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0034976~response to endoplasmic reticulum stress,GO:0035358~regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035963~cellular response to interleukin-13,GO:0042060~wound healing,GO:0043277~apoptotic cell clearance,GO:0051122~hepoxilin biosynthetic process,GO:0055114~oxidation-reduction process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071277~cellular response to calcium ion,GO:1901074~regulation of engulfment of apoptotic cell,GO:2001303~lipoxin A4 biosynthetic process,	GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004052~arachidonate 12-lipoxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0047977~hepoxilin-epoxide hydrolase activity,GO:0050473~arachidonate 15-lipoxygenase activity,GO:0051120~hepoxilin A3 synthase activity,GO:0097260~eoxin A4 synthase activity,	IPR000907:Lipoxygenase,IPR001024:Lipoxygenase, LH2,IPR001885:Lipoxygenase, mammalian,IPR013819:Lipoxygenase, C-terminal,IPR020833:Lipoxygenase, iron binding site,IPR020834:Lipoxygenase, conserved site,	hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,			SM00308:LH2,	3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Cytoplasm,Dioxygenase,Direct protein sequencing,Fatty acid metabolism,Iron,Lipid droplet,Lipid metabolism,Lipid-binding,Membrane,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	chain:Arachidonate 15-lipoxygenase,domain:Lipoxygenase,domain:PLAT,metal ion-binding site:Iron; catalytic,metal ion-binding site:Iron; via carboxylate; catalytic,mutagenesis site,sequence conflict,sequence variant,
ENSG00000179148	arachidonate lipoxygenase 3(ALOXE3)	Homo sapiens				GO:0006665~sphingolipid metabolic process,GO:0019233~sensory perception of pain,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0035357~peroxisome proliferator activated receptor signaling pathway,GO:0043651~linoleic acid metabolic process,GO:0045444~fat cell differentiation,GO:0046513~ceramide biosynthetic process,GO:0051122~hepoxilin biosynthetic process,GO:0055114~oxidation-reduction process,GO:0061436~establishment of skin barrier,	GO:0005737~cytoplasm,	GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0016829~lyase activity,GO:0046872~metal ion binding,GO:0051120~hepoxilin A3 synthase activity,	IPR000907:Lipoxygenase,IPR001024:Lipoxygenase, LH2,IPR001885:Lipoxygenase, mammalian,IPR013819:Lipoxygenase, C-terminal,IPR020833:Lipoxygenase, iron binding site,IPR020834:Lipoxygenase, conserved site,		606545~Ichthyosis, congenital, autosomal recessive 3,		SM00308:LH2,	Alternative splicing,Complete proteome,Cytoplasm,Dioxygenase,Disease mutation,Fatty acid metabolism,Ichthyosis,Iron,Isomerase,Lipid metabolism,Lyase,Metal-binding,Oxidoreductase,Proteomics identification,Reference proteome,	chain:Epidermis-type lipoxygenase 3,domain:Lipoxygenase,domain:PLAT,metal ion-binding site:Iron; catalytic,metal ion-binding site:Iron; via carboxylate; catalytic,sequence conflict,sequence variant,
ENSG00000111676	atrophin 1(ATN1)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007417~central nervous system development,GO:0051402~neuron apoptotic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016363~nuclear matrix,GO:0030054~cell junction,GO:0048471~perinuclear region of cytoplasm,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,	IPR002951:Atrophin-like,IPR017993:Atrophin-1,		125370~Dentatorubro-pallidoluysian atrophy,			Acetylation,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Epilepsy,Methylation,Neurodegeneration,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,Triplet repeat expansion,	chain:Atrophin-1,compositionally biased region:Ala/Arg-rich,compositionally biased region:Arg/Glu-rich (mixed charge),compositionally biased region:Glu/Ser-rich,compositionally biased region:Poly-Gln,compositionally biased region:Poly-His,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,
ENSG00000158321	autism susceptibility candidate 2(AUTS2)	Homo sapiens				GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0060013~righting reflex,GO:0098582~innate vocalization behavior,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR023246:Autism susceptibility gene 2 protein,		615834~Mental retardation, autosomal dominant 26,			Alternative splicing,Autism,Autism spectrum disorder,Chromosomal rearrangement,Complete proteome,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Autism susceptibility gene 2 protein,compositionally biased region:His-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000160224	autoimmune regulator(AIRE)	Homo sapiens				GO:0002458~peripheral T cell tolerance induction,GO:0002509~central tolerance induction to self antigen,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006417~regulation of translation,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0032602~chemokine production,GO:0045060~negative thymic T cell selection,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0097536~thymus epithelium morphogenesis,GO:2000410~regulation of thymocyte migration,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0016604~nuclear body,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003682~chromatin binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0044212~transcription regulatory region DNA binding,GO:0045182~translation regulator activity,	IPR000770:SAND domain,IPR001965:Zinc finger, PHD-type,IPR004865:Sp100,IPR008087:Autoimmune regulator, AIRE,IPR010919:SAND domain-like,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR019786:Zinc finger, PHD-type, conserved site,IPR019787:Zinc finger, PHD-finger,	hsa04120:Ubiquitin mediated proteolysis,hsa05340:Primary immunodeficiency,	240300~Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia,		SM00249:PHD,SM00258:SAND,	3D-structure,Activator,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Autoimmune regulator,domain:HSR,domain:SAND,helix,mutagenesis site,region of interest:Interaction with histone H3 not methylated at 'Lys-4',sequence conflict,sequence variant,short sequence motif:LXXLL motif 1,short sequence motif:LXXLL motif 2,short sequence motif:LXXLL motif 3,short sequence motif:LXXLL motif 4,splice variant,strand,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
ENSG00000167995	bestrophin 1(BEST1)	Homo sapiens				GO:0006821~chloride transport,GO:0007601~visual perception,GO:0015701~bicarbonate transport,GO:0030321~transepithelial chloride transport,GO:0034220~ion transmembrane transport,GO:0050908~detection of light stimulus involved in visual perception,GO:0051924~regulation of calcium ion transport,GO:1902476~chloride transmembrane transport,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0034707~chloride channel complex,	GO:0005229~intracellular calcium activated chloride channel activity,GO:0005254~chloride channel activity,GO:0015106~bicarbonate transmembrane transporter activity,GO:0042802~identical protein binding,	IPR000615:Bestrophin,IPR021134:Bestrophin/UPF0187,		153700~Macular dystrophy, vitelliform, 2,193220~Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma,193220~Vitreoretinochoroidopathy,611809~Bestrophinopathy, autosomal recessive,613194~Retinitis pigmentosa, concentric,613194~Retinitis pigmentosa-50,			Alternative splicing,Calcium,Cell membrane,Chloride,Chloride channel,Complete proteome,Disease mutation,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Sensory transduction,Transmembrane,Transmembrane helix,Transport,Vision,	chain:Bestrophin-1,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,topological domain:In membrane,transmembrane region,
ENSG00000169255	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)(B3GALNT1)	Homo sapiens				GO:0006486~protein glycosylation,GO:0009312~oligosaccharide biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,	GO:0008378~galactosyltransferase activity,GO:0008499~UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,GO:0047273~galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,	IPR002659:Glycosyl transferase, family 31,	hsa00603:Glycosphingolipid biosynthesis - globo series,hsa01100:Metabolic pathways,	111400~Blood group, P1PK system, P(k) phenotype,615021~Blood group, globoside system,			Blood group antigen,Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Magnesium,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:UDP-GalNAc:beta-1,3-N- acetylgalactosaminyltransferase 1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000109956	beta-1,3-glucuronyltransferase 1(B3GAT1)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0030203~glycosaminoglycan metabolic process,GO:0030204~chondroitin sulfate metabolic process,GO:0050650~chondroitin sulfate proteoglycan biosynthetic process,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,	GO:0015018~galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,GO:0046872~metal ion binding,	IPR005027:Glycosyl transferase, family 43,	hsa00514:Other types of O-glycan biosynthesis,				3D-structure,Alternative splicing,Complete proteome,Endoplasmic reticulum,Glycoprotein,Golgi apparatus,Manganese,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	active site:Proton acceptor,chain:Galactosylgalactosylxylosylprotein 3- beta-glucuronosyltransferase 1,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Manganese,sequence conflict,sequence variant,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
ENSG00000118276	beta-1,4-galactosyltransferase 6(B4GALT6)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0006486~protein glycosylation,GO:0018146~keratan sulfate biosynthetic process,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0003831~beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,GO:0008378~galactosyltransferase activity,GO:0016757~transferase activity, transferring glycosyl groups,GO:0046872~metal ion binding,	IPR003859:Galactosyltransferase, metazoa,	hsa00600:Sphingolipid metabolism,hsa01100:Metabolic pathways,				Alternative splicing,Calcium,Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Magnesium,Manganese,Membrane,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,4-galactosyltransferase 6,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Manganese,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000182240	beta-site APP-cleaving enzyme 2(BACE2)	Homo sapiens				GO:0006508~proteolysis,GO:0006509~membrane protein ectodomain proteolysis,GO:0016486~peptide hormone processing,GO:0030163~protein catabolic process,GO:0042985~negative regulation of amyloid precursor protein biosynthetic process,GO:0050435~beta-amyloid metabolic process,	GO:0005768~endosome,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0001540~beta-amyloid binding,GO:0004190~aspartic-type endopeptidase activity,	IPR001461:Peptidase A1,IPR001969:Peptidase aspartic, active site,IPR009119:Peptidase A1, beta-site APP cleaving enzyme, BACE,IPR009121:Peptidase A1, beta-site APP cleaving enzyme 2, BACE 2,IPR021109:Aspartic peptidase,	hsa05010:Alzheimer's disease,				3D-structure,Alternative splicing,Aspartyl protease,Autocatalytic cleavage,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Hydrolase,Membrane,Protease,Reference proteome,Signal,Transmembrane,Transmembrane helix,Zymogen,	chain:Beta-secretase 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,sequence conflict,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000169627	bolA family member 2B(BOLA2B)	Homo sapiens					GO:0070062~extracellular exosome,		IPR002634:BolA protein,			PIRSF003113:Stress-induced morphoprotein, BolA type,		Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Proteomics identification,Reference proteome,	chain:BolA-like protein 2,modified residue,splice variant,
ENSG00000242252	bone gamma-carboxyglutamate protein(BGLAP)	Homo sapiens				GO:0001501~skeletal system development,GO:0001649~osteoblast differentiation,GO:0002076~osteoblast development,GO:0006465~signal peptide processing,GO:0006888~ER to Golgi vesicle-mediated transport,GO:0007155~cell adhesion,GO:0007569~cell aging,GO:0009612~response to mechanical stimulus,GO:0009629~response to gravity,GO:0010043~response to zinc ion,GO:0014823~response to activity,GO:0017187~peptidyl-glutamic acid carboxylation,GO:0030282~bone mineralization,GO:0030500~regulation of bone mineralization,GO:0032571~response to vitamin K,GO:0033280~response to vitamin D,GO:0033574~response to testosterone,GO:0033594~response to hydroxyisoflavone,GO:0042476~odontogenesis,GO:0042493~response to drug,GO:0043627~response to estrogen,GO:0045124~regulation of bone resorption,GO:0045471~response to ethanol,GO:0045670~regulation of osteoclast differentiation,GO:0051384~response to glucocorticoid,GO:0060348~bone development,GO:0071305~cellular response to vitamin D,GO:0071363~cellular response to growth factor stimulus,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0005791~rough endoplasmic reticulum,GO:0005796~Golgi lumen,GO:0030425~dendrite,GO:0031988~membrane-bounded vesicle,GO:0043204~perikaryon,	GO:0005198~structural molecule activity,GO:0005509~calcium ion binding,GO:0008147~structural constituent of bone,GO:0046848~hydroxyapatite binding,	IPR000294:Gamma-carboxyglutamic acid-rich (GLA) domain,IPR002384:Osteocalcin/matrix Gla protein,				SM00069:GLA,	Biomineralization,Calcium,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Gamma-carboxyglutamic acid,Metal-binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Osteocalcin,chain:Polyamine-modulated factor 1,disulfide bond,domain:Gla,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,modified residue,sequence conflict,sequence variant,signal peptide,site:Not hydroxylated,splice variant,
ENSG00000164929	brain and acute leukemia, cytoplasmic(BAALC)	Homo sapiens					GO:0005737~cytoplasm,GO:0016020~membrane,		IPR009728:BAALC,					Alternative splicing,Complete proteome,Cytoplasm,Lipoprotein,Membrane,Myristate,Palmitate,Polymorphism,Reference proteome,	chain:Brain and acute leukemia cytoplasmic protein,lipid moiety-binding region:N-myristoyl glycine,lipid moiety-binding region:S-palmitoyl cysteine,region of interest:Interaction with CAMK2A,sequence variant,splice variant,
ENSG00000183092	brain enriched guanylate kinase associated(BEGAIN)	Homo sapiens			Cell division and chromosome partitioning,		GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0005515~protein binding,						Acetylation,Coiled coil,Complete proteome,Cytoplasm,Membrane,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Brain-enriched guanylate kinase- associated protein,modified residue,
ENSG00000133169	brain expressed X-linked 1(BEX1)	Homo sapiens				GO:0007399~nervous system development,GO:0030154~cell differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0001102~RNA polymerase II activating transcription factor binding,GO:0005515~protein binding,	IPR007623:Brain-expressed X-linked protein,IPR021156:Transcription elongation factor A-like/Brain expressed X-linked-like,			PIRSF008633:brain-expressed X-linked protein,		Complete proteome,Cytoplasm,Developmental protein,Differentiation,Neurogenesis,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Protein BEX1,modified residue,sequence conflict,sequence variant,
ENSG00000064787	breast carcinoma amplified sequence 1(BCAS1)	Homo sapiens					GO:0005737~cytoplasm,GO:0070062~extracellular exosome,		IPR026115:Novel Amplified in Breast Cancer-1,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Breast carcinoma-amplified sequence 1,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000101542	cadherin 20(CDH20)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR000233:Cadherin, cytoplasmic domain,IPR002126:Cadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,IPR027397:Catenin binding domain,				SM00112:CA,	Calcium,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Glycoprotein,Membrane,Metal-binding,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Cadherin-20,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000075275	cadherin EGF LAG seven-pass G-type receptor 1(CELSR1)	Homo sapiens				GO:0001736~establishment of planar polarity,GO:0001764~neuron migration,GO:0001843~neural tube closure,GO:0001942~hair follicle development,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007266~Rho protein signal transduction,GO:0007417~central nervous system development,GO:0007626~locomotory behavior,GO:0009952~anterior/posterior pattern specification,GO:0032956~regulation of actin cytoskeleton organization,GO:0042060~wound healing,GO:0042249~establishment of planar polarity of embryonic epithelium,GO:0042472~inner ear morphogenesis,GO:0045176~apical protein localization,GO:0048105~establishment of body hair planar orientation,GO:0060071~Wnt signaling pathway, planar cell polarity pathway,GO:0060488~orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,GO:0060489~planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,GO:0060490~lateral sprouting involved in lung morphogenesis,GO:0090179~planar cell polarity pathway involved in neural tube closure,GO:0090251~protein localization involved in establishment of planar polarity,	GO:0005654~nucleoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0005509~calcium ion binding,GO:0046983~protein dimerization activity,	IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000203:GPS domain,IPR000742:Epidermal growth factor-like domain,IPR000832:GPCR, family 2, secretin-like,IPR001791:Laminin G domain,IPR001879:GPCR, family 2, extracellular hormone receptor domain,IPR001881:EGF-like calcium-binding,IPR002049:EGF-like, laminin,IPR002126:Cadherin,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR015919:Cadherin-like,IPR017981:GPCR, family 2-like,IPR020894:Cadherin conserved site,				SM00008:HormR,SM00112:CA,SM00179:EGF_CA,SM00180:EGF_Lam,SM00181:EGF,SM00282:LamG,SM00303:GPS,	Alternative splicing,Calcium,Cell membrane,Complete proteome,Developmental protein,Disease mutation,Disulfide bond,EGF-like domain,G-protein coupled receptor,Glycoprotein,Hydroxylation,Laminin EGF-like domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Cadherin EGF LAG seven-pass G-type receptor 1,compositionally biased region:Poly-Leu,disulfide bond,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,domain:Cadherin 8,domain:Cadherin 9,domain:EGF-like 1; calcium-binding,domain:EGF-like 2; calcium-binding,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:GPS,domain:Laminin EGF-like,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000141837	calcium voltage-gated channel subunit alpha1 A(CACNA1A)	Homo sapiens				GO:0000096~sulfur amino acid metabolic process,GO:0006006~glucose metabolic process,GO:0006816~calcium ion transport,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007274~neuromuscular synaptic transmission,GO:0007416~synapse assembly,GO:0007628~adult walking behavior,GO:0008219~cell death,GO:0014051~gamma-aminobutyric acid secretion,GO:0014056~regulation of acetylcholine secretion, neurotransmission,GO:0016049~cell growth,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0019226~transmission of nerve impulse,GO:0021522~spinal cord motor neuron differentiation,GO:0021590~cerebellum maturation,GO:0021679~cerebellar molecular layer development,GO:0021702~cerebellar Purkinje cell differentiation,GO:0021750~vestibular nucleus development,GO:0030644~cellular chloride ion homeostasis,GO:0032353~negative regulation of hormone biosynthetic process,GO:0034765~regulation of ion transmembrane transport,GO:0035249~synaptic transmission, glutamatergic,GO:0042133~neurotransmitter metabolic process,GO:0042445~hormone metabolic process,GO:0043113~receptor clustering,GO:0043524~negative regulation of neuron apoptotic process,GO:0048266~behavioral response to pain,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0048813~dendrite morphogenesis,GO:0050770~regulation of axonogenesis,GO:0050796~regulation of insulin secretion,GO:0050883~musculoskeletal movement, spinal reflex action,GO:0050885~neuromuscular process controlling balance,GO:0051899~membrane depolarization,GO:0060024~rhythmic synaptic transmission,GO:0070588~calcium ion transmembrane transport,GO:0086010~membrane depolarization during action potential,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,GO:0016021~integral component of membrane,GO:0030425~dendrite,GO:0042995~cell projection,GO:0043025~neuronal cell body,GO:0098793~presynapse,	GO:0005216~ion channel activity,GO:0005245~voltage-gated calcium channel activity,GO:0005262~calcium channel activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008331~high voltage-gated calcium channel activity,GO:0019905~syntaxin binding,GO:0046872~metal ion binding,	IPR002077:Voltage-dependent calcium channel, alpha-1 subunit,IPR005447:Voltage-dependent calcium channel, N-type, alpha-1 subunit,IPR005448:Voltage-dependent calcium channel, P/Q-type, alpha-1 subunit,IPR005821:Ion transport domain,IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04721:Synaptic vesicle cycle,hsa04723:Retrograde endocannabinoid signaling,hsa04724:Glutamatergic synapse,hsa04725:Cholinergic synapse,hsa04726:Serotonergic synapse,hsa04727:GABAergic synapse,hsa04728:Dopaminergic synapse,hsa04730:Long-term depression,hsa04742:Taste transduction,hsa04930:Type II diabetes mellitus,hsa05032:Morphine addiction,hsa05033:Nicotine addiction,	108500~Episodic ataxia, type 2,141500~Migraine, familial hemiplegic, 1,141500~Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia,183086~Spinocerebellar ataxia 6,		SM01062:SM01062,	3D-structure,Alternative splicing,Calcium,Calcium channel,Calcium transport,Coiled coil,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Metal-binding,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Spinocerebellar ataxia,Transmembrane,Transmembrane helix,Transport,Triplet repeat expansion,Voltage-gated channel,	chain:Voltage-dependent P/Q-type calcium channel subunit alpha-1A,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-His,compositionally biased region:Poly-Pro,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Binding to the beta subunit,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,site:Calcium ion selectivity and permeability,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000162545	calcium/calmodulin dependent protein kinase II inhibitor 1(CAMK2N1)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,	GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0045211~postsynaptic membrane,	GO:0004860~protein kinase inhibitor activity,GO:0008427~calcium-dependent protein kinase inhibitor activity,GO:0019901~protein kinase binding,	IPR026779:Calcium/calmodulin-dependent protein kinase II inhibitor,					Cell junction,Cell membrane,Complete proteome,Membrane,Postsynaptic cell membrane,Protein kinase inhibitor,Reference proteome,Synapse,Synaptosome,	chain:Calcium/calmodulin-dependent protein kinase II inhibitor 1,region of interest:Inhibitory domain,
ENSG00000182472	calpain 12(CAPN12)	Homo sapiens				GO:0006508~proteolysis,	GO:0005622~intracellular,GO:0005737~cytoplasm,	GO:0004198~calcium-dependent cysteine-type endopeptidase activity,GO:0005509~calcium ion binding,	IPR000169:Cysteine peptidase, cysteine active site,IPR001300:Peptidase C2, calpain, catalytic domain,IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,IPR022682:Peptidase C2, calpain, large subunit, domain III,IPR022683:Peptidase C2, calpain, domain III,IPR022684:Peptidase C2, calpain family,				SM00230:CysPc,SM00720:calpain_III,	Calcium,Complete proteome,Hydrolase,Metal-binding,Polymorphism,Protease,Reference proteome,Thiol protease,	chain:Calpain-12,domain:Calpain catalytic,domain:EF-hand,region of interest:Domain III,region of interest:Domain IV,sequence variant,
ENSG00000177640	cancer susceptibility candidate 2 (non-protein coding)(CASC2)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein CASC2, isoform 3,chain:Protein CASC2, isoforms 1/2,sequence conflict,sequence variant,splice variant,
ENSG00000163751	carboxypeptidase A3(CPA3)	Homo sapiens				GO:0002003~angiotensin maturation,GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0030133~transport vesicle,GO:0030141~secretory granule,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase M14, carboxypeptidase A,IPR003146:Proteinase inhibitor, carboxypeptidase propeptide,IPR009020:Proteinase inhibitor, propeptide,	hsa04614:Renin-angiotensin system,hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00631:Zn_pept,	Carboxypeptidase,Complete proteome,Cytoplasmic vesicle,Direct protein sequencing,Disulfide bond,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Signal,Zinc,Zymogen,	active site:Nucleophile,chain:Mast cell carboxypeptidase A,disulfide bond,metal ion-binding site:Zinc,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,
ENSG00000158525	carboxypeptidase A5(CPA5)	Homo sapiens				GO:0006508~proteolysis,	GO:0005615~extracellular space,	GO:0004180~carboxypeptidase activity,GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase M14, carboxypeptidase A,IPR003146:Proteinase inhibitor, carboxypeptidase propeptide,IPR009020:Proteinase inhibitor, propeptide,				SM00631:Zn_pept,	Alternative splicing,Carboxypeptidase,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal,Zinc,Zymogen,	active site:Nucleophile,binding site:Substrate,chain:Carboxypeptidase A5,disulfide bond,metal ion-binding site:Zinc; catalytic,propeptide:Activation peptide,region of interest:Substrate binding,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000106066	carboxypeptidase, vitellogenic like(CPVL)	Homo sapiens				GO:0051603~proteolysis involved in cellular protein catabolic process,	GO:0070062~extracellular exosome,	GO:0004185~serine-type carboxypeptidase activity,	IPR001563:Peptidase S10, serine carboxypeptidase,IPR018202:Peptidase S10, serine carboxypeptidase, active site,					Carboxypeptidase,Complete proteome,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Signal,Zymogen,	chain:Probable serine carboxypeptidase CPVL,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000105352	carcinoembryonic antigen related cell adhesion molecule 4(CEACAM4)	Homo sapiens				GO:0006909~phagocytosis,	GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,					Complete proteome,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Carcinoembryonic antigen-related cell adhesion molecule 4,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000205560	carnitine palmitoyltransferase 1B(CPT1B)	Homo sapiens				GO:0006635~fatty acid beta-oxidation,GO:0006853~carnitine shuttle,GO:0015909~long-chain fatty acid transport,	GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0016021~integral component of membrane,	GO:0004095~carnitine O-palmitoyltransferase activity,GO:0005515~protein binding,GO:0016746~transferase activity, transferring acyl groups,	IPR000542:Acyltransferase ChoActase/COT/CPT,	hsa00071:Fatty acid degradation,hsa01212:Fatty acid metabolism,hsa03320:PPAR signaling pathway,hsa04152:AMPK signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,				Acyltransferase,Alternative splicing,Complete proteome,Fatty acid metabolism,Lipid metabolism,Membrane,Mitochondrion,Mitochondrion outer membrane,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,Transport,	active site:Proton acceptor,binding site:ATP,binding site:Carnitine,chain:Carnitine O-palmitoyltransferase 1, muscle isoform,chain:Choline/ethanolamine kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Coenzyme A binding,region of interest:Substrate binding,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Mitochondrial intermembrane,transmembrane region,turn,
ENSG00000187796	caspase recruitment domain family member 9(CARD9)	Homo sapiens				GO:0002223~stimulatory C-type lectin receptor signaling pathway,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0009620~response to fungus,GO:0032494~response to peptidoglycan,GO:0032495~response to muramyl dipeptide,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0042493~response to drug,GO:0042534~regulation of tumor necrosis factor biosynthetic process,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043330~response to exogenous dsRNA,GO:0045076~regulation of interleukin-2 biosynthetic process,GO:0045087~innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045408~regulation of interleukin-6 biosynthetic process,GO:0046330~positive regulation of JNK cascade,GO:0050830~defense response to Gram-positive bacterium,GO:0051607~defense response to virus,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,GO:0042803~protein homodimerization activity,GO:0050700~CARD domain binding,	IPR001315:Caspase Recruitment,IPR011029:Death-like domain,	hsa04621:NOD-like receptor signaling pathway,hsa05152:Tuberculosis,	212050~Candidiasis, familial, 2, autosomal recessive,			Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Disease mutation,Immunity,Innate immunity,Phosphoprotein,Polymorphism,Reference proteome,	chain:Caspase recruitment domain-containing protein 9,domain:CARD,modified residue,sequence variant,splice variant,
ENSG00000111665	cell division cycle associated 3(CDCA3)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0016567~protein ubiquitination,GO:0051301~cell division,	GO:0005829~cytosol,GO:0005911~cell-cell junction,	GO:0005515~protein binding,						Cell cycle,Cell division,Complete proteome,Cytoplasm,Mitosis,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,	chain:Cell division cycle-associated protein 3,modified residue,region of interest:F-box-like,short sequence motif:KEN box,
ENSG00000146670	cell division cycle associated 5(CDCA5)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006302~double-strand break repair,GO:0007062~sister chromatid cohesion,GO:0007064~mitotic sister chromatid cohesion,GO:0007067~mitotic nuclear division,GO:0007076~mitotic chromosome condensation,GO:0007080~mitotic metaphase plate congression,GO:0031536~positive regulation of exit from mitosis,GO:0051301~cell division,GO:0071922~regulation of cohesin loading,GO:1901989~positive regulation of cell cycle phase transition,	GO:0000775~chromosome, centromeric region,GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0008278~cohesin complex,	GO:0003682~chromatin binding,GO:0005515~protein binding,	IPR018605:Sororin protein,	hsa05206:MicroRNAs in cancer,				Cell cycle,Cell division,Chromosome,Coiled coil,Complete proteome,Cytoplasm,Mitosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Sororin,modified residue,sequence variant,short sequence motif:KEN box,
ENSG00000143320	cellular retinoic acid binding protein 2(CRABP2)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006810~transport,GO:0007165~signal transduction,GO:0008544~epidermis development,GO:0035115~embryonic forelimb morphogenesis,GO:0042573~retinoic acid metabolic process,GO:0048385~regulation of retinoic acid receptor signaling pathway,GO:0048672~positive regulation of collateral sprouting,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0001972~retinoic acid binding,GO:0005215~transporter activity,GO:0005501~retinoid binding,GO:0005515~protein binding,GO:0016918~retinal binding,GO:0019841~retinol binding,	IPR000463:Cytosolic fatty-acid binding,IPR000566:Lipocalin/cytosolic fatty-acid binding protein domain,IPR011038:Calycin-like,IPR012674:Calycin,					3D-structure,Complete proteome,Cytoplasm,Endoplasmic reticulum,Isopeptide bond,Nucleus,Proteomics identification,Reference proteome,Retinol-binding,Transport,Ubl conjugation,Vitamin A,	chain:Cellular retinoic acid-binding protein 2,helix,mutagenesis site,region of interest:Retinoic acid binding,short sequence motif:Nuclear localization signal,strand,
ENSG00000123219	centromere protein K(CENPK)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000777~condensed chromosome kinetochore,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,	IPR020993:Centromere protein Cenp-K,					Centromere,Chromosomal rearrangement,Chromosome,Coiled coil,Complete proteome,Kinetochore,Nucleus,Proteomics identification,Reference proteome,	chain:Centromere protein K,sequence conflict,site:Breakpoint for translocation to form MLL- CENPK oncogene,
ENSG00000100162	centromere protein M(CENPM)	Homo sapiens				GO:0007062~sister chromatid cohesion,GO:0034080~CENP-A containing nucleosome assembly,	GO:0000777~condensed chromosome kinetochore,GO:0005654~nucleoplasm,GO:0005829~cytosol,		IPR020987:Centromere protein Cenp-M,					3D-structure,Alternative splicing,Centromere,Chromosome,Complete proteome,Cytoplasm,Kinetochore,Nucleus,Proteomics identification,Reference proteome,	chain:Centromere protein M,splice variant,
ENSG00000167123	cerebral endothelial cell adhesion molecule(CERCAM)	Homo sapiens				GO:0006928~movement of cell or subcellular component,GO:0007155~cell adhesion,GO:0007159~leukocyte cell-cell adhesion,	GO:0005788~endoplasmic reticulum lumen,GO:0005886~plasma membrane,		IPR002654:Glycosyl transferase, family 25,					Alternative splicing,Cell adhesion,Complete proteome,Endoplasmic reticulum,Glycoprotein,Proteomics identification,Reference proteome,Signal,	chain:Glycosyltransferase 25 family member 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,short sequence motif:Prevents secretion from ER,signal peptide,splice variant,
ENSG00000169583	chloride intracellular channel 3(CLIC3)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0006821~chloride transport,GO:0007165~signal transduction,GO:0034765~regulation of ion transmembrane transport,GO:1902476~chloride transmembrane transport,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0034707~chloride channel complex,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0005244~voltage-gated ion channel activity,GO:0005254~chloride channel activity,GO:0005515~protein binding,	IPR002946:Intracellular chloride channel,IPR004045:Glutathione S-transferase, N-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,					3D-structure,Chloride,Chloride channel,Complete proteome,Cytoplasm,Disulfide bond,Ion channel,Ion transport,Membrane,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Chloride intracellular channel protein 3,domain:GST C-terminal,domain:GST N-terminal,helix,region of interest:Required for insertion into the membrane,sequence variant,strand,transmembrane region,
ENSG00000016391	choline dehydrogenase(CHDH)	Homo sapiens				GO:0019285~glycine betaine biosynthetic process from choline,GO:0042426~choline catabolic process,GO:0055114~oxidation-reduction process,	GO:0005743~mitochondrial inner membrane,	GO:0005515~protein binding,GO:0008812~choline dehydrogenase activity,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0050660~flavin adenine dinucleotide binding,	IPR000172:Glucose-methanol-choline oxidoreductase, N-terminal,IPR007867:Glucose-methanol-choline oxidoreductase, C-terminal,IPR012132:Glucose-methanol-choline oxidoreductase,IPR023753:Pyridine nucleotide-disulphide oxidoreductase, FAD/NAD(P)-binding domain,	hsa00260:Glycine, serine and threonine metabolism,hsa01100:Metabolic pathways,		PIRSF000137:glucose-methanol-choline oxidoreductase,		Acetylation,Complete proteome,FAD,Flavoprotein,Membrane,Mitochondrion,Mitochondrion inner membrane,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Choline dehydrogenase, mitochondrial,modified residue,nucleotide phosphate-binding region:FAD,sequence conflict,sequence variant,transit peptide:Mitochondrion,
ENSG00000173894	chromobox 2(CBX2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0016925~protein sumoylation,GO:0030154~cell differentiation,GO:0045137~development of primary sexual characteristics,	GO:0000791~euchromatin,GO:0000792~heterochromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0031519~PcG protein complex,GO:0035102~PRC1 complex,	GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0035064~methylated histone binding,	IPR000953:Chromo domain/shadow,IPR016197:Chromo domain-like,IPR023779:Chromo domain, conserved site,IPR023780:Chromo domain,		613080~46XY sex reversal 5,		SM00298:CHROMO,	3D-structure,Alternative splicing,Chromatin regulator,Complete proteome,Differentiation,Disease mutation,DNA-binding,Methylation,Nucleus,Phosphoprotein,Reference proteome,Repressor,Sexual differentiation,Transcription,Transcription regulation,	chain:Chromobox protein homolog 2,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,DNA-binding region:A.T hook,domain:Chromo,helix,short sequence motif:Nuclear localization signal,splice variant,strand,turn,
ENSG00000116667	chromosome 1 open reading frame 21(C1orf21)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Phosphoprotein,Reference proteome,	chain:Uncharacterized protein C1orf21,modified residue,
ENSG00000125462	chromosome 1 open reading frame 61(C1orf61)	Homo sapiens					GO:0005634~nucleus,							Complete proteome,Nucleus,Reference proteome,	chain:Protein CROC-4,
ENSG00000204161	chromosome 10 open reading frame 128(C10orf128)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Putative uncharacterized protein C10orf128,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000166352	chromosome 11 open reading frame 74(C11orf74)	Homo sapiens												Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C11orf74,splice variant,
ENSG00000188549	chromosome 15 open reading frame 52(C15orf52)	Homo sapiens						GO:0044822~poly(A) RNA binding,						Alternative splicing,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C15orf52,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000166455	chromosome 16 open reading frame 46(C16orf46)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,							Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Uncharacterized protein C16orf46,sequence conflict,sequence variant,splice variant,
ENSG00000260456	chromosome 16 open reading frame 95(C16orf95)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000205710	chromosome 17 open reading frame 107(C17orf107)	Homo sapiens												Complete proteome,Reference proteome,	chain:Uncharacterized protein FLJ46558,
ENSG00000258315	chromosome 17 open reading frame 49(C17orf49)	Homo sapiens				GO:0016569~covalent chromatin modification,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016589~NURF complex,GO:0071339~MLL1 complex,	GO:0003677~DNA binding,	IPR009057:Homeodomain-like,					Alternative splicing,Chromatin regulator,Complete proteome,DNA-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,	chain:MLL1/MLL complex subunit C17orf49,domain:SANT,modified residue,
ENSG00000177576	chromosome 18 open reading frame 32(C18orf32)	Homo sapiens				GO:0007165~signal transduction,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,		GO:0004871~signal transducer activity,	IPR026776:Uncharacterised protein family UPF0729,					Complete proteome,Polymorphism,Reference proteome,	chain:UPF0729 protein C18orf32,sequence variant,
ENSG00000188493	chromosome 19 open reading frame 54(C19orf54)	Homo sapiens												Alternative splicing,Complete proteome,Phosphoprotein,Proteomics identification,Reference proteome,	chain:UPF0692 protein C19orf54,modified residue,splice variant,
ENSG00000185453	chromosome 19 open reading frame 68(C19orf68)	Homo sapiens				GO:0006511~ubiquitin-dependent protein catabolic process,GO:0006915~apoptotic process,GO:0007275~multicellular organism development,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR004162:Seven-in-absentia protein, sina,IPR007527:Zinc finger, SWIM-type,					Complete proteome,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C19orf68,
ENSG00000221916	chromosome 19 open reading frame 73(C19orf73)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C19orf73,sequence variant,
ENSG00000196476	chromosome 20 open reading frame 96(C20orf96)	Homo sapiens												Coiled coil,Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Uncharacterized protein C20orf96,compositionally biased region:Poly-Lys,sequence variant,
ENSG00000243449	chromosome 4 open reading frame 48(C4orf48)	Homo sapiens					GO:0005576~extracellular region,							Alternative splicing,Complete proteome,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein C4orf48,compositionally biased region:Poly-Leu,compositionally biased region:Pro-rich,
ENSG00000141086	chymotrypsin like(CTRL)	Homo sapiens				GO:0006508~proteolysis,GO:0007586~digestion,	GO:0005615~extracellular space,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00020:Tryp_SPc,	Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Chymotrypsin-like protease CTRL-1,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),propeptide:Activation peptide,sequence variant,signal peptide,
ENSG00000159208	circadian associated repressor of transcription(CIART)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0045475~locomotor rhythm,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0016605~PML body,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0005515~protein binding,GO:0070888~E-box binding,						Alternative splicing,Biological rhythms,Complete proteome,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Uncharacterized protein C1orf51,compositionally biased region:Ser-rich,sequence conflict,splice variant,
ENSG00000160318	claudin domain containing 2(CLDND2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR004031:PMP-22/EMP/MP20/Claudin,IPR004032:PMP-22/EMP/MP20,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Claudin domain-containing protein 2,transmembrane region,
ENSG00000159884	coiled-coil domain containing 107(CCDC107)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Coiled coil,Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Coiled-coil domain-containing protein 107,sequence variant,signal peptide,splice variant,transmembrane region,
ENSG00000105479	coiled-coil domain containing 114(CCDC114)	Homo sapiens				GO:0003341~cilium movement,GO:0036158~outer dynein arm assembly,	GO:0005929~cilium,GO:0005930~axoneme,GO:0036157~outer dynein arm,	GO:0005515~protein binding,			615067~Ciliary dyskinesia, primary, 20,			Alternative splicing,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Phosphoprotein,Polymorphism,Primary ciliary dyskinesia,Reference proteome,	chain:Coiled-coil domain-containing protein 114,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,
ENSG00000151773	coiled-coil domain containing 122(CCDC122)	Homo sapiens												Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 122,sequence variant,splice variant,
ENSG00000244607	coiled-coil domain containing 13(CCDC13)	Homo sapiens				GO:0006974~cellular response to DNA damage stimulus,GO:0031122~cytoplasmic microtubule organization,GO:0035058~nonmotile primary cilium assembly,	GO:0005813~centrosome,GO:0034451~centriolar satellite,GO:0042995~cell projection,	GO:0005515~protein binding,						Cell projection,Cilium biogenesis/degradation,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Reference proteome,	chain:Coiled-coil domain-containing protein 13,sequence variant,
ENSG00000170160	coiled-coil domain containing 144A(CCDC144A)	Homo sapiens			Cell division and chromosome partitioning,				IPR021885:Protein of unknown function DUF3496,					Alternative splicing,Coiled coil,Complete proteome,Isopeptide bond,Reference proteome,	chain:Coiled-coil domain-containing protein 144A,chain:Coiled-coil domain-containing protein 144B,compositionally biased region:Poly-Ser,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),sequence conflict,splice variant,
ENSG00000171502	collagen type XXIV alpha 1 chain(COL24A1)	Homo sapiens				GO:0002244~hematopoietic progenitor cell differentiation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,	IPR000885:Fibrillar collagen, C-terminal,IPR001791:Laminin G domain,IPR008160:Collagen triple helix repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04974:Protein digestion and absorption,hsa05146:Amoebiasis,			SM00038:COLFI,SM00210:TSPN,	Alternative splicing,Collagen,Complete proteome,Extracellular matrix,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(XXIV) chain,compositionally biased region:Poly-Tyr,domain:Collagen-like 1,domain:Collagen-like 10,domain:Collagen-like 11,domain:Collagen-like 12,domain:Collagen-like 13,domain:Collagen-like 14,domain:Collagen-like 15,domain:Collagen-like 16,domain:Collagen-like 17,domain:Collagen-like 2,domain:Collagen-like 3,domain:Collagen-like 4,domain:Collagen-like 5,domain:Collagen-like 6,domain:Collagen-like 7,domain:Collagen-like 8,domain:Collagen-like 9,domain:Fibrillar collagen NC1,domain:Laminin G-like,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000119535	colony stimulating factor 3 receptor(CSF3R)	Homo sapiens				GO:0006952~defense response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0045637~regulation of myeloid cell differentiation,GO:0097186~amelogenesis,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0051916~granulocyte colony-stimulating factor binding,	IPR003529:Long hematopoietin receptor, Gp130 family 2, conserved site,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR010457:Immunoglobulin C2-set-like, ligand-binding,IPR013783:Immunoglobulin-like fold,	hsa04060:Cytokine-cytokine receptor interaction,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,	162830~Neutrophilia, hereditary,		SM00060:FN3,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Granulocyte colony-stimulating factor receptor,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,short sequence motif:Box 1 motif,short sequence motif:WSXWS motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000203710	complement C3b/C4b receptor 1 (Knops blood group)(CR1)	Homo sapiens		h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0002430~complement receptor mediated signaling pathway,GO:0006958~complement activation, classical pathway,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,GO:0045957~negative regulation of complement activation, alternative pathway,GO:0045959~negative regulation of complement activation, classical pathway,GO:0046718~viral entry into host cell,GO:1900004~negative regulation of serine-type endopeptidase activity,GO:1900005~positive regulation of serine-type endopeptidase activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001851~complement component C3b binding,GO:0001855~complement component C4b binding,GO:0001861~complement component C4b receptor activity,GO:0004877~complement component C3b receptor activity,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05144:Malaria,hsa05152:Tuberculosis,	607486~Blood group, Knops system,611162~Malaria, severe, resistance to,CR1 deficiency~CR1 deficiency,SLE susceptibility~SLE susceptibility,		SM00032:CCP,	3D-structure,Blood group antigen,Complement pathway,Complete proteome,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Membrane,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Receptor,Reference proteome,Repeat,Signal,Sushi,Transmembrane,Transmembrane helix,	chain:Complement receptor type 1,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 21,domain:Sushi 22,domain:Sushi 23,domain:Sushi 24,domain:Sushi 25,domain:Sushi 26,domain:Sushi 27,domain:Sushi 28,domain:Sushi 29,domain:Sushi 3,domain:Sushi 30,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000117322	complement C3d receptor 2(CR2)	Homo sapiens	6.CD23_engagement,	h_blymphocytePathway:B Lymphocyte Cell Surface Molecules,		GO:0002430~complement receptor mediated signaling pathway,GO:0006955~immune response,GO:0006958~complement activation, classical pathway,GO:0030183~B cell differentiation,GO:0042100~B cell proliferation,GO:0045087~innate immune response,GO:0046718~viral entry into host cell,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0001848~complement binding,GO:0003677~DNA binding,GO:0004875~complement receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0042803~protein homodimerization activity,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa04640:Hematopoietic cell lineage,hsa04662:B cell receptor signaling pathway,hsa05169:Epstein-Barr virus infection,	610927~Systemic lupus erythematosus, susceptibility to, 9,614699~Immunodeficiency, common variable, 7,		SM00032:CCP,	3D-structure,Alternative splicing,Complement pathway,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunity,Innate immunity,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Sushi,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Complement receptor type 2,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 2,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000197766	complement factor D(CFD)	Homo sapiens		h_alternativePathway:Alternative Complement Pathway,h_compPathway:Complement Pathway,		GO:0002576~platelet degranulation,GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	613912~Complement factor D deficiency,		SM00020:Tryp_SPc,	3D-structure,Complement alternate pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Hydrolase,Immunity,Innate immunity,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Complement factor D,disulfide bond,domain:Peptidase S1,helix,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000168993	complexin 1(CPLX1)	Homo sapiens				GO:0006836~neurotransmitter transport,GO:0006887~exocytosis,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0014047~glutamate secretion,GO:0016079~synaptic vesicle exocytosis,GO:0017157~regulation of exocytosis,GO:0030073~insulin secretion,	GO:0005829~cytosol,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0043195~terminal bouton,GO:0070032~synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,GO:0070554~synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,	GO:0005326~neurotransmitter transporter activity,GO:0017075~syntaxin-1 binding,	IPR008849:Synaphin,	hsa04721:Synaptic vesicle cycle,				3D-structure,Coiled coil,Complete proteome,Cytoplasm,Exocytosis,Neurotransmitter transport,Proteomics identification,Reference proteome,Transport,	chain:Complexin-1,region of interest:Interaction with the SNARE complex,
ENSG00000145708	corticotropin releasing hormone binding protein(CRHBP)	Homo sapiens				GO:0001963~synaptic transmission, dopaminergic,GO:0002125~maternal aggressive behavior,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0007565~female pregnancy,GO:0007611~learning or memory,GO:0009755~hormone-mediated signaling pathway,GO:0033554~cellular response to stress,GO:0035690~cellular response to drug,GO:0035865~cellular response to potassium ion,GO:0042445~hormone metabolic process,GO:0045055~regulated exocytosis,GO:0048149~behavioral response to ethanol,GO:0051459~regulation of corticotropin secretion,GO:0051460~negative regulation of corticotropin secretion,GO:0071277~cellular response to calcium ion,GO:0071314~cellular response to cocaine,GO:0071320~cellular response to cAMP,GO:0071356~cellular response to tumor necrosis factor,GO:0071391~cellular response to estrogen stimulus,GO:0071392~cellular response to estradiol stimulus,GO:0097211~cellular response to gonadotropin-releasing hormone,GO:1900011~negative regulation of corticotropin-releasing hormone receptor activity,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005634~nucleus,GO:0005767~secondary lysosome,GO:0005771~multivesicular body,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0030141~secretory granule,GO:0030425~dendrite,GO:0031045~dense core granule,GO:0043196~varicosity,GO:0043204~perikaryon,GO:0043679~axon terminus,	GO:0005515~protein binding,GO:0042277~peptide binding,GO:0051424~corticotropin-releasing hormone binding,	IPR000859:CUB domain,IPR008435:Corticotropin-releasing factor binding,			PIRSF009279:corticotropin-releasing factor binding protein,		Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Corticotropin-releasing factor-binding protein,disulfide bond,glycosylation site:N-linked (GlcNAc...),signal peptide,
ENSG00000117266	cyclin dependent kinase 18(CDK18)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0051726~regulation of cell cycle,		GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	Alternative splicing,ATP-binding,Complete proteome,Kinase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 18,domain:Protein kinase,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ENSG00000250506	cyclin dependent kinase 3(CDK3)	Homo sapiens		h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0006468~protein phosphorylation,GO:0006974~cellular response to DNA damage stimulus,GO:0007067~mitotic nuclear division,GO:0008283~cell proliferation,GO:0045023~G0 to G1 transition,GO:0051301~cell division,GO:0051726~regulation of cell cycle,		GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004693~cyclin-dependent protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00220:S_TKc,	3D-structure,ATP-binding,Cell cycle,Cell division,Complete proteome,Kinase,Mitosis,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,	active site:Proton acceptor,binding site:ATP,chain:Cell division protein kinase 3,domain:Protein kinase,helix,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,strand,turn,
ENSG00000124762	cyclin dependent kinase inhibitor 1A(CDKN1A)	Homo sapiens	1.RBphosphoE2F,108.Regulating_glucose_transport,157.14-3-3_Cell_Cycle,26.cyclin-CDK_complexes,94.E2F_transcriptional_activity_cell_cycle,	h_atmPathway:ATM Signaling Pathway,h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,		GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000086~G2/M transition of mitotic cell cycle,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0010165~response to X-ray,GO:0010243~response to organonitrogen compound,GO:0010629~negative regulation of gene expression,GO:0030308~negative regulation of cell growth,GO:0030890~positive regulation of B cell proliferation,GO:0031100~organ regeneration,GO:0031668~cellular response to extracellular stimulus,GO:0033158~regulation of protein import into nucleus, translocation,GO:0034198~cellular response to amino acid starvation,GO:0034605~cellular response to heat,GO:0042326~negative regulation of phosphorylation,GO:0042493~response to drug,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0043066~negative regulation of apoptotic process,GO:0043068~positive regulation of programmed cell death,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045860~positive regulation of protein kinase activity,GO:0046685~response to arsenic-containing substance,GO:0048146~positive regulation of fibroblast proliferation,GO:0050821~protein stabilization,GO:0051412~response to corticosterone,GO:0055093~response to hyperoxia,GO:0060574~intestinal epithelial cell maturation,GO:0071479~cellular response to ionizing radiation,GO:0071480~cellular response to gamma radiation,GO:0071493~cellular response to UV-B,GO:0071850~mitotic cell cycle arrest,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:0090400~stress-induced premature senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:1904031~positive regulation of cyclin-dependent protein kinase activity,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000278~regulation of DNA biosynthetic process,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0043234~protein complex,GO:0048471~perinuclear region of cytoplasm,GO:0070557~PCNA-p21 complex,	GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019912~cyclin-dependent protein kinase activating kinase activity,GO:0030332~cyclin binding,GO:0031625~ubiquitin protein ligase binding,GO:0032403~protein complex binding,GO:0046872~metal ion binding,	IPR003175:Cyclin-dependent kinase inhibitor,	hsa04012:ErbB signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,				3D-structure,Acetylation,Cell cycle,Complete proteome,Cytoplasm,Direct protein sequencing,Kinase,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Protein kinase inhibitor,Reference proteome,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:Cyclin-dependent kinase inhibitor 1,helix,modified residue,mutagenesis site,sequence variant,short sequence motif:Nuclear localization signal,strand,zinc finger region:C4-type,
ENSG00000147889	cyclin dependent kinase inhibitor 2A(CDKN2A)	Homo sapiens	1.RBphosphoE2F,26.cyclin-CDK_complexes,94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_g1Pathway:Cell Cycle: G1/S Check Point ,		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0000422~mitophagy,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006351~transcription, DNA-templated,GO:0006364~rRNA processing,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0008285~negative regulation of cell proliferation,GO:0008637~apoptotic mitochondrial changes,GO:0010389~regulation of G2/M transition of mitotic cell cycle,GO:0016925~protein sumoylation,GO:0030308~negative regulation of cell growth,GO:0030889~negative regulation of B cell proliferation,GO:0031647~regulation of protein stability,GO:0031648~protein destabilization,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033235~positive regulation of protein sumoylation,GO:0034393~positive regulation of smooth muscle cell apoptotic process,GO:0035986~senescence-associated heterochromatin focus assembly,GO:0042326~negative regulation of phosphorylation,GO:0043065~positive regulation of apoptotic process,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046825~regulation of protein export from nucleus,GO:0048103~somatic stem cell division,GO:0050821~protein stabilization,GO:0051444~negative regulation of ubiquitin-protein transferase activity,GO:0051882~mitochondrial depolarization,GO:0070534~protein K63-linked ubiquitination,GO:0071158~positive regulation of cell cycle arrest,GO:0090398~cellular senescence,GO:0090399~replicative senescence,GO:1900182~positive regulation of protein localization to nucleus,GO:1901798~positive regulation of signal transduction by p53 class mediator,GO:1902510~regulation of apoptotic DNA fragmentation,GO:1903051~negative regulation of proteolysis involved in cellular protein catabolic process,GO:1903214~regulation of protein targeting to mitochondrion,GO:2000059~negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000774~positive regulation of cellular senescence,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0035985~senescence-associated heterochromatin focus,GO:0043234~protein complex,	GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0004861~cyclin-dependent protein serine/threonine kinase inhibitor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0019789~SUMO transferase activity,GO:0019901~protein kinase binding,GO:0044822~poly(A) RNA binding,GO:0051059~NF-kappaB binding,GO:0055105~ubiquitin-protein transferase inhibitor activity,GO:0097371~MDM2/MDM4 family protein binding,	IPR010868:Cyclin-dependent kinase inhibitor 2A,IPR020683:Ankyrin repeat-containing domain,	hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05223:Non-small cell lung cancer,	155601~Melanoma, cutaneous malignant, 2,155755~Melanoma and neural system tumor syndrome,606719~Pancreatic cancer/melanoma syndrome,Orolaryngeal cancer, multiple,~Orolaryngeal cancer, multiple,,			3D-structure,Acetylation,Alternative splicing,ANK repeat,Apoptosis,Cell cycle,Complete proteome,Cyclin,Cytoplasm,Disease mutation,DNA-binding,Kinase,Li-Fraumeni syndrome,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,rRNA processing,Transcription,Transcription regulation,Transferase,Tumor suppressor,Ubl conjugation,Ubl conjugation pathway,	chain:Cyclin-dependent kinase inhibitor 2A, isoform 4,chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000101439	cystatin C(CST3)	Homo sapiens				GO:0001654~eye development,GO:0001666~response to hypoxia,GO:0001775~cell activation,GO:0006915~apoptotic process,GO:0006952~defense response,GO:0007420~brain development,GO:0007431~salivary gland development,GO:0007566~embryo implantation,GO:0008284~positive regulation of cell proliferation,GO:0009636~response to toxic substance,GO:0009743~response to carbohydrate,GO:0010466~negative regulation of peptidase activity,GO:0010711~negative regulation of collagen catabolic process,GO:0010716~negative regulation of extracellular matrix disassembly,GO:0031667~response to nutrient levels,GO:0032355~response to estradiol,GO:0034103~regulation of tissue remodeling,GO:0042493~response to drug,GO:0042747~circadian sleep/wake cycle, REM sleep,GO:0043067~regulation of programmed cell death,GO:0043206~extracellular fibril organization,GO:0044267~cellular protein metabolic process,GO:0045740~positive regulation of DNA replication,GO:0045861~negative regulation of proteolysis,GO:0048678~response to axon injury,GO:0060009~Sertoli cell development,GO:0060311~negative regulation of elastin catabolic process,GO:0060313~negative regulation of blood vessel remodeling,GO:0060548~negative regulation of cell death,GO:0070301~cellular response to hydrogen peroxide,GO:2000117~negative regulation of cysteine-type endopeptidase activity,	GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0005771~multivesicular body,GO:0005783~endoplasmic reticulum,GO:0030424~axon,GO:0031965~nuclear membrane,GO:0031982~vesicle,GO:0043025~neuronal cell body,GO:0043292~contractile fiber,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0001540~beta-amyloid binding,GO:0002020~protease binding,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000010:Proteinase inhibitor I25, cystatin,IPR018073:Proteinase inhibitor I25, cystatin, conserved site,IPR027214:Cystatin,	hsa04970:Salivary secretion,	105150~Cerebral amyloid angiopathy,611953~Macular degeneration, age-related, 11,		SM00043:CY,	3D-structure,Age-related macular degeneration,Amyloid,Amyloidosis,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Phosphoprotein,Polymorphism,Protease inhibitor,Reference proteome,Secreted,Signal,Thiol protease inhibitor,	chain:Cystatin-C,disulfide bond,helix,mutagenesis site,sequence variant,short sequence motif:Secondary area of contact,signal peptide,site:Reactive site,strand,turn,
ENSG00000077984	cystatin F(CST7)	Homo sapiens				GO:0006955~immune response,GO:2000117~negative regulation of cysteine-type endopeptidase activity,	GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0002020~protease binding,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,	IPR000010:Proteinase inhibitor I25, cystatin,IPR027214:Cystatin,				SM00043:CY,	3D-structure,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Protease inhibitor,Reference proteome,Secreted,Signal,Thiol protease inhibitor,	chain:Cystatin-F,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,short sequence motif:Secondary area of contact,signal peptide,site:Reactive site,strand,turn,
ENSG00000036530	cytochrome P450 family 46 subfamily A member 1(CYP46A1)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0006699~bile acid biosynthetic process,GO:0006707~cholesterol catabolic process,GO:0006805~xenobiotic metabolic process,GO:0007399~nervous system development,GO:0016125~sterol metabolic process,GO:0055114~oxidation-reduction process,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,	GO:0005506~iron ion binding,GO:0008395~steroid hydroxylase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0020037~heme binding,GO:0033781~cholesterol 24-hydroxylase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR017972:Cytochrome P450, conserved site,	hsa00120:Primary bile acid biosynthesis,				3D-structure,Alternative splicing,Cholesterol metabolism,Complete proteome,Endoplasmic reticulum,Heme,Iron,Lipid metabolism,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Proteomics identification,Reference proteome,Signal,Steroid metabolism,Sterol metabolism,Transmembrane,Transmembrane helix,	chain:Cholesterol 24-hydroxylase,compositionally biased region:Poly-Pro,helix,metal ion-binding site:Iron (heme axial ligand),strand,transmembrane region,turn,
ENSG00000121570	developmental pluripotency associated 4(DPPA4)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0035019~somatic stem cell population maintenance,GO:0060484~lung-associated mesenchyme development,	GO:0005654~nucleoplasm,	GO:0005515~protein binding,	IPR025891:Developmental pluripotency-associated protein 2/4, C-terminal domain,IPR025892:Developmental pluripotency-associated protein 2/4, central domain,					Complete proteome,Developmental protein,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Developmental pluripotency-associated protein 4,sequence variant,
ENSG00000151640	dihydropyrimidinase like 4(DPYSL4)	Homo sapiens				GO:0007399~nervous system development,GO:0070997~neuron death,GO:0097485~neuron projection guidance,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0016810~hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,GO:0031005~filamin binding,	IPR006680:Amidohydrolase 1,IPR011059:Metal-dependent hydrolase, composite domain,IPR011778:Hydantoinase/dihydropyrimidinase,					Complete proteome,Cytoplasm,Direct protein sequencing,Methylation,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Dihydropyrimidinase-related protein 4,modified residue,sequence conflict,
ENSG00000069696	dopamine receptor D4(DRD4)	Homo sapiens				GO:0000187~activation of MAPK activity,GO:0001662~behavioral fear response,GO:0001963~synaptic transmission, dopaminergic,GO:0001975~response to amphetamine,GO:0006874~cellular calcium ion homeostasis,GO:0007194~negative regulation of adenylate cyclase activity,GO:0007195~adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0007212~dopamine receptor signaling pathway,GO:0008344~adult locomotory behavior,GO:0030818~negative regulation of cAMP biosynthetic process,GO:0032417~positive regulation of sodium:proton antiporter activity,GO:0033674~positive regulation of kinase activity,GO:0034776~response to histamine,GO:0035176~social behavior,GO:0042053~regulation of dopamine metabolic process,GO:0042417~dopamine metabolic process,GO:0042596~fear response,GO:0042752~regulation of circadian rhythm,GO:0048148~behavioral response to cocaine,GO:0048149~behavioral response to ethanol,GO:0048511~rhythmic process,GO:0050482~arachidonic acid secretion,GO:0050709~negative regulation of protein secretion,GO:0051586~positive regulation of dopamine uptake involved in synaptic transmission,GO:0060080~inhibitory postsynaptic potential,GO:1901386~negative regulation of voltage-gated calcium channel activity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0098794~postsynapse,	GO:0001588~dopamine neurotransmitter receptor activity, coupled via Gs,GO:0001591~dopamine neurotransmitter receptor activity, coupled via Gi/Go,GO:0004952~dopamine neurotransmitter receptor activity,GO:0005515~protein binding,GO:0008144~drug binding,GO:0015459~potassium channel regulator activity,GO:0017124~SH3 domain binding,GO:0035240~dopamine binding,GO:0042802~identical protein binding,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000929:Dopamine receptor family,IPR002185:Dopamine D4 receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04728:Dopaminergic synapse,	143465~Attention deficit-hyperactivity disorder,601696~Novelty seeking personality,Autonomic nervous system dysfunction~Autonomic nervous system dysfunction,		SM01381:SM01381,	Biological rhythms,Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Transducer,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:D(4) dopamine receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:7 X 16 AA approximate tandem repeats of [PA]-A-P-G-L-P-[PQR]-[DG]-P-C-G-P-D-C-A- P,repeat:1; approximate,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7; approximate,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000177990	dpy-19 like 2(DPY19L2)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007286~spermatid development,GO:0018406~protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,	GO:0005634~nucleus,GO:0005637~nuclear inner membrane,GO:0016021~integral component of membrane,	GO:0000030~mannosyltransferase activity,	IPR018732:Dpy-19,		613958~Spermatogenic failure 9,			Alternative splicing,Complete proteome,Developmental protein,Differentiation,Glycosyltransferase,Membrane,Polymorphism,Proteomics identification,Reference proteome,Spermatogenesis,Transferase,Transmembrane,Transmembrane helix,	chain:Protein dpy-19 homolog 2,sequence conflict,sequence variant,transmembrane region,
ENSG00000120738	early growth response 1(EGR1)	Homo sapiens	114.Genomic_reformatting_Brain_Ischemia,	h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway,	Transcription / Cell division and chromosome partitioning,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001666~response to hypoxia,GO:0002931~response to ischemia,GO:0006366~transcription from RNA polymerase II promoter,GO:0009749~response to glucose,GO:0030217~T cell differentiation,GO:0030509~BMP signaling pathway,GO:0032868~response to insulin,GO:0033233~regulation of protein sumoylation,GO:0035914~skeletal muscle cell differentiation,GO:0042981~regulation of apoptotic process,GO:0044849~estrous cycle,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046886~positive regulation of hormone biosynthetic process,GO:0050725~positive regulation of interleukin-1 beta biosynthetic process,GO:0060337~type I interferon signaling pathway,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070498~interleukin-1-mediated signaling pathway,GO:0071480~cellular response to gamma radiation,GO:0071504~cellular response to heparin,GO:0071506~cellular response to mycophenolic acid,GO:0072110~glomerular mesangial cell proliferation,GO:0072303~positive regulation of glomerular metanephric mesangial cell proliferation,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:0098759~cellular response to interleukin-8,GO:2000182~regulation of progesterone biosynthetic process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0010385~double-stranded methylated DNA binding,GO:0035035~histone acetyltransferase binding,GO:0043565~sequence-specific DNA binding,GO:0044729~hemi-methylated DNA-binding,GO:0046872~metal ion binding,GO:1990841~promoter-specific chromatin binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR021839:Protein of unknown function DUF3432,IPR021849:Protein of unknown function DUF3446,	hsa05020:Prion diseases,hsa05166:HTLV-I infection,			SM00355:ZnF_C2H2,	3D-structure,Activator,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Early growth response protein 1,compositionally biased region:Gly/Ser-rich,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
ENSG00000112796	ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)(ENPP5)	Homo sapiens				GO:0007154~cell communication,GO:0008152~metabolic process,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0003824~catalytic activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR002591:Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase,IPR017849:Alkaline phosphatase-like, alpha/beta/alpha,IPR017850:Alkaline-phosphatase-like, core domain,IPR024873:Ectonucleotide pyrophosphatase/phosphodiesterase family,					Complete proteome,Glycoprotein,Hydrolase,Membrane,Metal-binding,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,Zinc,	chain:Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,transmembrane region,
ENSG00000128886	elongation factor for RNA polymerase II 3(ELL3)	Homo sapiens				GO:0006354~DNA-templated transcription, elongation,GO:0006366~transcription from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0007283~spermatogenesis,GO:0010717~regulation of epithelial to mesenchymal transition,GO:0032786~positive regulation of DNA-templated transcription, elongation,GO:0042795~snRNA transcription from RNA polymerase II promoter,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048863~stem cell differentiation,GO:0050769~positive regulation of neurogenesis,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000179~positive regulation of neural precursor cell proliferation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0008023~transcription elongation factor complex,	GO:0005515~protein binding,GO:0035326~enhancer binding,	IPR010844:Occludin/RNA polymerase II elongation factor, ELL domain,IPR019464:RNA polymerase II elongation factor ELL,					Alternative splicing,Complete proteome,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:RNA polymerase II elongation factor ELL3,sequence conflict,sequence variant,
ENSG00000167136	endonuclease G(ENDOG)	Homo sapiens		h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,		GO:0001701~in utero embryonic development,GO:0006309~apoptotic DNA fragmentation,GO:0006310~DNA recombination,GO:0007568~aging,GO:0009612~response to mechanical stimulus,GO:0032355~response to estradiol,GO:0034612~response to tumor necrosis factor,GO:0036475~neuron death in response to oxidative stress,GO:0046677~response to antibiotic,GO:0071277~cellular response to calcium ion,GO:0071333~cellular response to glucose stimulus,GO:0071456~cellular response to hypoxia,GO:1901300~positive regulation of hydrogen peroxide-mediated programmed cell death,GO:1902512~positive regulation of apoptotic DNA fragmentation,	GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0043204~perikaryon,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004536~deoxyribonuclease activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001604:DNA/RNA non-specific endonuclease,IPR018524:DNA/RNA non-specific endonuclease, active site,IPR020821:Extracellular Endonuclease, subunit A,	hsa04210:Apoptosis,			SM00477:NUC,SM00892:SM00892,	Complete proteome,Endonuclease,Hydrolase,Magnesium,Manganese,Metal-binding,Mitochondrion,Nuclease,Polymorphism,Reference proteome,Transit peptide,	active site:Proton acceptor,chain:Endonuclease G, mitochondrial,metal ion-binding site:Magnesium or manganese; catalytic,sequence conflict,sequence variant,transit peptide:Mitochondrion,
ENSG00000149564	endothelial cell adhesion molecule(ESAM)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0016337~single organismal cell-cell adhesion,GO:0050900~leukocyte migration,	GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0005923~bicellular tight junction,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04670:Leukocyte transendothelial migration,			SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Tight junction,Transmembrane,Transmembrane helix,Transmembrane helixFT                                PLGLSFSAPKMEWLWKWRDAH,	chain:Endothelial cell-selective adhesion molecule,disulfide bond,domain:Ig-like C2-type,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000134463	enoyl-CoA hydratase domain containing 3(ECHDC3)	Homo sapiens				GO:0008152~metabolic process,	GO:0005739~mitochondrion,	GO:0003824~catalytic activity,	IPR001753:Crotonase superfamily,					3D-structure,Alternative splicing,Complete proteome,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Transit peptide,	chain:Enoyl-CoA hydratase domain-containing protein 3, mitochondrial,helix,sequence conflict,sequence variant,splice variant,strand,transit peptide:Mitochondrion,turn,
ENSG00000167880	envoplakin(EVPL)	Homo sapiens			Cell division and chromosome partitioning,	GO:0008544~epidermis development,GO:0018149~peptide cross-linking,GO:0030216~keratinocyte differentiation,GO:0031424~keratinization,GO:0098609~cell-cell adhesion,	GO:0001533~cornified envelope,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005913~cell-cell adherens junction,GO:0030057~desmosome,GO:0045111~intermediate filament cytoskeleton,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,GO:0019215~intermediate filament binding,GO:0030674~protein binding, bridging,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001101:Plectin repeat,IPR018159:Spectrin/alpha-actinin,				SM00150:SPEC,SM00250:PLEC,	3D-structure,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Isopeptide bond,Keratinization,Lipoprotein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Envoplakin,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),lipid moiety-binding region:Omega-hydroxyceramide glutamate ester,modified residue,region of interest:4 X 4 AA tandem repeats of K-G-S-P,region of interest:Central fibrous rod domain,region of interest:Globular 1,region of interest:Globular 2,repeat:Plectin 1,repeat:Plectin 2,repeat:Plectin 3,repeat:Plectin 4,repeat:Plectin 5,repeat:Plectin 6,repeat:Plectin 7,repeat:Spectrin,sequence variant,
ENSG00000086289	ependymin related 1(EPDR1)	Homo sapiens				GO:0007160~cell-matrix adhesion,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0070062~extracellular exosome,	GO:0005509~calcium ion binding,	IPR001299:Ependymin,IPR018224:Ependymin, conserved site,				SM00026:EPEND,	Alternative splicing,Complete proteome,Glycoprotein,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Mammalian ependymin-related protein 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
ENSG00000143590	ephrin A3(EFNA3)	Homo sapiens				GO:0007267~cell-cell signaling,GO:0007411~axon guidance,GO:0048013~ephrin receptor signaling pathway,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,	GO:0005005~transmembrane-ephrin receptor activity,GO:0005515~protein binding,GO:0046875~ephrin receptor binding,	IPR001799:Ephrin,IPR008972:Cupredoxin,IPR019765:Ephrin, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04360:Axon guidance,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Lipoprotein,Membrane,Polymorphism,Reference proteome,Signal,	chain:Ephrin-A3,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,
ENSG00000124882	epiregulin(EREG)	Homo sapiens				GO:0000165~MAPK cascade,GO:0001525~angiogenesis,GO:0001550~ovarian cumulus expansion,GO:0001556~oocyte maturation,GO:0001819~positive regulation of cytokine production,GO:0007143~female meiotic division,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0009299~mRNA transcription,GO:0009653~anatomical structure morphogenesis,GO:0009887~organ morphogenesis,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030216~keratinocyte differentiation,GO:0030728~ovulation,GO:0038128~ERBB2 signaling pathway,GO:0042060~wound healing,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042327~positive regulation of phosphorylation,GO:0042700~luteinizing hormone signaling pathway,GO:0043434~response to peptide hormone,GO:0043547~positive regulation of GTPase activity,GO:0043616~keratinocyte proliferation,GO:0045089~positive regulation of innate immune response,GO:0045410~positive regulation of interleukin-6 biosynthetic process,GO:0045740~positive regulation of DNA replication,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045840~positive regulation of mitotic nuclear division,GO:0045860~positive regulation of protein kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048146~positive regulation of fibroblast proliferation,GO:0048160~primary follicle stage,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051151~negative regulation of smooth muscle cell differentiation,GO:0051781~positive regulation of cell division,GO:2000145~regulation of cell motility,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005887~integral component of plasma membrane,	GO:0004713~protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005154~epidermal growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000742:Epidermal growth factor-like domain,IPR013032:EGF-like, conserved site,IPR015497:Epidermal growth factor receptor ligand,	hsa04012:ErbB signaling pathway,				3D-structure,Angiogenesis,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disulfide bond,EGF-like domain,Glycoprotein,Growth factor,Membrane,Mitogen,Polymorphism,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Epiregulin,chain:Proepiregulin,compositionally biased region:Arg/Lys-rich (basic),disulfide bond,domain:EGF-like,glycosylation site:N-linked (GlcNAc...),propeptide:Removed in mature form,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000253626	eukaryotic translation initiation factor 5A-like 1(EIF5AL1)	Homo sapiens				GO:0006452~translational frameshifting,GO:0015031~protein transport,GO:0045901~positive regulation of translational elongation,GO:0045905~positive regulation of translational termination,GO:0051028~mRNA transport,	GO:0005643~nuclear pore,GO:0005789~endoplasmic reticulum membrane,	GO:0003746~translation elongation factor activity,GO:0043022~ribosome binding,	IPR001884:Translation elongation factor IF5A,IPR008991:Translation protein SH3-like domain,IPR012340:Nucleic acid-binding, OB-fold,IPR014722:Ribosomal protein L2 domain 2,IPR019769:Translation elongation factor, IF5A, hypusine site,IPR020189:Translation elongation factor, IF5A C-terminal,			PIRSF003025:translation initiation factor eIF-5A,	SM01376:SM01376,	Complete proteome,Cytoplasm,Elongation factor,Endoplasmic reticulum,Hypusine,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Protein biosynthesis,Protein transport,Reference proteome,RNA-binding,Translocation,Transport,	chain:Eukaryotic translation initiation factor 5A-1,chain:Eukaryotic translation initiation factor 5A-1-like,helix,modified residue,mutagenesis site,region of interest:DOHH-binding,sequence conflict,splice variant,strand,turn,
ENSG00000203950	family with sequence similarity 127 member B(FAM127B)	Homo sapiens						GO:0005515~protein binding,						Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM127B,sequence variant,
ENSG00000109794	family with sequence similarity 149 member A(FAM149A)	Homo sapiens							IPR022194:Protein of unknown function DUF3719,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM149A,compositionally biased region:Poly-Ala,compositionally biased region:Pro-rich,compositionally biased region:Ser-rich,sequence conflict,sequence variant,splice variant,
ENSG00000168754	family with sequence similarity 178 member B(FAM178B)	Homo sapiens							IPR026161:FAM178 family,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM178B,sequence variant,splice variant,
ENSG00000189350	family with sequence similarity 179 member A(FAM179A)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,IPR024395:CLASP N-terminal domain,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM179A,sequence conflict,sequence variant,splice variant,
ENSG00000160767	family with sequence similarity 189 member B(FAM189B)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0050699~WW domain binding,	IPR007237:CD20-like,					Alternative splicing,Complete proteome,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein FAM189B,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),sequence variant,transmembrane region,
ENSG00000188820	family with sequence similarity 26 member F(FAM26F)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0098655~cation transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005261~cation channel activity,						Alternative splicing,Complete proteome,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Protein FAM26F,compositionally biased region:Poly-Ala,modified residue,sequence variant,transmembrane region,
ENSG00000226777	family with sequence similarity 30, member A(FAM30A)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000185112	family with sequence similarity 43 member A(FAM43A)	Homo sapiens							IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,				SM00462:PTB,	Complete proteome,Reference proteome,	chain:Protein FAM43A,sequence conflict,
ENSG00000197872	family with sequence similarity 49 member A(FAM49A)	Homo sapiens					GO:0005622~intracellular,		IPR009828:Protein of unknown function DUF1394,					Complete proteome,Proteomics identification,Reference proteome,	chain:Protein FAM49A,
ENSG00000172717	family with sequence similarity 71 member D(FAM71D)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,		IPR022168:Protein of unknown function DUF3699,					Alternative splicing,Complete proteome,Reference proteome,	chain:Protein FAM71D,sequence conflict,splice variant,
ENSG00000142530	family with sequence similarity 71 member E1(FAM71E1)	Homo sapiens					GO:0005634~nucleus,		IPR022168:Protein of unknown function DUF3699,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM71E1,sequence variant,splice variant,
ENSG00000186523	family with sequence similarity 86 member B1(FAM86B1)	Homo sapiens				GO:0032259~methylation,		GO:0008168~methyltransferase activity,	IPR019410:Nicotinamide N-methyltransferase-like,					Alternative splicing,Complete proteome,Methyltransferase,Reference proteome,S-adenosyl-L-methionine,Transferase,	chain:Protein FAM86A,chain:Protein FAM86B1,chain:Protein FAM86B2,sequence conflict,sequence variant,splice variant,
ENSG00000164687	fatty acid binding protein 5(FABP5)	Homo sapiens				GO:0006006~glucose metabolic process,GO:0006629~lipid metabolic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0008544~epidermis development,GO:0009611~response to wounding,GO:0015758~glucose transport,GO:0019433~triglyceride catabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005504~fatty acid binding,GO:0005515~protein binding,GO:0008289~lipid binding,	IPR000463:Cytosolic fatty-acid binding,IPR000566:Lipocalin/cytosolic fatty-acid binding protein domain,IPR011038:Calycin-like,IPR012674:Calycin,	hsa03320:PPAR signaling pathway,				3D-structure,Acetylation,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Lipid-binding,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	binding site:Fatty acid,chain:Fatty acid-binding protein, epidermal,disulfide bond,helix,modified residue,region of interest:Fatty acid binding,strand,
ENSG00000141965	fem-1 homolog A(FEM1A)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0050728~negative regulation of inflammatory response,GO:0051438~regulation of ubiquitin-protein transferase activity,	GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0031867~EP4 subtype prostaglandin E2 receptor binding,	IPR002110:Ankyrin repeat,IPR011990:Tetratricopeptide-like helical,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Cytoplasm,Polymorphism,Reference proteome,Repeat,TPR repeat,Ubl conjugation pathway,	chain:Protein fem-1 homolog A,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,repeat:TPR 1,repeat:TPR 2,sequence variant,
ENSG00000137441	fibroblast growth factor binding protein 2(FGFBP2)	Homo sapiens					GO:0005615~extracellular space,	GO:0019838~growth factor binding,	IPR010510:FGF binding 1,					Complete proteome,Disulfide bond,Growth factor binding,Polymorphism,Reference proteome,Secreted,Signal,	chain:Fibroblast growth factor-binding protein 2,disulfide bond,sequence variant,signal peptide,
ENSG00000105255	fibronectin type III and SPRY domain containing 1(FSD1)	Homo sapiens				GO:0007067~mitotic nuclear division,GO:0051301~cell division,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0005874~microtubule,GO:0032154~cleavage furrow,		IPR001870:B30.2/SPRY domain,IPR003649:B-box, C-terminal,IPR003877:SPla/RYanodine receptor SPRY,IPR003961:Fibronectin, type III,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR017903:COS domain,				SM00060:FN3,SM00449:SPRY,SM00502:BBC,	Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Methylation,Microtubule,Mitosis,Nucleus,Polymorphism,Proteomics identification,Reference proteome,	chain:Fibronectin type III and SPRY domain- containing protein 1,domain:B30.2/SPRY,domain:COS,domain:Fibronectin type-III,modified residue,mutagenesis site,sequence conflict,sequence variant,
ENSG00000163520	fibulin 2(FBLN2)	Homo sapiens				GO:0010811~positive regulation of cell-substrate adhesion,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:1903561~extracellular vesicle,	GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0050840~extracellular matrix binding,	IPR000020:Anaphylatoxin/fibulin,IPR000152:EGF-type aspartate/asparagine hydroxylation site,IPR000742:Epidermal growth factor-like domain,IPR001881:EGF-like calcium-binding,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR013032:EGF-like, conserved site,IPR018097:EGF-like calcium-binding, conserved site,IPR026823:Complement Clr-like EGF domain,				SM00104:ANATO,SM00179:EGF_CA,SM00181:EGF,	Alternative splicing,Calcium,Complete proteome,Disulfide bond,EGF-like domain,Extracellular matrix,Glycoprotein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Fibulin-2,disulfide bond,domain:Anaphylatoxin-like 1,domain:Anaphylatoxin-like 2,domain:Anaphylatoxin-like 3,domain:EGF-like 10; calcium-binding,domain:EGF-like 1; calcium-binding,domain:EGF-like 2,domain:EGF-like 3; calcium-binding,domain:EGF-like 4; calcium-binding,domain:EGF-like 5; calcium-binding,domain:EGF-like 6; calcium-binding,domain:EGF-like 7; calcium-binding,domain:EGF-like 8; calcium-binding,domain:EGF-like 9; calcium-binding,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Domain III,region of interest:N,region of interest:Subdomain NA (Cys-rich),region of interest:Subdomain NB (Cys-free),sequence conflict,sequence variant,signal peptide,
ENSG00000122025	fms related tyrosine kinase 3(FLT3)	Homo sapiens		h_erythPathway:Erythrocyte Differentiation Pathway,		GO:0001776~leukocyte homeostasis,GO:0002318~myeloid progenitor cell differentiation,GO:0002328~pro-B cell differentiation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0008284~positive regulation of cell proliferation,GO:0010243~response to organonitrogen compound,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0030097~hemopoiesis,GO:0030154~cell differentiation,GO:0030183~B cell differentiation,GO:0031100~organ regeneration,GO:0035726~common myeloid progenitor cell proliferation,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0042981~regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0046651~lymphocyte proliferation,GO:0046777~protein autophosphorylation,GO:0071345~cellular response to cytokine stimulus,GO:0071385~cellular response to glucocorticoid stimulus,GO:0097028~dendritic cell differentiation,	GO:0005634~nucleus,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0043234~protein complex,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004896~cytokine receptor activity,GO:0005021~vascular endothelial growth factor-activated receptor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0032403~protein complex binding,GO:0035259~glucocorticoid receptor binding,GO:0042803~protein homodimerization activity,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001824:Tyrosine-protein kinase, receptor class III, conserved site,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,hsa05230:Central carbon metabolism in cancer,	601626~Leukemia, acute myeloid, reduced survival in, somatic,601626~Leukemia, acute myeloid, somatic,613065~Leukemia, acute lymphoblastic, somatic,		SM00219:TyrKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Endoplasmic reticulum,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:FL cytokine receptor,domain:Ig-like C2-type,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000134363	follistatin(FST)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002244~hematopoietic progenitor cell differentiation,GO:0007165~signal transduction,GO:0032926~negative regulation of activin receptor signaling pathway,GO:0051798~positive regulation of hair follicle development,	GO:0005576~extracellular region,	GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0048185~activin binding,	IPR002350:Kazal domain,IPR003645:Follistatin-like, N-terminal,IPR015369:Follistatin/Osteonectin EGF domain,IPR017878:TB domain,	hsa04350:TGF-beta signaling pathway,			SM00274:FOLN,SM00280:KAZAL,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Follistatin,compositionally biased region:Asp/Glu-rich (highly acidic),disulfide bond,domain:Follistatin-like 1,domain:Follistatin-like 2,domain:Follistatin-like 3,domain:Kazal-like 1,domain:Kazal-like 2,domain:Kazal-like 3,domain:TB,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,splice variant,strand,turn,
ENSG00000137166	forkhead box P4(FOXP4)	Homo sapiens			Transcription,	GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001766:Transcription factor, fork head,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00339:FH,	Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Forkhead box protein P4,compositionally biased region:Gln-rich,DNA-binding region:Fork-head,domain:Leucine-zipper,modified residue,sequence variant,zinc finger region:C2H2-type,
ENSG00000160282	formimidoyltransferase cyclodeaminase(FTCD)	Homo sapiens				GO:0006548~histidine catabolic process,GO:0006760~folic acid-containing compound metabolic process,GO:0007010~cytoskeleton organization,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,GO:0035999~tetrahydrofolate interconversion,GO:0044237~cellular metabolic process,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005794~Golgi apparatus,GO:0005814~centriole,GO:0005829~cytosol,GO:0030868~smooth endoplasmic reticulum membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0005515~protein binding,GO:0005542~folic acid binding,GO:0008017~microtubule binding,GO:0016740~transferase activity,GO:0030407~formimidoyltransferase activity,GO:0030409~glutamate formimidoyltransferase activity,GO:0030412~formimidoyltetrahydrofolate cyclodeaminase activity,	IPR004227:Formiminotransferase catalytic domain,IPR007044:Cyclodeaminase/cyclohydrolase,IPR012886:Formiminotransferase, N-terminal subdomain,IPR013802:Formiminotransferase, C-terminal subdomain,IPR022384:Formiminotransferas, N- and C-terminal subdomains,	hsa00340:Histidine metabolism,hsa00670:One carbon pool by folate,hsa01100:Metabolic pathways,	229100~Glutamate formiminotransferase deficiency,		SM01221:SM01221,SM01222:SM01222,	Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Folate-binding,Golgi apparatus,Histidine metabolism,Lyase,Multifunctional enzyme,Phosphoprotein,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,	active site:For cyclodeaminase activity,active site:For formimidoyltransferase activity,chain:Formimidoyltransferase-cyclodeaminase,modified residue,region of interest:Cyclodeaminase/cyclohydrolase,region of interest:Formiminotransferase C-subdomain,region of interest:Formiminotransferase N-subdomain,region of interest:Linker,sequence variant,splice variant,
ENSG00000248905	formin 1(FMN1)	Homo sapiens				GO:0010467~gene expression,GO:0035136~forelimb morphogenesis,GO:0035137~hindlimb morphogenesis,GO:0045010~actin nucleation,GO:0048705~skeletal system morphogenesis,GO:0048813~dendrite morphogenesis,GO:0051127~positive regulation of actin nucleation,GO:0051894~positive regulation of focal adhesion assembly,GO:0072092~ureteric bud invasion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0005886~plasma membrane,GO:0005912~adherens junction,GO:0015630~microtubule cytoskeleton,	GO:0003779~actin binding,GO:0008017~microtubule binding,GO:0017124~SH3 domain binding,	IPR001265:Formin,IPR015425:Actin-binding FH2,				SM00498:FH2,	Actin-binding,Alternative splicing,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Formin-1,compositionally biased region:Pro-rich,domain:FH1,domain:FH2,modified residue,region of interest:Mediates interaction with alpha-catenin,region of interest:Microtubule-binding,sequence variant,splice variant,
ENSG00000180549	fucosyltransferase 7(FUT7)	Homo sapiens		h_aMANpathway:Steps in the Glycosylation of Mammalian N-linked Oligosaccarides,		GO:0002361~CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,GO:0002522~leukocyte migration involved in immune response,GO:0006486~protein glycosylation,GO:0006487~protein N-linked glycosylation,GO:0036065~fucosylation,GO:0042355~L-fucose catabolic process,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0032580~Golgi cisterna membrane,	GO:0008417~fucosyltransferase activity,GO:0046920~alpha-(1->3)-fucosyltransferase activity,	IPR001503:Glycosyl transferase, family 10,	hsa00514:Other types of O-glycan biosynthesis,hsa00601:Glycosphingolipid biosynthesis - lacto and neolacto series,hsa01100:Metabolic pathways,				Complete proteome,Disulfide bond,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-(1,3)-fucosyltransferase,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000149328	galactosidase beta 1 like 2(GLB1L2)	Homo sapiens				GO:0005975~carbohydrate metabolic process,	GO:0005576~extracellular region,GO:0005773~vacuole,	GO:0004565~beta-galactosidase activity,	IPR001944:Glycoside hydrolase, family 35,IPR008979:Galactose-binding domain-like,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,IPR019801:Glycoside hydrolase, family 35, conserved site,IPR026283:Beta-galactosidase 1-like,			PIRSF006336:beta-galactosidase,		Complete proteome,Glycosidase,Hydrolase,Reference proteome,Secreted,Signal,	active site:Nucleophile,active site:Proton donor,chain:Beta-galactosidase-1-like protein 2,sequence conflict,signal peptide,
ENSG00000131981	galectin 3(LGALS3)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030593~neutrophil chemotaxis,GO:0030855~epithelial cell differentiation,GO:0042129~regulation of T cell proliferation,GO:0045087~innate immune response,GO:0045806~negative regulation of endocytosis,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050918~positive chemotaxis,GO:0070232~regulation of T cell apoptotic process,GO:0071674~mononuclear cell migration,GO:0071677~positive regulation of mononuclear cell migration,GO:0090280~positive regulation of calcium ion import,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000521~negative regulation of immunological synapse formation,GO:2001189~negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:2001200~positive regulation of dendritic cell differentiation,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0019863~IgE binding,GO:0030246~carbohydrate binding,GO:0042056~chemoattractant activity,GO:0043236~laminin binding,GO:0044822~poly(A) RNA binding,	IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00276:GLECT,SM00908:SM00908,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Differentiation,Disulfide bond,IgE-binding protein,Immunity,Innate immunity,Lectin,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Spliceosome,	chain:Galectin-3,disulfide bond,domain:Galectin,helix,modified residue,region of interest:8 X 9 AA tandem repeats of Y-P-G-X(3)-P- G-A,region of interest:Beta-galactoside binding,repeat:1,repeat:2,repeat:3,repeat:4; approximate,repeat:5,repeat:6; approximate,repeat:7; approximate,repeat:8; approximate,sequence conflict,sequence variant,strand,
ENSG00000121742	gap junction protein beta 6(GJB6)	Homo sapiens				GO:0006915~apoptotic process,GO:0007154~cell communication,GO:0007568~aging,GO:0007605~sensory perception of sound,GO:0008285~negative regulation of cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0042471~ear morphogenesis,GO:0048839~inner ear development,GO:0051602~response to electrical stimulus,GO:0071333~cellular response to glucose stimulus,	GO:0005829~cytosol,GO:0005922~connexon complex,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0030054~cell junction,		IPR000500:Connexin,IPR013092:Connexin, N-terminal,IPR017990:Connexin, conserved site,IPR019570:Gap junction protein, cysteine-rich domain,		129500~Ectodermal dysplasia 2, Clouston type,220290~Deafness, digenic GJB2/GJB6,612643~Deafness, autosomal dominant 3B,612645~Deafness, autosomal recessive 1B,		SM00037:CNX,SM01089:SM01089,	Cell junction,Cell membrane,Complete proteome,Deafness,Disease mutation,Ectodermal dysplasia,Gap junction,Hearing,Membrane,Non-syndromic deafness,Palmoplantar keratoderma,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Gap junction beta-6 protein,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000167914	gasdermin A(GSDMA)	Homo sapiens				GO:0006915~apoptotic process,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0048471~perinuclear region of cytoplasm,		IPR007677:Gasdermin,					Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Membrane,Necrosis,Polymorphism,Proteomics identification,Reference proteome,	chain:Gasdermin-A,sequence conflict,sequence variant,
ENSG00000145736	general transcription factor IIH subunit 2(GTF2H2)	Homo sapiens				GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0002031~G-protein coupled receptor internalization,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0006412~translation,GO:0006468~protein phosphorylation,GO:0009411~response to UV,GO:0033683~nucleotide-excision repair, DNA incision,GO:0070911~global genome nucleotide-excision repair,	GO:0000439~core TFIIH complex,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0008135~translation factor activity, RNA binding,GO:0008270~zinc ion binding,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,GO:0047485~protein N-terminus binding,	IPR002035:von Willebrand factor, type A,IPR004595:TFIIH C1-like domain,IPR007087:Zinc finger, C2H2,IPR007198:Ssl1-like,IPR012170:TFIIH subunit Ssl1/p44,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,hsa05203:Viral carcinogenesis,		PIRSF015919:TFIIH basal transcription factor complex, SSL1 subunit,	SM00327:VWA,SM01047:SM01047,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,DNA damage,DNA repair,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:General transcription factor IIH subunit 2,chain:General transcription factor IIH subunit 2-like protein,domain:VWFA,helix,mutagenesis site,sequence conflict,sequence variant,strand,turn,zinc finger region:C4-type,
ENSG00000213780	general transcription factor IIH subunit 4(GTF2H4)	Homo sapiens				GO:0000717~nucleotide-excision repair, DNA duplex unwinding,GO:0006281~DNA repair,GO:0006283~transcription-coupled nucleotide-excision repair,GO:0006289~nucleotide-excision repair,GO:0006293~nucleotide-excision repair, preincision complex stabilization,GO:0006294~nucleotide-excision repair, preincision complex assembly,GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion,GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006362~transcription elongation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,GO:0006366~transcription from RNA polymerase II promoter,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006368~transcription elongation from RNA polymerase II promoter,GO:0006370~7-methylguanosine mRNA capping,GO:0033683~nucleotide-excision repair, DNA incision,GO:0070816~phosphorylation of RNA polymerase II C-terminal domain,GO:0070911~global genome nucleotide-excision repair,	GO:0000439~core TFIIH complex,GO:0005654~nucleoplasm,GO:0005669~transcription factor TFIID complex,GO:0005675~holo TFIIH complex,	GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004003~ATP-dependent DNA helicase activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008094~DNA-dependent ATPase activity,GO:0008353~RNA polymerase II carboxy-terminal domain kinase activity,	IPR004598:Transcription factor TFIIH subunit p52/Tfb2,	hsa03022:Basal transcription factors,hsa03420:Nucleotide excision repair,hsa05203:Viral carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,DNA damage,DNA repair,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:General transcription factor IIH subunit 4,sequence variant,
ENSG00000063169	glioma tumor suppressor candidate region gene 1(GLTSCR1)	Homo sapiens						GO:0005515~protein binding,						Acetylation,Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Glioma tumor suppressor candidate region gene 1 protein,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,modified residue,sequence variant,splice variant,
ENSG00000106633	glucokinase(GCK)	Homo sapiens			Carbohydrate transport and metabolism,	GO:0001678~cellular glucose homeostasis,GO:0006096~glycolytic process,GO:0006110~regulation of glycolytic process,GO:0006739~NADP metabolic process,GO:0010827~regulation of glucose transport,GO:0015758~glucose transport,GO:0032024~positive regulation of insulin secretion,GO:0032869~cellular response to insulin stimulus,GO:0042593~glucose homeostasis,GO:0043266~regulation of potassium ion transport,GO:0044320~cellular response to leptin stimulus,GO:0045721~negative regulation of gluconeogenesis,GO:0045725~positive regulation of glycogen biosynthetic process,GO:0046835~carbohydrate phosphorylation,GO:0050796~regulation of insulin secretion,GO:0051156~glucose 6-phosphate metabolic process,GO:0051594~detection of glucose,GO:0061621~canonical glycolysis,GO:0070509~calcium ion import,	GO:0005623~cell,GO:0005654~nucleoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0004340~glucokinase activity,GO:0004396~hexokinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008865~fructokinase activity,GO:0019158~mannokinase activity,	IPR001312:Hexokinase,IPR019807:Hexokinase, conserved site,IPR022672:Hexokinase, N-terminal,IPR022673:Hexokinase, C-terminal,	hsa00010:Glycolysis / Gluconeogenesis,hsa00052:Galactose metabolism,hsa00500:Starch and sucrose metabolism,hsa00520:Amino sugar and nucleotide sugar metabolism,hsa00524:Butirosin and neomycin biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01200:Carbon metabolism,hsa04910:Insulin signaling pathway,hsa04911:Insulin secretion,hsa04917:Prolactin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04930:Type II diabetes mellitus,hsa04950:Maturity onset diabetes of the young,hsa05230:Central carbon metabolism in cancer,	125851~MODY, type II,125853~Diabetes mellitus, noninsulin-dependent, late onset,602485~Hyperinsulinemic hypoglycemia, familial, 3,606176~Diabetes mellitus, permanent neonatal,			3D-structure,Allosteric enzyme,Alternative splicing,ATP-binding,Coiled coil,Complete proteome,Cytoplasm,Diabetes mellitus,Disease mutation,Glycolysis,Kinase,Nucleotide-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transferase,	binding site:ATP,binding site:Substrate,chain:Glucokinase,helix,mutagenesis site,nucleotide phosphate-binding region:ATP,region of interest:Substrate binding,sequence variant,splice variant,strand,turn,
ENSG00000105737	glutamate ionotropic receptor kainate type subunit 5(GRIK5)	Homo sapiens				GO:0006621~protein retention in ER lumen,GO:0031630~regulation of synaptic vesicle fusion to presynaptic membrane,GO:0034220~ion transmembrane transport,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0035249~synaptic transmission, glutamatergic,GO:0043113~receptor clustering,GO:0043525~positive regulation of neuron apoptotic process,GO:0051649~establishment of localization in cell,GO:0060079~excitatory postsynaptic potential,GO:0071333~cellular response to glucose stimulus,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0030425~dendrite,GO:0032983~kainate selective glutamate receptor complex,GO:0042734~presynaptic membrane,GO:0043195~terminal bouton,GO:0043204~perikaryon,GO:0045211~postsynaptic membrane,	GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0015276~ligand-gated ion channel activity,GO:0015277~kainate selective glutamate receptor activity,GO:0017124~SH3 domain binding,GO:0030165~PDZ domain binding,GO:0042802~identical protein binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04080:Neuroactive ligand-receptor interaction,hsa04724:Glutamatergic synapse,			SM00079:PBPe,SM00918:SM00918,	Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Membrane,Postsynaptic cell membrane,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Glutamate receptor, ionotropic kainate 5,compositionally biased region:Poly-Arg,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000134202	glutathione S-transferase mu 3(GSTM3)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008065~establishment of blood-nerve barrier,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:0043627~response to estrogen,GO:0070458~cellular detoxification of nitrogen compound,GO:1901687~glutathione derivative biosynthetic process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0035686~sperm fibrous sheath,GO:0070062~extracellular exosome,	GO:0004364~glutathione transferase activity,GO:0019899~enzyme binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 3,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,strand,
ENSG00000168765	glutathione S-transferase mu 4(GSTM4)	Homo sapiens				GO:0006749~glutathione metabolic process,GO:0008152~metabolic process,GO:0018916~nitrobenzene metabolic process,GO:0042178~xenobiotic catabolic process,GO:1901687~glutathione derivative biosynthetic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004364~glutathione transferase activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042803~protein homodimerization activity,GO:0043295~glutathione binding,	IPR003081:Glutathione S-transferase, Mu class,IPR004045:Glutathione S-transferase, N-terminal,IPR004046:Glutathione S-transferase, C-terminal,IPR010987:Glutathione S-transferase, C-terminal-like,IPR012336:Thioredoxin-like fold,	hsa00480:Glutathione metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa05204:Chemical carcinogenesis,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Polymorphism,Proteomics identification,Reference proteome,Transferase,	chain:Glutathione S-transferase Mu 4,domain:GST C-terminal,domain:GST N-terminal,helix,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000147257	glypican 3(GPC3)	Homo sapiens				GO:0001523~retinoid metabolic process,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0006024~glycosaminoglycan biosynthetic process,GO:0006027~glycosaminoglycan catabolic process,GO:0009653~anatomical structure morphogenesis,GO:0009948~anterior/posterior axis specification,GO:0010171~body morphogenesis,GO:0010466~negative regulation of peptidase activity,GO:0030203~glycosaminoglycan metabolic process,GO:0030282~bone mineralization,GO:0030316~osteoclast differentiation,GO:0030324~lung development,GO:0030513~positive regulation of BMP signaling pathway,GO:0035116~embryonic hindlimb morphogenesis,GO:0045732~positive regulation of protein catabolic process,GO:0045807~positive regulation of endocytosis,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045926~negative regulation of growth,GO:0046326~positive regulation of glucose import,GO:0050680~negative regulation of epithelial cell proliferation,GO:0060976~coronary vasculature development,GO:0072138~mesenchymal cell proliferation involved in ureteric bud development,GO:0072180~mesonephric duct morphogenesis,GO:0072203~cell proliferation involved in metanephros development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:2000096~positive regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0043202~lysosomal lumen,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0043395~heparan sulfate proteoglycan binding,GO:0060422~peptidyl-dipeptidase inhibitor activity,	IPR001863:Glypican,IPR015501:Glypican-3,IPR019803:Glypican, conserved site,	hsa05205:Proteoglycans in cancer,	194070~Wilms tumor, somatic,312870~Simpson-Golabi-Behmel syndrome, type 1,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Glycoprotein,GPI-anchor,Heparan sulfate,Lipoprotein,Membrane,Phosphoprotein,Protease inhibitor,Proteoglycan,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Glypican-3,chain:Secreted glypican-3,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (Xyl...) (heparan sulfate),propeptide:Removed in mature form,sequence variant,signal peptide,
ENSG00000239857	golgi to ER traffic protein 4(GET4)	Homo sapiens				GO:0006810~transport,GO:0051220~cytoplasmic sequestering of protein,GO:0071816~tail-anchored membrane protein insertion into ER membrane,GO:1904378~maintenance of unfolded protein involved in ERAD pathway,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0071818~BAT3 complex,	GO:0005515~protein binding,GO:0051087~chaperone binding,	IPR007317:Uncharacterised protein family UPF0363,					Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Phosphoprotein,Proteomics identification,Reference proteome,Transport,	chain:UPF0363 protein C7orf20,modified residue,sequence conflict,splice variant,
ENSG00000174567	golgi transport 1A(GOLT1A)	Homo sapiens				GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,	GO:0000139~Golgi membrane,GO:0016021~integral component of membrane,		IPR007305:Vesicle transport protein, Got1/SFT2-like,					Complete proteome,Golgi apparatus,Membrane,Protein transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Vesicle transport protein GOT1A,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000115523	granulysin(GNLY)	Homo sapiens				GO:0006968~cellular defense response,GO:0031640~killing of cells of other organism,GO:0042742~defense response to bacterium,GO:0050832~defense response to fungus,	GO:0005615~extracellular space,		IPR008138:Saposin-like type B, 2,IPR008139:Saposin B,IPR011001:Saposin-like,				SM00741:SapB,	3D-structure,Alternative splicing,Antibiotic,Antimicrobial,Complete proteome,Disulfide bond,Fungicide,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Granulysin,disulfide bond,domain:Saposin B-type,helix,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000100450	granzyme H(GZMH)	Homo sapiens				GO:0006915~apoptotic process,GO:0006955~immune response,GO:0016485~protein processing,GO:0019835~cytolysis,	GO:0005737~cytoplasm,GO:0016020~membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	3D-structure,Alternative splicing,Complete proteome,Cytolysis,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Granzyme H,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence variant,signal peptide,strand,turn,
ENSG00000213512	guanylate binding protein 7(GBP7)	Homo sapiens					GO:0016020~membrane,	GO:0003924~GTPase activity,GO:0005525~GTP binding,	IPR003191:Guanylate-binding protein, C-terminal,IPR015894:Guanylate-binding protein, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Antimicrobial,Complete proteome,GTP-binding,Membrane,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Guanylate-binding protein 7,nucleotide phosphate-binding region:GTP,sequence variant,transmembrane region,
ENSG00000164116	guanylate cyclase 1 soluble subunit alpha(GUCY1A3)	Homo sapiens		h_raccPathway:Ion Channels and Their Functional Role in Vascular Endothelium,		GO:0006182~cGMP biosynthetic process,GO:0007263~nitric oxide mediated signal transduction,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0030828~positive regulation of cGMP biosynthetic process,GO:0035556~intracellular signal transduction,GO:0052565~response to defense-related host nitric oxide production,GO:0060087~relaxation of vascular smooth muscle,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0008074~guanylate cyclase complex, soluble,GO:0016021~integral component of membrane,	GO:0000166~nucleotide binding,GO:0004016~adenylate cyclase activity,GO:0004383~guanylate cyclase activity,GO:0004872~receptor activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0020037~heme binding,	IPR001054:Adenylyl cyclase class-3/4/guanylyl cyclase,IPR011644:Heme-NO binding,IPR011645:Haem NO binding associated,IPR018297:Adenylyl cyclase class-3/4/guanylyl cyclase, conserved site,IPR024096:NO signalling/Golgi transport  ligand-binding domain,	hsa00230:Purine metabolism,hsa04022:cGMP-PKG signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04540:Gap junction,hsa04611:Platelet activation,hsa04713:Circadian entrainment,hsa04730:Long-term depression,hsa04921:Oxytocin signaling pathway,hsa04924:Renin secretion,hsa04970:Salivary secretion,	615750~Moyamoya 6 with achalasia,		SM00044:CYCc,	3D-structure,Alternative splicing,cGMP biosynthesis,Coiled coil,Complete proteome,Cytoplasm,GTP-binding,Lyase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Guanylate cyclase soluble subunit alpha- 3,domain:Guanylate cyclase,sequence conflict,sequence variant,
ENSG00000126803	heat shock protein family A (Hsp70) member 2(HSPA2)	Homo sapiens				GO:0006986~response to unfolded protein,GO:0007140~male meiosis,GO:0007141~male meiosis I,GO:0007283~spermatogenesis,GO:0007286~spermatid development,GO:0009408~response to heat,GO:0009409~response to cold,GO:0031662~positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,GO:0042026~protein refolding,GO:0070194~synaptonemal complex disassembly,GO:0090084~negative regulation of inclusion body assembly,GO:1901896~positive regulation of calcium-transporting ATPase activity,	GO:0000795~synaptonemal complex,GO:0001673~male germ cell nucleus,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0009986~cell surface,GO:0016020~membrane,GO:0036128~CatSper complex,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:0072687~meiotic spindle,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0051082~unfolded protein binding,GO:0051861~glycolipid binding,	IPR013126:Heat shock protein 70 family,IPR018181:Heat shock protein 70, conserved site,	hsa03040:Spliceosome,hsa04010:MAPK signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04144:Endocytosis,hsa04612:Antigen processing and presentation,hsa04915:Estrogen signaling pathway,hsa05134:Legionellosis,hsa05145:Toxoplasmosis,hsa05162:Measles,hsa05164:Influenza A,hsa05169:Epstein-Barr virus infection,				3D-structure,ATP-binding,Chaperone,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Methylation,Nucleotide-binding,Phosphoprotein,Polymorphism,Reference proteome,Spermatogenesis,Stress response,	chain:Heat shock-related 70 kDa protein 2,helix,modified residue,sequence conflict,sequence variant,strand,turn,
ENSG00000152804	hematopoietically expressed homeobox(HHEX)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001570~vasculogenesis,GO:0001701~in utero embryonic development,GO:0002573~myeloid leukocyte differentiation,GO:0006351~transcription, DNA-templated,GO:0006406~mRNA export from nucleus,GO:0007219~Notch signaling pathway,GO:0007492~endoderm development,GO:0008283~cell proliferation,GO:0009611~response to wounding,GO:0009952~anterior/posterior pattern specification,GO:0010621~negative regulation of transcription by transcription factor localization,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0016055~Wnt signaling pathway,GO:0016525~negative regulation of angiogenesis,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0022027~interkinetic nuclear migration,GO:0030154~cell differentiation,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030183~B cell differentiation,GO:0030878~thyroid gland development,GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031016~pancreas development,GO:0034504~protein localization to nucleus,GO:0035050~embryonic heart tube development,GO:0035264~multicellular organism growth,GO:0042127~regulation of cell proliferation,GO:0043434~response to peptide hormone,GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048853~forebrain morphogenesis,GO:0060431~primary lung bud formation,GO:0061010~gall bladder development,GO:0061011~hepatic duct development,GO:0061017~hepatoblast differentiation,GO:0070365~hepatocyte differentiation,GO:0071103~DNA conformation change,GO:0090009~primitive streak formation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0032993~protein-DNA complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0008190~eukaryotic initiation factor 4E binding,GO:0008301~DNA binding, bending,GO:0017025~TBP-class protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0070491~repressing transcription factor binding,GO:0071837~HMG box domain binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,	hsa04950:Maturity onset diabetes of the young,hsa05202:Transcriptional misregulation in cancer,			SM00389:HOX,	3D-structure,Complete proteome,Developmental protein,Differentiation,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Wnt signaling pathway,	chain:Hematopoietically-expressed homeobox protein hhex,compositionally biased region:Pro-rich,DNA-binding region:Homeobox,helix,sequence conflict,
ENSG00000013583	heme binding protein 1(HEBP1)	Homo sapiens				GO:0007623~circadian rhythm,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0020037~heme binding,	IPR006917:SOUL haem-binding protein,IPR011256:Regulatory factor, effector, bacterial,					Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Reference proteome,	chain:Heme-binding protein 1,sequence conflict,sequence variant,
ENSG00000100292	heme oxygenase 1(HMOX1)	Homo sapiens		h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,		GO:0001525~angiogenesis,GO:0001666~response to hypoxia,GO:0001935~endothelial cell proliferation,GO:0002246~wound healing involved in inflammatory response,GO:0002686~negative regulation of leukocyte migration,GO:0006788~heme oxidation,GO:0006879~cellular iron ion homeostasis,GO:0006979~response to oxidative stress,GO:0007264~small GTPase mediated signal transduction,GO:0007588~excretion,GO:0008217~regulation of blood pressure,GO:0008219~cell death,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010656~negative regulation of muscle cell apoptotic process,GO:0014806~smooth muscle hyperplasia,GO:0016239~positive regulation of macroautophagy,GO:0031670~cellular response to nutrient,GO:0032764~negative regulation of mast cell cytokine production,GO:0034101~erythrocyte homeostasis,GO:0034383~low-density lipoprotein particle clearance,GO:0034395~regulation of transcription from RNA polymerase II promoter in response to iron,GO:0034605~cellular response to heat,GO:0035094~response to nicotine,GO:0035556~intracellular signal transduction,GO:0042167~heme catabolic process,GO:0042542~response to hydrogen peroxide,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043305~negative regulation of mast cell degranulation,GO:0043392~negative regulation of DNA binding,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress,GO:0043627~response to estrogen,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045765~regulation of angiogenesis,GO:0045766~positive regulation of angiogenesis,GO:0045909~positive regulation of vasodilation,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,GO:0051260~protein homooligomerization,GO:0055072~iron ion homeostasis,GO:0071243~cellular response to arsenic-containing substance,GO:0071276~cellular response to cadmium ion,GO:0071456~cellular response to hypoxia,GO:0072719~cellular response to cisplatin,GO:0097421~liver regeneration,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1904036~negative regulation of epithelial cell apoptotic process,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004392~heme oxygenase (decyclizing) activity,GO:0004630~phospholipase D activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0020037~heme binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,	IPR002051:Haem oxygenase,IPR016053:Haem oxygenase-like,IPR016084:Haem oxygenase-like, multi-helical,IPR018207:Haem oxygenase conserved site,	hsa00860:Porphyrin and chlorophyll metabolism,hsa04978:Mineral absorption,	606963~Pulmonary disease, chronic obstructive, susceptibility to,614034~Heme oxygenase-1 deficiency,	PIRSF000343:heme oxygenase (decyclizing),		3D-structure,Apoptosis,Complete proteome,Cyclin,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Heme oxygenase 1,helix,metal ion-binding site:Iron (heme axial ligand),modified residue,sequence variant,turn,
ENSG00000188290	hes family bHLH transcription factor 4(HES4)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0008134~transcription factor binding,GO:0046983~protein dimerization activity,	IPR003650:Orange,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,SM00511:ORANGE,	Complete proteome,Developmental protein,Differentiation,DNA-binding,Neurogenesis,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor HES-4,compositionally biased region:Pro-rich,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,short sequence motif:WRPW motif,
ENSG00000144485	hes family bHLH transcription factor 6(HES6)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007399~nervous system development,GO:0030154~cell differentiation,	GO:0005634~nucleus,GO:0005667~transcription factor complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003712~transcription cofactor activity,GO:0008134~transcription factor binding,GO:0046983~protein dimerization activity,	IPR003650:Orange,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,				SM00353:HLH,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Nucleus,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription cofactor HES-6,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,sequence conflict,sequence variant,short sequence motif:WRPW motif,splice variant,
ENSG00000124575	histone cluster 1 H1 family member d(HIST1H1D)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0000790~nuclear chromatin,GO:0005719~nuclear euchromatin,	GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00526:H15,	Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,	chain:Histone H1.3,modified residue,sequence variant,
ENSG00000168298	histone cluster 1 H1 family member e(HIST1H1E)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006334~nucleosome assembly,GO:0016584~nucleosome positioning,GO:0080182~histone H3-K4 trimethylation,GO:0098532~histone H3-K27 trimethylation,	GO:0000786~nucleosome,GO:0005634~nucleus,GO:0005720~nuclear heterochromatin,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0031490~chromatin DNA binding,GO:0044822~poly(A) RNA binding,	IPR005818:Histone H1/H5,IPR005819:Histone H5,IPR011991:Winged helix-turn-helix DNA-binding domain,				SM00526:H15,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Isopeptide bond,Methylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Histone H1.4,modified residue,region of interest:Globular,sequence variant,
ENSG00000180596	histone cluster 1 H2B family member c(HIST1H2BC)	Homo sapiens				GO:0002227~innate immune response in mucosa,GO:0006334~nucleosome assembly,GO:0019731~antibacterial humoral response,GO:0050830~defense response to Gram-positive bacterium,	GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR000558:Histone H2B,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05203:Viral carcinogenesis,hsa05322:Systemic lupus erythematosus,			SM00427:H2B,	3D-structure,Acetylation,Antibiotic,Antimicrobial,Chromosome,Complete proteome,Direct protein sequencing,DNA-binding,Glycoprotein,Isopeptide bond,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ubl conjugation,	chain:Histone H2B type 1-C/E/F/G/I,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),modified residue,sequence conflict,sequence variant,
ENSG00000197409	histone cluster 1 H3 family member d(HIST1H3D)	Homo sapiens				GO:0000183~chromatin silencing at rDNA,GO:0006334~nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0007596~blood coagulation,GO:0031047~gene silencing by RNA,GO:0032200~telomere organization,GO:0044267~cellular protein metabolic process,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045815~positive regulation of gene expression, epigenetic,GO:0051290~protein heterotetramerization,GO:0060968~regulation of gene silencing,GO:0098609~cell-cell adhesion,	GO:0000228~nuclear chromosome,GO:0000784~nuclear chromosome, telomeric region,GO:0000786~nucleosome,GO:0000788~nuclear nucleosome,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0043234~protein complex,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0031492~nucleosomal DNA binding,GO:0042393~histone binding,GO:0046982~protein heterodimerization activity,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000164:Histone H3,IPR007125:Histone core,IPR009072:Histone-fold,	hsa05034:Alcoholism,hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,			SM00428:H3,	3D-structure,Acetylation,Chromosome,Citrullination,Complete proteome,Direct protein sequencing,DNA-binding,Methylation,Nucleosome core,Nucleus,Phosphoprotein,Reference proteome,Ubl conjugation,	chain:Histone H2A type 1-D,chain:Histone H3.1,chain:Histone H3.2,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,modified residue,mutagenesis site,sequence conflict,sequence variant,strand,
ENSG00000100429	histone deacetylase 10(HDAC10)	Homo sapiens			Chromatin structure and dynamics / Secondary metabolites biosynthesis, transport, and catabolism,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006325~chromatin organization,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006476~protein deacetylation,GO:0014003~oligodendrocyte development,GO:0016575~histone deacetylation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0070932~histone H3 deacetylation,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004407~histone deacetylase activity,GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0019899~enzyme binding,GO:0032041~NAD-dependent histone deacetylase activity (H3-K14 specific),GO:0033558~protein deacetylase activity,GO:0042826~histone deacetylase binding,	IPR000286:Histone deacetylase superfamily,IPR023801:Histone deacetylase domain,	hsa05034:Alcoholism,hsa05203:Viral carcinogenesis,				Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Hydrolase,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Histone deacetylase 10,mutagenesis site,region of interest:Histone deacetylase,sequence conflict,sequence variant,splice variant,
ENSG00000078399	homeobox A9(HOXA9)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0007338~single fertilization,GO:0008584~male gonad development,GO:0009952~anterior/posterior pattern specification,GO:0009954~proximal/distal pattern formation,GO:0030879~mammary gland development,GO:0035115~embryonic forelimb morphogenesis,GO:0042118~endothelial cell activation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0048706~embryonic skeletal system development,GO:0060065~uterus development,GO:0060216~definitive hemopoiesis,	GO:0005634~nucleus,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR006711:Hox9, N-terminal activation domain,IPR009057:Homeodomain-like,IPR017112:Homeobox protein Hox9,IPR017970:Homeobox, conserved site,IPR020479:Homeodomain, metazoa,			PIRSF037109:homeobox protein, Hox9 type,	SM00389:HOX,	Chromosomal rearrangement,Complete proteome,Developmental protein,DNA-binding,Homeobox,Methylation,Nucleus,Proto-oncogene,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-A9,DNA-binding region:Homeobox,sequence conflict,site:Breakpoint for translocation to form MSI2/HOXA9 fusion protein,
ENSG00000182742	homeobox B4(HOXB4)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002011~morphogenesis of an epithelial sheet,GO:0006351~transcription, DNA-templated,GO:0008283~cell proliferation,GO:0009952~anterior/posterior pattern specification,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048103~somatic stem cell division,GO:0048536~spleen development,GO:0048539~bone marrow development,GO:0048704~embryonic skeletal system morphogenesis,GO:0060216~definitive hemopoiesis,GO:0060218~hematopoietic stem cell differentiation,GO:2000738~positive regulation of stem cell differentiation,	GO:0005634~nucleus,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,	IPR001356:Homeodomain,IPR001827:Homeobox protein, antennapedia type, conserved site,IPR009057:Homeodomain-like,IPR017970:Homeobox, conserved site,IPR017995:Homeobox protein, antennapedia type,IPR020479:Homeodomain, metazoa,				SM00389:HOX,	Complete proteome,Developmental protein,DNA-binding,Homeobox,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,	chain:Homeobox protein Hox-B4,compositionally biased region:Poly-Pro,compositionally biased region:Pro-rich (part of the transcriptional activation domain),DNA-binding region:Homeobox,short sequence motif:Antp-type hexapeptide,
ENSG00000127124	human immunodeficiency virus type I enhancer binding protein 3(HIVEP3)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0035914~skeletal muscle cell differentiation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Transcription factor HIVEP3,compositionally biased region:Glu/Pro-rich,compositionally biased region:Ser-rich,modified residue,region of interest:6 X 4 AA tandem repeats of S-P-X-[RK],region of interest:Acidic 1,region of interest:Acidic 2,region of interest:Acidic 3,region of interest:No DNA binding activity or transactivation activity, but complete prevention of TRAF-dependent NF-Kappa-B activation; associates with TRAF2 and JUN,region of interest:ZAS1,region of interest:ZAS2,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3; degenerate,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
ENSG00000164120	hydroxyprostaglandin dehydrogenase 15-(NAD)(HPGD)	Homo sapiens				GO:0006693~prostaglandin metabolic process,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007565~female pregnancy,GO:0007567~parturition,GO:0019372~lipoxygenase pathway,GO:0030728~ovulation,GO:0045786~negative regulation of cell cycle,GO:0055114~oxidation-reduction process,GO:0070493~thrombin receptor signaling pathway,GO:0097070~ductus arteriosus closure,GO:2001300~lipoxin metabolic process,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0003824~catalytic activity,GO:0004957~prostaglandin E receptor activity,GO:0016404~15-hydroxyprostaglandin dehydrogenase (NAD+) activity,GO:0016491~oxidoreductase activity,GO:0042803~protein homodimerization activity,GO:0051287~NAD binding,GO:0070403~NAD+ binding,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,	hsa05202:Transcriptional misregulation in cancer,	119900~Digital clubbing, isolated congenital,259100~Cranioosteoarthropathy,259100~Hypertrophic osteoarthropathy, primary, autosomal recessive 1,			3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Fatty acid metabolism,Lipid metabolism,NAD,Oxidoreductase,Polymorphism,Prostaglandin metabolism,Proteomics identification,Reference proteome,Tumor suppressor,	active site:Proton acceptor,binding site:NAD; via carbonyl oxygen,binding site:Substrate,chain:15-hydroxyprostaglandin dehydrogenase [NAD+],helix,mutagenesis site,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,strand,turn,
ENSG00000087076	hydroxysteroid 17-beta dehydrogenase 14(HSD17B14)	Homo sapiens				GO:0006703~estrogen biosynthetic process,GO:0006706~steroid catabolic process,GO:0055114~oxidation-reduction process,	GO:0005829~cytosol,	GO:0004303~estradiol 17-beta-dehydrogenase activity,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0042802~identical protein binding,GO:0047045~testosterone 17-beta-dehydrogenase (NADP+) activity,	IPR002347:Glucose/ribitol dehydrogenase,IPR016040:NAD(P)-binding domain,IPR020904:Short-chain dehydrogenase/reductase, conserved site,					3D-structure,Complete proteome,Cytoplasm,Lipid metabolism,NAD,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,Steroid metabolism,	active site:Proton acceptor,binding site:NAD,binding site:Substrate,chain:17-beta-hydroxysteroid dehydrogenase 14,helix,nucleotide phosphate-binding region:NAD,sequence conflict,sequence variant,strand,turn,
ENSG00000188483	immediate early response 5 like(IER5L)	Homo sapiens							IPR008653:Immediate early response,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Immediate early response gene 5-like protein,compositionally biased region:Ala-rich,compositionally biased region:Gln-rich,sequence variant,splice variant,
ENSG00000254709	immunoglobulin lambda like polypeptide 5(IGLL5)	Homo sapiens				GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006958~complement activation, classical pathway,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,	GO:0009897~external side of plasma membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003823~antigen binding,GO:0034987~immunoglobulin receptor binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00407:IGc1,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Proteomics identification,Reference proteome,Secreted,Signal,
ENSG00000125968	inhibitor of DNA binding 1, HLH protein(ID1)	Homo sapiens	71.Id_proteins_G0-to-S_cell_cycle,			GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0001886~endothelial cell morphogenesis,GO:0006351~transcription, DNA-templated,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007420~brain development,GO:0007507~heart development,GO:0007623~circadian rhythm,GO:0010621~negative regulation of transcription by transcription factor localization,GO:0010628~positive regulation of gene expression,GO:0030182~neuron differentiation,GO:0030509~BMP signaling pathway,GO:0031648~protein destabilization,GO:0032233~positive regulation of actin filament bundle assembly,GO:0032963~collagen metabolic process,GO:0036164~cell-abiotic substrate adhesion,GO:0043066~negative regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043534~blood vessel endothelial cell migration,GO:0045602~negative regulation of endothelial cell differentiation,GO:0045668~negative regulation of osteoblast differentiation,GO:0045765~regulation of angiogenesis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0046677~response to antibiotic,GO:0048514~blood vessel morphogenesis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050774~negative regulation of dendrite morphogenesis,GO:0060425~lung morphogenesis,GO:0060426~lung vasculature development,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0090074~negative regulation of protein homodimerization activity,GO:1901653~cellular response to peptide,GO:1903026~negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,GO:1903351~cellular response to dopamine,GO:1990090~cellular response to nerve growth factor stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0005813~centrosome,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0008134~transcription factor binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,GO:0047485~protein N-terminus binding,GO:0070628~proteasome binding,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR026052:DNA-binding protein inhibitor,	hsa04015:Rap1 signaling pathway,hsa04350:TGF-beta signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00353:HLH,	Alternative splicing,Biological rhythms,Complete proteome,Cytoplasm,Developmental protein,Nucleus,Polymorphism,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:DNA-binding protein inhibitor ID-1,domain:Helix-loop-helix motif,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000205730	inositol 1,4,5-trisphosphate receptor interacting protein like 2(ITPRIPL2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR024798:Inositol 1,4,5-triphosphate receptor-interacting protein-like 2,IPR024810:Mab-21 domain,IPR026250:Inositol 1,4,5-trisphosphate receptor-interacting protein,				SM01265:SM01265,	Complete proteome,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Inositol 1,4,5-triphosphate receptor- interacting protein-like 2,compositionally biased region:Poly-Pro,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000141753	insulin like growth factor binding protein 4(IGFBP4)	Homo sapiens		h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,		GO:0001501~skeletal system development,GO:0001558~regulation of cell growth,GO:0006259~DNA metabolic process,GO:0006954~inflammatory response,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0010906~regulation of glucose metabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0043567~regulation of insulin-like growth factor receptor signaling pathway,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0044267~cellular protein metabolic process,GO:0044342~type B pancreatic cell proliferation,GO:0090090~negative regulation of canonical Wnt signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005102~receptor binding,GO:0031994~insulin-like growth factor I binding,GO:0031995~insulin-like growth factor II binding,	IPR000716:Thyroglobulin type-1,IPR000867:Insulin-like growth factor-binding protein, IGFBP,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR009168:Insulin-like growth factor binding protein,IPR017891:Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site,IPR022321:Insulin-like growth factor-binding protein family 1-6, chordata,IPR022327:Insulin-like growth factor-binding protein 4,				SM00121:IB,SM00211:TY,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor binding,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	chain:Insulin-like growth factor-binding protein 4,disulfide bond,domain:IGFBP N-terminal,domain:Thyroglobulin type-1,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000005961	integrin subunit alpha 2b(ITGA2B)	Homo sapiens				GO:0002576~platelet degranulation,GO:0002687~positive regulation of leukocyte migration,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030198~extracellular matrix organization,GO:0070527~platelet aggregation,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0031092~platelet alpha granule membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,GO:0050840~extracellular matrix binding,GO:0070051~fibrinogen binding,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04611:Platelet activation,hsa04640:Hematopoietic cell lineage,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,	187800~Bleeding disorder, platelet-type, 16, autosomal dominant,273800~Glanzmann thrombasthenia,Thrombocytopenia, neonatal alloimmune, BAK antigen related~Thrombocytopenia, neonatal alloimmune, BAK antigen related,		SM00191:Int_alpha,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Integrin,Membrane,Metal-binding,Polymorphism,Proteomics identification,Pyrrolidone carboxylic acid,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-IIb,chain:Integrin alpha-IIb heavy chain,chain:Integrin alpha-IIb light chain, form 1,chain:Integrin alpha-IIb light chain, form 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),glycosylation site:O-linked (GalNAc...); in alloantigen HPA- 3B,helix,modified residue,mutagenesis site,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,short sequence motif:GFFKR motif,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000144668	integrin subunit alpha 9(ITGA9)	Homo sapiens				GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0030198~extracellular matrix organization,GO:0030593~neutrophil chemotaxis,GO:0042060~wound healing,	GO:0005886~plasma membrane,GO:0008305~integrin complex,GO:0009925~basal plasma membrane,GO:0034679~integrin alpha9-beta1 complex,	GO:0005518~collagen binding,GO:0043236~laminin binding,GO:0046872~metal ion binding,	IPR000413:Integrin alpha chain,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa04514:Cell adhesion molecules (CAMs),hsa04810:Regulation of actin cytoskeleton,hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),hsa05414:Dilated cardiomyopathy,			SM00191:Int_alpha,	Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Integrin,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-9,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence variant,short sequence motif:GFFKR motif,signal peptide,site:Cleavage,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000169896	integrin subunit alpha M(ITGAM)	Homo sapiens	37.Akt-PKB_Effector_of_P13K_in_Vivo,8.MonocytesIFNF_IL4,	h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes,h_monocytePathway:Monocyte and its Surface Molecules,h_neutrophilPathway:Neutrophil and Its Surface Molecules,		GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0010668~ectodermal cell differentiation,GO:0030198~extracellular matrix organization,GO:0034142~toll-like receptor 4 signaling pathway,GO:0050900~leukocyte migration,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0008305~integrin complex,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,	IPR000413:Integrin alpha chain,IPR002035:von Willebrand factor, type A,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04015:Rap1 signaling pathway,hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04640:Hematopoietic cell lineage,hsa04670:Leukocyte transendothelial migration,hsa04810:Regulation of actin cytoskeleton,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05140:Leishmaniasis,hsa05146:Amoebiasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05202:Transcriptional misregulation in cancer,	609939~Systemic lupus erythematous, association with susceptibility to, 6,		SM00191:Int_alpha,SM00327:VWA,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Integrin,Magnesium,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Integrin alpha-M,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,short sequence motif:GFFKR motif,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000140678	integrin subunit alpha X(ITGAX)	Homo sapiens		h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,		GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0009887~organ morphogenesis,GO:0030198~extracellular matrix organization,GO:0034113~heterotypic cell-cell adhesion,GO:0050900~leukocyte migration,GO:0051607~defense response to virus,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005886~plasma membrane,GO:0008305~integrin complex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000413:Integrin alpha chain,IPR002035:von Willebrand factor, type A,IPR013517:FG-GAP repeat,IPR013519:Integrin alpha beta-propellor,IPR013649:Integrin alpha-2,IPR018184:Integrin alpha chain, C-terminal cytoplasmic region, conserved site,	hsa04810:Regulation of actin cytoskeleton,hsa05152:Tuberculosis,			SM00191:Int_alpha,SM00327:VWA,	3D-structure,Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Integrin,Magnesium,Membrane,Metal-binding,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Integrin alpha-X,disulfide bond,domain:VWFA,glycosylation site:N-linked (GlcNAc...),helix,repeat:FG-GAP 1,repeat:FG-GAP 2,repeat:FG-GAP 3,repeat:FG-GAP 4,repeat:FG-GAP 5,repeat:FG-GAP 6,repeat:FG-GAP 7,sequence conflict,sequence variant,short sequence motif:GFFKR motif,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000117595	interferon regulatory factor 6(IRF6)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0030216~keratinocyte differentiation,GO:0043616~keratinocyte proliferation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048468~cell development,GO:0060333~interferon-gamma-mediated signaling pathway,GO:0060337~type I interferon signaling pathway,GO:0060644~mammary gland epithelial cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000975~regulatory region DNA binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,	IPR001346:Interferon regulatory factor DNA-binding domain,IPR008984:SMAD/FHA domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR017855:SMAD domain-like,IPR019471:Interferon regulatory factor-3,IPR019817:Interferon regulatory factor, conserved site,		119300~van der Woude syndrome,119500~Popliteal pterygium syndrome 1,608864~Orofacial cleft 6,		SM00348:IRF,SM01243:SM01243,	Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Disease mutation,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Interferon regulatory factor 6,DNA-binding region:Tryptophan pentad repeat,sequence variant,
ENSG00000136634	interleukin 10(IL10)	Homo sapiens	111.Stress_influences_immunity,112.StressandCRHinfluence,113.Th1andTh2cells,125.T_Cells_CNS-APCs,19.Cytokine_microglia,22.Cytokine-chemokine_CNS,35.Chemokines_EAE_Autoreactive_T_Cells,56.Macrophage_regulation_of_CD4+T_cells,58.(CD40L)_immnosurveillance,59.L-type_Ca2+_Tat_immune_cells,80.T_cell_Activation,88.Alternatively_Activated_APC,9.CKS-17_cytokines,97.Immune_injury_MS-lesions_MS_antigen,	h_asbcellPathway:Antigen Dependent B Cell Activation,h_cytokinePathway:Cytokine Network,h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,h_il10Pathway:IL-10 Anti-inflammatory Signaling Pathway,h_inflamPathway:Cytokines and Inflammatory Response,		GO:0002237~response to molecule of bacterial origin,GO:0002740~negative regulation of cytokine secretion involved in immune response,GO:0002875~negative regulation of chronic inflammatory response to antigenic stimulus,GO:0002904~positive regulation of B cell apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0014823~response to activity,GO:0014854~response to inactivity,GO:0030097~hemopoiesis,GO:0030183~B cell differentiation,GO:0030595~leukocyte chemotaxis,GO:0030886~negative regulation of myeloid dendritic cell activation,GO:0030889~negative regulation of B cell proliferation,GO:0032689~negative regulation of interferon-gamma production,GO:0032692~negative regulation of interleukin-1 production,GO:0032695~negative regulation of interleukin-12 production,GO:0032701~negative regulation of interleukin-18 production,GO:0032715~negative regulation of interleukin-6 production,GO:0032717~negative regulation of interleukin-8 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032800~receptor biosynthetic process,GO:0032868~response to insulin,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0034465~response to carbon monoxide,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0042092~type 2 immune response,GO:0042100~B cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042493~response to drug,GO:0042536~negative regulation of tumor necrosis factor biosynthetic process,GO:0042742~defense response to bacterium,GO:0042832~defense response to protozoan,GO:0043032~positive regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0044130~negative regulation of growth of symbiont in host,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0045191~regulation of isotype switching,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045355~negative regulation of interferon-alpha biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0050715~positive regulation of cytokine secretion,GO:0050807~regulation of synapse organization,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051384~response to glucocorticoid,GO:0060302~negative regulation of cytokine activity,GO:0060670~branching involved in labyrinthine layer morphogenesis,GO:0071222~cellular response to lipopolysaccharide,GO:0071392~cellular response to estradiol stimulus,GO:0071650~negative regulation of chemokine (C-C motif) ligand 5 production,GO:0072577~endothelial cell apoptotic process,GO:0097421~liver regeneration,GO:1903034~regulation of response to wounding,GO:1903659~regulation of complement-dependent cytotoxicity,GO:1904057~negative regulation of sensory perception of pain,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000352~negative regulation of endothelial cell apoptotic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0005125~cytokine activity,GO:0005141~interleukin-10 receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR000098:Interleukin-10,IPR009079:Four-helical cytokine-like, core,IPR012351:Four-helical cytokine, core,IPR020423:Interleukin-10, conserved site,IPR020443:Interleukin-10/19/20/24,	hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05169:Epstein-Barr virus infection,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,	180300~Rheumatoid arthritis, progression of,609423~HIV-1, susceptibility to,614395~Graft-versus-host disease, protection against,		SM00188:IL10,	3D-structure,Complete proteome,Cytokine,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Reference proteome,Secreted,Signal,	chain:Interleukin-10,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,turn,
ENSG00000163701	interleukin 17 receptor E(IL17RE)	Homo sapiens				GO:0006954~inflammatory response,GO:0019221~cytokine-mediated signaling pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0030368~interleukin-17 receptor activity,	IPR013568:SEFIR,					Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Glycoprotein,Inflammatory response,Membrane,Polymorphism,Receptor,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Interleukin-17 receptor E,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000173801	junction plakoglobin(JUP)	Homo sapiens				GO:0002159~desmosome assembly,GO:0007016~cytoskeletal anchoring at plasma membrane,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0016337~single organismal cell-cell adhesion,GO:0016477~cell migration,GO:0034332~adherens junction organization,GO:0034333~adherens junction assembly,GO:0042127~regulation of cell proliferation,GO:0042307~positive regulation of protein import into nucleus,GO:0043588~skin development,GO:0050982~detection of mechanical stimulus,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051291~protein heterooligomerization,GO:0071603~endothelial cell-cell adhesion,GO:0071681~cellular response to indole-3-methanol,GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication,GO:0086091~regulation of heart rate by cardiac conduction,GO:0090002~establishment of protein localization to plasma membrane,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:0098911~regulation of ventricular cardiac muscle cell action potential,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0005915~zonula adherens,GO:0005916~fascia adherens,GO:0005925~focal adhesion,GO:0009898~cytoplasmic side of plasma membrane,GO:0014704~intercalated disc,GO:0015629~actin cytoskeleton,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0016342~catenin complex,GO:0030018~Z disc,GO:0030056~hemidesmosome,GO:0030057~desmosome,GO:0031012~extracellular matrix,GO:0032993~protein-DNA complex,GO:0070062~extracellular exosome,GO:0071665~gamma-catenin-TCF7L2 complex,	GO:0003713~transcription coactivator activity,GO:0004871~signal transducer activity,GO:0005198~structural molecule activity,GO:0005199~structural constituent of cell wall,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0042803~protein homodimerization activity,GO:0045294~alpha-catenin binding,GO:0045296~cadherin binding,GO:0050839~cell adhesion molecule binding,GO:0086083~cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000225:Armadillo,IPR011989:Armadillo-like helical,IPR013284:Beta-catenin,IPR016024:Armadillo-type fold,	hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),	601214~Naxos disease,611528~Arrhythmogenic right ventricular dysplasia 12,		SM00185:ARM,	3D-structure,Acetylation,Cardiomyopathy,Cell adhesion,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Glycoprotein,Membrane,Palmoplantar keratoderma,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Junction plakoglobin,helix,modified residue,repeat:ARM 1,repeat:ARM 2,repeat:ARM 3,repeat:ARM 4,repeat:ARM 5,repeat:ARM 6,repeat:ARM 7,repeat:ARM 8,repeat:ARM 9,sequence conflict,sequence variant,strand,turn,
ENSG00000189182	keratin 77(KRT77)	Homo sapiens					GO:0005856~cytoskeleton,GO:0005882~intermediate filament,GO:0045095~keratin filament,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,	IPR001664:Intermediate filament protein,IPR003054:Type II keratin,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Citrullination,Coiled coil,Complete proteome,Intermediate filament,Keratin,Methylation,Polymorphism,Proteomics identification,Reference proteome,	chain:Keratin, type II cytoskeletal 1b,modified residue,region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Rod,region of interest:Tail,sequence conflict,sequence variant,site:Stutter,
ENSG00000134539	killer cell lectin like receptor D1(KLRD1)	Homo sapiens		h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,		GO:0002228~natural killer cell mediated immunity,GO:0007166~cell surface receptor signaling pathway,GO:0045087~innate immune response,GO:0050776~regulation of immune response,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0023024~MHC class I protein complex binding,GO:0023030~MHC class Ib protein binding, via antigen binding groove,GO:0030246~carbohydrate binding,GO:1990405~protein antigen binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,	hsa04612:Antigen processing and presentation,hsa04650:Natural killer cell mediated cytotoxicity,			SM00034:CLECT,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Lectin,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Natural killer cells antigen CD94,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000126259	kin of IRRE like 2 (Drosophila)(KIRREL2)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0007155~cell adhesion,GO:0016337~single organismal cell-cell adhesion,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0036057~slit diaphragm,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Kin of IRRE-like protein 2,compositionally biased region:Poly-Glu,compositionally biased region:Pro-rich,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000171435	kinase suppressor of ras 2(KSR2)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005524~ATP binding,GO:0046872~metal ion binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR025561:Kinase suppressor of RAS, SAM-like domain,	hsa04014:Ras signaling pathway,			SM00109:C1,SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Kinase,Membrane,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Zinc,Zinc-finger,	chain:Kinase suppressor of Ras 2,compositionally biased region:Pro-rich,domain:Protein kinase,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,modified residue,sequence variant,splice variant,zinc finger region:Phorbol-ester/DAG-type,
ENSG00000196169	kinesin family member 19(KIF19)	Homo sapiens				GO:0007018~microtubule-based movement,GO:0060404~axonemal microtubule depolymerization,GO:0070462~plus-end specific microtubule depolymerization,	GO:0005737~cytoplasm,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0008017~microtubule binding,GO:0008574~ATP-dependent microtubule motor activity, plus-end-directed,GO:0016887~ATPase activity,	IPR001752:Kinesin, motor domain,IPR019821:Kinesin, motor region, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00129:KISc,	Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Kinesin-like protein KIF19,domain:Kinesin-motor,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
ENSG00000153902	leucine rich repeat LGI family member 4(LGI4)	Homo sapiens			Function unknown,	GO:0008344~adult locomotory behavior,GO:0014009~glial cell proliferation,GO:0022011~myelination in peripheral nervous system,GO:0042551~neuron maturation,	GO:0005576~extracellular region,GO:0005615~extracellular space,		IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR005492:Leucine-rich glioma-inactivated , EPTP repeat,IPR009039:EAR,				SM00082:LRRCT,SM00369:LRR_TYP,	Alternative splicing,Complete proteome,Glycoprotein,Leucine-rich repeat,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Leucine-rich repeat LGI family member 4,glycosylation site:N-linked (GlcNAc...),repeat:EAR 1,repeat:EAR 2,repeat:EAR 3,repeat:EAR 4,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,signal peptide,splice variant,
ENSG00000162620	leucine rich repeats and IQ motif containing 3(LRRIQ3)	Homo sapiens						GO:0005515~protein binding,	IPR000048:IQ motif, EF-hand binding site,IPR001611:Leucine-rich repeat,IPR025875:Leucine rich repeat 4,					Alternative splicing,Coiled coil,Complete proteome,Leucine-rich repeat,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Leucine-rich repeat and IQ domain- containing protein 3,domain:IQ,repeat:LRR 1,repeat:LRR 2,sequence conflict,sequence variant,splice variant,
ENSG00000182195	leucine zipper down-regulated in cancer 1(LDOC1)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0005515~protein binding,						Complete proteome,Nucleus,Reference proteome,	chain:Protein LDOC1,compositionally biased region:Asp/Glu-rich (highly acidic),
ENSG00000197980	leucine, glutamate and lysine rich 1(LEKR1)	Homo sapiens												Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Leucine-, glutamate- and lysine-rich protein 1,compositionally biased region:Poly-Arg,sequence variant,
ENSG00000167618	leukocyte associated immunoglobulin like receptor 2(LAIR2)	Homo sapiens				GO:0050776~regulation of immune response,	GO:0005576~extracellular region,	GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,				SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Immunoglobulin domain,Polymorphism,Proteomics identification,Receptor,Reference proteome,Secreted,Signal,	chain:Leukocyte-associated immunoglobulin-like receptor 2,disulfide bond,domain:Ig-like C2-type,sequence variant,signal peptide,splice variant,
ENSG00000213658	linker for activation of T-cells(LAT)	Homo sapiens	63.LAT_couples_T-cell_receptor,	h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_tcrPathway:T Cell Receptor Signaling Pathway,		GO:0000165~MAPK cascade,GO:0002250~adaptive immune response,GO:0002260~lymphocyte homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0007265~Ras protein signal transduction,GO:0009967~positive regulation of signal transduction,GO:0010467~gene expression,GO:0019722~calcium-mediated signaling,GO:0030168~platelet activation,GO:0035556~intracellular signal transduction,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0042110~T cell activation,GO:0043303~mast cell degranulation,GO:0043547~positive regulation of GTPase activity,GO:0045860~positive regulation of protein kinase activity,GO:0050852~T cell receptor signaling pathway,GO:0050863~regulation of T cell activation,	GO:0001772~immunological synapse,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0008180~COP9 signalosome,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0042629~mast cell granule,GO:0045121~membrane raft,	GO:0005070~SH3/SH2 adaptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR008359:Linker-for-activation of T cells (LAT) protein,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,				Adaptive immunity,Alternative splicing,Cell membrane,Complete proteome,Direct protein sequencing,Immunity,Lipoprotein,Mast cell degranulation,Membrane,Palmitate,Phosphoprotein,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Linker for activation of T-cells family member 1,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:Interaction with GRB2, GRAP2 and PIK3R1,region of interest:Interaction with PLCG1,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000166035	lipase C, hepatic type(LIPC)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0008203~cholesterol metabolic process,GO:0019433~triglyceride catabolic process,GO:0034372~very-low-density lipoprotein particle remodeling,GO:0034373~intermediate-density lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0034382~chylomicron remnant clearance,GO:0034638~phosphatidylcholine catabolic process,GO:0042632~cholesterol homeostasis,GO:0043691~reverse cholesterol transport,GO:0044241~lipid digestion,GO:0070328~triglyceride homeostasis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0034364~high-density lipoprotein particle,	GO:0004620~phospholipase activity,GO:0004806~triglyceride lipase activity,GO:0008201~heparin binding,GO:0030169~low-density lipoprotein particle binding,GO:0034185~apolipoprotein binding,	IPR000734:Lipase,IPR001024:Lipoxygenase, LH2,IPR002333:Hepatic lipase,IPR013818:Lipase, N-terminal,IPR016272:Lipoprotein lipase, LIPH,	hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,	125853~Diabetes mellitus, noninsulin-dependent,612797~High density lipoprotein cholesterol level QTL 12,614025~Hepatic lipase deficiency,	PIRSF000865:lipoprotein lipase, LIPH type,	SM00308:LH2,	Complete proteome,Direct protein sequencing,Disease mutation,Glycoprotein,HDL,Heparin-binding,Hydrolase,Lipid degradation,Lipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	active site:Charge relay system,active site:Nucleophile,chain:Hepatic triacylglycerol lipase,domain:PLAT,glycosylation site:N-linked (GlcNAc...),region of interest:Heparin-binding,sequence conflict,sequence variant,signal peptide,
ENSG00000184925	lipocalin 12(LCN12)	Homo sapiens				GO:0006629~lipid metabolic process,GO:0015909~long-chain fatty acid transport,	GO:0005576~extracellular region,	GO:0001972~retinoic acid binding,GO:0005215~transporter activity,	IPR000566:Lipocalin/cytosolic fatty-acid binding protein domain,IPR002972:Prostaglandin D synthase,IPR011038:Calycin-like,IPR012674:Calycin,					Complete proteome,Disulfide bond,Reference proteome,Secreted,Signal,Transport,	chain:Epididymal-specific lipocalin-12,disulfide bond,signal peptide,
ENSG00000197251	long intergenic non-protein coding RNA 336(LINC00336)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Putative uncharacterized protein C6orf227,sequence variant,
ENSG00000187942	low density lipoprotein receptor class A domain containing 2(LDLRAD2)	Homo sapiens					GO:0016021~integral component of membrane,		IPR000859:CUB domain,IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,				SM00192:LDLa,	Complete proteome,Disulfide bond,Glycoprotein,Lipoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Low-density lipoprotein receptor class A domain-containing protein 2,disulfide bond,domain:LDL-receptor class A,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000089692	lymphocyte activating 3(LAG3)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0045085~negative regulation of interleukin-2 biosynthetic process,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050868~negative regulation of T cell activation,	GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0003823~antigen binding,GO:0004888~transmembrane signaling receptor activity,GO:0042289~MHC class II protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015621:Interleukin-1 receptor family,				SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Lymphocyte activation gene 3 protein,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),region of interest:12 X 2 AA tandem repeats of E-X,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000204428	lymphocyte antigen 6 complex, locus G5C(LY6G5C)	Homo sapiens					GO:0005576~extracellular region,GO:0016021~integral component of membrane,		IPR026110:Lymphocyte antigen 6 complex locus protein G5c,					Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Lymphocyte antigen 6 complex locus protein G5c,disulfide bond,domain:UPAR/Ly6,glycosylation site:N-linked (GlcNAc...),signal peptide,splice variant,
ENSG00000111321	lymphotoxin beta receptor(LTBR)	Homo sapiens				GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0016032~viral process,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0043011~myeloid dendritic cell differentiation,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0046330~positive regulation of JNK cascade,GO:0071260~cellular response to mechanical stimulus,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,	IPR001368:TNFR/NGFR cysteine-rich region,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR017349:Tumour necrosis factor receptor 3,	hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05166:HTLV-I infection,hsa05203:Viral carcinogenesis,		PIRSF037999:tumor necrosis factor receptor superfamily member 3,	SM00208:TNFR,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Disulfide bond,Glycoprotein,Host-virus interaction,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 3,disulfide bond,glycosylation site:N-linked (GlcNAc...),repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000087253	lysophosphatidylcholine acyltransferase 2(LPCAT2)	Homo sapiens				GO:0006663~platelet activating factor biosynthetic process,GO:0008152~metabolic process,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0061024~membrane organization,	GO:0000139~Golgi membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005795~Golgi stack,GO:0005811~lipid particle,GO:0016021~integral component of membrane,	GO:0003841~1-acylglycerol-3-phosphate O-acyltransferase activity,GO:0005509~calcium ion binding,GO:0016746~transferase activity, transferring acyl groups,GO:0047144~2-acylglycerol-3-phosphate O-acyltransferase activity,GO:0047184~1-acylglycerophosphocholine O-acyltransferase activity,GO:0047192~1-alkylglycerophosphocholine O-acetyltransferase activity,	IPR002048:EF-hand domain,IPR002123:Phospholipid/glycerol acyltransferase,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa01100:Metabolic pathways,			SM00054:EFh,SM00563:PlsC,	Acyltransferase,Alternative splicing,Calcium,Complete proteome,Endoplasmic reticulum,Golgi apparatus,Lipid biosynthesis,Lipid droplet,Lipid metabolism,Membrane,Metal-binding,Phospholipid biosynthesis,Phospholipid metabolism,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	calcium-binding region:1,calcium-binding region:2,chain:Lysophosphatidylcholine acyltransferase 2,domain:EF-hand 1,domain:EF-hand 2,sequence variant,short sequence motif:HXXXXD motif,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000090382	lysozyme(LYZ)	Homo sapiens				GO:0001895~retina homeostasis,GO:0006954~inflammatory response,GO:0008152~metabolic process,GO:0016998~cell wall macromolecule catabolic process,GO:0019835~cytolysis,GO:0044267~cellular protein metabolic process,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0003796~lysozyme activity,GO:0042802~identical protein binding,	IPR000974:Glycoside hydrolase, family 22, lysozyme,IPR001916:Glycoside hydrolase, family 22,IPR019799:Glycoside hydrolase, family 22, conserved site,IPR023346:Lysozyme-like domain,	hsa04970:Salivary secretion,	105200~Amyloidosis, renal,		SM00263:LYZ1,	3D-structure,Amyloid,Amyloidosis,Antimicrobial,Bacteriolytic enzyme,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycosidase,Hydrolase,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Lysozyme C,disulfide bond,helix,sequence conflict,sequence variant,signal peptide,strand,turn,
ENSG00000240972	macrophage migration inhibitory factor (glycosylation-inhibiting factor)(MIF)	Homo sapiens				GO:0001516~prostaglandin biosynthetic process,GO:0002906~negative regulation of mature B cell apoptotic process,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0010629~negative regulation of gene expression,GO:0010739~positive regulation of protein kinase A signaling,GO:0019752~carboxylic acid metabolic process,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0030890~positive regulation of B cell proliferation,GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway,GO:0032269~negative regulation of cellular protein metabolic process,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0042327~positive regulation of phosphorylation,GO:0043030~regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045087~innate immune response,GO:0048146~positive regulation of fibroblast proliferation,GO:0050715~positive regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050900~leukocyte migration,GO:0050918~positive chemotaxis,GO:0061078~positive regulation of prostaglandin secretion involved in immune response,GO:0061081~positive regulation of myeloid leukocyte cytokine production involved in immune response,GO:0070207~protein homotrimerization,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071157~negative regulation of cell cycle arrest,GO:0090238~positive regulation of arachidonic acid secretion,GO:0090344~negative regulation of cell aging,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000343~positive regulation of chemokine (C-X-C motif) ligand 2 production,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0031982~vesicle,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0004167~dopachrome isomerase activity,GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005126~cytokine receptor binding,GO:0005515~protein binding,GO:0042056~chemoattractant activity,GO:0050178~phenylpyruvate tautomerase activity,	IPR001398:Macrophage migration inhibitory factor,IPR014347:Tautomerase/MIF superfamily,IPR019829:Macrophage migration inhibitory factor, conserved site,	hsa00350:Tyrosine metabolism,hsa00360:Phenylalanine metabolism,	604302~Rheumatoid arthritis, systemic juvenile, susceptibility to,			3D-structure,Acetylation,Complete proteome,Cytokine,Cytoplasm,Direct protein sequencing,Immunity,Inflammatory response,Innate immunity,Isomerase,Reference proteome,Secreted,	active site:Proton acceptor; via imino nitrogen,binding site:Substrate,binding site:Substrate; via amide nitrogen,chain:Macrophage migration inhibitory factor,helix,modified residue,sequence conflict,strand,
ENSG00000204839	maestro heat like repeat family member 6(MROH6)	Homo sapiens							IPR011989:Armadillo-like helical,IPR016024:Armadillo-type fold,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Putative uncharacterized protein C8orf73,compositionally biased region:Leu-rich,sequence variant,
ENSG00000213920	magnesium dependent phosphatase 1(MDP1)	Homo sapiens				GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0070062~extracellular exosome,	GO:0004725~protein tyrosine phosphatase activity,GO:0046872~metal ion binding,	IPR010033:HAD-superfamily phosphatase, subfamily IIIC,IPR010036:Magnesium-dependent phosphatase-1, eukaryotic/arcaheal type,IPR023214:HAD-like domain,IPR024734:Magnesium-dependent phosphatase-1, eukaryotic type,					3D-structure,Alternative splicing,Complete proteome,Hydrolase,Magnesium,Metal-binding,Protein phosphatase,Reference proteome,	active site:Nucleophile,active site:Proton donor,binding site:Phosphate,binding site:Phosphate; via amide nitrogen,binding site:Substrate,chain:Magnesium-dependent phosphatase 1,helix,metal ion-binding site:Magnesium,modified residue,splice variant,strand,turn,
ENSG00000196735	major histocompatibility complex, class II, DQ alpha 1(HLA-DQA1)	Homo sapiens				GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0031295~T cell costimulation,GO:0050852~T cell receptor signaling pathway,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0042613~MHC class II protein complex,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0032395~MHC class II receptor activity,GO:0042605~peptide antigen binding,	IPR001003:MHC class II, alpha chain, N-terminal,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	212750~Celiac disease, susceptibility to,		SM00407:IGc1,SM00920:SM00920,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Lysosome,Membrane,MHC II,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:HLA class II histocompatibility antigen, DQ alpha 1 chain,chain:HLA class II histocompatibility antigen, DQ(W3) alpha chain,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Alpha-1,region of interest:Alpha-2,region of interest:Connecting peptide,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000179344	major histocompatibility complex, class II, DQ beta 1(HLA-DQB1)	Homo sapiens				GO:0002381~immunoglobulin production involved in immunoglobulin mediated immune response,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0031295~T cell costimulation,GO:0050852~T cell receptor signaling pathway,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0042612~MHC class I protein complex,GO:0042613~MHC class II protein complex,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0032395~MHC class II receptor activity,GO:0042605~peptide antigen binding,GO:0046872~metal ion binding,	IPR000353:MHC class II, beta chain, N-terminal,IPR001039:MHC class I, alpha chain, alpha1/alpha2,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR010579:MHC class I, alpha chain, C-terminal,IPR011161:MHC class I-like antigen recognition,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,	123400~Creutzfeldt-Jakob disease, variant, resistance to,126200~Multiple sclerosis, susceptibility to, 1,212750~Celiac disease, susceptibility to,		SM00407:IGc1,SM00921:SM00921,	3D-structure,Calcium,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Immunoglobulin domain,Lysosome,Membrane,Metal-binding,MHC I,MHC II,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:HLA class II histocompatibility antigen, DQ(1) beta chain,chain:HLA class II histocompatibility antigen, DQ(3) beta chain,chain:HLA class II histocompatibility antigen, DQ(W1.1) beta chain,chain:HLA class II histocompatibility antigen, DQ(W3) beta chain,chain:HLA class II histocompatibility antigen, DQB1*0602 beta chain,chain:lymphocyte antigen,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Beta-1,region of interest:Beta-2,region of interest:Connecting peptide,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000198502	major histocompatibility complex, class II, DR beta 5(HLA-DRB5)	Homo sapiens				GO:0002381~immunoglobulin production involved in immunoglobulin mediated immune response,GO:0002437~inflammatory response to antigenic stimulus,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002504~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,GO:0006955~immune response,GO:0016045~detection of bacterium,GO:0019882~antigen processing and presentation,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0031295~T cell costimulation,GO:0032673~regulation of interleukin-4 production,GO:0032689~negative regulation of interferon-gamma production,GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus,GO:0042088~T-helper 1 type immune response,GO:0042130~negative regulation of T cell proliferation,GO:0050852~T cell receptor signaling pathway,GO:0051262~protein tetramerization,GO:0060333~interferon-gamma-mediated signaling pathway,GO:2001179~regulation of interleukin-10 secretion,	GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005765~lysosomal membrane,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0012507~ER to Golgi transport vesicle membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030658~transport vesicle membrane,GO:0030666~endocytic vesicle membrane,GO:0030669~clathrin-coated endocytic vesicle membrane,GO:0031902~late endosome membrane,GO:0032588~trans-Golgi network membrane,GO:0042613~MHC class II protein complex,GO:0070062~extracellular exosome,GO:0071556~integral component of lumenal side of endoplasmic reticulum membrane,	GO:0042605~peptide antigen binding,	IPR000353:MHC class II, beta chain, N-terminal,IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR007110:Immunoglobulin-like domain,IPR011162:MHC classes I/II-like antigen recognition protein,IPR013783:Immunoglobulin-like fold,IPR014745:MHC class II, alpha/beta chain, N-terminal,	hsa04145:Phagosome,hsa04514:Cell adhesion molecules (CAMs),hsa04612:Antigen processing and presentation,hsa04640:Hematopoietic cell lineage,hsa04672:Intestinal immune network for IgA production,hsa04940:Type I diabetes mellitus,hsa05140:Leishmaniasis,hsa05145:Toxoplasmosis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05323:Rheumatoid arthritis,hsa05330:Allograft rejection,hsa05332:Graft-versus-host disease,hsa05416:Viral myocarditis,			SM00407:IGc1,SM00921:SM00921,	3D-structure,Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Golgi apparatus,Immunity,Isopeptide bond,Lysosome,Membrane,MHC II,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:HLA class II histocompatibility antigen, DR beta 5 chain,chain:HLA class II histocompatibility antigen, DRB1-9 beta chain,disulfide bond,domain:Ig-like C1-type,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Beta-1,region of interest:Beta-2,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000011028	mannose receptor C type 2(MRC2)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0030574~collagen catabolic process,	GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0030246~carbohydrate binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR013806:Kringle-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,hsa05152:Tuberculosis,			SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	3D-structure,Calcium,Complete proteome,Direct protein sequencing,Disulfide bond,Endocytosis,Glycoprotein,Isopeptide bond,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:C-type mannose receptor 2,disulfide bond,domain:C-type lectin 1,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000168282	mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase(MGAT2)	Homo sapiens				GO:0006487~protein N-linked glycosylation,GO:0009311~oligosaccharide metabolic process,GO:0009312~oligosaccharide biosynthetic process,GO:0018279~protein N-linked glycosylation via asparagine,	GO:0000139~Golgi membrane,GO:0005794~Golgi apparatus,GO:0005795~Golgi stack,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008455~alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,GO:0030246~carbohydrate binding,	IPR007754:N-acetylglucosaminyltransferase II,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,	212066~Congenital disorder of glycosylation, type IIa,			Complete proteome,Congenital disorder of glycosylation,Direct protein sequencing,Disease mutation,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Alpha-1,6-mannosyl-glycoprotein 2-beta-N- acetylglucosaminyltransferase,glycosylation site:N-linked (GlcNAc...),sequence variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000128268	mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase(MGAT3)	Homo sapiens				GO:0006487~protein N-linked glycosylation,	GO:0000139~Golgi membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0003830~beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,	IPR006813:Glycosyl transferase, family 17,	hsa00510:N-Glycan biosynthesis,hsa01100:Metabolic pathways,				Complete proteome,Glycoprotein,Glycosyltransferase,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Beta-1,4-mannosyl-glycoprotein 4-beta-N- acetylglucosaminyltransferase,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000170476	marginal zone B and B1 cell specific protein(MZB1)	Homo sapiens				GO:0002642~positive regulation of immunoglobulin biosynthetic process,GO:0006915~apoptotic process,GO:0008284~positive regulation of cell proliferation,GO:0030888~regulation of B cell proliferation,GO:0033622~integrin activation,GO:0042127~regulation of cell proliferation,GO:2001274~negative regulation of glucose import in response to insulin stimulus,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005788~endoplasmic reticulum lumen,GO:0034663~endoplasmic reticulum chaperone complex,		IPR021852:Domain of unknown function DUF3456,					Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Disulfide bond,Endoplasmic reticulum,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Proapoptotic caspase adapter protein,signal peptide,splice variant,
ENSG00000148773	marker of proliferation Ki-67(MKI67)	Homo sapiens				GO:0006259~DNA metabolic process,GO:0007088~regulation of mitotic nuclear division,GO:0007126~meiotic nuclear division,GO:0008283~cell proliferation,GO:0014070~response to organic cyclic compound,GO:0030212~hyaluronan metabolic process,GO:0031100~organ regeneration,GO:0034605~cellular response to heat,GO:0051983~regulation of chromosome segregation,GO:1902275~regulation of chromatin organization,	GO:0000775~chromosome, centromeric region,GO:0000793~condensed chromosome,GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0044822~poly(A) RNA binding,	IPR000253:Forkhead-associated (FHA) domain,IPR008984:SMAD/FHA domain,IPR012568:K167R,				SM00240:FHA,SM01295:SM01295,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Cell cycle,Chromosome,Complete proteome,DNA-binding,Isopeptide bond,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Ubl conjugation,	chain:Antigen KI-67,domain:FHA,modified residue,nucleotide phosphate-binding region:ATP,region of interest:16 X 122 AA approximate repeats,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,splice variant,strand,
ENSG00000008516	matrix metallopeptidase 25(MMP25)	Homo sapiens				GO:0006508~proteolysis,GO:0006954~inflammatory response,GO:0060022~hard palate development,	GO:0005578~proteinaceous extracellular matrix,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,	IPR000585:Hemopexin-like domain,IPR001818:Peptidase M10, metallopeptidase,IPR002477:Peptidoglycan binding-like,IPR006026:Peptidase, metallopeptidase,IPR016293:Peptidase M10A, metazoans,IPR018487:Hemopexin-like repeats,IPR021190:Peptidase M10A,IPR024079:Metallopeptidase, catalytic domain,			PIRSF001191:matrix metalloproteinase, stromelysin type,	SM00120:HX,SM00235:ZnMc,	Calcium,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Membrane,Metal-binding,Metalloprotease,Protease,Reference proteome,Repeat,Secreted,Signal,Zinc,Zymogen,	chain:Matrix metalloproteinase-25,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Leu,disulfide bond,domain:Hemopexin-like 1,domain:Hemopexin-like 2,domain:Hemopexin-like 3,domain:Hemopexin-like 4,lipid moiety-binding region:GPI-anchor amidated alanine,metal ion-binding site:Zinc; catalytic,metal ion-binding site:Zinc; in inhibited form,propeptide:Removed in mature form,sequence conflict,short sequence motif:Cysteine switch,signal peptide,
ENSG00000100427	megalencephalic leukoencephalopathy with subcortical cysts 1(MLC1)	Homo sapiens				GO:0006810~transport,GO:0006811~ion transport,GO:0015031~protein transport,GO:0016192~vesicle-mediated transport,GO:0032388~positive regulation of intracellular transport,GO:0047484~regulation of response to osmotic stress,GO:0051259~protein oligomerization,GO:0071397~cellular response to cholesterol,GO:0072584~caveolin-mediated endocytosis,	GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005911~cell-cell junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0030136~clathrin-coated vesicle,GO:0031410~cytoplasmic vesicle,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0032403~protein complex binding,			604004~Megalencephalic leukoencephalopathy with subcortical cysts,			Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Membrane protein MLC1,compositionally biased region:Poly-Lys,region of interest:Pore-region,sequence conflict,sequence variant,transmembrane region,
ENSG00000168070	membrane anchored junction protein(MAJIN)	Homo sapiens				GO:0007129~synapsis,GO:0045141~meiotic telomere clustering,GO:0070197~meiotic attachment of telomere to nuclear envelope,	GO:0000784~nuclear chromosome, telomeric region,GO:0005639~integral component of nuclear inner membrane,	GO:0003677~DNA binding,						Alternative splicing,Chromosome,Complete proteome,DNA-binding,Meiosis,Membrane,Nucleus,Reference proteome,Telomere,Transmembrane,Transmembrane helix,	chain:Uncharacterized protein C11orf85,
ENSG00000173838	membrane associated ring-CH-type finger 10(MARCH10)	Homo sapiens				GO:0016567~protein ubiquitination,		GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR011016:Zinc finger, RING-CH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00744:RINGv,	Complete proteome,Ligase,Metal-binding,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Probable E3 ubiquitin-protein ligase MARCH10,compositionally biased region:Poly-Ser,modified residue,sequence conflict,sequence variant,zinc finger region:RING-CH-type,
ENSG00000142606	membrane metalloendopeptidase like 1(MMEL1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006508~proteolysis,	GO:0005576~extracellular region,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0046872~metal ion binding,	IPR000718:Peptidase M13,IPR008753:Peptidase M13, N-terminal domain,IPR018497:Peptidase M13, C-terminal domain,IPR024079:Metallopeptidase, catalytic domain,					Alternative splicing,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Hydrolase,Membrane,Metal-binding,Metalloprotease,Polymorphism,Protease,Reference proteome,Secreted,Signal-anchor,Transmembrane,Transmembrane helix,Zinc,	active site:Proton donor,binding site:Substrate carboxyl,chain:Membrane metallo-endopeptidase-like 1,chain:Membrane metallo-endopeptidase-like 1, soluble form,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc; catalytic,sequence conflict,sequence variant,site:Cleavage,splice variant,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000110077	membrane spanning 4-domains A6A(MS4A6A)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007237:CD20-like,					Alternative splicing,Complete proteome,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Membrane-spanning 4-domains subfamily A member 6A,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000128309	mercaptopyruvate sulfurtransferase(MPST)	Homo sapiens			Inorganic ion transport and metabolism,	GO:0001822~kidney development,GO:0001889~liver development,GO:0009440~cyanate catabolic process,GO:0009636~response to toxic substance,GO:0019346~transsulfuration,GO:0021510~spinal cord development,GO:0070814~hydrogen sulfide biosynthetic process,	GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0030054~cell junction,GO:0043005~neuron projection,GO:0045202~synapse,GO:0070062~extracellular exosome,	GO:0004792~thiosulfate sulfurtransferase activity,GO:0016784~3-mercaptopyruvate sulfurtransferase activity,GO:0042802~identical protein binding,	IPR001307:Thiosulphate sulfurtransferase, conserved site,IPR001763:Rhodanese-like domain,	hsa00270:Cysteine and methionine metabolism,hsa00920:Sulfur metabolism,hsa01100:Metabolic pathways,hsa04122:Sulfur relay system,			SM00450:RHOD,	3D-structure,Acetylation,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Mitochondrion,Phosphoprotein,Proteomics identification,Pyruvate,Redox-active center,Reference proteome,Repeat,Synapse,Synaptosome,Transferase,	active site:Cysteine persulfide intermediate,binding site:Substrate,chain:3-mercaptopyruvate sulfurtransferase,domain:Rhodanese 1,domain:Rhodanese 2,region of interest:Hinge,sequence conflict,
ENSG00000176055	metallo-beta-lactamase domain containing 2(MBLAC2)	Homo sapiens					GO:0070062~extracellular exosome,	GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR001279:Beta-lactamase-like,				SM00849:SM00849,	Acetylation,Alternative splicing,Complete proteome,Hydrolase,Metal-binding,Polymorphism,Reference proteome,Zinc,	chain:Metallo-beta-lactamase domain-containing protein 2,metal ion-binding site:Zinc 1,metal ion-binding site:Zinc 2,sequence conflict,sequence variant,splice variant,
ENSG00000066382	metallophosphoesterase domain containing 2(MPPED2)	Homo sapiens			General function prediction only,	GO:0007399~nervous system development,		GO:0005515~protein binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,	IPR004843:Metallophosphoesterase domain,IPR024201:Calcineurin-like phosphoesterase,			PIRSF035808:phosphoesterase, brain protein 239 type,		Alternative splicing,Cobalt,Complete proteome,Hydrolase,Manganese,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,	chain:Metallophosphoesterase MPPED2,sequence variant,
ENSG00000169715	metallothionein 1E(MT1E)	Homo sapiens				GO:0045926~negative regulation of growth,GO:0071276~cellular response to cadmium ion,GO:0071294~cellular response to zinc ion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR000006:Metallothionein, vertebrate,IPR003019:Metallothionein superfamily, eukaryotic,IPR017854:Metallothionein domain,IPR018064:Metallothionein, vertebrate, metal binding site,IPR023587:Metallothionein domain, vertebrate,	hsa04978:Mineral absorption,				Acetylation,Alternative splicing,Cadmium,Complete proteome,Copper,Direct protein sequencing,Metal-binding,Metal-thiolate cluster,Reference proteome,Zinc,	chain:Metallothionein-1E,metal ion-binding site:Divalent metal cation; cluster A,metal ion-binding site:Divalent metal cation; cluster B,modified residue,region of interest:Alpha,region of interest:Beta,
ENSG00000176845	meteorin like, glial cell differentiation regulator(METRNL)	Homo sapiens				GO:0009409~response to cold,GO:0014850~response to muscle activity,GO:0045444~fat cell differentiation,GO:0050728~negative regulation of inflammatory response,GO:0050873~brown fat cell differentiation,GO:0090336~positive regulation of brown fat cell differentiation,GO:2000507~positive regulation of energy homeostasis,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005179~hormone activity,						Alternative splicing,Complete proteome,Hormone,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Meteorin-like protein,signal peptide,
ENSG00000174099	methionine sulfoxide reductase B3(MSRB3)	Homo sapiens				GO:0006979~response to oxidative stress,GO:0030091~protein repair,GO:0055114~oxidation-reduction process,	GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0033743~peptide-methionine (R)-S-oxide reductase activity,	IPR002579:Peptide methionine sulphoxide reductase MrsB,IPR011057:Mss4-like,		613718~Deafness, autosomal recessive 74,			Acetylation,Alternative splicing,Complete proteome,Deafness,Disease mutation,Endoplasmic reticulum,Metal-binding,Mitochondrion,Non-syndromic deafness,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Zinc,	active site:Nucleophile,chain:Methionine-R-sulfoxide reductase B3, mitochondrial,metal ion-binding site:Zinc,mutagenesis site,splice variant,transit peptide:Mitochondrion,
ENSG00000166987	methyl-CpG binding domain protein 6(MBD6)	Homo sapiens					GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0010369~chromocenter,	GO:0003677~DNA binding,GO:0003682~chromatin binding,	IPR001739:Methyl-CpG DNA binding,IPR016177:DNA-binding, integrase-type,				SM00391:MBD,	Chromosome,Complete proteome,Nucleus,Proteomics identification,Reference proteome,	chain:Methyl-CpG-binding domain protein 6,compositionally biased region:Pro-rich,domain:MBD,sequence conflict,
ENSG00000141854	microRNA 1199(MIR1199)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000074416	monoglyceride lipase(MGLL)	Homo sapiens			Lipid metabolism,	GO:0006629~lipid metabolic process,GO:0006633~fatty acid biosynthetic process,GO:0006954~inflammatory response,GO:0009966~regulation of signal transduction,GO:0019369~arachidonic acid metabolic process,GO:0019433~triglyceride catabolic process,GO:0036155~acylglycerol acyl-chain remodeling,GO:0046464~acylglycerol catabolic process,GO:0050727~regulation of inflammatory response,GO:0051930~regulation of sensory perception of pain,GO:2000124~regulation of endocannabinoid signaling pathway,	GO:0005654~nucleoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0019898~extrinsic component of membrane,	GO:0004622~lysophospholipase activity,GO:0042803~protein homodimerization activity,GO:0047372~acylglycerol lipase activity,	IPR000073:Alpha/beta hydrolase fold-1,IPR022742:Alpha/beta hydrolase, N-terminal,	hsa00561:Glycerolipid metabolism,hsa01100:Metabolic pathways,hsa04723:Retrograde endocannabinoid signaling,hsa04923:Regulation of lipolysis in adipocytes,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Fatty acid biosynthesis,Fatty acid metabolism,Hydrolase,Lipid biosynthesis,Lipid degradation,Lipid metabolism,Membrane,Nitration,Phosphoprotein,Proteomics identification,Reference proteome,Serine esterase,	active site:Charge relay system,chain:Monoglyceride lipase,
ENSG00000185499	mucin 1, cell surface associated(MUC1)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0007565~female pregnancy,GO:0010944~negative regulation of transcription by competitive promoter binding,GO:0016266~O-glycan processing,GO:0030855~epithelial cell differentiation,GO:0033629~negative regulation of cell adhesion mediated by integrin,GO:0036003~positive regulation of transcription from RNA polymerase II promoter in response to stress,GO:0043618~regulation of transcription from RNA polymerase II promoter in response to stress,GO:0071300~cellular response to retinoic acid,GO:0090240~positive regulation of histone H4 acetylation,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,	GO:0000790~nuclear chromatin,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005796~Golgi lumen,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031982~vesicle,GO:0070062~extracellular exosome,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0002039~p53 binding,GO:0003712~transcription cofactor activity,GO:0005515~protein binding,	IPR000082:SEA domain,IPR023217:Mucin-1,		174000~Medullary cystic kidney disease 1,		SM00200:SEA,	3D-structure,Alternative splicing,Autocatalytic cleavage,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Glycoprotein,Lipoprotein,Membrane,Nucleus,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,Tumor suppressor,	chain:Mucin-1,chain:Mucin-1 subunit alpha,chain:Mucin-1 subunit beta,domain:SEA,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,region of interest:42 X 20 AA approximate tandem repeats of P-A-P-G-S-T-A-P-P-A-H-G-V-T-S-A-P-D-T-R,region of interest:Interaction with p53,region of interest:Required for interaction with beta- and gamma-catenins,region of interest:Required for interaction with GSK3B,repeat:1,repeat:10,repeat:11,repeat:12,repeat:13,repeat:14,repeat:15,repeat:16,repeat:17,repeat:18,repeat:19,repeat:2,repeat:20,repeat:21,repeat:22,repeat:23,repeat:24,repeat:25,repeat:26,repeat:27,repeat:28,repeat:29,repeat:3,repeat:30,repeat:31,repeat:32,repeat:33,repeat:34,repeat:35,repeat:36,repeat:37,repeat:38,repeat:39,repeat:4,repeat:40,repeat:41; approximate,repeat:42; approximate,repeat:5,repeat:6,repeat:7,repeat:8,repeat:9,sequence conflict,sequence variant,short sequence motif:Interaction with GRB2,short sequence motif:Interaction with SRC and ESR1,short sequence motif:Required for interaction with AP1S2,signal peptide,site:Cleavage; by autolysis,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000099866	mucosal vascular addressin cell adhesion molecule 1(MADCAM1)	Homo sapiens		h_lymPathway:Adhesion and Diapedesis of Lymphocytes,		GO:0002687~positive regulation of leukocyte migration,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0007229~integrin-mediated signaling pathway,GO:0007568~aging,GO:0030198~extracellular matrix organization,GO:0034113~heterotypic cell-cell adhesion,GO:0043113~receptor clustering,GO:0050776~regulation of immune response,GO:0050901~leukocyte tethering or rolling,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0098640~integrin binding involved in cell-matrix adhesion,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013783:Immunoglobulin-like fold,IPR015169:Adhesion molecule, immunoglobulin-like,	hsa04514:Cell adhesion molecules (CAMs),hsa04672:Intestinal immune network for IgA production,			SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Mucosal addressin cell adhesion molecule 1,disulfide bond,domain:Ig-like 1,domain:Ig-like 2,glycosylation site:N-linked (GlcNAc...),helix,region of interest:5.5 X 8 AA tandem repeats of [PS]-P-D-T- T-S-[QP]-E,region of interest:Mucin-like,repeat:1; truncated,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000204410	mutS homolog 5(MSH5)	Homo sapiens				GO:0000710~meiotic mismatch repair,GO:0006298~mismatch repair,GO:0051026~chiasma assembly,	GO:0000795~synaptonemal complex,GO:0032300~mismatch repair complex,	GO:0003684~damaged DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0030983~mismatched DNA binding,	IPR000432:DNA mismatch repair protein MutS, C-terminal,IPR007696:DNA mismatch repair protein MutS, core,IPR007861:DNA mismatch repair protein MutS, clamp,IPR011184:DNA mismatch repair protein, MSH2,IPR027417:P-loop containing nucleoside triphosphate hydrolase,			PIRSF005813:DNA mismatch repair protein, eukaryotic MSH2 type,	SM00533:MUTSd,SM00534:MUTSac,	Alternative splicing,ATP-binding,Complete proteome,DNA-binding,Meiosis,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Signal,	chain:MutS protein homolog 5,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,
ENSG00000005381	myeloperoxidase(MPO)	Homo sapiens				GO:0001878~response to yeast,GO:0002149~hypochlorous acid biosynthetic process,GO:0002679~respiratory burst involved in defense response,GO:0006952~defense response,GO:0006979~response to oxidative stress,GO:0007568~aging,GO:0009612~response to mechanical stimulus,GO:0019430~removal of superoxide radicals,GO:0032094~response to food,GO:0032496~response to lipopolysaccharide,GO:0034374~low-density lipoprotein particle remodeling,GO:0042742~defense response to bacterium,GO:0042744~hydrogen peroxide catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0044130~negative regulation of growth of symbiont in host,GO:0050832~defense response to fungus,GO:0055114~oxidation-reduction process,GO:1990268~response to gold nanoparticle,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0030141~secretory granule,GO:0042582~azurophil granule,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0004601~peroxidase activity,GO:0008201~heparin binding,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR010255:Haem peroxidase,IPR019791:Haem peroxidase, animal, subgroup,	hsa04145:Phagosome,hsa05202:Transcriptional misregulation in cancer,	104300~Alzheimer disease, susceptibility to,254600~Myeloperoxidase deficiency,Lung cancer, protection against, in smokers~Lung cancer, protection against, in smokers,			3D-structure,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Heme,Hydrogen peroxide,Iron,Lysosome,Metal-binding,Nitration,Oxidation,Oxidoreductase,Peroxidase,Polymorphism,Proteomics identification,Reference proteome,Signal,	active site:Proton acceptor,binding site:Heme (covalent; via 3 links),chain:84 kDa myeloperoxidase,chain:89 kDa myeloperoxidase,chain:Myeloperoxidase,chain:Myeloperoxidase heavy chain,chain:Myeloperoxidase light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,signal peptide,site:Transition state stabilizer,splice variant,strand,turn,
ENSG00000081189	myocyte enhancer factor 2C(MEF2C)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mapkPathway:MAPKinase Signaling Pathway,h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pgc1aPathway:Regulation of PGC-1a,	Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001764~neuron migration,GO:0001782~B cell homeostasis,GO:0001947~heart looping,GO:0001958~endochondral ossification,GO:0001974~blood vessel remodeling,GO:0002062~chondrocyte differentiation,GO:0002467~germinal center formation,GO:0002634~regulation of germinal center formation,GO:0002931~response to ischemia,GO:0003138~primary heart field specification,GO:0003139~secondary heart field specification,GO:0003151~outflow tract morphogenesis,GO:0003185~sinoatrial valve morphogenesis,GO:0003211~cardiac ventricle formation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007399~nervous system development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007521~muscle cell fate determination,GO:0007611~learning or memory,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0014033~neural crest cell differentiation,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0014902~myotube differentiation,GO:0021542~dentate gyrus development,GO:0030182~neuron differentiation,GO:0030220~platelet formation,GO:0030224~monocyte differentiation,GO:0030279~negative regulation of ossification,GO:0030318~melanocyte differentiation,GO:0030501~positive regulation of bone mineralization,GO:0030890~positive regulation of B cell proliferation,GO:0033197~response to vitamin E,GO:0035690~cellular response to drug,GO:0035914~skeletal muscle cell differentiation,GO:0035984~cellular response to trichostatin A,GO:0042100~B cell proliferation,GO:0043406~positive regulation of MAP kinase activity,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045652~regulation of megakaryocyte differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046928~regulation of neurotransmitter secretion,GO:0048167~regulation of synaptic plasticity,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048703~embryonic viscerocranium morphogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050853~B cell receptor signaling pathway,GO:0051145~smooth muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051963~regulation of synapse assembly,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0060021~palate development,GO:0060025~regulation of synaptic activity,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060079~excitatory postsynaptic potential,GO:0060290~transdifferentiation,GO:0060297~regulation of sarcomere organization,GO:0060536~cartilage morphogenesis,GO:0060998~regulation of dendritic spine development,GO:0061333~renal tubule morphogenesis,GO:0071222~cellular response to lipopolysaccharide,GO:0071277~cellular response to calcium ion,GO:0071300~cellular response to retinoic acid,GO:0071333~cellular response to glucose stimulus,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071498~cellular response to fluid shear stress,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071864~positive regulation of cell proliferation in bone marrow,GO:0072102~glomerulus morphogenesis,GO:0072160~nephron tubule epithelial cell differentiation,GO:0090073~positive regulation of protein homodimerization activity,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,GO:2000727~positive regulation of cardiac muscle cell differentiation,GO:2000987~positive regulation of behavioral fear response,GO:2001013~epithelial cell proliferation involved in renal tubule morphogenesis,GO:2001016~positive regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0098794~postsynapse,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0033613~activating transcription factor binding,GO:0035198~miRNA binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0071837~HMG box domain binding,	IPR002100:Transcription factor, MADS-box,IPR022102:Holliday junction regulator protein family C-terminal,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05202:Transcriptional misregulation in cancer,	613443~Chromosome 5q14.3 deletion syndrome,613443~Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations,		SM00432:MADS,	Acetylation,Activator,Alternative splicing,Apoptosis,Complete proteome,Developmental protein,Differentiation,DNA-binding,Epilepsy,Isopeptide bond,Mental retardation,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Myocyte-specific enhancer factor 2C,compositionally biased region:Lys-rich (basic),compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Mef2-type,domain:MADS-box,modified residue,mutagenesis site,region of interest:Beta domain,region of interest:Transcription repressor,site:Cleavage,splice variant,
ENSG00000036448	myomesin 2(MYOM2)	Homo sapiens				GO:0006936~muscle contraction,	GO:0005739~mitochondrion,GO:0031430~M band,GO:0032982~myosin filament,	GO:0005515~protein binding,GO:0008307~structural constituent of muscle,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,SM00408:IGc2,SM00409:IG,	Complete proteome,Cytoplasm,Immunoglobulin domain,Muscle protein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Thick filament,	chain:Myomesin-2,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,sequence conflict,sequence variant,
ENSG00000113389	natriuretic peptide receptor 3(NPR3)	Homo sapiens				GO:0001501~skeletal system development,GO:0002158~osteoclast proliferation,GO:0006171~cAMP biosynthetic process,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0008217~regulation of blood pressure,GO:0009190~cyclic nucleotide biosynthetic process,GO:0019933~cAMP-mediated signaling,GO:0030157~pancreatic juice secretion,GO:0033688~regulation of osteoblast proliferation,GO:0035810~positive regulation of urine volume,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0051000~positive regulation of nitric-oxide synthase activity,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004016~adenylate cyclase activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0016941~natriuretic peptide receptor activity,GO:0017046~peptide hormone binding,GO:0042562~hormone binding,GO:0042803~protein homodimerization activity,	IPR001170:Natriuretic peptide receptor,IPR001828:Extracellular ligand-binding receptor,		Hypertension, salt-resistant~Hypertension, salt-resistant,			3D-structure,Alternative splicing,Chloride,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	binding site:Chloride,binding site:Chloride; via amide nitrogen,chain:Atrial natriuretic peptide receptor 3,disulfide bond,glycosylation site:N-linked (GlcNAc...) (complex),glycosylation site:N-linked (GlcNAc...) (high mannose),helix,modified residue,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000105374	natural killer cell granule protein 7(NKG7)	Homo sapiens					GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR004031:PMP-22/EMP/MP20/Claudin,IPR004032:PMP-22/EMP/MP20,					Cell membrane,Complete proteome,Direct protein sequencing,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein NKG7,transmembrane region,
ENSG00000110400	nectin cell adhesion molecule 1(NECTIN1)	Homo sapiens				GO:0002089~lens morphogenesis in camera-type eye,GO:0002934~desmosome organization,GO:0006826~iron ion transport,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007165~signal transduction,GO:0007411~axon guidance,GO:0008037~cell recognition,GO:0016337~single organismal cell-cell adhesion,GO:0034332~adherens junction organization,GO:0046718~viral entry into host cell,GO:0051963~regulation of synapse assembly,GO:0060041~retina development in camera-type eye,GO:0070166~enamel mineralization,GO:1902414~protein localization to cell junction,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005912~adherens junction,GO:0005913~cell-cell adherens junction,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016342~catenin complex,GO:0030424~axon,GO:0032584~growth cone membrane,GO:0042734~presynaptic membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0043296~apical junction complex,GO:0044291~cell-cell contact zone,	GO:0001618~virus receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0015026~coreceptor activity,GO:0030246~carbohydrate binding,GO:0042803~protein homodimerization activity,GO:0046790~virion binding,GO:0046982~protein heterodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013162:CD80-like, immunoglobulin C2-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04520:Adherens junction,hsa05168:Herpes simplex infection,	225060~Cleft lip/palate-ectodermal dysplasia syndrome,225060~Orofacial cleft 7,		SM00406:IGv,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Ectodermal dysplasia,Glycoprotein,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Membrane,Phosphoprotein,Receptor,Reference proteome,Repeat,Secreted,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Poliovirus receptor-related protein 1,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000107281	neural proliferation, differentiation and control 1(NPDC1)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,	IPR009635:Neural proliferation differentiation control-1,					Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Neural proliferation differentiation and control protein 1,compositionally biased region:Pro/Ser/Thr-rich,modified residue,sequence conflict,signal peptide,transmembrane region,
ENSG00000125841	neurensin 2(NRSN2)	Homo sapiens					GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030133~transport vesicle,GO:0043025~neuronal cell body,		IPR024883:Neurensin,					Complete proteome,Membrane,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Neurensin-2,sequence variant,transmembrane region,
ENSG00000104722	neurofilament, medium polypeptide(NEFM)	Homo sapiens			Cell envelope biogenesis, outer membrane,	GO:0033693~neurofilament bundle assembly,GO:0061564~axon development,	GO:0005883~neurofilament,GO:0030424~axon,GO:0097418~neurofibrillary tangle,	GO:0005198~structural molecule activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0008017~microtubule binding,	IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR006821:Intermediate filament head, DNA-binding domain,IPR018039:Intermediate filament protein, conserved site,	hsa05014:Amyotrophic lateral sclerosis (ALS),			SM01391:SM01391,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Direct protein sequencing,Glycoprotein,Intermediate filament,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Neurofilament medium polypeptide,glycosylation site:O-linked (GlcNAc),modified residue,region of interest:6 X 13 AA approximate tandem repeats of K-S-P-V-[PS]-K-S-P-V-E-E-[KA]-[GAK],region of interest:Coil 1A,region of interest:Coil 1B,region of interest:Coil 2A,region of interest:Coil 2B,region of interest:Head,region of interest:Linker 1,region of interest:Linker 12,region of interest:Linker 2,region of interest:Rod,region of interest:Tail,repeat:1,repeat:2,repeat:3,repeat:4,repeat:5,repeat:6,sequence conflict,sequence variant,
ENSG00000154146	neurogranin(NRGN)	Homo sapiens				GO:0007165~signal transduction,GO:0007399~nervous system development,GO:0008306~associative learning,GO:0021537~telencephalon development,GO:1900273~positive regulation of long-term synaptic potentiation,	GO:0005634~nucleus,GO:0012510~trans-Golgi network transport vesicle membrane,GO:0014069~postsynaptic density,GO:0030424~axon,GO:0031966~mitochondrial membrane,GO:0043025~neuronal cell body,GO:0044327~dendritic spine head,	GO:0005516~calmodulin binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0016301~kinase activity,GO:0070300~phosphatidic acid binding,	IPR000048:IQ motif, EF-hand binding site,				SM00015:IQ,	Acetylation,Calmodulin-binding,Citrullination,Complete proteome,Kinase,Methylation,Phosphoprotein,Reference proteome,Transferase,	chain:Neurogranin,domain:Collagen-like,domain:IQ,modified residue,peptide:NEUG(55-78),
ENSG00000169992	neuroligin 2(NLGN2)	Homo sapiens			Lipid metabolism,	GO:0002087~regulation of respiratory gaseous exchange by neurological system process,GO:0007158~neuron cell-cell adhesion,GO:0007416~synapse assembly,GO:0016337~single organismal cell-cell adhesion,GO:0019233~sensory perception of pain,GO:0032024~positive regulation of insulin secretion,GO:0032230~positive regulation of synaptic transmission, GABAergic,GO:0035418~protein localization to synapse,GO:0035641~locomotory exploration behavior,GO:0045217~cell-cell junction maintenance,GO:0050804~modulation of synaptic transmission,GO:0050808~synapse organization,GO:0050885~neuromuscular process controlling balance,GO:0051965~positive regulation of synapse assembly,GO:0051968~positive regulation of synaptic transmission, glutamatergic,GO:0072553~terminal button organization,GO:0097104~postsynaptic membrane assembly,GO:0097105~presynaptic membrane assembly,GO:0097116~gephyrin clustering involved in postsynaptic density assembly,GO:0097119~postsynaptic density protein 95 clustering,GO:0097151~positive regulation of inhibitory postsynaptic potential,GO:1902474~positive regulation of protein localization to synapse,GO:1904862~inhibitory synapse assembly,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,GO:2000463~positive regulation of excitatory postsynaptic potential,GO:2000809~positive regulation of synaptic vesicle clustering,	GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0030054~cell junction,GO:0042734~presynaptic membrane,GO:0045202~synapse,GO:0045211~postsynaptic membrane,GO:0060077~inhibitory synapse,GO:0099055~integral component of postsynaptic membrane,	GO:0004872~receptor activity,GO:0042043~neurexin family protein binding,GO:0050839~cell adhesion molecule binding,GO:0052689~carboxylic ester hydrolase activity,	IPR000460:Neuroligin,IPR002018:Carboxylesterase, type B,IPR019819:Carboxylesterase type B, conserved site,	hsa04514:Cell adhesion molecules (CAMs),				Cell adhesion,Cell junction,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,	chain:Neuroligin-2,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000170485	neuronal PAS domain protein 2(NPAS2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007417~central nervous system development,GO:0007623~circadian rhythm,GO:0032922~circadian regulation of gene expression,GO:0045739~positive regulation of DNA repair,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051775~response to redox state,GO:0060548~negative regulation of cell death,GO:2001020~regulation of response to DNA damage stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001047~core promoter binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,GO:0046983~protein dimerization activity,GO:0051879~Hsp90 protein binding,	IPR000014:PAS domain,IPR001067:Nuclear translocator,IPR001610:PAC motif,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR013767:PAS fold,	hsa04710:Circadian rhythm,			SM00086:PAC,SM00091:PAS,SM00353:HLH,	Activator,Biological rhythms,Complete proteome,DNA damage,DNA-binding,Heme,Iron,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,	chain:Neuronal PAS domain-containing protein 2,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:PAC,domain:PAS 1,domain:PAS 2,sequence conflict,sequence variant,
ENSG00000091129	neuronal cell adhesion molecule(NRCAM)	Homo sapiens				GO:0001525~angiogenesis,GO:0001764~neuron migration,GO:0007409~axonogenesis,GO:0007413~axonal fasciculation,GO:0007416~synapse assembly,GO:0007417~central nervous system development,GO:0008104~protein localization,GO:0016337~single organismal cell-cell adhesion,GO:0019227~neuronal action potential propagation,GO:0030516~regulation of axon extension,GO:0031290~retinal ganglion cell axon guidance,GO:0034113~heterotypic cell-cell adhesion,GO:0045162~clustering of voltage-gated sodium channels,GO:0045666~positive regulation of neuron differentiation,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0043005~neuron projection,GO:0043194~axon initial segment,GO:0045202~synapse,	GO:0005515~protein binding,GO:0030506~ankyrin binding,GO:0086080~protein binding involved in heterotypic cell-cell adhesion,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR026966:Fibronectin type III C-terminal domain,	hsa04514:Cell adhesion molecules (CAMs),			SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Cell projection,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Neuronal cell adhesion molecule,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Ig-like 1,domain:Ig-like 2,domain:Ig-like 3,domain:Ig-like 4,domain:Ig-like 5,domain:Ig-like 6,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000172260	neuronal growth regulator 1(NEGR1)	Homo sapiens				GO:0007626~locomotory behavior,GO:0007631~feeding behavior,GO:0010976~positive regulation of neuron projection development,GO:0016337~single organismal cell-cell adhesion,	GO:0005886~plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),			SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Phosphoprotein,Reference proteome,Repeat,Signal,	chain:Neuronal growth regulator 1,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated glycine,modified residue,propeptide:Removed in mature form,sequence conflict,signal peptide,
ENSG00000134986	neuronal regeneration related protein(NREP)	Homo sapiens				GO:0017015~regulation of transforming growth factor beta receptor signaling pathway,GO:0031103~axon regeneration,GO:0045664~regulation of neuron differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0005515~protein binding,	IPR024417:Neuronal protein 3.1,					Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,	chain:Neuronal protein 3.1,modified residue,mutagenesis site,sequence variant,
ENSG00000171119	neurturin(NRTN)	Homo sapiens				GO:0000165~MAPK cascade,GO:0001755~neural crest cell migration,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007399~nervous system development,GO:0021675~nerve development,GO:0031175~neuron projection development,GO:0043547~positive regulation of GTPase activity,	GO:0005576~extracellular region,GO:0005622~intracellular,GO:0030424~axon,	GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0008083~growth factor activity,	IPR001839:Transforming growth factor-beta, C-terminal,					Complete proteome,Disease mutation,Disulfide bond,Growth factor,Hirschsprung disease,Polymorphism,Reference proteome,Secreted,Signal,	chain:Neurturin,disulfide bond,sequence variant,signal peptide,
ENSG00000158517	neutrophil cytosolic factor 1(NCF1)	Homo sapiens		h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,		GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006612~protein targeting to membrane,GO:0006801~superoxide metabolic process,GO:0006915~apoptotic process,GO:0006968~cellular defense response,GO:0042554~superoxide anion generation,GO:0043085~positive regulation of catalytic activity,GO:0045087~innate immune response,GO:0045454~cell redox homeostasis,GO:0045730~respiratory burst,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0055114~oxidation-reduction process,	GO:0005737~cytoplasm,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0019898~extrinsic component of membrane,GO:0030425~dendrite,GO:0032010~phagolysosome,GO:0043020~NADPH oxidase complex,GO:0043025~neuronal cell body,	GO:0005515~protein binding,GO:0009055~electron carrier activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0016176~superoxide-generating NADPH oxidase activator activity,GO:0017124~SH3 domain binding,GO:0035091~phosphatidylinositol binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,	IPR001452:Src homology-3 domain,IPR001655:Neutrophil cytosol factor 1,IPR001683:Phox homologous domain,IPR015039:NADPH oxidase subunit p47Phox, C-terminal,	hsa04062:Chemokine signaling pathway,hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04666:Fc gamma R-mediated phagocytosis,hsa04670:Leukocyte transendothelial migration,hsa05140:Leishmaniasis,	233700~Chronic granulomatous disease due to deficiency of NCF-1,		SM00312:PX,SM00326:SH3,	3D-structure,Alternative splicing,Chronic granulomatous disease,Complete proteome,Cytoplasm,Disease mutation,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,	chain:Neutrophil cytosol factor 1,compositionally biased region:Arg/Lys-rich (highly basic),compositionally biased region:Asp/Glu-rich (highly acidic),domain:PX,domain:SH3 1,domain:SH3 2,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000116701	neutrophil cytosolic factor 2(NCF2)	Homo sapiens		h_fmlpPathway:fMLP induced chemokine gene expression in HMC-1 cells,h_rac1Pathway:Rac 1 cell motility signaling pathway,		GO:0002479~antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,GO:0006801~superoxide metabolic process,GO:0006968~cellular defense response,GO:0042554~superoxide anion generation,GO:0045087~innate immune response,GO:0045454~cell redox homeostasis,GO:0045730~respiratory burst,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0055114~oxidation-reduction process,	GO:0001669~acrosomal vesicle,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0032010~phagolysosome,GO:0043020~NADPH oxidase complex,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0009055~electron carrier activity,GO:0016175~superoxide-generating NADPH oxidase activity,GO:0048365~Rac GTPase binding,	IPR000270:Phox/Bem1p,IPR001452:Src homology-3 domain,IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,	hsa04145:Phagosome,hsa04380:Osteoclast differentiation,hsa04670:Leukocyte transendothelial migration,hsa05140:Leishmaniasis,	233710~Chronic granulomatous disease due to deficiency of NCF-2,		SM00028:TPR,SM00326:SH3,SM00666:PB1,	3D-structure,Alternative splicing,Chronic granulomatous disease,Complete proteome,Cytoplasm,Disease mutation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,TPR repeat,	chain:Neutrophil cytosol factor 2,domain:OPR,domain:SH3 1,domain:SH3 2,helix,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence variant,strand,turn,
ENSG00000165028	nipsnap homolog 3B(NIPSNAP3B)	Homo sapiens					GO:0005739~mitochondrion,		IPR011008:Dimeric alpha-beta barrel,IPR012577:NIPSNAP,					Complete proteome,Polymorphism,Proteomics identification,Reference proteome,	chain:Protein NipSnap homolog 3B,sequence conflict,sequence variant,
ENSG00000007171	nitric oxide synthase 2(NOS2)	Homo sapiens	8.MonocytesIFNF_IL4,	h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),	Inorganic ion transport and metabolism,	GO:0001666~response to hypoxia,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0002227~innate immune response in mucosa,GO:0006527~arginine catabolic process,GO:0006801~superoxide metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0007263~nitric oxide mediated signal transduction,GO:0007623~circadian rhythm,GO:0009617~response to bacterium,GO:0010629~negative regulation of gene expression,GO:0018119~peptidyl-cysteine S-nitrosylation,GO:0031284~positive regulation of guanylate cyclase activity,GO:0032310~prostaglandin secretion,GO:0035690~cellular response to drug,GO:0042127~regulation of cell proliferation,GO:0042177~negative regulation of protein catabolic process,GO:0042742~defense response to bacterium,GO:0043457~regulation of cellular respiration,GO:0045454~cell redox homeostasis,GO:0045776~negative regulation of blood pressure,GO:0045909~positive regulation of vasodilation,GO:0050796~regulation of insulin secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0051712~positive regulation of killing of cells of other organism,GO:0055114~oxidation-reduction process,GO:0071222~cellular response to lipopolysaccharide,GO:0071346~cellular response to interferon-gamma,GO:0072604~interleukin-6 secretion,GO:0072606~interleukin-8 secretion,GO:1900015~regulation of cytokine production involved in inflammatory response,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0030863~cortical cytoskeleton,GO:0048471~perinuclear region of cytoplasm,	GO:0004517~nitric-oxide synthase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0010181~FMN binding,GO:0020037~heme binding,GO:0034617~tetrahydrobiopterin binding,GO:0034618~arginine binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR001094:Flavodoxin,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001709:Flavoprotein pyridine nucleotide cytochrome reductase,IPR003097:FAD-binding, type 1,IPR004030:Nitric oxide synthase, oxygenase domain,IPR008254:Flavodoxin/nitric oxide synthase,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,IPR023173:NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain-3,	hsa00220:Arginine biosynthesis,hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04146:Peroxisome,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	145500~Hypertension, susceptibility to,611162~Malaria, resistance to,			3D-structure,Alternative splicing,Calcium,Calmodulin-binding,Complete proteome,FAD,Flavoprotein,FMN,Heme,Iron,Metal-binding,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Zinc,	chain:Nitric oxide synthase, inducible,domain:FAD-binding FR-type,domain:Flavodoxin-like,helix,metal ion-binding site:Iron (heme axial ligand),metal ion-binding site:Zinc,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NADP,region of interest:Calmodulin-binding,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000141905	nuclear factor I C(NFIC)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000647:CTF transcription factor/nuclear factor 1,IPR003619:MAD homology 1, Dwarfin-type,IPR019548:CTF transcription factor/nuclear factor 1, N-terminal,IPR019739:CTF transcription factor/nuclear factor 1, conserved site,IPR020604:CTF transcription factor/nuclear factor 1, DNA-binding domain,				SM00523:DWA,	Acetylation,Activator,Alternative splicing,Complete proteome,Direct protein sequencing,DNA replication,DNA-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Nuclear factor 1 C-type,DNA-binding region:CTF/NF-I,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000123405	nuclear factor, erythroid 2(NFE2)	Homo sapiens				GO:0006337~nucleosome disassembly,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007275~multicellular organism development,GO:0007596~blood coagulation,GO:0007599~hemostasis,GO:0008015~blood circulation,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0015629~actin cytoskeleton,GO:0016605~PML body,	GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0047485~protein N-terminus binding,GO:0050699~WW domain binding,	IPR004826:Basic leucine zipper domain, Maf-type,IPR004827:Basic-leucine zipper domain,IPR008917:Eukaryotic transcription factor, Skn-1-like, DNA-binding,				SM00338:BRLZ,	3D-structure,Activator,Coiled coil,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Transcription factor NF-E2 45 kDa subunit,compositionally biased region:Poly-Pro,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO-1),DNA-binding region:Basic motif,domain:Leucine-zipper,helix,mutagenesis site,sequence conflict,
ENSG00000183793	nuclear pore complex interacting protein family member A5(NPIPA5)	Homo sapiens							IPR009443:Nuclear pore complex interacting,					Alternative splicing,Complete proteome,Reference proteome,
ENSG00000254206	nuclear pore complex interacting protein family member B11(NPIPB11)	Homo sapiens					GO:0016021~integral component of membrane,		IPR009443:Nuclear pore complex interacting,					Complete proteome,Membrane,Reference proteome,Signal,Transmembrane,Transmembrane helix,
ENSG00000196436	nuclear pore complex interacting protein family member B15(NPIPB15)	Homo sapiens					GO:0005576~extracellular region,		IPR009443:Nuclear pore complex interacting,					Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,
ENSG00000198064	nuclear pore complex interacting protein family, member B13(NPIPB13)	Homo sapiens					GO:0016021~integral component of membrane,		IPR009443:Nuclear pore complex interacting,					Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,
ENSG00000185290	nuclear protein 2, transcriptional regulator(NUPR2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0007050~cell cycle arrest,GO:0008285~negative regulation of cell proliferation,GO:0009267~cellular response to starvation,GO:0071157~negative regulation of cell cycle arrest,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR018792:Nuclear phosphoprotein p8, DNA binding,					Cell cycle,Complete proteome,Growth arrest,Nucleus,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Uncharacterized protein LOC389493,
ENSG00000160113	nuclear receptor subfamily 2 group F member 6(NR2F6)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0007165~signal transduction,GO:0030522~intracellular receptor signaling pathway,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043401~steroid hormone mediated signaling pathway,GO:0048666~neuron development,GO:0050965~detection of temperature stimulus involved in sensory perception of pain,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004887~thyroid hormone receptor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003068:Transcription factor COUP,IPR013088:Zinc finger, NHR/GATA-type,				SM00399:ZnF_C4,SM00430:HOLI,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Receptor,Reference proteome,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 2 group F member 6,DNA-binding region:Nuclear receptor,modified residue,sequence conflict,zinc finger region:NR C4-type,
ENSG00000123358	nuclear receptor subfamily 4 group A member 1(NR4A1)	Homo sapiens				GO:0001938~positive regulation of endothelial cell proliferation,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0006351~transcription, DNA-templated,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0030522~intracellular receptor signaling pathway,GO:0035767~endothelial cell chemotaxis,GO:0035914~skeletal muscle cell differentiation,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0043065~positive regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043401~steroid hormone mediated signaling pathway,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045444~fat cell differentiation,GO:0045786~negative regulation of cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0061469~regulation of type B pancreatic cell proliferation,GO:0071376~cellular response to corticotropin-releasing hormone stimulus,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,GO:0031965~nuclear membrane,	GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003707~steroid hormone receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,	IPR000536:Nuclear hormone receptor, ligand-binding, core,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR001723:Steroid hormone receptor,IPR003070:Orphan nuclear receptor,IPR003071:Orphan nuclear receptor, HMR type,IPR013088:Zinc finger, NHR/GATA-type,	hsa04010:MAPK signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04925:Aldosterone synthesis and secretion,			SM00399:ZnF_C4,SM00430:HOLI,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Nuclear receptor subfamily 4 group A member 1,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,DNA-binding region:Nuclear receptor,helix,modified residue,region of interest:Ligand-binding,sequence conflict,sequence variant,strand,turn,zinc finger region:NR C4-type,
ENSG00000140939	nucleolar protein 3(NOL3)	Homo sapiens				GO:0001666~response to hypoxia,GO:0001974~blood vessel remodeling,GO:0002931~response to ischemia,GO:0006376~mRNA splice site selection,GO:0008380~RNA splicing,GO:0010659~cardiac muscle cell apoptotic process,GO:0010667~negative regulation of cardiac muscle cell apoptotic process,GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway,GO:0014736~negative regulation of muscle atrophy,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0014876~response to injury involved in regulation of muscle adaptation,GO:0042345~regulation of NF-kappaB import into nucleus,GO:0042981~regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0051259~protein oligomerization,GO:0060547~negative regulation of necrotic cell death,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:0097193~intrinsic apoptotic signaling pathway,GO:1902109~negative regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902176~negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1990001~inhibition of cysteine-type endopeptidase activity involved in apoptotic process,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0016020~membrane,GO:0016529~sarcoplasmic reticulum,	GO:0003723~RNA binding,GO:0005123~death receptor binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0035877~death effector domain binding,GO:0042802~identical protein binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0089720~caspase binding,	IPR001315:Caspase Recruitment,IPR011029:Death-like domain,		614937~Myoclonus, familial cortical,		SM00114:CARD,	3D-structure,Alternative splicing,Apoptosis,Calcium,Complete proteome,Cytoplasm,Disease mutation,Lipoprotein,Membrane,Metal-binding,Mitochondrion,mRNA processing,mRNA splicing,Myristate,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Sarcoplasmic reticulum,Ubl conjugation,	chain:Nucleolar protein 3,domain:CARD,splice variant,
ENSG00000158806	nucleophosmin/nucleoplasmin 2(NPM2)	Homo sapiens				GO:0006338~chromatin remodeling,GO:0007096~regulation of exit from mitosis,GO:0007338~single fertilization,GO:0009790~embryo development,GO:0009994~oocyte differentiation,GO:0016569~covalent chromatin modification,GO:0043085~positive regulation of catalytic activity,GO:0045740~positive regulation of DNA replication,GO:0045836~positive regulation of meiotic nuclear division,GO:0051260~protein homooligomerization,	GO:0000789~cytoplasmic chromatin,GO:0000790~nuclear chromatin,GO:0005634~nucleus,	GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0042393~histone binding,	IPR004301:Nucleoplasmin,IPR024057:Nucleoplasmin core domain,					3D-structure,Alternative splicing,Chaperone,Chromatin regulator,Complete proteome,Developmental protein,Fertilization,Nucleus,Proteomics identification,Reference proteome,	chain:Nucleoplasmin-2,compositionally biased region:Poly-Glu,compositionally biased region:Poly-Lys,
ENSG00000141447	oxysterol binding protein like 1A(OSBPL1A)	Homo sapiens				GO:0006869~lipid transport,GO:0008203~cholesterol metabolic process,GO:0016192~vesicle-mediated transport,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005770~late endosome,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0015485~cholesterol binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,IPR020683:Ankyrin repeat-containing domain,				SM00233:PH,SM00248:ANK,	Alternative splicing,ANK repeat,Coiled coil,Complete proteome,Endosome,Lipid transport,Lipid-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transport,	chain:Oxysterol-binding protein-related protein 1,domain:PH,modified residue,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence conflict,sequence variant,splice variant,
ENSG00000021762	oxysterol binding protein like 5(OSBPL5)	Homo sapiens				GO:0006869~lipid transport,GO:0006893~Golgi to plasma membrane transport,GO:0008203~cholesterol metabolic process,GO:0015914~phospholipid transport,GO:0030301~cholesterol transport,	GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0001786~phosphatidylserine binding,GO:0005548~phospholipid transporter activity,GO:0008142~oxysterol binding,GO:0015485~cholesterol binding,GO:0070273~phosphatidylinositol-4-phosphate binding,	IPR000648:Oxysterol-binding protein,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR018494:Oxysterol-binding protein, conserved site,				SM00233:PH,	Alternative splicing,Coiled coil,Complete proteome,Endoplasmic reticulum,Lipid transport,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Oxysterol-binding protein-related protein 5,domain:PH,modified residue,sequence variant,
ENSG00000125618	paired box 8(PAX8)	Homo sapiens				GO:0001655~urogenital system development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001822~kidney development,GO:0001823~mesonephros development,GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006790~sulfur compound metabolic process,GO:0007275~multicellular organism development,GO:0007417~central nervous system development,GO:0009653~anatomical structure morphogenesis,GO:0030154~cell differentiation,GO:0030878~thyroid gland development,GO:0038194~thyroid-stimulating hormone signaling pathway,GO:0039003~pronephric field specification,GO:0042472~inner ear morphogenesis,GO:0042981~regulation of apoptotic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048793~pronephros development,GO:0071371~cellular response to gonadotropin stimulus,GO:0071599~otic vesicle development,GO:0072050~S-shaped body morphogenesis,GO:0072108~positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,GO:0072164~mesonephric tubule development,GO:0072207~metanephric epithelium development,GO:0072221~metanephric distal convoluted tubule development,GO:0072278~metanephric comma-shaped body morphogenesis,GO:0072284~metanephric S-shaped body morphogenesis,GO:0072289~metanephric nephron tubule formation,GO:0072305~negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:1900212~negative regulation of mesenchymal cell apoptotic process involved in metanephros development,GO:1900215~negative regulation of apoptotic process involved in metanephric collecting duct development,GO:1900218~negative regulation of apoptotic process involved in metanephric nephron tubule development,GO:2000594~positive regulation of metanephric DCT cell differentiation,GO:2000611~positive regulation of thyroid hormone generation,GO:2000612~regulation of thyroid-stimulating hormone secretion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0004996~thyroid-stimulating hormone receptor activity,GO:0005515~protein binding,GO:0044212~transcription regulatory region DNA binding,	IPR001523:Paired domain,IPR009057:Homeodomain-like,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR022130:Paired-box protein 2 C-terminal,	hsa04918:Thyroid hormone synthesis,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05216:Thyroid cancer,	218700~Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia,		SM00351:PAX,	3D-structure,Alternative splicing,Complete proteome,Congenital hypothyroidism,Developmental protein,Differentiation,Disease mutation,DNA-binding,Nucleus,Paired box,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Paired box protein Pax-8,compositionally biased region:Ser-rich,domain:Paired,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000148498	par-3 family cell polarity regulator(PARD3)	Homo sapiens				GO:0006461~protein complex assembly,GO:0006612~protein targeting to membrane,GO:0007049~cell cycle,GO:0007163~establishment or maintenance of cell polarity,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0007409~axonogenesis,GO:0008356~asymmetric cell division,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0022011~myelination in peripheral nervous system,GO:0031643~positive regulation of myelination,GO:0060341~regulation of cellular localization,GO:0070830~bicellular tight junction assembly,GO:0090162~establishment of epithelial cell polarity,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005923~bicellular tight junction,GO:0005938~cell cortex,GO:0012505~endomembrane system,GO:0030054~cell junction,GO:0033269~internode region of axon,GO:0043025~neuronal cell body,GO:0043234~protein complex,GO:0044295~axonal growth cone,	GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0019903~protein phosphatase binding,GO:0032266~phosphatidylinositol-3-phosphate binding,	IPR001478:PDZ domain,IPR021922:Protein of unknown function DUF3534,	hsa04015:Rap1 signaling pathway,hsa04062:Chemokine signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04144:Endocytosis,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04530:Tight junction,			SM00228:PDZ,	3D-structure,Acetylation,Alternative splicing,Cell cycle,Cell division,Cell junction,Cell membrane,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Tight junction,	chain:Fibrocystin,chain:Partitioning defective 3 homolog,compositionally biased region:Lys-rich,domain:IPT/TIG 10,domain:IPT/TIG 11,domain:IPT/TIG 12; atypical,domain:IPT/TIG 1; atypical,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:IPT/TIG 4,domain:IPT/TIG 5,domain:IPT/TIG 6; atypical,domain:IPT/TIG 7,domain:IPT/TIG 8; atypical,domain:IPT/TIG 9,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:Interacts with PRKCZ,repeat:PbH1 1,repeat:PbH1 2,repeat:PbH1 3,repeat:PbH1 4,repeat:PbH1 5,repeat:PbH1 6,repeat:PbH1 7,repeat:PbH1 8,repeat:PbH1 9,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000204851	paraneoplastic Ma antigen family like 2(PNMAL2)	Homo sapiens							IPR026523:Paraneoplastic antigen Ma,					Alternative splicing,Complete proteome,Reference proteome,	chain:PNMA-like protein 2,splice variant,
ENSG00000159335	parathymosin(PTMS)	Homo sapiens				GO:0002376~immune system process,GO:0006260~DNA replication,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0008270~zinc ion binding,	IPR004931:Prothymosin/parathymosin,					Acetylation,Coiled coil,Complete proteome,Direct protein sequencing,Immunity,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Parathymosin,compositionally biased region:Asp/Glu-rich (acidic),modified residue,
ENSG00000188677	parvin beta(PARVB)	Homo sapiens				GO:0007155~cell adhesion,GO:0030031~cell projection assembly,GO:0030032~lamellipodium assembly,GO:0031532~actin cytoskeleton reorganization,GO:0071963~establishment or maintenance of cell polarity regulating cell shape,	GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0030018~Z disc,GO:0030027~lamellipodium,	GO:0003779~actin binding,GO:0005515~protein binding,	IPR001715:Calponin homology domain,	hsa04510:Focal adhesion,			SM00033:CH,	3D-structure,Actin-binding,Alternative splicing,Cell adhesion,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Beta-parvin,domain:CH 1,domain:CH 2,modified residue,sequence conflict,sequence variant,
ENSG00000117425	patched 2(PTCH2)	Homo sapiens				GO:0001709~cell fate determination,GO:0007165~signal transduction,GO:0009957~epidermal cell fate specification,GO:0042633~hair cycle,GO:0043588~skin development,GO:0045606~positive regulation of epidermal cell differentiation,GO:0045879~negative regulation of smoothened signaling pathway,	GO:0016021~integral component of membrane,	GO:0005119~smoothened binding,GO:0008158~hedgehog receptor activity,GO:0097108~hedgehog family protein binding,	IPR000731:Sterol-sensing domain,IPR003392:Patched,IPR004766:Transmembrane receptor, patched,	hsa04340:Hedgehog signaling pathway,hsa05200:Pathways in cancer,hsa05217:Basal cell carcinoma,	109400~Basal cell nevus syndrome,155255~Medulloblastoma,605462~Basal cell carcinoma, somatic,			Alternative splicing,Complete proteome,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Transmembrane,Transmembrane helix,	chain:Protein patched homolog 2,domain:SSD,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000164530	peptidase inhibitor 16(PI16)	Homo sapiens				GO:0010466~negative regulation of peptidase activity,	GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0030414~peptidase inhibitor activity,	IPR001283:Allergen V5/Tpx-1-related,IPR014044:CAP domain,IPR018244:Allergen V5/Tpx-1-related, conserved site,				SM00198:SCP,	Alternative splicing,Complete proteome,Direct protein sequencing,Glycoprotein,Polymorphism,Protease inhibitor,Reference proteome,Secreted,Signal,	chain:Peptidase inhibitor 16,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000161031	peptidoglycan recognition protein 2(PGLYRP2)	Homo sapiens				GO:0001519~peptide amidation,GO:0002221~pattern recognition receptor signaling pathway,GO:0009253~peptidoglycan catabolic process,GO:0016045~detection of bacterium,GO:0032689~negative regulation of interferon-gamma production,GO:0032827~negative regulation of natural killer cell differentiation involved in immune response,GO:0044117~growth of symbiont in host,GO:0045087~innate immune response,GO:0050727~regulation of inflammatory response,GO:0050830~defense response to Gram-positive bacterium,	GO:0005622~intracellular,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0008270~zinc ion binding,GO:0008745~N-acetylmuramoyl-L-alanine amidase activity,GO:0016019~peptidoglycan receptor activity,GO:0042834~peptidoglycan binding,	IPR002502:N-acetylmuramoyl-L-alanine amidase domain,IPR006619:Peptidoglycan recognition protein family domain, metazoa/bacteria,IPR015510:Peptidoglycan recognition protein,				SM00644:Ami_2,SM00701:PGRP,	Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Immunity,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Zinc,	chain:N-acetylmuramoyl-L-alanine amidase,disulfide bond,glycosylation site:N-linked (GlcNAc...),metal ion-binding site:Zinc,modified residue,mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,
ENSG00000159339	peptidyl arginine deiminase 4(PADI4)	Homo sapiens				GO:0006325~chromatin organization,GO:0006334~nucleosome assembly,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006464~cellular protein modification process,GO:0018101~protein citrullination,GO:0019827~stem cell population maintenance,GO:0036413~histone H3-R26 citrullination,GO:0036414~histone citrullination,GO:0045087~innate immune response,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004668~protein-arginine deiminase activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0016990~arginine deiminase activity,	IPR004303:Protein-arginine deiminase,IPR008972:Cupredoxin,IPR013530:Protein-arginine deiminase, C-terminal,IPR013732:Protein-arginine deiminase (PAD) N-terminal,IPR013733:Protein-arginine deiminase (PAD), central domain,		180300~Rheumatoid arthritis, susceptibility to,	PIRSF001247:protein-arginine deiminase,		3D-structure,Calcium,Chromatin regulator,Citrullination,Complete proteome,Cytoplasm,Hydrolase,Immunity,Innate immunity,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	binding site:Substrate,binding site:Substrate; via carbonyl oxygen,chain:Protein-arginine deiminase type-4,helix,metal ion-binding site:Calcium 1,metal ion-binding site:Calcium 2,metal ion-binding site:Calcium 3,metal ion-binding site:Calcium 3; via carbonyl oxygen,metal ion-binding site:Calcium 4,metal ion-binding site:Calcium 4; via carbonyl oxygen,metal ion-binding site:Calcium 5,metal ion-binding site:Calcium 5; via carbonyl oxygen,mutagenesis site,sequence variant,strand,turn,
ENSG00000107719	phosphatase domain containing, paladin 1(PALD1)	Homo sapiens				GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005829~cytosol,	GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,	IPR003595:Protein-tyrosine phosphatase, catalytic,				SM00404:PTPc_motif,	Complete proteome,Cytoplasm,Lipoprotein,Myristate,Phosphoprotein,Polymorphism,Reference proteome,	chain:Paladin,lipid moiety-binding region:N-myristoyl glycine,sequence variant,
ENSG00000065989	phosphodiesterase 4A(PDE4A)	Homo sapiens				GO:0006198~cAMP catabolic process,GO:0007165~signal transduction,GO:0007608~sensory perception of smell,GO:0010738~regulation of protein kinase A signaling,GO:0035690~cellular response to drug,GO:0043949~regulation of cAMP-mediated signaling,	GO:0005829~cytosol,GO:0016020~membrane,GO:0032587~ruffle membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004115~3',5'-cyclic-AMP phosphodiesterase activity,GO:0005515~protein binding,GO:0030552~cAMP binding,GO:0046872~metal ion binding,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa04024:cAMP signaling pathway,hsa05032:Morphine addiction,			SM00471:HDc,	3D-structure,Alternative splicing,cAMP,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Hydrolase,Isopeptide bond,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	active site:Proton donor,binding site:cAMP,chain:cAMP-specific 3',5'-cyclic phosphodiesterase 4A,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,nucleotide phosphate-binding region:cAMP,region of interest:Catalytic,sequence variant,site:Binds AMP, but not cAMP,site:Cleavage; by caspase-3,splice variant,strand,turn,
ENSG00000105647	phosphoinositide-3-kinase regulatory subunit 2(PIK3R2)	Homo sapiens				GO:0001678~cellular glucose homeostasis,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0008286~insulin receptor signaling pathway,GO:0010506~regulation of autophagy,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0015031~protein transport,GO:0032869~cellular response to insulin stimulus,GO:0034976~response to endoplasmic reticulum stress,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043547~positive regulation of GTPase activity,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046854~phosphatidylinositol phosphorylation,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051056~regulation of small GTPase mediated signal transduction,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005942~phosphatidylinositol 3-kinase complex,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019903~protein phosphatase binding,GO:0030971~receptor tyrosine kinase binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000198:Rho GTPase-activating protein domain,IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR001720:PI3 kinase, P85 regulatory subunit,IPR008936:Rho GTPase activation protein,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04921:Oxytocin signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	603387~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1,		SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	3D-structure,Coiled coil,Complete proteome,Disease mutation,Kinase,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Stress response,Transferase,Transport,Ubl conjugation,	chain:Phosphatidylinositol 3-kinase regulatory subunit beta,domain:Rho-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,modified residue,sequence variant,
ENSG00000176485	phospholipase A2 group XVI(PLA2G16)	Homo sapiens				GO:0006644~phospholipid metabolic process,GO:0008654~phospholipid biosynthetic process,GO:0016042~lipid catabolic process,GO:0036149~phosphatidylinositol acyl-chain remodeling,GO:0036150~phosphatidylserine acyl-chain remodeling,GO:0036151~phosphatidylcholine acyl-chain remodeling,GO:0036152~phosphatidylethanolamine acyl-chain remodeling,GO:0045786~negative regulation of cell cycle,	GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0004623~phospholipase A2 activity,GO:0005515~protein binding,GO:0008970~phosphatidylcholine 1-acylhydrolase activity,GO:0052739~phosphatidylserine 1-acylhydrolase activity,GO:0052740~1-acyl-2-lysophosphatidylserine acylhydrolase activity,	IPR007053:LRAT-like domain,	hsa00564:Glycerophospholipid metabolism,hsa00565:Ether lipid metabolism,hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa00592:alpha-Linolenic acid metabolism,hsa01100:Metabolic pathways,hsa04014:Ras signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,				3D-structure,Complete proteome,Cytoplasm,Hydrolase,Lipid degradation,Lipid metabolism,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Group XVI phospholipase A2,sequence conflict,transmembrane region,
ENSG00000234465	phospholipase A2 inhibitor and LY6/PLAUR domain containing(PINLYP)	Homo sapiens				GO:0043086~negative regulation of catalytic activity,	GO:0005576~extracellular region,	GO:0004859~phospholipase inhibitor activity,	IPR004126:Phospholipase A2 inhibitor,IPR016054:Ly-6 antigen / uPA receptor -like,					Alternative splicing,Complete proteome,Disulfide bond,Reference proteome,Secreted,Signal,	chain:Uncharacterized protein ENSP00000244321,disulfide bond,signal peptide,
ENSG00000187838	phospholipid scramblase 3(PLSCR3)	Homo sapiens				GO:0006915~apoptotic process,GO:0017121~phospholipid scrambling,GO:0042593~glucose homeostasis,GO:0042632~cholesterol homeostasis,GO:0071222~cellular response to lipopolysaccharide,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0017128~phospholipid scramblase activity,GO:0048306~calcium-dependent protein binding,	IPR005552:Scramblase,					Apoptosis,Calcium,Complete proteome,Lipoprotein,Membrane,Mitochondrion,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Repeat,SH3-binding,Transmembrane,Transmembrane helix,	chain:Phospholipid scramblase 3,compositionally biased region:Cys-rich,compositionally biased region:Poly-Pro,lipid moiety-binding region:S-palmitoyl cysteine,mutagenesis site,sequence conflict,sequence variant,short sequence motif:SH3-binding 1,short sequence motif:SH3-binding 2,short sequence motif:SH3-binding 3,short sequence motif:WW-binding,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000100504	phosphorylase, glycogen, liver(PYGL)	Homo sapiens				GO:0005975~carbohydrate metabolic process,GO:0005977~glycogen metabolic process,GO:0005980~glycogen catabolic process,GO:0006015~5-phosphoribose 1-diphosphate biosynthetic process,GO:0042593~glucose homeostasis,GO:0070266~necroptotic process,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,	GO:0002060~purine nucleobase binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0005536~glucose binding,GO:0008144~drug binding,GO:0008184~glycogen phosphorylase activity,GO:0016208~AMP binding,GO:0019842~vitamin binding,GO:0030170~pyridoxal phosphate binding,GO:0032052~bile acid binding,GO:0042803~protein homodimerization activity,	IPR000811:Glycosyl transferase, family 35,IPR011833:Glycogen/starch/alpha-glucan phosphorylase,	hsa00500:Starch and sucrose metabolism,hsa01100:Metabolic pathways,hsa04910:Insulin signaling pathway,hsa04922:Glucagon signaling pathway,hsa04931:Insulin resistance,	232700~Glycogen storage disease VI,	PIRSF000460:glucan phosphorylase,		3D-structure,Acetylation,Allosteric enzyme,Alternative splicing,Carbohydrate metabolism,Complete proteome,Disease mutation,Glycogen metabolism,Glycogen storage disease,Glycosyltransferase,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,	binding site:AMP,chain:Glycogen phosphorylase, liver form,helix,modified residue,sequence conflict,sequence variant,site:Involved in the association of subunits,site:May be involved in allosteric control,strand,turn,
ENSG00000119630	placental growth factor(PGF)	Homo sapiens				GO:0001525~angiogenesis,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001666~response to hypoxia,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002040~sprouting angiogenesis,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007565~female pregnancy,GO:0008284~positive regulation of cell proliferation,GO:0030154~cell differentiation,GO:0031100~organ regeneration,GO:0032870~cellular response to hormone stimulus,GO:0042493~response to drug,GO:0045766~positive regulation of angiogenesis,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0050930~induction of positive chemotaxis,GO:0051781~positive regulation of cell division,GO:0060688~regulation of morphogenesis of a branching structure,GO:0060754~positive regulation of mast cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,	GO:0005172~vascular endothelial growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,	IPR000072:Platelet-derived growth factor (PDGF),IPR023581:Platelet-derived growth factor, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa05200:Pathways in cancer,			SM00141:PDGF,	3D-structure,Alternative splicing,Angiogenesis,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Heparin-binding,Mitogen,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Placenta growth factor,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:Heparin-binding,sequence conflict,signal peptide,splice variant,strand,
ENSG00000011422	plasminogen activator, urokinase receptor(PLAUR)	Homo sapiens	73.Integrins_and_other_cell-surface_receptors,			GO:0001934~positive regulation of protein phosphorylation,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0016255~attachment of GPI anchor to protein,GO:0030162~regulation of proteolysis,GO:0038195~urokinase plasminogen activator signaling pathway,GO:0042730~fibrinolysis,GO:0043066~negative regulation of apoptotic process,GO:0043388~positive regulation of DNA binding,GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001268~negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,	GO:0005788~endoplasmic reticulum lumen,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016021~integral component of membrane,GO:0019898~extrinsic component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,GO:0071438~invadopodium membrane,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0016301~kinase activity,GO:0019899~enzyme binding,GO:0019904~protein domain specific binding,GO:0030377~urokinase plasminogen activator receptor activity,	IPR016054:Ly-6 antigen / uPA receptor -like,IPR018363:CD59 antigen, conserved site,	hsa04610:Complement and coagulation cascades,hsa05205:Proteoglycans in cancer,			SM00134:LU,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,GPI-anchor,Kinase,Lipoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transferase,	chain:Urokinase plasminogen activator surface receptor,disulfide bond,domain:UPAR/Ly6 1,domain:UPAR/Ly6 2,domain:UPAR/Ly6 3,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated glycine,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,site:Cleavage; by U-PA,splice variant,strand,turn,
ENSG00000187800	platelet endothelial aggregation receptor 1(PEAR1)	Homo sapiens				GO:0043654~recognition of apoptotic cell,GO:0045746~negative regulation of Notch signaling pathway,	GO:0001891~phagocytic cup,GO:0016021~integral component of membrane,		IPR000742:Epidermal growth factor-like domain,IPR002049:EGF-like, laminin,IPR011489:EMI domain,IPR013032:EGF-like, conserved site,				SM00180:EGF_Lam,SM00181:EGF,	Cell membrane,Complete proteome,Direct protein sequencing,Disulfide bond,EGF-like domain,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Platelet endothelial aggregation receptor 1,compositionally biased region:Pro-rich,disulfide bond,domain:EGF-like 1,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:EMI,glycosylation site:N-linked (GlcNAc...),modified residue,sequence variant,signal peptide,transmembrane region,
ENSG00000120278	pleckstrin homology and RhoGEF domain containing G1(PLEKHG1)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,		GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,	Complete proteome,Guanine-nucleotide releasing factor,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family G member 1,domain:DH,domain:PH,modified residue,sequence variant,
ENSG00000052126	pleckstrin homology domain containing A5(PLEKHA5)	Homo sapiens				GO:0061458~reproductive system development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,	GO:0005515~protein binding,GO:0005545~1-phosphatidylinositol binding,GO:0010314~phosphatidylinositol-5-phosphate binding,GO:0032266~phosphatidylinositol-3-phosphate binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0080025~phosphatidylinositol-3,5-bisphosphate binding,	IPR001202:WW domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00456:WW,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Cytoplasm,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,	chain:Pleckstrin homology domain-containing family A member 5,domain:PH,domain:WW 1,domain:WW 2,helix,modified residue,sequence conflict,splice variant,strand,
ENSG00000166689	pleckstrin homology domain containing A7(PLEKHA7)	Homo sapiens				GO:0045218~zonula adherens maintenance,GO:0090136~epithelial cell-cell adhesion,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005915~zonula adherens,GO:0030054~cell junction,GO:0070062~extracellular exosome,	GO:0070097~delta-catenin binding,	IPR001202:WW domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00456:WW,	Alternative splicing,Cell junction,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Pleckstrin homology domain-containing family A member 7,compositionally biased region:Pro-rich,domain:PH,domain:WW 1,domain:WW 2,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000076356	plexin A2(PLXNA2)	Homo sapiens				GO:0001756~somitogenesis,GO:0021785~branchiomotor neuron axon guidance,GO:0021915~neural tube development,GO:0021935~cerebellar granule cell precursor tangential migration,GO:0030334~regulation of cell migration,GO:0048841~regulation of axon extension involved in axon guidance,GO:0051642~centrosome localization,GO:0060037~pharyngeal system development,GO:0060174~limb bud formation,GO:0071526~semaphorin-plexin signaling pathway,GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance,	GO:0002116~semaphorin receptor complex,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0005515~protein binding,GO:0017154~semaphorin receptor activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR002909:Cell surface receptor IPT/TIG,IPR008936:Rho GTPase activation protein,IPR013548:Plexin, cytoplasmic RasGAP domain,IPR013783:Immunoglobulin-like fold,IPR014756:Immunoglobulin E-set,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,	hsa04360:Axon guidance,			SM00423:PSI,SM00429:IPT,SM00630:Sema,	3D-structure,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Plexin-A2,domain:IPT/TIG 1,domain:IPT/TIG 2,domain:IPT/TIG 3,domain:IPT/TIG 4,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000151846	poly(A) binding protein cytoplasmic 3(PABPC3)	Homo sapiens				GO:0016071~mRNA metabolic process,	GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0000166~nucleotide binding,GO:0003723~RNA binding,GO:0008143~poly(A) binding,	IPR000504:RNA recognition motif domain,IPR002004:Polyadenylate-binding protein/Hyperplastic disc protein,IPR003954:RNA recognition motif domain, eukaryote,IPR006515:Polyadenylate binding protein, human types 1, 2, 3, 4,IPR012677:Nucleotide-binding, alpha-beta plait,	hsa03013:RNA transport,hsa03015:mRNA surveillance pathway,hsa03018:RNA degradation,			SM00360:RRM,SM00361:RRM_1,SM00517:PolyA,	3D-structure,Complete proteome,Cytoplasm,Reference proteome,Repeat,RNA-binding,	chain:Polyadenylate-binding protein 3,domain:PABC,domain:RRM 1,domain:RRM 2,domain:RRM 3,domain:RRM 4,helix,modified residue,sequence conflict,strand,turn,
ENSG00000177469	polymerase I and transcript release factor(PTRF)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0006361~transcription initiation from RNA polymerase I promoter,GO:0006363~termination of RNA polymerase I transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005901~caveola,GO:0043234~protein complex,GO:0045121~membrane raft,	GO:0005515~protein binding,GO:0042134~rRNA primary transcript binding,GO:0044822~poly(A) RNA binding,	IPR026752:Cavin family,		613327~Lipodystrophy, congenital generalized, type 4,			Acetylation,Alternative splicing,Cell membrane,Coiled coil,Complete proteome,Congenital generalized lipodystrophy,Cytoplasm,Diabetes mellitus,Direct protein sequencing,Endoplasmic reticulum,Isopeptide bond,Membrane,Microsome,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,RNA-binding,rRNA-binding,Transcription,Transcription regulation,Transcription termination,Ubl conjugation,	chain:Polymerase I and transcript release factor,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000124780	potassium two pore domain channel subfamily K member 17(KCNK17)	Homo sapiens				GO:0006813~potassium ion transport,GO:0030322~stabilization of membrane potential,GO:0034765~regulation of ion transmembrane transport,GO:0071805~potassium ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005244~voltage-gated ion channel activity,GO:0005267~potassium channel activity,GO:0022841~potassium ion leak channel activity,	IPR003092:Two pore domain potassium channel, TASK family,IPR003280:Two pore domain potassium channel,IPR013099:Ion transport 2,			PIRSF038061:potassium channel, subfamily K type,		Alternative splicing,Complete proteome,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Potassium,Potassium channel,Potassium transport,Reference proteome,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium channel subfamily K member 17,glycosylation site:N-linked (GlcNAc...),region of interest:Pore-forming 1,region of interest:Pore-forming 2,sequence variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000131398	potassium voltage-gated channel subfamily C member 3(KCNC3)	Homo sapiens				GO:0034765~regulation of ion transmembrane transport,GO:0051260~protein homooligomerization,GO:0051262~protein tetramerization,GO:0071805~potassium ion transmembrane transport,	GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0008076~voltage-gated potassium channel complex,GO:0030054~cell junction,GO:0030424~axon,GO:0030425~dendrite,GO:0032591~dendritic spine membrane,GO:0042734~presynaptic membrane,GO:0043204~perikaryon,	GO:0005249~voltage-gated potassium channel activity,GO:0005251~delayed rectifier potassium channel activity,	IPR000210:BTB/POZ-like,IPR003131:Potassium channel tetramerisation-type BTB domain,IPR003968:Potassium channel, voltage dependent, Kv,IPR003974:Potassium channel, voltage dependent, Kv3,IPR005404:Potassium channel, voltage dependent, Kv3.3,IPR005821:Ion transport domain,IPR011333:BTB/POZ fold,IPR021105:Potassium channel, voltage dependent, Kv3, inactivation domain,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		605259~Spinocerebellar ataxia 13,		SM00225:BTB,	Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Methylation,Neurodegeneration,Phosphoprotein,Potassium,Potassium channel,Potassium transport,Proteomics identification,Reference proteome,Spinocerebellar ataxia,Synapse,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Potassium voltage-gated channel subfamily C member 3,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Selectivity filter,topological domain:Cytoplasmic,transmembrane region,
ENSG00000217930	presequence translocase associated motor 16 homolog(PAM16)	Homo sapiens				GO:0001503~ossification,GO:0030150~protein import into mitochondrial matrix,GO:0032780~negative regulation of ATPase activity,	GO:0001405~presequence translocase-associated import motor,GO:0005744~mitochondrial inner membrane presequence translocase complex,GO:0005759~mitochondrial matrix,GO:0031314~extrinsic component of mitochondrial inner membrane,GO:0043234~protein complex,	GO:0005515~protein binding,	IPR005341:Mitochondrial import inner membrane translocase subunit Tim16,		613320~Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type,			Complete proteome,Disease mutation,Dwarfism,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Protein transport,Reference proteome,Translocation,Transport,	chain:Mitochondrial import inner membrane translocase subunit Tim16,region of interest:J-like,sequence conflict,sequence variant,
ENSG00000124593	prickle planar cell polarity protein 4(PRICKLE4)	Homo sapiens					GO:0005634~nucleus,	GO:0008270~zinc ion binding,	IPR001781:Zinc finger, LIM-type,IPR010442:PET domain,				SM00132:LIM,	Alternative splicing,Complete proteome,LIM domain,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,	chain:Prickle-like protein 4,compositionally biased region:Poly-Ser,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:PET,sequence conflict,sequence variant,splice variant,
ENSG00000173947	primary cilia formation(PIFO)	Homo sapiens				GO:0030030~cell projection organization,GO:0031344~regulation of cell projection organization,GO:0033674~positive regulation of kinase activity,	GO:0005634~nucleus,GO:0005802~trans-Golgi network,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0031410~cytoplasmic vesicle,GO:0036064~ciliary basal body,	GO:0005515~protein binding,GO:0017137~Rab GTPase binding,GO:0019894~kinesin binding,GO:0019901~protein kinase binding,GO:0043015~gamma-tubulin binding,GO:0048487~beta-tubulin binding,						Alternative splicing,Cilium biogenesis/degradation,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Golgi apparatus,Polymorphism,Reference proteome,	chain:Uncharacterized protein C1orf88,sequence conflict,sequence variant,splice variant,
ENSG00000106333	procollagen C-endopeptidase enhancer(PCOLCE)	Homo sapiens				GO:0006508~proteolysis,GO:0007275~multicellular organism development,GO:0010952~positive regulation of peptidase activity,	GO:0005581~collagen trimer,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008201~heparin binding,GO:0016504~peptidase activator activity,	IPR000859:CUB domain,IPR001134:Netrin domain,IPR008993:Tissue inhibitor of metalloproteinases-like, OB-fold,IPR018933:Netrin module, non-TIMP type,				SM00042:CUB,SM00643:C345C,	3D-structure,Collagen,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Phosphoprotein,Reference proteome,Repeat,Secreted,Signal,	chain:Procollagen C-endopeptidase enhancer 1,disulfide bond,domain:CUB 1,domain:CUB 2,domain:NTR,glycosylation site:N-linked (GlcNAc...),helix,signal peptide,site:Cleavage,strand,turn,
ENSG00000188389	programmed cell death 1(PDCD1)	Homo sapiens				GO:0002644~negative regulation of tolerance induction,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0031295~T cell costimulation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0005515~protein binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa04660:T cell receptor signaling pathway,	126200~Multiple sclerosis, disease progression, modifier of,605218~Systemic lupus erythematosus, susceptibility to, 2,		SM00406:IGv,SM00409:IG,	3D-structure,Apoptosis,Complete proteome,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Polymorphism,Reference proteome,Signal,Systemic lupus erythematosus,Transmembrane,Transmembrane helix,	chain:Programmed cell death protein 1,disulfide bond,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000134222	proline and serine rich coiled-coil 1(PSRC1)	Homo sapiens				GO:0001578~microtubule bundle formation,GO:0007080~mitotic metaphase plate congression,GO:0030308~negative regulation of cell growth,GO:0031116~positive regulation of microtubule polymerization,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045893~positive regulation of transcription, DNA-templated,GO:0051301~cell division,GO:0060236~regulation of mitotic spindle organization,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005819~spindle,GO:0005829~cytosol,GO:0005876~spindle microtubule,GO:0015630~microtubule cytoskeleton,GO:0030496~midbody,	GO:0005515~protein binding,GO:0008017~microtubule binding,	IPR026657:Proline/serine-rich coiled-coil protein 1/G2 and S phase-expressed protein 1,IPR026658:Proline/serine-rich coiled-coil protein 1,					Alternative splicing,Cell cycle,Cell division,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Mitosis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Proline/serine-rich coiled-coil protein 1,compositionally biased region:Pro/Ser-rich,modified residue,region of interest:4 X 4 AA repeats of P-X-X-P,repeat:1,repeat:2,repeat:3,repeat:4,sequence variant,splice variant,
ENSG00000126460	proline rich and Gla domain 2(PRRG2)	Homo sapiens					GO:0005576~extracellular region,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000294:Gamma-carboxyglutamic acid-rich (GLA) domain,IPR017857:Coagulation factor, subgroup, Gla domain,				SM00069:GLA,	Complete proteome,Disulfide bond,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane gamma-carboxyglutamic acid protein 2,compositionally biased region:Poly-Pro,disulfide bond,domain:Gla,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000167371	proline rich transmembrane protein 2(PRRT2)	Homo sapiens				GO:0009607~response to biotic stimulus,GO:0050884~neuromuscular process controlling posture,	GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0045202~synapse,		IPR007593:Interferon-induced transmembrane protein,		128200~Episodic kinesigenic dyskinesia 1,602066~Convulsions, familial infantile, with paroxysmal choreoathetosis,605751~Seizures, benign familial infantile, 2,			Alternative splicing,Cell junction,Cell membrane,Complete proteome,Disease mutation,Dystonia,Epilepsy,Glycoprotein,Membrane,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Proline-rich transmembrane protein 2,compositionally biased region:Pro-rich,glycosylation site:N-linked (GlcNAc...),sequence conflict,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000224940	proline rich transmembrane protein 4(PRRT4)	Homo sapiens					GO:0016021~integral component of membrane,							Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Reference proteome,Signal,Transmembrane,Transmembrane helix,
ENSG00000007062	prominin 1(PROM1)	Homo sapiens				GO:0010842~retina layer formation,GO:0045494~photoreceptor cell maintenance,GO:0060042~retina morphogenesis in camera-type eye,GO:0060219~camera-type eye photoreceptor cell differentiation,GO:0072112~glomerular visceral epithelial cell differentiation,GO:0072139~glomerular parietal epithelial cell differentiation,GO:2000768~positive regulation of nephron tubule epithelial cell differentiation,	GO:0001750~photoreceptor outer segment,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031528~microvillus membrane,GO:0031982~vesicle,GO:0042622~photoreceptor outer segment membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0042805~actinin binding,GO:0045296~cadherin binding,	IPR008795:Prominin,	hsa05202:Transcriptional misregulation in cancer,	603786~Stargardt disease 4,608051~Macular dystrophy, retinal, 2,612095~Retinitis pigmentosa 41,612657~Cone-rod dystrophy 12,			Acetylation,Alternative splicing,Cell membrane,Cell projection,Cilium,Coiled coil,Complete proteome,Cone-rod dystrophy,Direct protein sequencing,Disease mutation,Endoplasmic reticulum,Glycoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Signal,Stargardt disease,Transmembrane,Transmembrane helix,	chain:Prominin-1,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000115138	proopiomelanocortin(POMC)	Homo sapiens	110.CRHandLC-NA,			GO:0006091~generation of precursor metabolites and energy,GO:0007165~signal transduction,GO:0007218~neuropeptide signaling pathway,GO:0007267~cell-cell signaling,GO:0008217~regulation of blood pressure,GO:0016486~peptide hormone processing,GO:0032098~regulation of appetite,GO:0032720~negative regulation of tumor necrosis factor production,GO:0033059~cellular pigmentation,GO:0042593~glucose homeostasis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0070873~regulation of glycogen metabolic process,GO:2000852~regulation of corticosterone secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005782~peroxisomal matrix,GO:0030141~secretory granule,GO:0034774~secretory granule lumen,	GO:0001664~G-protein coupled receptor binding,GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0005184~neuropeptide hormone activity,GO:0031781~type 3 melanocortin receptor binding,GO:0031782~type 4 melanocortin receptor binding,GO:0070996~type 1 melanocortin receptor binding,	IPR001941:Pro-opiomelanocortin/corticotropin, ACTH,IPR013531:Pro-opiomelanocortin/corticotropin, ACTH, central region,IPR013532:Opiodes neuropeptide,IPR013593:Pro-opiomelanocortin N-terminal,	hsa04916:Melanogenesis,hsa04920:Adipocytokine signaling pathway,	601665~Obesity, early-onset, susceptibility to,609734~Obesity, adrenal insufficiency, and red hair due to POMC deficiency,		SM01363:SM01363,SM01364:SM01364,SM01365:SM01365,	3D-structure,Acetylation,Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disulfide bond,Endorphin,Glycoprotein,Hormone,Obesity,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (HexNAc...),modified residue,peptide:Beta-endorphin,peptide:Corticotropin,peptide:Corticotropin-like intermediary peptide,peptide:Lipotropin beta,peptide:Lipotropin gamma,peptide:Melanotropin alpha,peptide:Melanotropin beta,peptide:Melanotropin gamma,peptide:Met-enkephalin,peptide:NPP,peptide:Potential peptide,sequence conflict,sequence variant,signal peptide,
ENSG00000102109	proprotein convertase subtilisin/kexin type 1 inhibitor(PCSK1N)	Homo sapiens				GO:0002021~response to dietary excess,GO:0007218~neuropeptide signaling pathway,GO:0009409~response to cold,GO:0010951~negative regulation of endopeptidase activity,GO:0016486~peptide hormone processing,	GO:0005615~extracellular space,GO:0005802~trans-Golgi network,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,	IPR010832:ProSAAS,					Cleavage on pair of basic residues,Complete proteome,Glycoprotein,Golgi apparatus,Neuropeptide,Polymorphism,Reference proteome,Secreted,Signal,	chain:ProSAAS,mutagenesis site,peptide:Big LEN,peptide:Big PEN-LEN,peptide:Big SAAS,peptide:KEP,peptide:Little LEN,peptide:Little SAAS,peptide:PEN,region of interest:C-terminal inhibitory domain; interacts with PCSK1,region of interest:ProSAAS(1-180),sequence variant,short sequence motif:Sufficient for inhibition of PCSK1,signal peptide,
ENSG00000160013	prostaglandin I2 (prostacyclin) receptor (IP)(PTGIR)	Homo sapiens		h_eicosanoidPathway:Eicosanoid Metabolism,		GO:0006954~inflammatory response,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007267~cell-cell signaling,GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0032496~response to lipopolysaccharide,GO:0043547~positive regulation of GTPase activity,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0071799~cellular response to prostaglandin D stimulus,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004930~G-protein coupled receptor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0016501~prostacyclin receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR000370:Prostacyclin (prostanoid IP) receptor,IPR008365:Prostanoid receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04080:Neuroactive ligand-receptor interaction,hsa04270:Vascular smooth muscle contraction,hsa04611:Platelet activation,				Cell membrane,Complete proteome,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Methylation,Palmitate,Polymorphism,Prenylation,Receptor,Reference proteome,Signal,Transducer,Transmembrane,Transmembrane helix,	chain:Prostacyclin receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-farnesyl cysteine,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,propeptide:Removed in mature form,sequence variant,site:Not S-palmitoylated,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000007038	protease, serine 21(PRSS21)	Homo sapiens				GO:0006508~proteolysis,GO:0007283~spermatogenesis,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Hydrolase,Lipoprotein,Membrane,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Testisin,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated serine,propeptide:Removed in mature form,sequence variant,signal peptide,splice variant,
ENSG00000178226	protease, serine 36(PRSS36)	Homo sapiens				GO:0006508~proteolysis,	GO:0005578~proteinaceous extracellular matrix,GO:0005737~cytoplasm,	GO:0004252~serine-type endopeptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR017326:Peptidase S1A, polyserase-2,IPR018114:Peptidase S1, trypsin family, active site,			PIRSF037933:polyserase-2,	SM00020:Tryp_SPc,	Alternative splicing,Complete proteome,Disulfide bond,Extracellular matrix,Glycoprotein,Hydrolase,Protease,Reference proteome,Repeat,Secreted,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Polyserase-2,disulfide bond,domain:Peptidase S1 1,domain:Peptidase S1 2,domain:Peptidase S1 3,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,
ENSG00000185198	protease, serine 57(PRSS57)	Homo sapiens				GO:0006508~proteolysis,	GO:0005615~extracellular space,GO:0035578~azurophil granule lumen,	GO:0004252~serine-type endopeptidase activity,GO:0008201~heparin binding,GO:0008236~serine-type peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,				SM00020:Tryp_SPc,	3D-structure,Complete proteome,Disulfide bond,Glycoprotein,Heparin-binding,Hydrolase,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Serine protease,Signal,	active site:Charge relay system,chain:Serine protease 1-like protein 1,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ENSG00000124507	protein kinase C and casein kinase substrate in neurons 1(PACSIN1)	Homo sapiens				GO:0007015~actin filament organization,GO:0030100~regulation of endocytosis,GO:0045806~negative regulation of endocytosis,GO:0048488~synaptic vesicle endocytosis,GO:0048666~neuron development,GO:0048812~neuron projection morphogenesis,GO:0072657~protein localization to membrane,GO:0090002~establishment of protein localization to plasma membrane,GO:0097320~membrane tubulation,GO:1900006~positive regulation of dendrite development,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0030137~COPI-coated vesicle,GO:0030659~cytoplasmic vesicle membrane,GO:0032587~ruffle membrane,GO:0043209~myelin sheath,GO:0043679~axon terminus,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008092~cytoskeletal protein binding,GO:0016301~kinase activity,	IPR001060:FCH domain,IPR001452:Src homology-3 domain,				SM00055:FCH,SM00326:SH3,	3D-structure,Cell junction,Cell membrane,Cell projection,Coiled coil,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Endocytosis,Kinase,Lipid-binding,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,SH3 domain,Synapse,Synaptosome,Transferase,	chain:Protein kinase C and casein kinase substrate in neurons protein 1,domain:FCH,domain:SH3,helix,modified residue,sequence variant,turn,
ENSG00000104881	protein phosphatase 1 regulatory subunit 13 like(PPP1R13L)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0003215~cardiac right ventricle morphogenesis,GO:0003229~ventricular cardiac muscle tissue development,GO:0006351~transcription, DNA-templated,GO:0006915~apoptotic process,GO:0009791~post-embryonic development,GO:0031076~embryonic camera-type eye development,GO:0035264~multicellular organism growth,GO:0042633~hair cycle,GO:0045597~positive regulation of cell differentiation,GO:0048871~multicellular organismal homeostasis,GO:0060048~cardiac muscle contraction,GO:0098609~cell-cell adhesion,GO:1901796~regulation of signal transduction by p53 class mediator,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005913~cell-cell adherens junction,GO:0030054~cell junction,GO:0045171~intercellular bridge,	GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001452:Src homology-3 domain,IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,SM00326:SH3,	3D-structure,Acetylation,ANK repeat,Apoptosis,Complete proteome,Cytoplasm,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,SH3 domain,Transcription,Transcription regulation,	chain:RelA-associated inhibitor,compositionally biased region:Gln-rich,compositionally biased region:Pro-rich,domain:SH3,helix,modified residue,repeat:ANK 1,repeat:ANK 2,sequence conflict,splice variant,strand,turn,
ENSG00000112655	protein tyrosine kinase 7 (inactive)(PTK7)	Homo sapiens				GO:0001736~establishment of planar polarity,GO:0003281~ventricular septum development,GO:0003401~axis elongation,GO:0006468~protein phosphorylation,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0010976~positive regulation of neuron projection development,GO:0016477~cell migration,GO:0031532~actin cytoskeleton reorganization,GO:0042060~wound healing,GO:0045198~establishment of epithelial cell apical/basal polarity,GO:0060026~convergent extension,GO:0060070~canonical Wnt signaling pathway,GO:0060484~lung-associated mesenchyme development,GO:0060976~coronary vasculature development,GO:0071300~cellular response to retinoic acid,GO:0090103~cochlea morphogenesis,GO:0090179~planar cell polarity pathway involved in neural tube closure,	GO:0005887~integral component of plasma membrane,GO:0005911~cell-cell junction,GO:0005925~focal adhesion,	GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:1904929~coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell adhesion,Cell junction,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Wnt signaling pathway,	chain:Tyrosine-protein kinase-like 7,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,domain:Protein kinase; inactive,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000184226	protocadherin 9(PCDH9)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0030900~forebrain development,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030426~growth cone,GO:0044291~cell-cell contact zone,	GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR013164:Cadherin, N-terminal,IPR013585:Protocadherin,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,				SM00112:CA,	3D-structure,Alternative splicing,Calcium,Cell adhesion,Cell membrane,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin-9,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,domain:Cadherin 7,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000113209	protocadherin beta 5(PCDHB5)	Homo sapiens				GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007268~chemical synaptic transmission,GO:0007416~synapse assembly,GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005509~calcium ion binding,	IPR002126:Cadherin,IPR013164:Cadherin, N-terminal,IPR015919:Cadherin-like,IPR020894:Cadherin conserved site,				SM00112:CA,	Acetylation,Calcium,Cell adhesion,Cell membrane,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Protocadherin beta-5,domain:Cadherin 1,domain:Cadherin 2,domain:Cadherin 3,domain:Cadherin 4,domain:Cadherin 5,domain:Cadherin 6,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000183010	pyrroline-5-carboxylate reductase 1(PYCR1)	Homo sapiens				GO:0006561~proline biosynthetic process,GO:0008652~cellular amino acid biosynthetic process,GO:0034599~cellular response to oxidative stress,GO:0051881~regulation of mitochondrial membrane potential,GO:0055114~oxidation-reduction process,GO:0055129~L-proline biosynthetic process,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,	GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,	GO:0004735~pyrroline-5-carboxylate reductase activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000304:Pyrroline-5-carboxylate reductase,IPR008927:6-phosphogluconate dehydrogenase, C-terminal-like,IPR016040:NAD(P)-binding domain,	hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01230:Biosynthesis of amino acids,	612940~Cutis laxa, autosomal recessive, type IIB,614438~Cutis laxa, autosomal recessive, type IIIB,	PIRSF000193:pyrroline-5-carboxylate reductase,		3D-structure,Acetylation,Alternative splicing,Amino-acid biosynthesis,Complete proteome,Direct protein sequencing,Disease mutation,Mitochondrion,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proline biosynthesis,Proteomics identification,Reference proteome,Stress response,	chain:Pyrroline-5-carboxylate reductase 1, mitochondrial,helix,modified residue,sequence conflict,sequence variant,strand,turn,
ENSG00000181031	rabphilin 3A-like (without C2 domains)(RPH3AL)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0006887~exocytosis,GO:0006906~vesicle fusion,GO:0017157~regulation of exocytosis,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0042493~response to drug,GO:0042593~glucose homeostasis,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0050714~positive regulation of protein secretion,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030658~transport vesicle membrane,GO:0030667~secretory granule membrane,	GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005544~calcium-dependent phospholipid binding,GO:0008092~cytoskeletal protein binding,GO:0017137~Rab GTPase binding,GO:0019905~syntaxin binding,GO:0030274~LIM domain binding,GO:0030276~clathrin binding,GO:0046872~metal ion binding,	IPR010911:Rab-binding domain,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017455:Zinc finger, FYVE-related,					Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Exocytosis,Membrane,Metal-binding,Proteomics identification,Reference proteome,Zinc,Zinc-finger,	chain:Rab effector Noc2,domain:RabBD,sequence conflict,splice variant,zinc finger region:FYVE-type,
ENSG00000068615	receptor accessory protein 1(REEP1)	Homo sapiens				GO:0032386~regulation of intracellular transport,GO:0051205~protein insertion into membrane,GO:0071786~endoplasmic reticulum tubular network organization,	GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031966~mitochondrial membrane,GO:0071782~endoplasmic reticulum tubular network,	GO:0005515~protein binding,GO:0008017~microtubule binding,GO:0031849~olfactory receptor binding,	IPR004345:TB2/DP1/HVA22-related protein,		610250~Spastic paraplegia 31, autosomal dominant,614751~Neuronopathy, distal hereditary motor, type VB,			Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Hereditary spastic paraplegia,Membrane,Mitochondrion,Neurodegeneration,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Receptor expression-enhancing protein 1,compositionally biased region:Poly-Pro,modified residue,sequence variant,transmembrane region,
ENSG00000132329	receptor activity modifying protein 1(RAMP1)	Homo sapiens				GO:0001525~angiogenesis,GO:0006816~calcium ion transport,GO:0006886~intracellular protein transport,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0015031~protein transport,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0031623~receptor internalization,GO:0060050~positive regulation of protein glycosylation,GO:0072659~protein localization to plasma membrane,	GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043235~receptor complex,	GO:0004872~receptor activity,GO:0004948~calcitonin receptor activity,GO:0005515~protein binding,GO:0008565~protein transporter activity,GO:0015026~coreceptor activity,GO:0031716~calcitonin receptor binding,	IPR006985:Receptor activity modifying protein,	hsa04270:Vascular smooth muscle contraction,				3D-structure,Complete proteome,Disulfide bond,Membrane,Proteomics identification,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Receptor activity-modifying protein 1,disulfide bond,helix,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000183421	receptor interacting serine/threonine kinase 4(RIPK4)	Homo sapiens				GO:0002009~morphogenesis of an epithelium,GO:0006468~protein phosphorylation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,	GO:0005737~cytoplasm,GO:0016020~membrane,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR002110:Ankyrin repeat,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,IPR020683:Ankyrin repeat-containing domain,		263650~Popliteal pterygium syndrome, Bartsocas-Papas type,		SM00220:S_TKc,SM00248:ANK,	Alternative splicing,ANK repeat,ATP-binding,Complete proteome,Cytoplasm,Disease mutation,Isopeptide bond,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Serine/threonine-protein kinase,Transferase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:Receptor-interacting serine/threonine- protein kinase 4,domain:Protein kinase,nucleotide phosphate-binding region:ATP,repeat:ANK 1,repeat:ANK 10,repeat:ANK 2,repeat:ANK 3,repeat:ANK 4,repeat:ANK 5,repeat:ANK 6,repeat:ANK 7,repeat:ANK 8,repeat:ANK 9,sequence conflict,sequence variant,site:Cleavage,splice variant,
ENSG00000134193	regenerating family member 4(REG4)	Homo sapiens					GO:0005576~extracellular region,GO:0005737~cytoplasm,	GO:0005509~calcium ion binding,GO:0008201~heparin binding,GO:2001065~mannan binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Lectin,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Regenerating islet-derived protein 4,disulfide bond,domain:C-type lectin,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,
ENSG00000143333	regulator of G-protein signaling 16(RGS16)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007601~visual perception,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0009968~negative regulation of signal transduction,GO:0043547~positive regulation of GTPase activity,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0031224~intrinsic component of membrane,	GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0005516~calmodulin binding,	IPR016137:Regulator of G protein signalling superfamily,IPR024066:Regulator of G-protein signaling, domain 1,				SM00315:RGS,	3D-structure,Complete proteome,GTPase activation,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Reference proteome,Signal transduction inhibitor,	chain:Regulator of G-protein signaling 16,domain:RGS,helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,mutagenesis site,sequence conflict,sequence variant,turn,
ENSG00000128253	ret finger protein like 2(RFPL2)	Homo sapiens						GO:0046872~metal ion binding,	IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR022723:RDM domain, Ret finger protein-like,				SM00449:SPRY,SM00589:PRY,	Alternative splicing,Complete proteome,Metal-binding,Polymorphism,Reference proteome,Zinc,Zinc-finger,	chain:Ret finger protein-like 2,chain:Ret finger protein-like 3,domain:B30.2/SPRY,sequence variant,splice variant,zinc finger region:RING-type,zinc finger region:RING-type; degenerate,
ENSG00000125744	reticulon 2(RTN2)	Homo sapiens				GO:0046324~regulation of glucose import,GO:0065002~intracellular protein transmembrane transport,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0014802~terminal cisterna,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,GO:0030315~T-tubule,	GO:0005515~protein binding,	IPR003388:Reticulon,		604805~Spastic paraplegia 12, autosomal dominant,			Alternative initiation,Alternative splicing,Complete proteome,Disease mutation,Endoplasmic reticulum,Hereditary spastic paraplegia,Membrane,Neurodegeneration,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Reticulon-2,domain:Reticulon,modified residue,sequence variant,splice variant,transmembrane region,
ENSG00000186907	reticulon 4 receptor-like 2(RTN4RL2)	Homo sapiens				GO:0006469~negative regulation of protein kinase activity,GO:0019221~cytokine-mediated signaling pathway,GO:0031103~axon regeneration,GO:0046426~negative regulation of JAK-STAT cascade,	GO:0005737~cytoplasm,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0045121~membrane raft,GO:0046658~anchored component of plasma membrane,GO:0070062~extracellular exosome,	GO:0004860~protein kinase inhibitor activity,GO:0004872~receptor activity,	IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,				SM00082:LRRCT,SM00369:LRR_TYP,	Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,GPI-anchor,Leucine-rich repeat,Lipoprotein,Membrane,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,	chain:Reticulon-4 receptor-like 2,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:GPI-anchor amidated cysteine,propeptide:Removed in mature form,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,sequence conflict,signal peptide,
ENSG00000131831	retinoic acid induced 2(RAI2)	Homo sapiens				GO:0009790~embryo development,		GO:0005515~protein binding,	IPR026092:Retinoic acid-induced protein 2/sine oculis-binding protein homolog,					Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Retinoic acid-induced protein 2,compositionally biased region:Pro-rich,sequence variant,
ENSG00000242732	retrotransposon gag domain containing 4(RGAG4)	Homo sapiens												Complete proteome,Polymorphism,Reference proteome,	chain:Retrotransposon gag domain-containing protein 4,compositionally biased region:Glu-rich,compositionally biased region:Poly-Pro,sequence variant,
ENSG00000145491	rhophilin associated tail protein 1 like(ROPN1L)	Homo sapiens				GO:0003351~epithelial cilium movement,	GO:0005737~cytoplasm,GO:0031514~motile cilium,	GO:0005515~protein binding,	IPR003117:cAMP-dependent protein kinase, regulatory subunit, type I/II alpha/beta,					Complete proteome,Polymorphism,Reference proteome,	chain:Ropporin-1-like protein,domain:RIIa,sequence variant,
ENSG00000169413	ribonuclease A family member k6(RNASE6)	Homo sapiens				GO:0006401~RNA catabolic process,GO:0006952~defense response,GO:0090501~RNA phosphodiester bond hydrolysis,	GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004540~ribonuclease activity,	IPR001427:Ribonuclease A,IPR023411:Ribonuclease A, active site,IPR023412:Ribonuclease A-domain,				SM00092:RNAse_Pc,	3D-structure,Complete proteome,Disulfide bond,Endonuclease,Glycoprotein,Hydrolase,Nuclease,Polymorphism,Reference proteome,Secreted,Signal,	active site:Proton acceptor,active site:Proton donor,binding site:Substrate,chain:Ribonuclease K6,disulfide bond,glycosylation site:N-linked (GlcNAc...),region of interest:Substrate binding,sequence variant,signal peptide,
ENSG00000219200	ribonuclease K(RNASEK)	Homo sapiens				GO:0009303~rRNA transcription,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,	GO:0016021~integral component of membrane,	GO:0004521~endoribonuclease activity,	IPR026770:Ribonuclease kappa,					Alternative splicing,Complete proteome,Endonuclease,Hydrolase,Membrane,Nuclease,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:Ribonuclease kappa,transmembrane region,
ENSG00000171848	ribonucleotide reductase regulatory subunit M2(RRM2)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006260~DNA replication,GO:0009186~deoxyribonucleoside diphosphate metabolic process,GO:0009263~deoxyribonucleotide biosynthetic process,GO:0015949~nucleobase-containing small molecule interconversion,GO:0051290~protein heterotetramerization,GO:0055114~oxidation-reduction process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005971~ribonucleoside-diphosphate reductase complex,	GO:0004748~ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,GO:0005515~protein binding,GO:0016491~oxidoreductase activity,GO:0046872~metal ion binding,	IPR000358:Ribonucleotide reductase small subunit,IPR009078:Ferritin-like superfamily,IPR012348:Ribonucleotide reductase-related,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa00480:Glutathione metabolism,hsa01100:Metabolic pathways,hsa04115:p53 signaling pathway,				3D-structure,Alternative splicing,Complete proteome,Cytoplasm,DNA replication,Iron,Metal-binding,Oxidoreductase,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Ribonucleoside-diphosphate reductase subunit M2,helix,metal ion-binding site:Iron 1,metal ion-binding site:Iron 2,modified residue,mutagenesis site,strand,turn,
ENSG00000141622	ring finger protein 165(RNF165)	Homo sapiens				GO:0000209~protein polyubiquitination,GO:0008045~motor neuron axon guidance,GO:0010259~multicellular organism aging,GO:0030163~protein catabolic process,GO:0030513~positive regulation of BMP signaling pathway,GO:0035136~forelimb morphogenesis,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0060384~innervation,GO:0061061~muscle structure development,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0043234~protein complex,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR011016:Zinc finger, RING-CH-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00184:RING,SM00744:RINGv,	3D-structure,Alternative splicing,Complete proteome,Glycoprotein,Ligase,Metal-binding,Reference proteome,Zinc,Zinc-finger,	chain:RING finger protein 165,glycosylation site:N-linked (GlcNAc...),zinc finger region:RING-type; atypical,
ENSG00000212864	ring finger protein 208(RNF208)	Homo sapiens				GO:0051865~protein autoubiquitination,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,					Complete proteome,Metal-binding,Phosphoprotein,Reference proteome,Zinc,Zinc-finger,	chain:RING finger protein 208,modified residue,zinc finger region:RING-type,
ENSG00000227500	secretory carrier membrane protein 4(SCAMP4)	Homo sapiens				GO:0015031~protein transport,	GO:0016021~integral component of membrane,		IPR007273:SCAMP,					Alternative splicing,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Secretory carrier-associated membrane protein 4,sequence variant,splice variant,topological domain:Cytoplasmic,transmembrane region,
ENSG00000198794	secretory carrier membrane protein 5(SCAMP5)	Homo sapiens				GO:0006887~exocytosis,GO:0015031~protein transport,GO:0034976~response to endoplasmic reticulum stress,GO:0045806~negative regulation of endocytosis,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0050715~positive regulation of cytokine secretion,	GO:0000139~Golgi membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0031201~SNARE complex,GO:0032588~trans-Golgi network membrane,GO:0055038~recycling endosome membrane,	GO:0005515~protein binding,	IPR007273:SCAMP,					Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasmic vesicle,Endosome,Exocytosis,Golgi apparatus,Membrane,Protein transport,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Secretory carrier-associated membrane protein 5,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000075223	semaphorin 3C(SEMA3C)	Homo sapiens				GO:0001755~neural crest cell migration,GO:0001756~somitogenesis,GO:0001974~blood vessel remodeling,GO:0003151~outflow tract morphogenesis,GO:0003215~cardiac right ventricle morphogenesis,GO:0003350~pulmonary myocardium development,GO:0006955~immune response,GO:0007411~axon guidance,GO:0009791~post-embryonic development,GO:0021915~neural tube development,GO:0030335~positive regulation of cell migration,GO:0042493~response to drug,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0060174~limb bud formation,GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,			SM00409:IG,SM00423:PSI,SM00630:Sema,	Alternative splicing,Complete proteome,Developmental protein,Differentiation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Neurogenesis,Polymorphism,Reference proteome,Secreted,Signal,	chain:Semaphorin-3C,compositionally biased region:Arg/Lys-rich (basic),disulfide bond,domain:Ig-like C2-type,domain:Sema,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
ENSG00000196189	semaphorin 4A(SEMA4A)	Homo sapiens				GO:0001525~angiogenesis,GO:0001755~neural crest cell migration,GO:0007409~axonogenesis,GO:0008360~regulation of cell shape,GO:0010594~regulation of endothelial cell migration,GO:0016525~negative regulation of angiogenesis,GO:0030335~positive regulation of cell migration,GO:0045063~T-helper 1 cell differentiation,GO:0048843~negative regulation of axon extension involved in axon guidance,GO:0050919~negative chemotaxis,GO:0071526~semaphorin-plexin signaling pathway,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0005515~protein binding,GO:0030215~semaphorin receptor binding,GO:0038191~neuropilin binding,GO:0045499~chemorepellent activity,	IPR001627:Semaphorin/CD100 antigen,IPR002165:Plexin,IPR015943:WD40/YVTN repeat-like-containing domain,IPR016201:Plexin-like fold,IPR027231:Semaphorin,	hsa04360:Axon guidance,	610282~Retinitis pigmentosa 35,610283~Cone-rod dystrophy 10,		SM00423:PSI,SM00630:Sema,	Adaptive immunity,Alternative splicing,Angiogenesis,Cell membrane,Complete proteome,Cone-rod dystrophy,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Glycoprotein,Immunity,Immunoglobulin domain,Membrane,Neurogenesis,Polymorphism,Proteomics identification,Reference proteome,Retinitis pigmentosa,Signal,Transmembrane,Transmembrane helix,	chain:Semaphorin-4A,disulfide bond,domain:Ig-like C2-type,domain:PSI,domain:Sema,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000166145	serine peptidase inhibitor, Kunitz type 1(SPINT1)	Homo sapiens				GO:0001843~neural tube closure,GO:0010951~negative regulation of endopeptidase activity,GO:0030198~extracellular matrix organization,GO:0045687~positive regulation of glial cell differentiation,GO:0060670~branching involved in labyrinthine layer morphogenesis,GO:0060674~placenta blood vessel development,GO:0071773~cellular response to BMP stimulus,GO:2000178~negative regulation of neural precursor cell proliferation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0004867~serine-type endopeptidase inhibitor activity,	IPR002172:Low-density lipoprotein (LDL) receptor class A repeat,IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR011106:Seven cysteines, N-terminal,IPR013980:Seven cysteines,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,IPR023415:Low-density lipoprotein (LDL) receptor class A, conserved site,	hsa05202:Transcriptional misregulation in cancer,			SM00131:KU,SM00192:LDLa,SM00765:MANEC,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,Transmembrane,Transmembrane helix,	chain:Kunitz-type protease inhibitor 1,disulfide bond,domain:BPTI/Kunitz inhibitor 1,domain:BPTI/Kunitz inhibitor 2,domain:LDL-receptor class A,domain:MANSC,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Reactive bond,splice variant,strand,turn,
ENSG00000135919	serpin family E member 2(SERPINE2)	Homo sapiens				GO:0007596~blood coagulation,GO:0008285~negative regulation of cell proliferation,GO:0010757~negative regulation of plasminogen activation,GO:0010766~negative regulation of sodium ion transport,GO:0010951~negative regulation of endopeptidase activity,GO:0010955~negative regulation of protein processing,GO:0014067~negative regulation of phosphatidylinositol 3-kinase signaling,GO:0021683~cerebellar granular layer morphogenesis,GO:0030195~negative regulation of blood coagulation,GO:0030308~negative regulation of cell growth,GO:0030334~regulation of cell migration,GO:0032940~secretion by cell,GO:0033363~secretory granule organization,GO:0042177~negative regulation of protein catabolic process,GO:0042628~mating plug formation,GO:0045861~negative regulation of proteolysis,GO:0045879~negative regulation of smoothened signaling pathway,GO:0048505~regulation of timing of cell differentiation,GO:0048711~positive regulation of astrocyte differentiation,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0060291~long-term synaptic potentiation,GO:0060384~innervation,GO:0061108~seminal vesicle epithelium development,GO:0090331~negative regulation of platelet aggregation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005829~cytosol,GO:0031012~extracellular matrix,GO:0031091~platelet alpha granule,GO:0031232~extrinsic component of external side of plasma membrane,GO:0031594~neuromuscular junction,GO:1903561~extracellular vesicle,	GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005539~glycosaminoglycan binding,GO:0008201~heparin binding,	IPR000215:Serpin family,IPR023795:Protease inhibitor I4, serpin, conserved site,IPR023796:Serpin domain,				SM00093:SERPIN,	3D-structure,Alternative splicing,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Glycoprotein,Heparin-binding,Neurogenesis,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Secreted,Serine protease inhibitor,Signal,	chain:Glia-derived nexin,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,site:Reactive bond,splice variant,
ENSG00000198892	shisa family member 4(SHISA4)	Homo sapiens					GO:0016021~integral component of membrane,		IPR026910:Shisa family,					Complete proteome,Membrane,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Protein shisa-4,compositionally biased region:Pro-rich,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000101307	signal regulatory protein beta 1(SIRPB1)	Homo sapiens				GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0045087~innate immune response,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003597:Immunoglobulin C1-set,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04380:Osteoclast differentiation,			SM00406:IGv,SM00407:IGc1,SM00409:IG,	3D-structure,Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:Signal-regulatory protein beta-1,chain:Signal-regulatory protein beta-1 isoform 3,disulfide bond,domain:Ig-like C1-type 1,domain:Ig-like C1-type 2,domain:Ig-like V-type,domain:Ig-like V-type 1,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
ENSG00000166002	single-pass membrane protein with coiled-coil domains 4(SMCO4)	Homo sapiens					GO:0016021~integral component of membrane,	GO:0005515~protein binding,						Coiled coil,Complete proteome,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0443 protein C11orf75,transmembrane region,
ENSG00000095932	small integral membrane protein 24(SMIM24)	Homo sapiens					GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,							Coiled coil,Complete proteome,Membrane,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Transmembrane protein HSPC323,sequence conflict,signal peptide,transmembrane region,
ENSG00000183963	smoothelin(SMTN)	Homo sapiens				GO:0006939~smooth muscle contraction,GO:0007517~muscle organ development,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0015629~actin cytoskeleton,	GO:0003779~actin binding,GO:0008307~structural constituent of muscle,	IPR001715:Calponin homology domain,IPR022189:Smoothelin cytoskeleton protein,				SM00033:CH,	3D-structure,Acetylation,Alternative promoter usage,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Smoothelin,compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:CH,helix,modified residue,sequence conflict,sequence variant,splice variant,turn,
ENSG00000124216	snail family transcriptional repressor 1(SNAI1)	Homo sapiens		h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001649~osteoblast differentiation,GO:0001707~mesoderm formation,GO:0001837~epithelial to mesenchymal transition,GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0010957~negative regulation of vitamin D biosynthetic process,GO:0016477~cell migration,GO:0030335~positive regulation of cell migration,GO:0031069~hair follicle morphogenesis,GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060021~palate development,GO:0060536~cartilage morphogenesis,GO:0060707~trophoblast giant cell differentiation,GO:0060806~negative regulation of cell differentiation involved in embryonic placenta development,GO:0060972~left/right pattern formation,GO:0061314~Notch signaling involved in heart development,GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:2000810~regulation of bicellular tight junction assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0005515~protein binding,GO:0019900~kinase binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa04520:Adherens junction,			SM00355:ZnF_C2H2,	3D-structure,ADP-ribosylation,Complete proteome,Cytoplasm,Developmental protein,DNA-binding,Glycoprotein,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein SNAI1,modified residue,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; atypical,
ENSG00000111319	sodium channel epithelial 1 alpha subunit(SCNN1A)	Homo sapiens				GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0050891~multicellular organismal water homeostasis,GO:0050896~response to stimulus,GO:0050909~sensory perception of taste,GO:0055078~sodium ion homeostasis,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031514~motile cilium,GO:0034706~sodium channel complex,GO:0060170~ciliary membrane,GO:0070062~extracellular exosome,	GO:0005272~sodium channel activity,GO:0005515~protein binding,GO:0015280~ligand-gated sodium channel activity,GO:0050699~WW domain binding,	IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,IPR020903:Na+ channel, amiloride-sensitive, conserved site,	hsa04742:Taste transduction,hsa04960:Aldosterone-regulated sodium reabsorption,	264350~Pseudohypoaldosteronism, type I,613021~Bronchiectasis with or without elevated sweat chloride 2,			3D-structure,Alternative splicing,Cell membrane,Cell projection,Complete proteome,Disease mutation,Glycoprotein,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Sensory transduction,Sodium,Sodium channel,Sodium transport,Taste,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,	chain:Amiloride-sensitive sodium channel subunit alpha,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000169432	sodium voltage-gated channel alpha subunit 9(SCN9A)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006954~inflammatory response,GO:0009636~response to toxic substance,GO:0009791~post-embryonic development,GO:0019228~neuronal action potential,GO:0019233~sensory perception of pain,GO:0034765~regulation of ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0048266~behavioral response to pain,GO:0060078~regulation of postsynaptic membrane potential,GO:0086010~membrane depolarization during action potential,	GO:0001518~voltage-gated sodium channel complex,GO:0005887~integral component of plasma membrane,GO:0042995~cell projection,	GO:0005248~voltage-gated sodium channel activity,GO:0031402~sodium ion binding,	IPR000048:IQ motif, EF-hand binding site,IPR001696:Voltage gated sodium channel, alpha subunit,IPR005821:Ion transport domain,IPR010526:Sodium ion transport-associated,IPR024583:Domain of unknown function DUF3451,IPR027359:Voltage-dependent potassium channel, four helix bundle domain,		133020~Erythermalgia, primary,133020~Small fiber neuropathy,243000~HSAN2D, autosomal recessive,243000~Insensitivity to pain, congenital,607208~Dravet syndrome, modifier of,613863~Epilepsy, generalized, with febrile seizures plus, type 7,613863~Febrile seizures, familial, 3B,Paroxysmal extreme pain disorder, 167400,~Paroxysmal extreme pain disorder, 167400,,		SM00015:IQ,	3D-structure,Alternative splicing,Cell membrane,Cell projection,Coiled coil,Complete proteome,Disease mutation,Epilepsy,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Ubl conjugation,Voltage-gated channel,	chain:Sodium channel protein type 9 subunit alpha,domain:IQ,glycosylation site:N-linked (GlcNAc...),modified residue,repeat:I,repeat:II,repeat:III,repeat:IV,sequence conflict,sequence variant,splice variant,transmembrane region,
ENSG00000105711	sodium voltage-gated channel beta subunit 1(SCN1B)	Homo sapiens				GO:0006814~sodium ion transport,GO:0007155~cell adhesion,GO:0007268~chemical synaptic transmission,GO:0007411~axon guidance,GO:0010765~positive regulation of sodium ion transport,GO:0010976~positive regulation of neuron projection development,GO:0019227~neuronal action potential propagation,GO:0021966~corticospinal neuron axon guidance,GO:0035725~sodium ion transmembrane transport,GO:0040011~locomotion,GO:0046684~response to pyrethroid,GO:0051899~membrane depolarization,GO:0060048~cardiac muscle contraction,GO:0060078~regulation of postsynaptic membrane potential,GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization,GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization,GO:0061337~cardiac conduction,GO:0086002~cardiac muscle cell action potential involved in contraction,GO:0086012~membrane depolarization during cardiac muscle cell action potential,GO:0086047~membrane depolarization during Purkinje myocyte cell action potential,GO:0086091~regulation of heart rate by cardiac conduction,GO:2000649~regulation of sodium ion transmembrane transporter activity,	GO:0001518~voltage-gated sodium channel complex,GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0014704~intercalated disc,GO:0030315~T-tubule,GO:0033268~node of Ranvier,	GO:0005248~voltage-gated sodium channel activity,GO:0005515~protein binding,GO:0017080~sodium channel regulator activity,GO:0019871~sodium channel inhibitor activity,GO:0086006~voltage-gated sodium channel activity involved in cardiac muscle cell action potential,GO:0086062~voltage-gated sodium channel activity involved in Purkinje myocyte action potential,	IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,IPR027098:Sodium channel subunit beta-1/beta-3,	hsa04261:Adrenergic signaling in cardiomyocytes,	604233~Epilepsy, generalized, with febrile seizures plus, type 1,612838~Brugada syndrome 5,612838~Cardiac conduction defect, nonspecific,615377~Atrial fibrillation, familial, 13,			Alternative splicing,Atrial fibrillation,Brugada syndrome,Cell adhesion,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Immunoglobulin domain,Ion channel,Ion transport,Membrane,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,Voltage-gated channel,	chain:Sodium channel subunit beta-1,disulfide bond,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000142583	solute carrier family 2 member 5(SLC2A5)	Homo sapiens				GO:0003044~regulation of systemic arterial blood pressure mediated by a chemical signal,GO:0005975~carbohydrate metabolic process,GO:0008643~carbohydrate transport,GO:0008645~hexose transport,GO:0009750~response to fructose,GO:0015755~fructose transport,GO:0015758~glucose transport,GO:0071332~cellular response to fructose stimulus,GO:1904659~glucose transmembrane transport,GO:1990539~fructose import across plasma membrane,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0042383~sarcolemma,GO:0070062~extracellular exosome,	GO:0005353~fructose transmembrane transporter activity,GO:0005355~glucose transmembrane transporter activity,GO:0022891~substrate-specific transmembrane transporter activity,GO:0070061~fructose binding,	IPR002442:Fructose transporter, type 5 (GLUT5),IPR003663:Sugar/inositol transporter,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa04973:Carbohydrate digestion and absorption,				3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Proteomics identification,Reference proteome,Sugar transport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 2, facilitated glucose transporter member 5,glycosylation site:N-linked (GlcNAc...),sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000254827	solute carrier family 22 member 18 antisense(SLC22A18AS)	Homo sapiens												Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein,sequence variant,splice variant,
ENSG00000259803	solute carrier family 22 member 31(SLC22A31)	Homo sapiens				GO:0015711~organic anion transport,GO:0055085~transmembrane transport,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0008514~organic anion transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR005828:General substrate transporter,IPR020846:Major facilitator superfamily domain,					Complete proteome,Ion transport,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Putative solute carrier family 22 member ENSG00000182157,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000125434	solute carrier family 25 member 35(SLC25A35)	Homo sapiens				GO:0006412~translation,GO:0006810~transport,	GO:0005743~mitochondrial inner membrane,GO:0016021~integral component of membrane,	GO:0003735~structural constituent of ribosome,	IPR018108:Mitochondrial substrate/solute carrier,IPR023395:Mitochondrial carrier domain,					Alternative splicing,Complete proteome,Membrane,Mitochondrion,Mitochondrion inner membrane,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 25 member 35,repeat:Solcar 1,repeat:Solcar 2,repeat:Solcar 3,sequence conflict,splice variant,transmembrane region,
ENSG00000080493	solute carrier family 4 member 4(SLC4A4)	Homo sapiens				GO:0006810~transport,GO:0006814~sodium ion transport,GO:0015698~inorganic anion transport,GO:0015701~bicarbonate transport,GO:0035725~sodium ion transmembrane transport,GO:0051453~regulation of intracellular pH,GO:0098656~anion transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0005452~inorganic anion exchanger activity,GO:0005515~protein binding,GO:0008510~sodium:bicarbonate symporter activity,	IPR003020:Bicarbonate transporter, eukaryotic,IPR003024:Sodium bicarbonate cotransporter,IPR011531:Bicarbonate transporter, C-terminal,IPR013769:Band 3 cytoplasmic domain,IPR016152:Phosphotransferase/anion transporter,	hsa04964:Proximal tubule bicarbonate reclamation,hsa04972:Pancreatic secretion,hsa04976:Bile secretion,	604278~Renal tubular acidosis, proximal, with ocular abnormalities,			Alternative splicing,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Ion transport,Membrane,Phosphoprotein,Reference proteome,Retinitis pigmentosa,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Electrogenic sodium bicarbonate cotransporter 1,compositionally biased region:Lys-rich,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:CA2-binding,region of interest:Interaction with CA4,region of interest:Required for basolateral targeting,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000158715	solute carrier family 45 member 3(SLC45A3)	Homo sapiens				GO:0010907~positive regulation of glucose metabolic process,GO:0015770~sucrose transport,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0048713~regulation of oligodendrocyte differentiation,GO:0055085~transmembrane transport,	GO:0016021~integral component of membrane,	GO:0008506~sucrose:proton symporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,	hsa05202:Transcriptional misregulation in cancer,hsa05206:MicroRNAs in cancer,				Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 45 member 3,compositionally biased region:Poly-Pro,transmembrane region,
ENSG00000092068	solute carrier family 7 member 8(SLC7A8)	Homo sapiens				GO:0006520~cellular amino acid metabolic process,GO:0006810~transport,GO:0006865~amino acid transport,GO:0009636~response to toxic substance,GO:0015695~organic cation transport,GO:0015804~neutral amino acid transport,GO:0015807~L-amino acid transport,GO:0050900~leukocyte migration,GO:0055065~metal ion homeostasis,GO:1901998~toxin transport,GO:1902475~L-alpha-amino acid transmembrane transport,	GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0015101~organic cation transmembrane transporter activity,GO:0015171~amino acid transmembrane transporter activity,GO:0015175~neutral amino acid transmembrane transporter activity,GO:0015179~L-amino acid transmembrane transporter activity,GO:0015297~antiporter activity,GO:0019534~toxin transporter activity,GO:0042605~peptide antigen binding,	IPR002293:Amino acid/polyamine transporter I,IPR004760:L-type amino acid transporter,	hsa04974:Protein digestion and absorption,		PIRSF006060:amino acid transporter,		Alternative splicing,Amino-acid transport,Cell membrane,Complete proteome,Cytoplasm,Disulfide bond,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,Transport,	chain:Large neutral amino acids transporter small subunit 2,sequence conflict,transmembrane region,
ENSG00000184985	sortilin related VPS10 domain containing receptor 2(SORCS2)	Homo sapiens				GO:0007218~neuropeptide signaling pathway,	GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0008188~neuropeptide receptor activity,	IPR000601:PKD domain,IPR006581:VPS10,IPR022409:PKD/Chitinase domain,				SM00089:PKD,SM00602:VPS10,	3D-structure,Complete proteome,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,	chain:VPS10 domain-containing receptor SorCS2,compositionally biased region:Pro-rich,domain:PKD,glycosylation site:N-linked (GlcNAc...),helix,repeat:BNR 1,repeat:BNR 2,repeat:BNR 3,repeat:BNR 4,repeat:BNR 5,repeat:BNR 6,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
ENSG00000187808	sosondowah ankyrin repeat domain family member D(SOWAHD)	Homo sapiens							IPR002110:Ankyrin repeat,IPR020683:Ankyrin repeat-containing domain,				SM00248:ANK,	ANK repeat,Complete proteome,Polymorphism,Reference proteome,Repeat,	chain:Ankyrin repeat domain-containing protein 58,repeat:ANK 1,repeat:ANK 2,repeat:ANK 3,sequence variant,
ENSG00000258484	sperm equatorial segment protein 1(SPESP1)	Homo sapiens				GO:0007275~multicellular organism development,GO:0007340~acrosome reaction,GO:0007342~fusion of sperm to egg plasma membrane,	GO:0001669~acrosomal vesicle,		IPR026743:Sperm equatorial segment protein 1,					Complete proteome,Cytoplasmic vesicle,Developmental protein,Direct protein sequencing,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:Sperm equatorial segment protein 1,compositionally biased region:Poly-Ala,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
ENSG00000160284	spermatogenesis and centriole associated 1-like(SPATC1L)	Homo sapiens					GO:0005813~centrosome,	GO:0005515~protein binding,	IPR026715:Speriolin,					Alternative splicing,Complete proteome,Phosphoprotein,Polymorphism,Reference proteome,	chain:Uncharacterized protein C21orf56,compositionally biased region:Poly-Leu,sequence conflict,sequence variant,
ENSG00000134548	spexin hormone(SPX)	Homo sapiens				GO:0003084~positive regulation of systemic arterial blood pressure,GO:0010459~negative regulation of heart rate,GO:0032099~negative regulation of appetite,GO:0035814~negative regulation of renal sodium excretion,GO:0044539~long-chain fatty acid import,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051930~regulation of sensory perception of pain,	GO:0005615~extracellular space,GO:0030133~transport vesicle,	GO:0005184~neuropeptide hormone activity,GO:0031765~type 2 galanin receptor binding,GO:0031766~type 3 galanin receptor binding,						Amidation,Cleavage on pair of basic residues,Complete proteome,Cytoplasmic vesicle,Hormone,Reference proteome,Secreted,Signal,	modified residue,peptide:Spexin,signal peptide,
ENSG00000169682	sphingolipid transporter 1 (putative)(SPNS1)	Homo sapiens				GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0006869~lipid transport,GO:0040011~locomotion,GO:0055085~transmembrane transport,	GO:0005743~mitochondrial inner membrane,GO:0005765~lysosomal membrane,GO:0016021~integral component of membrane,GO:0031982~vesicle,	GO:0005515~protein binding,GO:0046624~sphingolipid transporter activity,	IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Acetylation,Alternative splicing,Complete proteome,Lipid transport,Membrane,Mitochondrion,Mitochondrion inner membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:Protein spinster homolog 1,modified residue,sequence variant,splice variant,transmembrane region,
ENSG00000180739	sphingosine-1-phosphate receptor 5(S1PR5)	Homo sapiens				GO:0003376~sphingosine-1-phosphate signaling pathway,GO:0045664~regulation of neuron differentiation,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0038036~sphingosine-1-phosphate receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR004061:Sphingosine 1-phosphate receptor,IPR005386:EDG-8 sphingosine 1-phosphate receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04071:Sphingolipid signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,				Alternative splicing,Cell membrane,Complete proteome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Sphingosine 1-phosphate receptor 5,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000162032	splA/ryanodine receptor domain and SOCS box containing 3(SPSB3)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0035556~intracellular signal transduction,	GO:0005622~intracellular,	GO:0005515~protein binding,	IPR001496:SOCS protein, C-terminal,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00449:SPRY,SM00969:SM00969,	Complete proteome,Polymorphism,Proteomics identification,Receptor,Reference proteome,	chain:SPRY domain-containing SOCS box protein 3,domain:B30.2/SPRY,domain:SOCS box,sequence conflict,sequence variant,
ENSG00000159674	spondin 2(SPON2)	Homo sapiens				GO:0002448~mast cell mediated immunity,GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0008228~opsonization,GO:0032755~positive regulation of interleukin-6 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0043152~induction of bacterial agglutination,GO:0045087~innate immune response,GO:0050832~defense response to fungus,GO:0051607~defense response to virus,GO:0060907~positive regulation of macrophage cytokine production,GO:0071222~cellular response to lipopolysaccharide,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0001530~lipopolysaccharide binding,GO:0003823~antigen binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR000884:Thrombospondin, type 1 repeat,IPR009465:Spondin, N-terminal,				SM00209:TSP1,	3D-structure,Calcium,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Extracellular matrix,Glycoprotein,Immunity,Innate immunity,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Spondin-2,disulfide bond,domain:Spondin,domain:TSP type-1,glycosylation site:C-linked (Man),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Divalent metal cation,mutagenesis site,sequence variant,signal peptide,site:Important for metal ion-dependent interaction with integrin,strand,turn,
ENSG00000164056	sprouty RTK signaling antagonist 1(SPRY1)	Homo sapiens		h_spryPathway:Sprouty regulation of tyrosine kinase signals,		GO:0000132~establishment of mitotic spindle orientation,GO:0001656~metanephros development,GO:0001657~ureteric bud development,GO:0001759~organ induction,GO:0008285~negative regulation of cell proliferation,GO:0034260~negative regulation of GTPase activity,GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway,GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway,GO:0043407~negative regulation of MAP kinase activity,GO:0046580~negative regulation of Ras protein signal transduction,GO:0051387~negative regulation of neurotrophin TRK receptor signaling pathway,GO:0060449~bud elongation involved in lung branching,GO:0070373~negative regulation of ERK1 and ERK2 cascade,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,	GO:0005515~protein binding,	IPR007875:Sprouty,					Acetylation,Complete proteome,Cytoplasm,Developmental protein,Membrane,Proteomics identification,Reference proteome,	chain:Protein sprouty homolog 1,compositionally biased region:Cys-rich,domain:SPR,modified residue,
ENSG00000198369	sprouty related EVH1 domain containing 2(SPRED2)	Homo sapiens				GO:0000188~inactivation of MAPK activity,GO:0007275~multicellular organism development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009966~regulation of signal transduction,GO:0010801~negative regulation of peptidyl-threonine phosphorylation,GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator,GO:0090311~regulation of protein deacetylation,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0030658~transport vesicle membrane,	GO:0005173~stem cell factor receptor binding,GO:0005515~protein binding,GO:0019901~protein kinase binding,GO:0030291~protein serine/threonine kinase inhibitor activity,	IPR000697:EVH1,IPR007875:Sprouty,IPR011993:Pleckstrin homology-like domain,IPR023337:c-Kit-binding domain,				SM00461:WH1,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Sprouty-related, EVH1 domain-containing protein 2,domain:KBD,domain:SPR,domain:WH1,helix,modified residue,sequence conflict,strand,
ENSG00000188659	stabilizer of axonemal microtubules 2(SAXO2)	Homo sapiens						GO:0008017~microtubule binding,						Alternative splicing,Complete proteome,Polymorphism,Reference proteome,	chain:Protein FAM154B,sequence variant,
ENSG00000167780	sterol O-acyltransferase 2(SOAT2)	Homo sapiens				GO:0008203~cholesterol metabolic process,GO:0010742~macrophage derived foam cell differentiation,GO:0030299~intestinal cholesterol absorption,GO:0033344~cholesterol efflux,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034435~cholesterol esterification,GO:0042632~cholesterol homeostasis,	GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005903~brush border,GO:0016021~integral component of membrane,	GO:0000062~fatty-acyl-CoA binding,GO:0008374~O-acyltransferase activity,GO:0015485~cholesterol binding,GO:0016746~transferase activity, transferring acyl groups,GO:0034736~cholesterol O-acyltransferase activity,	IPR004299:Membrane bound O-acyl transferase, MBOAT,IPR014371:Sterol O-acyltransferase, ACAT/DAG/ARE types,	hsa00100:Steroid biosynthesis,		PIRSF000439:sterol O-acyltransferase, ACAT/DAG/ARE types,PIRSF500230:sterol O-acyltransferase, ACAT type [Parent=PIRSF000439],		Acyltransferase,Alternative splicing,Cholesterol metabolism,Coiled coil,Complete proteome,Endoplasmic reticulum,Lipid metabolism,Membrane,Polymorphism,Proteomics identification,Reference proteome,Steroid metabolism,Sterol metabolism,Transferase,Transmembrane,Transmembrane helix,	chain:Sterol O-acyltransferase 2,sequence conflict,sequence variant,transmembrane region,
ENSG00000165730	storkhead box 1(STOX1)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007067~mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0010821~regulation of mitochondrion organization,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0048839~inner ear development,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051301~cell division,GO:0051881~regulation of mitochondrial membrane potential,GO:0051897~positive regulation of protein kinase B signaling,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0071500~cellular response to nitrosative stress,GO:1901858~regulation of mitochondrial DNA metabolic process,GO:1902882~regulation of response to oxidative stress,GO:1904031~positive regulation of cyclin-dependent protein kinase activity,GO:1904120~positive regulation of otic vesicle morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005938~cell cortex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0005515~protein binding,	IPR019391:Storkhead-box protein, winged-helix domain,		609404~Preeclampsia/eclampsia 4,			Activator,Alternative splicing,Cell cycle,Cell division,Complete proteome,Cytoplasm,Cytoskeleton,Disease mutation,DNA-binding,Mitosis,Nucleus,Polymorphism,Reference proteome,Transcription,Transcription regulation,	chain:Storkhead-box protein 1,sequence variant,splice variant,
ENSG00000185518	synaptic vesicle glycoprotein 2B(SV2B)	Homo sapiens				GO:0001504~neurotransmitter uptake,GO:0055085~transmembrane transport,	GO:0001669~acrosomal vesicle,GO:0005886~plasma membrane,GO:0008021~synaptic vesicle,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0030672~synaptic vesicle membrane,GO:0043005~neuron projection,	GO:0005515~protein binding,GO:0022857~transmembrane transporter activity,	IPR001646:Pentapeptide repeat,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,IPR022308:Synaptic vesicle protein SV2,	hsa04512:ECM-receptor interaction,				Alternative splicing,Cell junction,Complete proteome,Cytoplasmic vesicle,Glycoprotein,Membrane,Neurotransmitter transport,Phosphoprotein,Reference proteome,Synapse,Transmembrane,Transmembrane helix,Transport,	chain:Synaptic vesicle glycoprotein 2B,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000172554	syntrophin gamma 2(SNTG2)	Homo sapiens				GO:0007417~central nervous system development,	GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016013~syntrophin complex,GO:0042383~sarcolemma,	GO:0003779~actin binding,GO:0005198~structural molecule activity,GO:0030165~PDZ domain binding,GO:0097109~neuroligin family protein binding,	IPR001478:PDZ domain,IPR011993:Pleckstrin homology-like domain,IPR015482:Syntrophin,				SM00228:PDZ,	Actin-binding,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Cytoskeleton,Membrane,Polymorphism,Reference proteome,	chain:Gamma-2-syntrophin,compositionally biased region:Poly-Pro,domain:PDZ,domain:PH,sequence variant,
ENSG00000145335	synuclein alpha(SNCA)	Homo sapiens		h_parkinPathway:Role of Parkin in the Ubiquitin-Proteasomal Pathway,h_parkinsonsPathway:Alpha-synuclein and Parkin-mediated proteolysis in Parkinson's disease,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001774~microglial cell activation,GO:0001921~positive regulation of receptor recycling,GO:0001933~negative regulation of protein phosphorylation,GO:0001956~positive regulation of neurotransmitter secretion,GO:0006631~fatty acid metabolic process,GO:0006638~neutral lipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007006~mitochondrial membrane organization,GO:0007568~aging,GO:0008344~adult locomotory behavior,GO:0010040~response to iron(II) ion,GO:0010517~regulation of phospholipase activity,GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway,GO:0014048~regulation of glutamate secretion,GO:0014059~regulation of dopamine secretion,GO:0031115~negative regulation of microtubule polymerization,GO:0031623~receptor internalization,GO:0031648~protein destabilization,GO:0032026~response to magnesium ion,GO:0032410~negative regulation of transporter activity,GO:0032496~response to lipopolysaccharide,GO:0032769~negative regulation of monooxygenase activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0034341~response to interferon-gamma,GO:0034599~cellular response to oxidative stress,GO:0035067~negative regulation of histone acetylation,GO:0040012~regulation of locomotion,GO:0042416~dopamine biosynthetic process,GO:0042493~response to drug,GO:0042775~mitochondrial ATP synthesis coupled electron transport,GO:0043030~regulation of macrophage activation,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043206~extracellular fibril organization,GO:0043524~negative regulation of neuron apoptotic process,GO:0044267~cellular protein metabolic process,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045807~positive regulation of endocytosis,GO:0045920~negative regulation of exocytosis,GO:0045963~negative regulation of dopamine metabolic process,GO:0048148~behavioral response to cocaine,GO:0048169~regulation of long-term neuronal synaptic plasticity,GO:0048488~synaptic vesicle endocytosis,GO:0050808~synapse organization,GO:0050812~regulation of acyl-CoA biosynthetic process,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051583~dopamine uptake involved in synaptic transmission,GO:0051585~negative regulation of dopamine uptake involved in synaptic transmission,GO:0051612~negative regulation of serotonin uptake,GO:0051622~negative regulation of norepinephrine uptake,GO:0055074~calcium ion homeostasis,GO:0055114~oxidation-reduction process,GO:0060079~excitatory postsynaptic potential,GO:0060291~long-term synaptic potentiation,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0070495~negative regulation of thrombin receptor signaling pathway,GO:0070555~response to interleukin-1,GO:0071280~cellular response to copper ion,GO:0071872~cellular response to epinephrine stimulus,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:1901215~negative regulation of neuron death,GO:1902957~negative regulation of mitochondrial electron transport, NADH to ubiquinone,GO:1903284~positive regulation of glutathione peroxidase activity,GO:1903285~positive regulation of hydrogen peroxide catabolic process,GO:1903421~regulation of synaptic vesicle recycling,GO:1903426~regulation of reactive oxygen species biosynthetic process,GO:1904715~negative regulation of chaperone-mediated autophagy,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005640~nuclear outer membrane,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005747~mitochondrial respiratory chain complex I,GO:0005764~lysosome,GO:0005791~rough endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0008021~synaptic vesicle,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0016234~inclusion body,GO:0030054~cell junction,GO:0030424~axon,GO:0030426~growth cone,GO:0030659~cytoplasmic vesicle membrane,GO:0031092~platelet alpha granule membrane,GO:0043195~terminal bouton,GO:0043205~fibril,GO:0048471~perinuclear region of cytoplasm,GO:0098794~postsynapse,	GO:0000287~magnesium ion binding,GO:0005504~fatty acid binding,GO:0005507~copper ion binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008017~microtubule binding,GO:0008198~ferrous iron binding,GO:0008270~zinc ion binding,GO:0016491~oxidoreductase activity,GO:0019894~kinesin binding,GO:0019904~protein domain specific binding,GO:0030544~Hsp70 protein binding,GO:0042393~histone binding,GO:0042802~identical protein binding,GO:0043014~alpha-tubulin binding,GO:0043027~cysteine-type endopeptidase inhibitor activity involved in apoptotic process,GO:0043274~phospholipase binding,GO:0044212~transcription regulatory region DNA binding,GO:0045502~dynein binding,GO:0047485~protein N-terminus binding,GO:0048156~tau protein binding,GO:0048487~beta-tubulin binding,GO:0051219~phosphoprotein binding,GO:0060961~phospholipase D inhibitor activity,	IPR001058:Synuclein,IPR002460:Alpha-synuclein,	hsa05010:Alzheimer's disease,hsa05012:Parkinson's disease,	127750~Dementia, Lewy body,168601~Parkinson disease 1,605543~Parkinson disease 4,			3D-structure,Acetylation,Alternative splicing,Alzheimer disease,Amyloid,Cell junction,Complete proteome,Copper,Cytoplasm,Direct protein sequencing,Disease mutation,Membrane,Metal-binding,Neurodegeneration,Nucleus,Parkinson disease,Parkinsonism,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Secreted,Synapse,Ubl conjugation,	chain:Alpha-synuclein,helix,modified residue,mutagenesis site,region of interest:4 X 11 AA tandem repeats of [EGS]-K-T-K- [EQ]-[GQ]-V-X(4),repeat:1,repeat:2,repeat:3; approximate,repeat:4,sequence variant,splice variant,strand,turn,
ENSG00000141198	target of myb1 like 1 membrane trafficking protein(TOM1L1)	Homo sapiens				GO:0006886~intracellular protein transport,GO:0007165~signal transduction,GO:0031954~positive regulation of protein autophosphorylation,GO:0032147~activation of protein kinase activity,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0045839~negative regulation of mitotic nuclear division,GO:2000278~regulation of DNA biosynthetic process,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005764~lysosome,GO:0005768~endosome,GO:0005795~Golgi stack,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0017124~SH3 domain binding,GO:0019901~protein kinase binding,GO:0030276~clathrin binding,GO:0030295~protein kinase activator activity,GO:0043130~ubiquitin binding,	IPR002014:VHS,IPR004152:GAT,IPR008942:ENTH/VHS,IPR014645:Target of Myb protein 1,IPR027428:Taget of Myb1-like 1,			PIRSF036948:target of Myb protein 1,	SM00288:VHS,	3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Endosome,Golgi apparatus,Membrane,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,SH3-binding,Transport,	chain:TOM1-like protein 1,domain:GAT,domain:VHS,modified residue,region of interest:Interaction with GRB2,region of interest:Interaction with PIK3R1,sequence conflict,sequence variant,short sequence motif:SH2-binding,short sequence motif:SH3-binding,
ENSG00000164362	telomerase reverse transcriptase(TERT)	Homo sapiens		h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000723~telomere maintenance,GO:0001172~transcription, RNA-templated,GO:0006278~RNA-dependent DNA biosynthetic process,GO:0007004~telomere maintenance via telomerase,GO:0007005~mitochondrion organization,GO:0010629~negative regulation of gene expression,GO:0022616~DNA strand elongation,GO:0030177~positive regulation of Wnt signaling pathway,GO:0030422~production of siRNA involved in RNA interference,GO:0031647~regulation of protein stability,GO:0032092~positive regulation of protein binding,GO:0032774~RNA biosynthetic process,GO:0042635~positive regulation of hair cycle,GO:0043524~negative regulation of neuron apoptotic process,GO:0045766~positive regulation of angiogenesis,GO:0046326~positive regulation of glucose import,GO:0046686~response to cadmium ion,GO:0051000~positive regulation of nitric-oxide synthase activity,GO:0060253~negative regulation of glial cell proliferation,GO:0070200~establishment of protein localization to telomere,GO:0071456~cellular response to hypoxia,GO:0071897~DNA biosynthetic process,GO:0090399~replicative senescence,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,GO:1902895~positive regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:1903620~positive regulation of transdifferentiation,GO:1903704~negative regulation of production of siRNA involved in RNA interference,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:1904751~positive regulation of protein localization to nucleolus,GO:1904754~positive regulation of vascular associated smooth muscle cell migration,GO:1904837~beta-catenin-TCF complex assembly,GO:2000352~negative regulation of endothelial cell apoptotic process,GO:2000648~positive regulation of stem cell proliferation,GO:2000773~negative regulation of cellular senescence,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,	GO:0000333~telomerase catalytic core complex,GO:0000781~chromosome, telomeric region,GO:0000783~nuclear telomere cap complex,GO:0000784~nuclear chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005697~telomerase holoenzyme complex,GO:0005730~nucleolus,GO:0005886~plasma membrane,GO:0016605~PML body,GO:0031379~RNA-directed RNA polymerase complex,GO:0042645~mitochondrial nucleoid,GO:1990572~TERT-RMRP complex,	GO:0000049~tRNA binding,GO:0001223~transcription coactivator binding,GO:0003677~DNA binding,GO:0003720~telomerase activity,GO:0003721~telomerase RNA reverse transcriptase activity,GO:0003723~RNA binding,GO:0003964~RNA-directed DNA polymerase activity,GO:0003968~RNA-directed RNA polymerase activity,GO:0005515~protein binding,GO:0016779~nucleotidyltransferase activity,GO:0042162~telomeric DNA binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0070034~telomerase RNA binding,	IPR000477:Reverse transcriptase,IPR003545:Telomere reverse transcriptase,IPR021891:Telomerase ribonucleoprotein complex - RNA-binding domain,	hsa05166:HTLV-I infection,	601626~Leukemia, acute myeloid,613989~Dyskeratosis congenita, autosomal dominant 2,613989~Dyskeratosis congenita, autosomal recessive 4,614742~Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1,615134~Melanoma, cutaneous malignant, 9,		SM00975:SM00975,	3D-structure,Alternative splicing,Chromosome,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Dyskeratosis congenita,Magnesium,Metal-binding,Nucleotidyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ribonucleoprotein,RNA-directed DNA polymerase,Signal,Telomere,Transferase,Ubl conjugation,	chain:Telomerase reverse transcriptase,domain:Reverse transcriptase,modified residue,mutagenesis site,region of interest:CP motif,region of interest:CTE,region of interest:GQ motif,region of interest:Linker,region of interest:Primer grip sequence,region of interest:QFP motif,region of interest:Required for oligomerization,region of interest:Required for regulating specificity for telomeric DNA and for processivity for primer elongation,region of interest:RNA-interacting domain 1,region of interest:RNA-interacting domain 2,sequence conflict,sequence variant,site:Required for nucleotide incorporation and primer extension rate,site:Required for optimal binding of telomeric ssDNA and incorporation of nucleotides at the second position of the template,splice variant,
ENSG00000088992	tescalcin(TESC)	Homo sapiens			Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only,	GO:0006469~negative regulation of protein kinase activity,GO:0008285~negative regulation of cell proliferation,GO:0008584~male gonad development,GO:0010628~positive regulation of gene expression,GO:0030219~megakaryocyte differentiation,GO:0030854~positive regulation of granulocyte differentiation,GO:0032417~positive regulation of sodium:proton antiporter activity,GO:0033628~regulation of cell adhesion mediated by integrin,GO:0045654~positive regulation of megakaryocyte differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0050821~protein stabilization,GO:0051604~protein maturation,GO:0071300~cellular response to retinoic acid,GO:0072661~protein targeting to plasma membrane,	GO:0001726~ruffle,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0030027~lamellipodium,GO:0032587~ruffle membrane,	GO:0000287~magnesium ion binding,GO:0004860~protein kinase inhibitor activity,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019212~phosphatase inhibitor activity,GO:0042803~protein homodimerization activity,	IPR002048:EF-hand domain,IPR011992:EF-hand-like domain,IPR018247:EF-Hand 1, calcium-binding site,				SM00054:EFh,	Alternative splicing,Calcium,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Differentiation,Disulfide bond,Lipoprotein,Membrane,Metal-binding,Myristate,Nucleus,Protein kinase inhibitor,Protein transport,Proteomics identification,Reference proteome,Transport,	chain:Tescalcin,domain:EF-hand,lipid moiety-binding region:N-myristoyl glycine,splice variant,
ENSG00000126467	testis specific serine kinase substrate(TSKS)	Homo sapiens				GO:0010923~negative regulation of phosphatase activity,	GO:0001669~acrosomal vesicle,GO:0005814~centriole,	GO:0005515~protein binding,GO:0019901~protein kinase binding,						Alternative splicing,Complete proteome,Cytoplasm,Cytoskeleton,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Testis-specific serine kinase substrate,sequence conflict,sequence variant,splice variant,
ENSG00000156298	tetraspanin 7(TSPAN7)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0016032~viral process,	GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,		IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,IPR018503:Tetraspanin, conserved site,	hsa05202:Transcriptional misregulation in cancer,	300210~Mental retardation, X-linked 58,	PIRSF002419:tetraspanin,		Complete proteome,Disease mutation,Glycoprotein,Host-virus interaction,Membrane,Mental retardation,Reference proteome,Transmembrane,Transmembrane helix,	chain:Tetraspanin-7,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000144115	threonine synthase like 2(THNSL2)	Homo sapiens			Amino acid transport and metabolism,	GO:0009071~serine family amino acid catabolic process,GO:0009088~threonine biosynthetic process,GO:0016311~dephosphorylation,GO:0046360~2-oxobutyrate biosynthetic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0004795~threonine synthase activity,GO:0005125~cytokine activity,GO:0016829~lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0070905~serine binding,	IPR001926:Tryptophan synthase beta subunit-like PLP-dependent enzymes superfamily,IPR004450:Threonine synthase-like,					Alternative splicing,Complete proteome,Cytokine,Lyase,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Secreted,	chain:Threonine synthase-like 2,modified residue,sequence conflict,sequence variant,splice variant,
ENSG00000198846	thymocyte selection associated high mobility group box(TOX)	Homo sapiens			Chromatin structure and dynamics,		GO:0005634~nucleus,	GO:0003677~DNA binding,	IPR009071:High mobility group (HMG) box domain,				SM00398:HMG,	Complete proteome,DNA-binding,Nucleus,Polymorphism,Reference proteome,	chain:Thymocyte selection-associated high mobility group box protein TOX,compositionally biased region:Poly-Pro,DNA-binding region:HMG box,sequence conflict,short sequence motif:Nuclear localization signal,
ENSG00000003436	tissue factor pathway inhibitor(TFPI)	Homo sapiens		h_amiPathway:Acute Myocardial Infarction,h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway,		GO:0007596~blood coagulation,GO:0007598~blood coagulation, extrinsic pathway,GO:0010951~negative regulation of endopeptidase activity,GO:0032355~response to estradiol,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0031090~organelle membrane,GO:0031225~anchored component of membrane,	GO:0004866~endopeptidase inhibitor activity,GO:0004867~serine-type endopeptidase inhibitor activity,GO:0030414~peptidase inhibitor activity,	IPR002223:Proteinase inhibitor I2, Kunitz metazoa,IPR020901:Proteinase inhibitor I2, Kunitz, conserved site,	hsa04610:Complement and coagulation cascades,			SM00131:KU,	3D-structure,Alternative splicing,Blood coagulation,Complete proteome,Direct protein sequencing,Disulfide bond,Endoplasmic reticulum,Glycoprotein,GPI-anchor,Hemostasis,Lipoprotein,Membrane,Microsome,Polymorphism,Protease inhibitor,Proteomics identification,Reference proteome,Repeat,Secreted,Serine protease inhibitor,Signal,	chain:Tissue factor pathway inhibitor,disulfide bond,domain:BPTI/Kunitz inhibitor 1,domain:BPTI/Kunitz inhibitor 2,domain:BPTI/Kunitz inhibitor 3,glycosylation site:N-linked (GlcNAc...),glycosylation site:O-linked (GalNAc...),glycosylation site:O-linked (GalNAc...); partial,helix,mutagenesis site,sequence variant,signal peptide,site:Not glycosylated,site:Reactive bond,splice variant,strand,turn,
ENSG00000164342	toll like receptor 3(TLR3)	Homo sapiens		h_tollPathway:Toll-Like Receptor Pathway,	Function unknown,	GO:0002224~toll-like receptor signaling pathway,GO:0002282~microglial cell activation involved in immune response,GO:0002730~regulation of dendritic cell cytokine production,GO:0002756~MyD88-independent toll-like receptor signaling pathway,GO:0006954~inflammatory response,GO:0006972~hyperosmotic response,GO:0007165~signal transduction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0007252~I-kappaB phosphorylation,GO:0008584~male gonad development,GO:0009597~detection of virus,GO:0010628~positive regulation of gene expression,GO:0032722~positive regulation of chemokine production,GO:0032728~positive regulation of interferon-beta production,GO:0032735~positive regulation of interleukin-12 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034123~positive regulation of toll-like receptor signaling pathway,GO:0034128~negative regulation of MyD88-independent toll-like receptor signaling pathway,GO:0034138~toll-like receptor 3 signaling pathway,GO:0034346~positive regulation of type III interferon production,GO:0035458~cellular response to interferon-beta,GO:0035666~TRIF-dependent toll-like receptor signaling pathway,GO:0035690~cellular response to drug,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0042742~defense response to bacterium,GO:0043065~positive regulation of apoptotic process,GO:0043330~response to exogenous dsRNA,GO:0045078~positive regulation of interferon-gamma biosynthetic process,GO:0045080~positive regulation of chemokine biosynthetic process,GO:0045087~innate immune response,GO:0045356~positive regulation of interferon-alpha biosynthetic process,GO:0045359~positive regulation of interferon-beta biosynthetic process,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046330~positive regulation of JNK cascade,GO:0050729~positive regulation of inflammatory response,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:0070266~necroptotic process,GO:0071260~cellular response to mechanical stimulus,GO:0071346~cellular response to interferon-gamma,GO:0071360~cellular response to exogenous dsRNA,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:0097527~necroptotic signaling pathway,	GO:0000139~Golgi membrane,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005789~endoplasmic reticulum membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0036020~endolysosome membrane,	GO:0003725~double-stranded RNA binding,GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR000157:Toll/interleukin-1 receptor homology (TIR) domain,IPR000483:Cysteine-rich flanking region, C-terminal,IPR001611:Leucine-rich repeat,IPR003591:Leucine-rich repeat, typical subtype,IPR026906:Leucine rich repeat 5,IPR027173:Toll-like receptor 3,	hsa04620:Toll-like receptor signaling pathway,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05168:Herpes simplex infection,	609423~HIV1 infection, resistance to,Herpes simplex encephalitis, susceptibility to, 2 613002~Herpes simplex encephalitis, susceptibility to, 2 613002,		SM00082:LRRCT,SM00255:TIR,SM00369:LRR_TYP,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Endoplasmic reticulum,Endosome,Glycoprotein,Immunity,Inflammatory response,Innate immunity,Leucine-rich repeat,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,RNA-binding,Signal,Transmembrane,Transmembrane helix,	chain:Toll-like receptor 3,disulfide bond,domain:TIR,glycosylation site:N-linked (GlcNAc...),helix,modified residue,mutagenesis site,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 14,repeat:LRR 15,repeat:LRR 16,repeat:LRR 17,repeat:LRR 18,repeat:LRR 19,repeat:LRR 2,repeat:LRR 20,repeat:LRR 21,repeat:LRR 22,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,turn,
ENSG00000148737	transcription factor 7 like 2(TCF7L2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001568~blood vessel development,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007050~cell cycle arrest,GO:0007223~Wnt signaling pathway, calcium modulating pathway,GO:0008283~cell proliferation,GO:0009749~response to glucose,GO:0010909~positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0016055~Wnt signaling pathway,GO:0031016~pancreas development,GO:0032024~positive regulation of insulin secretion,GO:0032092~positive regulation of protein binding,GO:0032350~regulation of hormone metabolic process,GO:0042593~glucose homeostasis,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043570~maintenance of DNA repeat elements,GO:0044334~canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,GO:0045444~fat cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046827~positive regulation of protein export from nucleus,GO:0048625~myoblast fate commitment,GO:0048660~regulation of smooth muscle cell proliferation,GO:0051897~positive regulation of protein kinase B signaling,GO:0060070~canonical Wnt signaling pathway,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1904837~beta-catenin-TCF complex assembly,GO:2000675~negative regulation of type B pancreatic cell apoptotic process,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0016605~PML body,GO:0032993~protein-DNA complex,GO:0070369~beta-catenin-TCF7L2 complex,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001103~RNA polymerase II repressing transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008013~beta-catenin binding,GO:0008134~transcription factor binding,GO:0019901~protein kinase binding,GO:0035257~nuclear hormone receptor binding,GO:0043565~sequence-specific DNA binding,GO:0044212~transcription regulatory region DNA binding,GO:0045295~gamma-catenin binding,GO:0070016~armadillo repeat domain binding,	IPR009071:High mobility group (HMG) box domain,IPR013558:CTNNB1 binding, N-teminal,IPR024940:Transcription factor TCF/LEF,IPR027397:Catenin binding domain,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04520:Adherens junction,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,hsa05210:Colorectal cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05221:Acute myeloid leukemia,hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC),	125853~Diabetes mellitus, type 2, susceptibility to,		SM00398:HMG,	3D-structure,Activator,Alternative splicing,Complete proteome,Diabetes mellitus,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,Wnt signaling pathway,	chain:Transcription factor 7-like 2,compositionally biased region:Pro-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:HMG box,helix,mutagenesis site,region of interest:CTNNB1-binding,region of interest:Promoter-specific activation domain,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,
ENSG00000105967	transcription factor EC(TFEC)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0034605~cellular response to heat,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0046983~protein dimerization activity,	IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,IPR021802:Basic helix-loop-helix leucine zipper transcrition factor MiT/TFE,IPR024101:Transcription factor EC,				SM00353:HLH,	Activator,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Transcription factor EC,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,region of interest:Necessary for transcriptional transactivation,sequence variant,splice variant,
ENSG00000106327	transferrin receptor 2(TFR2)	Homo sapiens				GO:0006826~iron ion transport,GO:0006879~cellular iron ion homeostasis,GO:0006898~receptor-mediated endocytosis,GO:0006953~acute-phase response,GO:0010039~response to iron ion,GO:0033572~transferrin transport,GO:0045807~positive regulation of endocytosis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0055072~iron ion homeostasis,GO:0071281~cellular response to iron ion,GO:0090277~positive regulation of peptide hormone secretion,GO:0097460~ferrous iron import into cell,GO:1903319~positive regulation of protein maturation,	GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,GO:0031410~cytoplasmic vesicle,GO:1990712~HFE-transferrin receptor complex,	GO:0001948~glycoprotein binding,GO:0004998~transferrin receptor activity,GO:0005515~protein binding,GO:0039706~co-receptor binding,	IPR003137:Protease-associated domain, PA,IPR007365:Transferrin receptor-like, dimerisation domain,IPR007484:Peptidase M28,		604250~Hemochromatosis, type 3,			Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Transferrin receptor protein 2,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Endocytosis signal,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
ENSG00000140682	transforming growth factor beta 1 induced transcript 1(TGFB1I1)	Homo sapiens				GO:0006366~transcription from RNA polymerase II promoter,GO:0007155~cell adhesion,GO:0008285~negative regulation of cell proliferation,GO:0009408~response to heat,GO:0010718~positive regulation of epithelial to mesenchymal transition,GO:0016055~Wnt signaling pathway,GO:0030154~cell differentiation,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030579~ubiquitin-dependent SMAD protein catabolic process,GO:0045893~positive regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005925~focal adhesion,GO:0016363~nuclear matrix,GO:0031012~extracellular matrix,	GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0048495~Roundabout binding,GO:0050681~androgen receptor binding,GO:0070411~I-SMAD binding,	IPR001781:Zinc finger, LIM-type,IPR017305:Leupaxin,			PIRSF037881:leupaxin ,	SM00132:LIM,	Acetylation,Activator,Alternative splicing,Cell junction,Complete proteome,Cytoplasm,Cytoskeleton,Differentiation,LIM domain,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Wnt signaling pathway,Zinc,	chain:Transforming growth factor beta-1-induced transcript 1 protein,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:LIM zinc-binding 4,modified residue,mutagenesis site,region of interest:Interaction with PTK2,region of interest:Interaction with PTK2B,region of interest:Transcription activation,sequence conflict,sequence variant,short sequence motif:LD motif 1,short sequence motif:LD motif 2,short sequence motif:LD motif 3,short sequence motif:LD motif 4,splice variant,
ENSG00000184986	transmembrane protein 121(TMEM121)	Homo sapiens					GO:0016021~integral component of membrane,							Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 121,compositionally biased region:Pro-rich,transmembrane region,
ENSG00000164112	transmembrane protein 155(TMEM155)	Homo sapiens					GO:0005576~extracellular region,							Complete proteome,Polymorphism,Reference proteome,Secreted,Signal,	chain:Protein TMEM155,sequence variant,signal peptide,
ENSG00000206140	transmembrane protein 191C(TMEM191C)	Homo sapiens					GO:0016021~integral component of membrane,							Coiled coil,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Transmembrane protein 191B,transmembrane region,
ENSG00000173334	tribbles pseudokinase 1(TRIB1)	Homo sapiens				GO:0006468~protein phosphorylation,GO:0006469~negative regulation of protein kinase activity,GO:0007254~JNK cascade,GO:0014912~negative regulation of smooth muscle cell migration,GO:0031665~negative regulation of lipopolysaccharide-mediated signaling pathway,GO:0032436~positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032496~response to lipopolysaccharide,GO:0043405~regulation of MAP kinase activity,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045645~positive regulation of eosinophil differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045659~negative regulation of neutrophil differentiation,GO:0048662~negative regulation of smooth muscle cell proliferation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0004672~protein kinase activity,GO:0004860~protein kinase inhibitor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0055106~ubiquitin-protein transferase regulator activity,	IPR000719:Protein kinase, catalytic domain,IPR011009:Protein kinase-like domain,IPR024104:Pseudokinase tribbles family/serine-threonine-protein kinase 40,IPR024105:Pseudokinase tribbles, TRB1,				SM00220:S_TKc,	3D-structure,Alternative splicing,Complete proteome,Polymorphism,Protein kinase inhibitor,Proteomics identification,Reference proteome,	chain:Tribbles homolog 1,domain:Protein kinase,sequence conflict,sequence variant,
ENSG00000204616	tripartite motif containing 31(TRIM31)	Homo sapiens				GO:0016567~protein ubiquitination,GO:0032897~negative regulation of viral transcription,GO:0045087~innate immune response,GO:0046597~negative regulation of viral entry into host cell,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0060333~interferon-gamma-mediated signaling pathway,GO:1902186~regulation of viral release from host cell,	GO:0005622~intracellular,GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,IPR020457:Zinc finger, B-box, chordata,				SM00184:RING,SM00336:BBOX,	3D-structure,Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Ligase,Metal-binding,Mitochondrion,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:E3 ubiquitin-protein ligase TRIM31,helix,sequence conflict,sequence variant,splice variant,strand,turn,zinc finger region:B box-type,zinc finger region:RING-type,
ENSG00000163462	tripartite motif containing 46(TRIM46)	Homo sapiens					GO:0005622~intracellular,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003961:Fibronectin, type III,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR013783:Immunoglobulin-like fold,IPR017903:COS domain,IPR017907:Zinc finger, RING-type, conserved site,IPR027370:RING-type zinc-finger, LisH dimerisation motif,				SM00184:RING,SM00336:BBOX,	Alternative splicing,Coiled coil,Complete proteome,Metal-binding,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 46,domain:B30.2/SPRY,domain:COS,domain:Fibronectin type-III,sequence conflict,splice variant,zinc finger region:B box-type,zinc finger region:RING-type 1; degenerate,zinc finger region:RING-type 2; degenerate,
ENSG00000162722	tripartite motif containing 58(TRIM58)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005622~intracellular,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Coiled coil,Complete proteome,Ligase,Metal-binding,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 58,domain:B30.2/SPRY,sequence conflict,sequence variant,zinc finger region:B box-type,zinc finger region:RING-type,
ENSG00000183439	tripartite motif containing 61(TRIM61)	Homo sapiens					GO:0005622~intracellular,	GO:0008270~zinc ion binding,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,	Complete proteome,Metal-binding,Reference proteome,Zinc,Zinc-finger,	chain:Putative tripartite motif-containing protein 61,zinc finger region:B box-type,zinc finger region:RING-type,
ENSG00000166340	tripeptidyl peptidase 1(TPP1)	Homo sapiens			Posttranslational modification, protein turnover, chaperones,	GO:0006508~proteolysis,GO:0006629~lipid metabolic process,GO:0007040~lysosome organization,GO:0007399~nervous system development,GO:0007417~central nervous system development,GO:0030163~protein catabolic process,GO:0030855~epithelial cell differentiation,GO:0036498~IRE1-mediated unfolded protein response,GO:0043171~peptide catabolic process,GO:0045453~bone resorption,GO:0050885~neuromuscular process controlling balance,	GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0042470~melanosome,GO:0043202~lysosomal lumen,GO:0070062~extracellular exosome,	GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008233~peptidase activity,GO:0008236~serine-type peptidase activity,GO:0008240~tripeptidyl-peptidase activity,GO:0042277~peptide binding,GO:0046872~metal ion binding,	IPR000209:Peptidase S8/S53 domain,IPR009020:Proteinase inhibitor, propeptide,IPR015366:Peptidase S53, propeptide,	hsa04142:Lysosome,	204500~Ceroid lipofuscinosis, neuronal, 2,609270~Spinocerebellar ataxia, autosomal recessive 7,		SM00944:SM00944,	3D-structure,Alternative splicing,Autocatalytic cleavage,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Hydrolase,Lysosome,Metal-binding,Neurodegeneration,Neuronal ceroid lipofuscinosis,Polymorphism,Protease,Proteomics identification,Reference proteome,Serine protease,Signal,Spinocerebellar ataxia,Zymogen,	active site:Charge relay system,chain:Tripeptidyl-peptidase 1,glycosylation site:N-linked (GlcNAc...),helix,mutagenesis site,propeptide:Removed in mature form,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
ENSG00000205133	triple QxxK/R motif containing(TRIQK)	Homo sapiens					GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,		IPR024842:Triple repetitive-sequence of QXXK/R protein,					Complete proteome,Endoplasmic reticulum,Membrane,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	chain:UPF0599 protein C8orf83,transmembrane region,
ENSG00000104804	tubby like protein 2(TULP2)	Homo sapiens				GO:0007601~visual perception,GO:0097500~receptor localization to nonmotile primary cilium,GO:1903546~protein localization to photoreceptor outer segment,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005929~cilium,	GO:0032403~protein complex binding,GO:0035091~phosphatidylinositol binding,	IPR000007:Tubby, C-terminal,IPR005398:Tubby, N-terminal,IPR018066:Tubby, C-terminal, conserved site,IPR025659:Tubby C-terminal-like domain,					Coiled coil,Complete proteome,Cytoplasm,Phosphoprotein,Polymorphism,Reference proteome,Secreted,	chain:Tubby-related protein 2,sequence conflict,sequence variant,
ENSG00000104833	tubulin beta 4A class IVa(TUBB4A)	Homo sapiens				GO:0000086~G2/M transition of mitotic cell cycle,GO:0007010~cytoskeleton organization,GO:0007017~microtubule-based process,	GO:0005634~nucleus,GO:0005829~cytosol,GO:0005874~microtubule,GO:0005929~cilium,GO:0033269~internode region of axon,GO:0043025~neuronal cell body,GO:0043209~myelin sheath,GO:0070062~extracellular exosome,	GO:0003924~GTPase activity,GO:0005200~structural constituent of cytoskeleton,GO:0005515~protein binding,GO:0005525~GTP binding,	IPR000217:Tubulin,IPR002453:Beta tubulin,IPR003008:Tubulin/FtsZ, GTPase domain,IPR004057:Epsilon tubulin,IPR008280:Tubulin/FtsZ, C-terminal,IPR013838:Beta tubulin, autoregulation binding site,IPR017975:Tubulin, conserved site,IPR018316:Tubulin/FtsZ, 2-layer sandwich domain,IPR023123:Tubulin, C-terminal,	hsa04145:Phagosome,hsa04540:Gap junction,hsa05130:Pathogenic Escherichia coli infection,	128101~Dystonia 4, torsion, autosomal dominant,612438~Leukodystrophy, hypomyelinating, 6,		SM00864:SM00864,SM00865:SM00865,	Complete proteome,Cytoplasm,Cytoskeleton,Direct protein sequencing,Disease mutation,Dystonia,GTP-binding,Isopeptide bond,Leukodystrophy,Microtubule,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Tubulin beta-4 chain,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
ENSG00000162571	tubulin tyrosine ligase like 10(TTLL10)	Homo sapiens				GO:0006464~cellular protein modification process,GO:0018094~protein polyglycylation,		GO:0005515~protein binding,GO:0005524~ATP binding,GO:0070735~protein-glycine ligase activity,	IPR004344:Tubulin-tyrosine ligase,					Alternative splicing,ATP-binding,Complete proteome,Nucleotide-binding,Polymorphism,Reference proteome,	chain:Inactive polyglycylase TTLL10,compositionally biased region:Pro-rich,domain:TTL,mutagenesis site,sequence conflict,sequence variant,splice variant,
ENSG00000173809	tudor domain containing 12(TDRD12)	Homo sapiens				GO:0007140~male meiosis,GO:0007275~multicellular organism development,GO:0007283~spermatogenesis,GO:0009566~fertilization,GO:0010501~RNA secondary structure unwinding,GO:0030154~cell differentiation,GO:0031047~gene silencing by RNA,GO:0034587~piRNA metabolic process,GO:0043046~DNA methylation involved in gamete generation,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:1990923~PET complex,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0005524~ATP binding,	IPR002999:Tudor domain,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,ATP-binding,Complete proteome,Developmental protein,Differentiation,Helicase,Hydrolase,Meiosis,Nucleotide-binding,Proteomics identification,Reference proteome,Repeat,RNA-mediated gene silencing,Spermatogenesis,	chain:Tudor domain-containing protein 12,domain:Tudor,sequence conflict,splice variant,
ENSG00000188001	tumor protein p63 regulated 1(TPRG1)	Homo sapiens					GO:0005737~cytoplasm,		IPR022158:Inositol phosphatase,					Complete proteome,Proteomics identification,Reference proteome,	chain:Tumor protein p63-regulated gene 1 protein,
ENSG00000187186	uncharacterized LOC730098(LOC730098)	Homo sapiens												Complete proteome,Reference proteome,
ENSG00000112715	vascular endothelial growth factor A(VEGFA)	Homo sapiens		h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System,h_no1Pathway:Actions of Nitric Oxide in the Heart,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001525~angiogenesis,GO:0001541~ovarian follicle development,GO:0001569~patterning of blood vessels,GO:0001570~vasculogenesis,GO:0001666~response to hypoxia,GO:0001701~in utero embryonic development,GO:0001822~kidney development,GO:0001934~positive regulation of protein phosphorylation,GO:0001938~positive regulation of endothelial cell proliferation,GO:0002042~cell migration involved in sprouting angiogenesis,GO:0002052~positive regulation of neuroblast proliferation,GO:0002053~positive regulation of mesenchymal cell proliferation,GO:0002092~positive regulation of receptor internalization,GO:0002575~basophil chemotaxis,GO:0002576~platelet degranulation,GO:0002687~positive regulation of leukocyte migration,GO:0003007~heart morphogenesis,GO:0003151~outflow tract morphogenesis,GO:0003169~coronary vein morphogenesis,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007399~nervous system development,GO:0007498~mesoderm development,GO:0007595~lactation,GO:0008284~positive regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0010595~positive regulation of endothelial cell migration,GO:0010628~positive regulation of gene expression,GO:0030224~monocyte differentiation,GO:0030225~macrophage differentiation,GO:0030324~lung development,GO:0030335~positive regulation of cell migration,GO:0030823~regulation of cGMP metabolic process,GO:0030855~epithelial cell differentiation,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031077~post-embryonic camera-type eye development,GO:0031334~positive regulation of protein complex assembly,GO:0031954~positive regulation of protein autophosphorylation,GO:0032147~activation of protein kinase activity,GO:0032793~positive regulation of CREB transcription factor activity,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035148~tube formation,GO:0035767~endothelial cell chemotaxis,GO:0035924~cellular response to vascular endothelial growth factor stimulus,GO:0036303~lymph vessel morphogenesis,GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,GO:0038084~vascular endothelial growth factor signaling pathway,GO:0038091~positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,GO:0038190~VEGF-activated neuropilin signaling pathway,GO:0040007~growth,GO:0042462~eye photoreceptor cell development,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0043066~negative regulation of apoptotic process,GO:0043117~positive regulation of vascular permeability,GO:0043129~surfactant homeostasis,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043406~positive regulation of MAP kinase activity,GO:0043536~positive regulation of blood vessel endothelial cell migration,GO:0045766~positive regulation of angiogenesis,GO:0045785~positive regulation of cell adhesion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048469~cell maturation,GO:0048593~camera-type eye morphogenesis,GO:0048739~cardiac muscle fiber development,GO:0048754~branching morphogenesis of an epithelial tube,GO:0048842~positive regulation of axon extension involved in axon guidance,GO:0048844~artery morphogenesis,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050918~positive chemotaxis,GO:0050927~positive regulation of positive chemotaxis,GO:0050930~induction of positive chemotaxis,GO:0051272~positive regulation of cellular component movement,GO:0051781~positive regulation of cell division,GO:0051894~positive regulation of focal adhesion assembly,GO:0060319~primitive erythrocyte differentiation,GO:0060749~mammary gland alveolus development,GO:0060754~positive regulation of mast cell chemotaxis,GO:0060948~cardiac vascular smooth muscle cell development,GO:0060982~coronary artery morphogenesis,GO:0061418~regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0061419~positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071456~cellular response to hypoxia,GO:0071542~dopaminergic neuron differentiation,GO:0071679~commissural neuron axon guidance,GO:0090037~positive regulation of protein kinase C signaling,GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0090259~regulation of retinal ganglion cell axon guidance,GO:1900086~positive regulation of peptidyl-tyrosine autophosphorylation,GO:1900745~positive regulation of p38MAPK cascade,GO:1901727~positive regulation of histone deacetylase activity,GO:1902336~positive regulation of retinal ganglion cell axon guidance,GO:1902966~positive regulation of protein localization to early endosome,GO:1903572~positive regulation of protein kinase D signaling,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0016020~membrane,GO:0030141~secretory granule,GO:0031093~platelet alpha granule lumen,	GO:0001968~fibronectin binding,GO:0005125~cytokine activity,GO:0005161~platelet-derived growth factor receptor binding,GO:0005172~vascular endothelial growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0008201~heparin binding,GO:0038191~neuropilin binding,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043183~vascular endothelial growth factor receptor 1 binding,GO:0043184~vascular endothelial growth factor receptor 2 binding,GO:0046982~protein heterodimerization activity,GO:0048018~receptor agonist activity,GO:0050840~extracellular matrix binding,	IPR000072:Platelet-derived growth factor (PDGF),IPR023581:Platelet-derived growth factor, conserved site,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04066:HIF-1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04370:VEGF signaling pathway,hsa04510:Focal adhesion,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05219:Bladder cancer,hsa05323:Rheumatoid arthritis,	603933~Microvascular complications of diabetes 1,		SM00141:PDGF,	3D-structure,Alternative initiation,Alternative promoter usage,Alternative splicing,Angiogenesis,Complete proteome,Developmental protein,Differentiation,Direct protein sequencing,Disulfide bond,Glycoprotein,Growth factor,Heparin-binding,Mitogen,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Vascular endothelial growth factor A,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,signal peptide,splice variant,strand,turn,
ENSG00000095397	whirlin(WHRN)	Homo sapiens				GO:0001895~retina homeostasis,GO:0007605~sensory perception of sound,GO:0010628~positive regulation of gene expression,GO:0021694~cerebellar Purkinje cell layer formation,GO:0045184~establishment of protein localization,GO:0050953~sensory perception of light stimulus,GO:0060122~inner ear receptor stereocilium organization,GO:1990227~paranodal junction maintenance,	GO:0001917~photoreceptor inner segment,GO:0002142~stereocilia ankle link complex,GO:0005737~cytoplasm,GO:0005884~actin filament,GO:0030426~growth cone,GO:0032391~photoreceptor connecting cilium,GO:0032420~stereocilium,GO:0032426~stereocilium tip,GO:0036064~ciliary basal body,GO:1990075~periciliary membrane compartment,GO:1990696~USH2 complex,	GO:0005515~protein binding,	IPR001478:PDZ domain,		607084~Deafness, autosomal recessive 31,611383~Usher syndrome, type 2D,		SM00228:PDZ,	3D-structure,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,Deafness,Hearing,Non-syndromic deafness,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Retinitis pigmentosa,Signal,Usher syndrome,	chain:Whirlin,compositionally biased region:Ala/Gly/Ser-rich,compositionally biased region:Pro-rich,domain:PDZ 1,domain:PDZ 2,domain:PDZ 3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
ENSG00000132846	zinc finger BED-type containing 3(ZBED3)	Homo sapiens				GO:0001933~negative regulation of protein phosphorylation,GO:0016055~Wnt signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050821~protein stabilization,GO:0090263~positive regulation of canonical Wnt signaling pathway,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005829~cytosol,GO:0016020~membrane,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR003656:Zinc finger, BED-type predicted,				SM00614:ZnF_BED,	Coiled coil,Complete proteome,Cytoplasm,Membrane,Metal-binding,Proteomics identification,Reference proteome,Wnt signaling pathway,Zinc,Zinc-finger,	chain:Zinc finger BED domain-containing protein 3,compositionally biased region:Arg-rich,modified residue,zinc finger region:BED-type,
ENSG00000175048	zinc finger DHHC-type containing 14(ZDHHC14)	Homo sapiens			General function prediction only,	GO:0018345~protein palmitoylation,	GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,	GO:0008270~zinc ion binding,GO:0016409~palmitoyltransferase activity,GO:0016740~transferase activity,GO:0019706~protein-cysteine S-palmitoyltransferase activity,	IPR001594:Zinc finger, DHHC-type, palmitoyltransferase,					Acyltransferase,Alternative splicing,Complete proteome,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transferase,Transmembrane,Transmembrane helix,	active site:S-palmitoyl cysteine intermediate,chain:Probable palmitoyltransferase ZDHHC14,modified residue,sequence variant,splice variant,transmembrane region,zinc finger region:DHHC-type,
ENSG00000169554	zinc finger E-box binding homeobox 2(ZEB2)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007399~nervous system development,GO:0045636~positive regulation of melanocyte differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048023~positive regulation of melanin biosynthetic process,GO:0048066~developmental pigmentation,GO:0050790~regulation of catalytic activity,GO:0097324~melanocyte migration,GO:1903056~regulation of melanosome organization,	GO:0005634~nucleus,	GO:0001227~transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0005515~protein binding,GO:0019208~phosphatase regulator activity,GO:0046872~metal ion binding,	IPR001356:Homeodomain,IPR007087:Zinc finger, C2H2,IPR008598:Drought induced 19/ RING finger protein 114,IPR009057:Homeodomain-like,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,	hsa05206:MicroRNAs in cancer,	235730~Mowat-Wilson syndrome,		SM00355:ZnF_C2H2,SM00389:HOX,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Disease mutation,DNA-binding,Epilepsy,Hirschsprung disease,Homeobox,Isopeptide bond,Mental retardation,Metal-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger E-box-binding homeobox 2,compositionally biased region:Glu-rich (acidic),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Homeobox; atypical,helix,modified residue,region of interest:SMAD-MH2 binding domain,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4; atypical,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7; atypical,
ENSG00000141497	zinc finger MYND-type containing 15(ZMYND15)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0007286~spermatid development,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0042826~histone deacetylase binding,GO:0046872~metal ion binding,	IPR002893:Zinc finger, MYND-type,		615842~Spermatogenic failure 14,			Alternative splicing,Complete proteome,Cytoplasm,Differentiation,Metal-binding,Nucleus,Polymorphism,Reference proteome,Spermatogenesis,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger MYND domain-containing protein 15,compositionally biased region:Glu-rich,compositionally biased region:Pro-rich,sequence variant,zinc finger region:MYND-type,
ENSG00000105278	zinc finger RNA binding protein 2(ZFR2)	Homo sapiens						GO:0003676~nucleic acid binding,GO:0008270~zinc ion binding,	IPR003604:Zinc finger, U1-type,IPR006561:DZF,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,SM00572:DZF,	Alternative splicing,Coiled coil,Complete proteome,Polymorphism,Reference proteome,	chain:Zinc finger RNA-binding protein 2,compositionally biased region:Pro-rich,domain:DZF,sequence conflict,sequence variant,
ENSG00000137185	zinc finger and SCAN domain containing 9(ZSCAN9)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 193,domain:SCAN box,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
ENSG00000170684	zinc finger protein 296(ZNF296)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0007283~spermatogenesis,	GO:0005634~nucleus,	GO:0001076~transcription factor activity, RNA polymerase II transcription factor binding,GO:0003676~nucleic acid binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 296,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ENSG00000198185	zinc finger protein 334(ZNF334)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 334,domain:KRAB,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000161642	zinc finger protein 385A(ZNF385A)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007599~hemostasis,GO:0007611~learning or memory,GO:0007626~locomotory behavior,GO:0010609~mRNA localization resulting in posttranscriptional regulation of gene expression,GO:0030220~platelet formation,GO:0035855~megakaryocyte development,GO:0045600~positive regulation of fat cell differentiation,GO:0070889~platelet alpha granule organization,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902164~positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:2000765~regulation of cytoplasmic translation,	GO:0000790~nuclear chromatin,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0002039~p53 binding,GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003730~mRNA 3'-UTR binding,GO:0008270~zinc ion binding,GO:0044822~poly(A) RNA binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00451:ZnF_U1,	Alternative initiation,Alternative splicing,Cell projection,Complete proteome,Cytoplasm,DNA damage,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,RNA-binding,Transcription,Transcription regulation,Translation regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Zinc finger protein 385A,splice variant,zinc finger region:Matrin-type 1,zinc finger region:Matrin-type 2,zinc finger region:Matrin-type 3,
ENSG00000186496	zinc finger protein 396(ZNF396)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0042552~myelination,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 396,domain:SCAN box,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,
ENSG00000170954	zinc finger protein 415(ZNF415)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0015630~microtubule cytoskeleton,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003656:Zinc finger, BED-type predicted,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,SM00614:ZnF_BED,	Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Metal-binding,Nucleus,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 415,sequence variant,splice variant,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 1; degenerate,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000181444	zinc finger protein 467(ZNF467)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 467,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000198633	zinc finger protein 534(ZNF534)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 528,domain:KRAB,sequence conflict,sequence variant,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000176472	zinc finger protein 575(ZNF575)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 575,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
ENSG00000142684	zinc finger protein 593(ZNF593)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,	GO:0003677~DNA binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0046872~metal ion binding,	IPR003604:Zinc finger, U1-type,IPR007087:Zinc finger, C2H2,IPR022755:Zinc finger, double-stranded RNA binding,				SM00451:ZnF_U1,	3D-structure,Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 593,helix,sequence variant,strand,turn,zinc finger region:C2H2-type,
ENSG00000157657	zinc finger protein 618(ZNF618)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR012337:Ribonuclease H-like domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Alternative splicing,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-fingerFT                                GMGVGGPGTGWASRW,	chain:Zinc finger protein 618,modified residue,sequence conflict,splice variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,
ENSG00000198046	zinc finger protein 667(ZNF667)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005622~intracellular,GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00349:KRAB,SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 667,domain:KRAB,sequence conflict,sequence variant,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 10,zinc finger region:C2H2-type 11,zinc finger region:C2H2-type 12,zinc finger region:C2H2-type 13,zinc finger region:C2H2-type 14,zinc finger region:C2H2-type 15,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5; degenerate,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7,zinc finger region:C2H2-type 8,zinc finger region:C2H2-type 9,
ENSG00000261221	zinc finger protein 865(ZNF865)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,	GO:0005634~nucleus,	GO:0003676~nucleic acid binding,GO:0003677~DNA binding,GO:0003712~transcription cofactor activity,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Complete proteome,DNA-binding,Metal-binding,Nucleus,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,
